Download ESC Congress 2011 - Final Programme - Tuesday

TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | London - Zone A
THE GREAT DEBATE – LEFT MAIN IN 2011: CABG OR PCI?
Chairperson(s): G. Wimmer-Greinecker (Bad Bevensen, DE)
In collaboration with EuroPCR - EAPCI
Focus Imaging Intervention
Panel for the great debate.
– A. Erglis (Riga, LV), V. Falk (Zurich, CH), D. Hildick-Smith (Brighton, GB), M.C. Morice (Massy, FR),
D. Taggart (Oxford, GB), L. Torracca (Ancona, IT)
3667
08:30-10:00 | The Hague - Zone A
CHALLENGING ISSUES IN PRIMARY PREVENTION
Chairperson(s): P. Giannuzzi (Veruno, IT); L. Tokgozoglu (Ankara, TR)
Focus Cardiology Practice
16 year old obese male: focusing on prevention in young adult.
50 year old male with high risk score: focusing on global risk modification.
Elderly man: focusing on whether prevention is worthy in elderly.
Panel.
– I. Daullxhiu (Prishtina, KS), S. Gielen (Leipzig, DE), J.W. Jukema (Leiden, NL), D. Milicic (Zagreb, HR)
3668
08:30-10:00 | Rabat - Zone A (QR 508*)
EMERGING BIOLOGICAL MECHANISMS OF CARDIOMYOPATHIES
Chairperson(s): B. Crozatier (Chatenay-Malabry, FR); M. Piper (Dusseldorf, DE)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
Spontaneous cardiac hypertrophy and adverse LV remodelling in a novel human relevant mouse
model of diabetes; a mechanistic insight.
– S. Gibbons, Z. Hegab, M. Zi, S. Prehar, T.M.A. Mohamed, R. Cox, E.J. Cartwright, L. Neyses, M.A. Mamas
(Manchester and Oxford, GB)
Dishevelled-induced cardiomyopathy is rescued by deletion of CaMKII.
– M. Zhang, M. Hagenmueller, P. Malekar, J. Riffel, C. Weiss, M. Ochs, J. Backs, S.E. Hardt, H.A. Katus
(Heidelberg, DE)
Matrix metalloproteinase inhibitors enhance hypertrophic growth and reduce apoptosis in
ventricular cardiomyocytes of rats.
– G. Euler, Y. Osygus, C. Sprejz, J. Heger (Giessen, DE)
Real-time imaging of cAMP dynamics in an in vitro model of cardiac hypertrophy.
– A. Zoccarato, M. Zaccolo (Glasgow, GB)
Dyxin mediates cardiac hypertrophic response during angiotensin II -induced hypertension.
– T. Karvonen, A.-M. Moilanen, E. Mustonen, J. Aro, H. Ruskoaho, J. Rysa (Oulu, FI)
Protein kinase A -mediated stimulation of activating transcription factor 3 by hypertrophic stimuli
in cardiomyocytes.
– E. Koivisto, A.-M. Moilanen, H. Tokola, J. Aro, H. Pennanen, H. Sakkinen, L. Kaikkonen, H. Ruskoaho,
J. Rysa (Oulu, FI)
3669
3670
3671
3672
3673
3674
08:30-10:00 | Stockholm - Zone A (QR 518*)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
Distinct entity of heart failure in the very elderly as compared with younger based on swedish
national heart failure registry.
– A. Holmstrom, L. Ma, R. Sigurjonsdottir, M. Edner, Å. Jonsson, U.G. Dahlstrom, M. Fu (Gothenburg, SE)
Differential expression of collagen turn-over markers in heart failure patients with preserved and
reduced ejection fraction.
– J.-M. Lin, J.-L. Ro, C.-T. Tsai, L.-P. Lai, J.-L. Lin (Keelung and Taipei, TW)
Diastolic heart failure and reduction in global longitudinal strain: a study with strain imaging and
NT-pro-BNP level in patients with rheumatoid arthritis.
– D. Ridjab, T. Schau, M. Zaenker, C. Butter (Bernau bei Berlin, DE)
Comparison between Framingham risk profile and NT-proBNP for predicting asymptomatic left
ventricular dysfunction in a population at high cardiovascular risk (DAVID-Berg study).
– A. Fontana, A. Grosu, S. Guideri, M. Gori, A. Iacovoni, P. Ferrari, A. Filippi, R. De Maria, M. Senni,
A. Gavazzi (Bergamo and Milan, IT)
Inflammation and left ventricular diastolic dysfunction.
– C.-K. Wu, J.-K. Lee, C.-T. Tsai, J.-J. Hwang, F.-T. Chiang (Taipei, TW)
GDF-15 levels but not NTproBNP levels predict diastolic heart failure in morbid obesity.
– M. Fischer, C. Strack, J. Bruxmeier, F. Wagner, E. Rousseva, G. Schmitz, G. Riegger, A. Baessler
(Regensburg, DE)
*Abstracts can
be accessed at:
QR 508
TUESDAY – MORNING
DISSECTING DIASTOLIC DYSFUNCTION FOR THE CLINICIAN
Chairperson(s): C. Tschoepe (Berlin, DE); P. de Groote (Lille, FR)
3675
3676 (W)
3677
3678
3679
3680
QR 518
225
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Tel Aviv - Zone A
INSULIN RESISTANCE OF THE FAILING HEART
Chairperson(s): S. Chlopicki (Krakow, PL); D.J. Hausenloy (London, GB)
08:30
08:52
09:15
09:37
Clinical Seminar
Mitochondrial reactive oxygen species.
– C. Maack (Homburg/Saar, DE)
Redox regulation in calcium and sodium handling.
– S. Wagner (Göttingen, DE)
Insulin resistance.
– M. Mamas (Manchester, GB)
Diabetes.
– B.M. Pieske (Graz, AT)
3681
3682
3683
3684
08:30-10:00 | Tripoli - Zone A (QR 520*)
PREDICTING PROGNOSIS IN HEART FAILURE
Chairperson(s): C. Mueller (Basel, CH); P. Kalra (Portsmouth, GB)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
Relation of serum sodium concentration to mortality in a large spectrum of heart failure patients
with preserved and reduced ejection fraction: results from the MAGGIC meta-analysis.
– D. Rusinaru, C. Tribouilloy, C. Berry, M. Richards, N. Earle, K. Poppe, M. Guazzi, S. Macin, M. Komajda,
R. Doughty (Amiens and Paris, FR; Glasgow, GB; Christchurch and Auckland, NZ; Milan, IT; Corrientes, AR)
The prognostic value of troponins in patients with heart failure: a meta-analysis.
– E. Gardini, F. Ottani, L. La Vecchia, D. Ferrini, M. Galvani (Forlì and Vicenza, IT)
Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and
sustained therapy.
– M. Biteker, E. Ilhan, D. Duman, M. Can, A. Dayan (Istanbul, TR)
Role of lung impedance monitoring in the outpatient clinic for predicting and preventing of
hospitalizations patients with chronic heart failure.
– M. Shochat, A. Shotan, M. Kazatsker, V. Gurovich, E. Noiman, I. Shochat, I. Dahan, Y. Levy, D. Blondheim,
S. Meisel (Hadera, IL)
Mid-region proHormone adrenomedullin identifies acutely dyspneic emergency department
patients with high 90 day mortality: results from the Biomarkers in Acute Heart Failure (BACH)
trial.
– R.M. Nowak, W.F. Peacock, C. Mueller, S.X. Neath, S. Disomma, C. Hogan, M. Richards, O. Hartmann,
S.D. Anker, A. Maisel (Detroit, Cleveland, San Diego and Richmond, US; Basel, CH; Rome, IT;
Hennigsdorf/Berlin, DE)
Five-year survival and predictors of mortality after hospitalization for acute heart failure.
– J.P.E. Lassus, K. Siirila-Waris, K. Peuhkurinen, M.S. Nieminen, V.-P. Harjola (Helsinki and Kuopio, FI)
3685
3686
3687
3688
3689
3690
08:30-10:00 | Vienna - Zone A
NO ROLE IN THE CLINIC?
Chairperson(s): J. Bauersachs (Hannover, DE); E. Cerbai (Florence, IT)
08:30
08:52
09:15
09:37
Nitric oxide and ischaemia-reperfusion.
– A. Bogdanova (Zurich, CH)
Nitric oxide and cardiac stem cells differentiation.
– J.L. Balligand (Brussels, BE)
Nitric oxide synthase and atrial fibrillation.
– B. Casadei (Oxford, GB)
The therapeutic potential of nitric oxide-cGMP signalling in cardiac disease.
– S. Janssens (Leuven, BE)
Symposium
3691
3692
3693
3694
08:30-10:00 | Warsaw - Zone A
CARDIORENAL SYNDROME, AN INEVITABLE CONSEQUENCE OF HEART FAILURE?
Chairperson(s): S.D. Anker (Berlin, DE); A.P. Maggioni (Florence, IT)
08:30
08:52
09:15
09:37
Pathophysiology of cardiorenal interactions.
– C. Ronco (Vicenza, IT)
New biomarkers for risk identification.
– A.A. Voors (Groningen, NL)
Anaemia and iron deficiency.
– P. Ponikowski (Wroclaw, PL)
Therapeutic options.
– G.S. Filippatos (Athens, GR)
*Abstracts can
be accessed at:
226
QR 520
Clinical Seminar
3695
3696
3697
3698
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Moscow - Zone B
MANAGEMENT OF SYNCOPE PATIENTS. STILL A CHALLENGE
Chairperson(s): E. Simantirakis (Heraklion, GR); P. Kulakowski (Warsaw, PL)
08:30
08:52
09:15
09:37
Clues from clinical history.
– R. Sutton (Monte Carlo, MC)
Syncope evaluation unit: organisation and benefits.
– A. Moya I Mitjans (Barcelona, ES)
Implantable loop recorders.
– M. Brignole (Lavagna, IT)
Pitfalls in the management of syncope.
– R.A. Kenny (Dublin, IE)
Clinical Seminar
3699
3700
3701
3702
08:30-10:00 | Oslo - Zone B
ESC GUIDELINES FOR THE MANAGEMENT OF CARDIOVASCULAR DISEASES DURING
PREGNANCY
Chairperson(s): C. Gohlke-Baerwolf (Ballrechten-Dottingen, DE); J.-M. Foidart (Liège, BE)
The Committee for Practice Guidelines
08:30
08:52
09:15
09:37
New aspects in the pregnancy guidelines.
– V. Regitz-Zagrosek (Berlin, DE)
Identification and management of the high-risk patient.
– J.W. Roos-Hesselink (Rotterdam, NL)
Which arrhythmias need treatment.
– C. Blomstrom-Lundqvist (Uppsala, SE)
How to manage anticoagulation in pregnant women.
– P.G. Pieper (Groningen, NL)
Symposium
3703
3704
3705
3706
08:30-10:00 | Prague - Zone B
PREVENTING SUDDEN DEATH
Chairperson(s): H.J. Wellens (Maastricht, NL); I. Fernandez Lozano (Madrid, ES)
08:30
08:52
09:15
09:37
Scope of the problem and risk stratification.
– X. Jouven (Paris, FR)
Autonomic testing.
– P.J. Schwartz (Pavia, IT)
Genetic testing.
– S. Kaab (Munich, DE)
Where to place automatic external defibrillators and who pays?
– H.-J. Trappe (Herne, DE)
Symposium
3707
3708
3709
3710
08:30-10:00 | Riga - Zone B (QR 646*)
ATRIAL FIBRILLATION AND ISCHAEMIC HEART DISEASE
Chairperson(s): M.H. Crawford (San Francisco, US); J. Kautzner (Prague, CZ)
08:45
09:00
09:15
09:30
09:45
Comparison of CHADS2 score with CHADSVASC-Score in a prospective multicenter registry on
3711
patients with atrial fibrillation undergoing coronary artery stenting (AFCAS-trial).
– A. Schlitt, A. Rubboli, J. Valencia, P. Karjalainen, M. Weber, M. Puurunen, P. Kirchhof, M. Niemelae,
G.Y.H. Lip, J. Airaksinen (Halle, Bad Nauheim and Münster, DE; Bologna, IT; Alicante, ES; Satakunta,
Helsinki, Oulu and Turku, FI; Birmingham, GB)
Transient atrial fibrillation complicating acute myocardial infarction: implications for future risk of
3712
ischemic stroke.
– D. Aronson, H. Hammerman, M. Kapeliovich, R. Dragu, R. Bishara (Haifa, IL)
Influence of new onset atrial fibrillation on long-term prognosis in patients aged >89 years with
3713
acute myocardial infarction.
– M. Martinez-Selles, T. Datino, L. Figueiras-Graillet, H. Bueno, F. Fernandez-Aviles (Madrid, ES)
The effect of acute onset atrial fibrillation and rapid atrial rates on markers of thrombogenesis in
3714
the human left atrium.
– H.S. Lim, S.R. Willoughby, C. Schultz, C. Gan, A.G. Brooks, M. Alasady, D.H. Lau, M.I. Worthley,
G.D. Young, P. Sanders (Adelaide, AU)
Reversal of rivaroxaban mediated anticoagulation in animal models by a recombinant antidote
3715
protein (r-Antidote, PRT064445).
– G. Lu, F.R. Deguzman, M.J. Karbarz, S.J. Hollenbach, P.B. Conley, A. Hutchaleelaha, U. Sinha (South San
Francisco, US)
Impact of atrial fibrillation on 5-year-mortality of patients with stable angina and documented
3716
coronary artery disease in clinical practice: results of the STAR-Registry.
– A.K. Gitt, F. Towae, A. Papp, R. Zahn, C. Juenger, J. Senges (Ludwigshafen am Rhein and Ludwigshafen, DE)
*Abstracts can
be accessed at:
TUESDAY – MORNING
08:30
Abstract Session
QR 646
227
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Rome - Zone B (QR 642*)
HEART RATE MATTERS
Chairperson(s): H. Darius (Berlin, DE); J.T. Parissis (Athens, GR)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
Heart rate and cardiac allograft vasculopathy in heart transplant recipients.
– M.T. La Rovere, F. Olmetti, G.D. Pinna, R. Maestri, D. Lilleri, A. D’Armini, M. Vigano, O. Febo (Montescano
and Pavia, IT)
Impact of radiofrequency catheter ablation on echocardiographic and cardiopulmonary
performance in patients with ventricular extrasystolic beats and suspected arrhythmia-induced
cardiomyopathy.
– T. Krynski, S.M. Stec, S. Szmit, B. Zaborska, P. Kulakowski (Warsaw, PL)
Selective heart rate reduction with ivabradine improves left ventricular remodeling and function:
insights from the SHIFT echocardiography sub-study.
– J.-C. Tardif, E. O’Meara, M. Komajda, M. Böhm, J.S. Borer, I. Ford, L. Tavazzi, K. Swedberg (Montreal, CA;
Paris, FR; Homburg/Saar, DE; Brooklyn, US; Glasgow, GB; Cotignola, IT; Gothenburg, SE)
Effects of ivabradine plus beta blockers as first step therapy on heart rate, compliance, quality of
life and exercise tolerance in patients with chronic heart failure.
– A. Macchi, I. Franzoni, I. Rosa, M.C. Pedrigi, F. Buzzetti, R. Gorla, G.V. Gaudio, P.G. Camici, A. Margonato
(Milan and Somma Lombardo, IT)
Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses
ventricular dysfunction and improves long-term survival in chronic heart failure rats.
– M. Li, C. Zheng, T. Kawada, M. Inagaki, H. Takaki, M. Sugimachi (Osaka and Kochi, JP)
Vagus nerve stimulation improves left ventricular function in heart failure: results of a 6 month
investigation with a cross-over design in dogs with experimental heart failure.
– H.N. Sabbah, M. Wang, R.C. Gupta, S. Rastogi, S.B. Ruble, J.J. Hamann (Detroit and St. Paul, US)
3717
3718
3719 (W)
3720
3721
3722
08:30-10:00 | Sofia - Zone B (QR 650*)
EVERY HEART BEAT COUNTS
Chairperson(s): U.C. Hoppe (Cologne, DE); G. Parcharidis (Thessaloniki, GR)
08:30
08:45
09:00
09:15
09:30
09:45
The relationship between baseline resting heart rate and death and cardiovascular complications
in patients with type 2 diabetes mellitus.
– G.S. Hillis, M. Woodward, A. Rodgers, C. Chow, S. Zoungas, A. Patel, R. Webster, G. Batty, T. Ninomiya,
J. Chalmers (Sydney, AU; London, GB; Fukuoka, JP)
Modest weight-loss in moderately overweight postmenopausal woman improves heart rate
variability.
– M.R. Mouridsen, N.T. Bendsen, A. Astrup, S.B. Haugaard, Z. Binici, A. Sajadieh (Copenhagen, DK)
Epicardial fat thickness predicts blunted heart rate recovery in patients with metabolic syndrome.
– C. Sengul, D. Duman (Istanbul, TR)
The Influence of body-mass index on outcomes in subjects with atrial fibrillation and heart failure:
data from the AF-CHF study.
– A. Nigam, P. Khairy, M. Talajic, S. Levesque, D. Roy (Montreal, CA)
Increased incidence of atrial fibrillation associated with the use of cyclooxygenase-2 inhibitors in
a nationwide cohort study of 7 million individuals.
– M. Back, L. Yin, E. Ingelsson (Stockholm, SE)
Influence of atrial fibrillation on cardiopulmonary function during exercise in patients with cardiac
disease.
– H. Tsuneoka, A. Koike, O. Nagayama, K. Sakurada, H. Sawada, K. Aonuma, T. Aizawa (Tsukuba and
Tokyo, JP)
*Abstracts can
be accessed at:
228
Abstract Session
QR 642
QR 650
3723
3724
3725
3726
3727
3728
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Brussels - Zone D (QR 536*)
HOW TO ACHIEVE BETTER BLOOD PRESSURE CONTROL?
Chairperson(s): A.M. Heagerty (Manchester, GB); V.S. Ram (Dallas, US)
09:45
09:30
08:45
09:00
08:30
09:15
Abstract Session
Patient persistence with antihypertensive drugs in France, Germany and the UK.
– B. Ehlken, K. Kostev, A. Sandberg, B. Holz, A. Oberdiek (Munich and Frankfurt, DE)
Genetic variation in renin predicts the effects of thiazide diuretics.
– C.-C. Huang, C.-M. Chung, S.-I. Hung, H.-B. Leu, T.-C. Wu, P.-H. Huang, S.-J. Lin, W.-H. Pan,
J.-W. Chen (Taipei, TW)
Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in
Japanese hypertensive patients: a subanalysis of the VART.
– H. Hasegawa, H. Takano, H. Narumi, S. Shindo, H. Mizuma, Y. Kuwabara, Y. Kobayashi, I. Komuro (Chiba
and Osaka, JP)
Effective hemodynamically guided antihypertensive therapy with use of impedance cardiography a randomized, controlled trial.
– P. Krzesinski, G.G. Gielerak, J.J. Kowal (Warsaw, PL)
Prediction of response to spironolactone treatment in patients with resistant arterial
hypertension: insights from the ASPIRANT trial.
– J. Vaclavik, E. Kocianova, R. Sedlak, M. Plachy, K. Navratil, J. Plasek, J. Jarkovsky, T. Vaclavik, M. Svestak,
M. Taborsky (Olomouc, Prostejov, Brno, Ostrava and Prague, CZ)
Individualized programming demonstrates feasibility of unilateral approach to delivery of
baroreflex activation therapy.
– A. Kroon, D. Sica, J. Bisognano, M. Nadim, L. Sanchez, G. Bakris (Maastricht, NL; Richmond, Rochester,
Los Angeles, St. Louis and Chicago, US)
3729
3730
3731
3732
3733
3734
08:30-10:00 | Copenhagen - Zone D
CARDIOVASCULAR RISK – CHALLENGE OF THE FUTURE
Chairperson(s): F.J. Pinto (Lisbon, PT); H.K. Najm (Riyadh, SA)
The European Society of Cardiology and the Saudi Heart Association
08:30
08:52
09:15
09:37
Symposium
Hypertension and diabetes in arabic countries.
– M.B. Bdeir (Riyadh, SA)
Concept of prevention.
– I.M. Graham (Dublin, IE)
Crisis management of diabetes tsunami in Saudi Arabia, prevention before treatment.
– K. Al Rubeaan (Riyadh, SA)
New strategies for resistant hypertension with metabolic syndrome.
– F. Mahfoud (Homburg/Saar, DE)
3735
3736
3737
3738
08:30-10:00 | Damascus - Zone D (QR 554*)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
The impact of sFAS on mortality in patients with carotid atherosclerosis.
– M. Hoke, M. Schillinger, A. Wonnerth, W.S. Speidl, G. Maurer, R. Koppensteiner, E. Minar, J. Wojta,
A. Niessner (Vienna, AT)
Cause-specific cardiovascular risk associated with use of nonsteroidal anti-inflammatory drugs
among patients with prior myocardial infarction - a nationwide study.
– A.M. Olsen, E.L. Fosbol, J. Lindhardsen, F. Folke, M. Charlot, J.B. Olesen, P.R. Hansen, L. Kober,
C. Torp-Pedersen, G.H. Gislason (Hellerup and Copenhagen, DK; Durham, US)
NT-proBNP, CRP, and the prediction of cardiovascular events: results from 15-year follow-up of
the WOSCOPS study.
– P. Welsh, O. Doolin, C. Packard, I. Ford, N. Sattar (Glasgow, GB)
Elevated cardiac troponin T and C-reactive protein interactively increased cardiovascular and
all-cause mortality risk in chronic hemodialysis patients -10-year prospective study.
– T. Aoyama, H. Ishii, H. Takahashi, Y. Kumada, M. Tanaka, D. Kamoi, Y. Kawamura, K. Kawashima, J. Ishii,
T. Murohara (Nagoya and Toyoake, JP)
A new cardiovascular score for the low risk and aged mediterranean population: the
ERICE-SCORE.
– R. Gabriel Sanchez, C. Brotons, M.J. Tormo, A. Segura, F. Rigo, R. Elosua, J. Carbayo, J. Tuomilehto,
A. Ortega, J. Muniz (Madrid, Barcelona, Murcia, Toledo, Palma de Mallorca, Albacete and La Coruña, ES)
The impact of gout and hyperuricaemia on total and cardiovascular mortality in the general
population.
– A. Hanley, A. Stack (Letterkenny, IE)
*Abstracts can
be accessed at:
QR 536
3739
3740
TUESDAY – MORNING
THE COMPLEXITY OF RISK IN HEART DISEASE
Chairperson(s): T. Zdrojewski (Sopot, PL); P. Kala (Brno, CZ)
3741
3742
3743
3744
QR 554
229
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Helsinki - Zone D
NOVEL TARGETS TO ATTACK EXERCISE INTOLERANCE IN HEART FAILURE
Chairperson(s): A. Mezzani (Veruno, IT); L.E.M. Vanhees (Leuven, BE)
08:30
08:52
09:15
09:37
Symposium
Cardiomyocytes.
– O.J. Kemi (Glasgow, GB)
Skeletal muscle.
– R.F. Ventura-Clapier (Chatenay-Malabry, FR)
Bone marrow.
– A.H.P. Linke (Leipzig, DE)
Cellular effects of iron.
– V. Conraads (Edegem, BE)
3745
3746
3747
3748
08:30-10:00 | Lisbon - Zone D
CAN THE POLYPILL SAVE THE WORLD?
Chairperson(s): D.A. Wood (London, GB); S. Smith (Chapel Hill, US)
The European Society of Cardiology and the World Heart Federation
08:30
08:52
09:15
09:37
Symposium
Cardiovascular prevention; a global problem.
– U. Keil (Münster, DE)
Polypill for primary prevention.
– S. Yusuf (Hamilton, CA)
Polypill for secondary prevention.
– V. Fuster (New York, US)
Alternatives to polypills.
– A.J. Taylor (Washington, US)
3749
3750
3751
3752
08:30-10:00 | Madrid - Zone D (QR 557*)
EVOLVING EVIDENCE FOR PSYCHOSOCIAL ISSUES IN HEART DISEASE
Chairperson(s): L. Kopin (Rochester, US); G.S. Tell (Bergen, NO)
08:30
08:45
09:00
09:15
09:30
09:45
Endothelial function and circulating adhesion molecules and in depressed subjects with coronary
risk factors.
– C. Pizzi, L. Manzoli, G.M. Costa, L. Santarella, R. Bugiardini (Bologna and Chieti, IT)
Anger predicts long-term mortality in patients with myocardial infarction.
– F. Bonaguidi, C. Michelassi, C. Carpeggiani, M.G. Trivella, E. Picano, D. Rovai, A. L’Abbate (Pisa, IT)
Stressful life events and depression are predictors of fatal and nonfatal events in patients with
arterial hypertension and coronary heart disease.
– N. Pogosova, R.G. Oganov, Y.M. Yufereva, I.E. Koltunov, A.D. Deev (Moscow, RU)
Cognitive behaviour therapy benefits depressed cardiac patients: results of a randomised
controlled trial.
– M. Worcester, B. Murphy, A. Turner, R. Higgins, P. Elliott, H. Navaratnam, M. Le Grande, A. Goble
(Melbourne, AU)
Increased levels of psychological stress in a population undergoing family heart screening for
inheritable cardiac diseases.
– C. McShane, C. McGorrian, C. O’Donnell, O. Constant, T. Keelan, J. Galvin, J. O’Neill, N.G. Mahon (Dublin,
IE)
Does cardiac resynchronisation therapy affect the burden of depression in patients with heart
failure?
– V. Nayar, F.Z. Khan, T. Robinson, P. Cantelon, D.P. Dutka, P.J. Pugh (Cambridge, GB)
*Abstracts can
be accessed at:
230
Abstract Session
QR 557
3753
3754
3755
3756
3757
3758
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Beirut - Zone E (QR 560*)
PEDIATRIC PULMONARY ARTERIAL HYPERTENSION
Chairperson(s): M. Beghetti (Geneva, CH); M.A. Gomez Sanchez (Pozuelo de Alarcon, ES)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
Hemodynamic characterization at diagnosis in children with Pulmonary Hypertension (PH):
insights from the global TOPP registry (Tracking Outcomes and Practice in Pediatric Pulmonary
Hypertension).
– I. Schulze-Neick, T. Humpl, R.M.F. Berger, G. Raskob, R. Weintraub, B. Saji, D. Yung, R.J. Barst,
M. Beghetti (London, GB; Toronto, CA; Groningen, NL; Oklahoma City, Seattle and New York, US;
Melbourne, AU; Tokyo, JP; Geneva, CH)
Pediatric pulmonary hypertension: insights from the Tracking Outcomes and Practice in Pediatric
Pulmonary Hypertension (TOPP) global registry.
– R.M.F. Berger, T. Humpl, I. Schulze-Neick, G. Raskob, D.D. Ivy, Z.-C. Jing, D. Bonnet, M. Beghetti,
R.J. Barst (Groningen, NL; Toronto, CA; London, GB; Oklahoma City, Denver and New York, US; Shanghai,
CN; Paris, FR; Geneva, CH)
Current era survival in patients with pediatric pulmonary arterial hypertension.
– F. Sciarra, E. Leci, M. Palazzini, E. Conficoni, F. Sgro’, E. Beciani, C. Bachetti, A. Manes, A. Branzi,
N. Galie’ (Bologna, IT)
Pulmonary arterial stroke volume: a new and strong prognostic factor in pediatric pulmonary
arterial hypertension.
– J.M. Douwes, M.T.R. Roofthooft, M. Talsma, H.L. Hillege, R.M.F. Berger (Groningen, NL)
Prognostic implications of cardiac MRI in paediatric patients with pulmonary hypertension.
– S. Moledina, S.G. Haworth, A.M. Taylor, I. Schulze-Neick, V. Muthurangu (London, GB)
Palliative Potts shunt in children with idiopathic pulmonary arterial hypertension: short and mid
-term results.
– A.-E. Baruteau, D. Bonnet, M. Humbert, J. Petit, M. Levy, X. Jais, A.-E. Serraf, P. Vouhe, G. Simonneau,
E. Belli (Le Plessis-Robinson, Paris and Clamart, FR)
3759
3760
3761
3762
3763
3764
08:30-10:00 | Berne - Zone E
GENETIC BACKGROUND OF DILATED CARDIOMYOPATHIES
Chairperson(s): P.M. Elliott (London, GB); H. Seggewiss (Schweinfurt, DE)
08:30
08:48
09:06
09:24
3765
3766
3767
3768
3769
TUESDAY – MORNING
09:42
Lessons from animal models.
– W. Rottbauer (Ulm, DE)
Phenotypic and genetic heterogeneity: an overview.
– E. Arbustini (Pavia, IT)
Laminopathies: from genetic defect to treatment.
– Y. Pinto (Amsterdam, NL)
Genome wide approach in dilated cardiomyopathy.
– P. Charron (Paris, FR)
Familial forms of inflammatory cardiomyopathy.
– A.L.P. Caforio (Padua, IT)
Symposium
*Abstracts can
be accessed at:
QR 560
231
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Bratislava - Zone E (QR 576*)
RIGHT VENTRICULAR FUNCTION: NEW TECHNOLOGY FOR BETTER PROGNOSIS
Chairperson(s): A. Vonk Noordegraaf (Amsterdam, NL); M.M. Barbosa (Nova Lima, BR)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
Greater accuracy of two-dimensional strain measures of right ventricle for diagnosis of
arrhythmogenic right ventricular dysplasia/cardiomyopathy.
– M. Iacoviello, A. Puzzovivo, C. Forleo, I. Nalin, F. Monitillo, S. Sorrentino, P. Guida, M. Anaclerio,
V. Marangelli, S. Favale (Bari, IT)
Detection of right ventricular involvement by speckle tracking derived longitudinal strain imaging
in patient with acute inferior ST elevation myocardial infarction and proximal right coronary artery.
– M. Hutyra, T. Skala, J. Precek, D. Vindis, D. Richter, D. Horak, Z. Tudos, M. Koecher, M. Taborsky
(Olomouc, CZ)
Feasibility and accuracy of 3-dimensional echocardiography for measurements of the right
ventricular volumes and function in adult patients: validation with magnetic resonance imaging.
– E. Ostenfeld, K. Shahgaldi, A. Roijer, M. Carlsson, J. Holm (Malmo, Stockholm and Lund, SE)
Right ventricular free wall strain has a closer correlation with right ventricular ejection fraction
than other echocardiographic indices of right ventricular function: A comparison with cardiac
MRI.
– R.F. Duncan, A.J. Nelson, J. Schuster, B.K. Dundon, M.I. Worthley, A. Carbone, A. Zaman, S.G. Worthley
(Newcastle-upon-Tyne, GB; Adelaide, AU)
Importance of right ventricular function in patient referred for cardiac surgery.
– M. Berry, J. Nahum, L. Macron, J.P. Couetil, O. Zaghden, O. Lairez, T. Damy, J.L. Dubois Rande,
P. Gueret, P. Lim (Toulouse and Créteil, FR)
Prognostic value of right ventricular function assessed by the tricuspid annular plane systolic
excursion in acute myocardial infarction.
– G. Bedetti, L. Gargani, C. Pizzi, R. Sicari, E. Picano (Imola, Pisa and Bologna, IT)
3770
3771
3772
3773
3774
3775
08:30-10:00 | Bucharest - Zone E
CONTROVERSIAL ISSUES: DOES IMAGING IMPROVE OUTCOME?
Chairperson(s): M.J. Zellweger (Basel, CH); M. Lombardi (Pisa, IT)
08:30
08:52
09:15
09:37
Main Session
Cardiac magnetic resonance.
– J. Schwitter (Lausanne, CH)
Nuclear techniques.
– F.M. Bengel (Hannover, DE)
Echocardiography.
– L.A. Pierard (Liège, BE)
Computed tomography coronary angiography.
– P.J. De Feyter (Rotterdam, NL)
3776
3777
3778
3779
08:30-10:00 | Budapest - Zone E
REMOTE MONITORING OF CARDIAC RYTHM DEVICES: PRESENT AND FUTURE
Chairperson(s): D.L. Scher (Harrisburg, US); B. Gorenek (Eskisehir, TR)
08:30
08:52
09:15
09:37
Symposium
Pacemakers and implantable cardioverter-defibrillators.
– P. Mabo (Rennes, FR)
Heart failure.
– F. Braunschweig (Stockholm, SE)
Patient management and legal issues.
– G. Boriani (Bologna, IT)
Data exchange between remote monitoring databases and local electronic patient record system.
– E.T. van der Velde (Leiden, NL)
3780
3781
3782
3783
08:30-10:00 | Cairo - Zone E
CONTROVERSIAL ISSUES ON TRANSCATHETER AORTIC VALVE IMPLANTATION
Chairperson(s): H. Eltchaninoff (Rouen, FR); F.W. Mohr (Leipzig, DE)
08:30
08:52
09:15
09:37
What are the current indications?
– G.C. Schuler (Leipzig, DE)
Very high-risk patients with aortic stenosis: TAVI, balloon or nothing?
– J. Rodes Cabau (Sainte-Foy, CA)
Is it time to expand indications to include low-risk patients?
– N. Piazza (Munich, DE)
Is valve-in-valve the preferred treatment for bioprosthesis failure?
– D. Himbert (Paris, FR)
*Abstracts can
be accessed at:
232
QR 576
Clinical Seminar
3784
3785
3786
3787
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Ankara - Zone F (QR 591*)
A FRESH LOOK AT OLD AND NEW RISK FACTORS
Chairperson(s): J.-P. Bassand (Besançcon, FR); S.D. Wiviott (Boston, US)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
Comparison of known genetic variants to coronary heart disease risk between Indian Asians and
Europeans.
– D. Das, J. Sehmi, N. Ahmed, A. Kooner, K. Miller, J. Scott, P. Elliot, J.C. Chambers, J.S. Kooner (London,
GB)
Plasma lipidomic analysis of stable and unstable coronary artery disease.
– B.A. Kingwell, D. Tsorotes, B. Goudey, A. Kowolczyk, I. Haviv, A. White, A. Dart, S. Duffy, G.L.R. Jennings,
P. Meikle (Melbourne, AU)
Low levels of IgM antibodies to oxidized cardiolipin increase but high levels decrease risk of
cardiovascular disease in 60-year olds from Stockholm County.
– J. Frostegard, J. Su, X. Hua, M. Vikstrom, K. Leander, B. Gigante, M.L. Hellenius, U. De Faire (Stockholm,
SE)
Interleukin 18 gene variation is associated with myocardial infarction.
– W. Koch, A. Schatke, H. Wolferstetter, W. Latz, M. Eichinger, A. Schoemig, A. Kastrati (Munich, DE)
Do diabetic patients really have a higher threshold for ischemic pain?
– J.C. Nicolau, M. Franken, F.G. Lima, C.V. Serrano Jr, R.R. Giraldez, L.M. Baracioli, F. Ganem, T.F. Pinto,
R. Kalil Filho, J.A.F. Ramires (São Paulo, BR)
Impact of carotid artery ultrasound and ankle-brachial index for prediction of the severity of the
SYNTAX score.
– N. Ikeda, N. Kogame, R. Iijima, M. Nakamura, K. Sugi (Tokyo, JP)
3788
3789
3790
3791
3792
3793
08:30-10:00 | Athens - Zone F
PRIMARY PERCUTANEOUS CORONARY INTERVENTION: FROM EVIDENCE TO PRACTICE
Chairperson(s): A.H. Gershlick (Leicester, GB); P. Widimsky (Prague, CZ)
08:30
08:52
09:15
09:37
Controversies in antithrombotic treatment.
– A. Kastrati (Munich, DE)
Drug-eluting or bare metal stents?
– M. Valgimigli (Ferrara, IT)
The challenge of multi-vessel disease.
– C. Di Mario (London, GB)
Dealing with microvascular obstruction.
– F. Crea (Rome, IT)
Clinical Seminar
3794
3795
3796
3797
08:30-10:00 | Belgrade - Zone F
08:30
08:52
09:15
09:37
Surgical strategies.
– M. De Bonis (Milan, IT)
Percutaneous edge to edge technique.
– O.W. Franzen (Copenhagen, DK)
Percutaneous coronary sinus annuloplasty.
– J. Harnek (Lund, SE)
The bird’s eye view.
– A. Vahanian (Paris, FR)
Clinical Seminar
3798
3799
3800
3801
TUESDAY – MORNING
NEW THERAPIES FOR MITRAL REGURGITATION
Chairperson(s): M. Sousa Uva (Lisbon, PT); F. Weidinger (Vienna, AT)
08:30-10:00 | Berlin - Zone F
CONTROVERSIAL ISSUES IN MYOCARDIAL REVASCULARISATION
Chairperson(s): P.H. Kolh (Liège, BE); J. Fernandes E Fernandes (Lisbon, PT)
08:30
08:52
09:15
09:37
Functional evaluation as a guidance for revascularisation: non-invasive aproach.
– P.A. Kaufmann (Zurich, CH)
Functional evaluation as a guidance for revascularisation: invasive aproach.
– B. De Bruyne (Aalst, BE)
Percutaneous coronary intervention for left main stenosis.
– F.J. Neumann (Bad Krozingen, DE)
Surgery for left main stenosis.
– P.T. Sergeant (Bertem, BE)
*Abstracts can
be accessed at:
Symposium
3802
3803
3804
3805
QR 591
233
TUESDAY, 30 AUGUST 2011 – MORNING
08:30-10:00 | Tunis - Zone F (QR 599*)
PREDICTORS OF OUTCOME IN HIGH RISK CORONARY INTERVENTIONS
Chairperson(s): A. Hoye (Hull, GB); U. Limbruno (Grosseto, IT)
08:30
08:45
09:00
09:15
09:30
09:45
Abstract Session
Long-term safety and efficacy of drug eluting and bare metal stents implanted in saphenous vein
grafts in sweden.
– F. Schersten, S.K. James, U. Stenestrand, J. Carlsson, O. Frobert, B. Lagerqvist (Lund, Uppsala,
Linköping, Kalmar and Örebro, SE)
Merging SYNTAX score with EuroSCORE improves risk stratification of patients undergoing left
main angioplasty.
– J.D. Brito, R. Teles, P. Goncalves, P. Sousa, M. Santos, F. Costa, P. Santos, L. Raposo, M. Almeida,
M. Mendes (Carnaxide, PT)
Long-term benefit of drug-eluting compared to bare-metal stents in patients with versus without
chronic renal insufficiency, a BASKET-PROVE substudy.
– M. Wanitschek, A. Hvelplund, F. Nietlispach, R. Jeger, A. Iversen, J.S. Jensen, S. Galatius, C.H. Kaiser,
M. Pfisterer, H.F. Alber (Innsbruck, AT; Gentofte, DK; Basel, CH)
5-year outcomes of the MISSION intervention study; a randomized comparison of
sirolimus-eluting to bare-metal stent implantation in patients with STEMI.
– H. Boden, B.L. Van Der Hoeven, J.Z. Atary, S.S. Liem, E.E. Van Der Wall, M.J. Schalij (Leiden, NL)
Five year follow-up of DIABETES trial: the final results.
– P. Jimenez-Quevedo, L. Hernando, J.A. Gomez-Hospital, A. Iniguez, A. Sanroman, F. Alfonso, D. Angiolillo,
J. Escaned, C. Macaya, M. Sabate (Madrid, Barcelona, Vigo and Valladolid, ES; Jacksonville, US)
Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital; results
of the HORIZONS-AMI trial.
– B.E.P.M. Claessen, G.D. Dangas, R. Mehran, B. Witzenbichler, G. Gaugliumi, J. Peruga, K. Xu, G.W. Stone
(New York, US)
3806
3807
3808
3809
3810
3811
08:30-10:00 | Zagreb - Zone F (QR 597*)
UPDATE ON VASCULAR TREATMENT
Chairperson(s): M. Roffi (Geneva, CH); F. Vermassen (Ghent, BE)
08:30
08:45
09:00
09:15
09:30
09:45
Vardenafil in patients with raynaud’s syndrome.
– E. Caglayan, S. Axmann, M. Hellmich, P. Moinzadeh, M. Huntgeburth, N. Hunzelmann, T. Krieg,
E. Erdmann, S. Rosenkranz (Cologne, DE)
Immediate results of subclavian and innominate artery angioplasty and factors influencing stent
patency.
– T. Przewlocki, A. Kablak-Ziembicka, P. Pieniazek, P. Musialek, A. Kozanecki, L. Wrotniak, P. Podolec
(Krakow, PL)
Renal fractional flow reserve and hypertension response after renal artery stenting.
– J.M. Kadziela, A. Witkowski, A. Januszewicz, A. Prejbisz, I. Michalowska, K. Cedro, L. Kalinczuk,
E. Florczak, B. Norwa-Otto, E. Warchol (Warsaw, PL)
LDL-cholesterol: the lower, the better: is it true for plaque regression? Statin alone versus
combination of ezetimibe and statin.
– K. Miyauchi, N. Nakajima, T. Kojima, T. Yokoyama, K. Yokoyama, T. Kurata, H. Tamura, S. Suwa, H. Daida
(Tokyo and Shizuoka, JP)
Transradial vascular access for proximal iliofemoral percutaneous interventions: a single-center
experience.
– F. Marcos-Sanchez, S. Rodriguez De Leiras-Otero, C. Carrrascosa-Rosillo, M. Vizcaino-Arellano,
P. Cerrato-Garcia, R.J. Ruiz-Salmeron (Seville, ES)
Simultaneous hybrid revascularization of carotid and coronary disease in patients with acute
coronary syndrome: initial results of a new therapeutic approach.
– M. Ponte, R. Fontes Carvalho, G. Pires De Morais, A. Albuquerque, P. Braga, A. Rodrigues, M. Veloso,
L. Simoes, L. Vouga, V. Ribeiro (Vila Nova de Gaia, PT)
*Abstracts can
be accessed at:
234
Abstract Session
QR 599
QR 597
3812
3813
3814
3815
3816
3817
TUESDAY, 30 AUGUST 2011 – MORNING
09:00-10:20 | Hands-On Tutorial Room 1 - Zone B
3D GUIDED INTERVENTIONS FOR STRUCTURAL AND CORONARY HEART DISEASE
Chairperson(s): G. Brockmann (Munich, DE); H. Rittger (Coburg, DE)
Hands-On Tutorial organised by Siemens AG, Healthcare Sector (on-site registration)
Hands-On Tutorial
09:00-10:30 | Hands-On Tutorial Room 2 - Zone B
A FAST NEW HYBRID TOOL FOR COMPREHENSIVE IMAGING OF CAD: CZT SPECT
COMBINED WITH 64 SLICE CT
Hands-On Tutorial organised by GE Healthcare (on-site registration)
Hands-On Tutorial
Review of clinical cases where hybrid imaging has impacted patient management.
– M.G. Goldstein (Brussels, BE)
3818
09:00-10:30 | Hands-On Tutorial Room 3 - Zone B
IMPROVING CARDIAC CARE BY PATIENT-SPECIFIC MODELING – FOCUS ON CARDIAC
Hands-On Tutorial
RESYNCHRONIZATION THERAPY
Chairperson(s): R. Razavi (London, GB); J. Weese (Hamburg, DE); M. Sermesant (Sophia Antipolis, FR)
Hands-On Tutorial organised by Philips Healthcare (on-site registration)
10:00-11:00 | Moderated Posters - Poster Zone C (QR 351*)
OUTCOME, PROCEDURES AND TREATMENT IN ACUTE CORONARY SYNDROME
Chairperson(s): D.L. Bhatt (Newton, US); E. Giannitsis (Heidelberg, DE)
Moderated Posters
Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30 to
12:30.The following abstracts were chosen for their outstanding quality and will be discussed in a special area in the Poster
hall during the Moderated Poster Session chaired by the two above-mentioned chairpersons between 10:00 and 11:00.
10:07
10:15
10:22
10:30
10:37
10:45
10:52
Clinical criteria for early invasive strategy in non-STE acute coronary syndrome in the real world.
Development and validation of a decision model.
– M. De Abreu, A. Silberstein, J. Mariani, J. Gagliardi, H. Doval, C. Tajer (Buenos Aires, AR)
Contrast induced nephropathy predicts later mortality among patients with non-ST-segment
elevation acute coronary syndrome undergoing PCI: a sub-analysis from the EARLY ACS study.
– G.M. De Ferrari, F. Van De Werf, P. Armstrong, C. Bode, B.S. Lewis, P. Tricoci, J. Guo, C. Contant,
K. Newby, R.P. Giugliano (Pavia, IT; Leuven, BE; Edmonton, CA; Freiburg, DE; Haifa, IL; Durham and
Boston, US)
Impact on short- and long-term mortality of invasive vs. conservative strategy in non-ST elevation
acute coronary syndromes: a meta-analysis.
– S. Stavrakis, J.A. Stoner, U. Thadani (Oklahoma City, US)
Long-term outcomes after procedure-related or spontaneous myocardial infarction in patients
presenting with non-ST-elevation acute coronary syndrome.
– P. Damman, F. Windhausen, A. Hirsch, K.A.A. Fox, T. Clayton, S.J. Pocock, B. Lagerqvist, L. Wallentin,
J.G.P. Tijssen, R.J. De Winter (Amsterdam, NL; Edinburgh and London, GB; Uppsala, SE)
Temporal trends in treatment and outcomes of patients with non-ST-segment elevation
myocardial infarction (NSTEMI) in clinical practice - analysis from the PL-ACS registry.
– L. Polonski, M. Gasior, M. Gierlotka, P. Buszman, W. Ruzyllo, J. Dubiel, W. Banasiak, Z. Kalarus,
M. Zembala, G. Opolski (Zabrze, Katowice, Warsaw, Krakow and Wroclaw, PL)
Non-invasive assessment of atherosclerotic plaque inflammation by microwave radiometry: an
experimental and histopathological study.
– K. Toutouzas, C. Grassos, M. Drakopoulou, A. Synetos, A. Michelongona, C. Patsa, G. Agrogiannis,
E. Patsouris, E. Siores, C. Stefanadis (Athens, GR; Bolton, GB)
Percutaneous left ventricular support with the Impella 2.5 in cardiogenic shock - Results of the
INTERPELLA-shock-registry.
– A. Lauten, A. Engstroem, C. Jung, K. Empen, S. Cook, M. Bergmann, M. Haude, J.P. Henriques,
H.R. Figulla, M. Ferrari (Jena, Greifswald, Hamburg and Neuss, DE; Amsterdam, NL; Berne, CH)
Effects of early and late re-infarction on mortality in patients with re-canalized or conservatively
treated occluded coronary arteries in long term follow up of the Occluded Artery Trial (OAT).
– C. Adlbrecht, K. Huber, H.R. Reynolds, A.C. Carvalho, H.D. White, P.G. Steg, L. Liu, C.A. Pearte,
P. Marino, J.S. Hochman (Vienna, AT; New York and Owings Mills, US; São Paulo, BR; Auckland, NZ;
Paris, FR; Novara, IT)
*Abstracts can
be accessed at:
P3819 (W)
P3820
P3821
P3822
P3823
TUESDAY – MORNING
10:00
P3824
P3825
P3826
QR 351
235
TUESDAY, 30 AUGUST 2011 – MORNING
10:00-11:00 | Moderated Posters - Poster Zone C (QR 352*)
DIASTOLIC FUNCTION
Chairperson(s): P. Poredos (Ljubljana, SI); J.-W. Ha (Seoul, KR)
Moderated Posters
Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30 to
12:30.The following abstracts were chosen for their outstanding quality and will be discussed in a special area in the Poster
hall during the Moderated Poster Session chaired by the two above-mentioned chairpersons between 10:00 and 11:00.
10:00
10:07
10:15
10:22
10:30
10:37
10:45
10:52
Phasic left atrial volumes changed before and after hemodialysis.
– W.W. Lin, K.Y. Wang, P.S. Lin, T.L. Jou, M.C. Chen, C.T. Ting, Y.T. Chen (Taichung, TW)
Global left ventricular circumferential strain is a marker for both systolic and diastolic myocardial
function.
– T. Onishi, S.K. Saha, D. Ludwig, E. Schelbert, D. Schwartzman, J. Gorcsan (Pittsburgh, US; Sundsvall, SE)
Validation of European association of echocardiography/American Society of echocardiography
decision-making algorithm for the estimation of filling pressures.
– Z.B. Popovic, K. Negishi, J.D. Thomas, T. Marwick (Cleveland, US)
Predictive value of strain diastolic index in detecting elevated N-terminal-pro BNP level in
asymptomatic hypertensive patients with preserved left ventricular ejection fraction.
– S.J. Chiang, M. Daimon, S. Miyazaki, Y. Koiso, H. Suzuki, M.-H. Yeh, B.-T. Huang, H. Daida (Taipei, TW;
Tokyo, JP)
Utility of global strain by 2D and 3D speckle tracking in assessing diastolic function: comparison
with pressure-volume loop analysis.
– S.-H. Shin, S.-D. Park, W.-I. Woo, D.-H. Kim, K.-S. Park, J. Kwan (Incheon, KR)
Estimation of left ventricular stiffness by three-dimensional echocardiography in comparison with
conductance catheter measurements.
– M. Kasner, D. Westermann, D.L. Sinning, H.P. Schultheiss, C. Tschoepe (Berlin, DE)
Relationship between new diastolic strain rate indexes of left ventricular filling pressure and
exercise capacity in patients with chronic heart failure.
– K. Suzuki, S. Kou, M. Izumo, K. Mziukoshi, R. Kamijima, M. Takai, N. Osada, Y.J. Akashi, K. Omiya,
F. Miyake (Kawasaki, JP)
A novel global tissue Doppler index in the assessment of cardiac diastolic adaptive changes in
athletes is dependent on body composition.
– D. Popovic, M. Ostojic, M. Petrovic, B. Vujisic-Tesic, A. Arandjelovic, A. Kocijancic, B. Popovic,
S. Damjanovic (Belgrade, RS)
P3827
P3828
P3829
P3830
P3831
P3832
P3833
P3834
10:05-10:55 | Sofia - Zone B
THE BEST OF THE EUROPEAN HEART JOURNAL – ACUTE CORONARY SYNDROME
Chairperson(s): F. Crea (Rome, IT); U. Landmesser (Zurich, CH)
10:05
10:10
10:20
10:30
10:40
10:50
Introduction: acute coronary syndrome.
– F. Crea (Rome, IT)
In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical
coherence tomography.
– T. Yonetsu (Tsuchiura, JP)
Non-culprit coronary artery PCI during acute ST-segment elevation myocardial infarction: insights
from the APEX-AMI trial.
– M. Toma (Vancouver, CA)
Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary
syndromes - Observations from the MERLIN-TIMI 36 Trial.
– B. Scirica (Boston, US)
Effect of the direct renin inhibitor Aliskiren on left ventricular remodeling following myocardial
infarction with systolic dysfunction.
– M. Pfeffer (Boston, US)
Conclusion.
*Abstracts can
be accessed at:
236
Special Session
QR 352
3835
3836
3837
3838
3839
TUESDAY, 30 AUGUST 2011 – MORNING
10:10-10:50 | Oslo - Zone B
MEET THE GUIDELINES TASK FORCE I
Chairperson(s): J.J. Bax (Leiden, NL); U. Sechtem (Stuttgart, DE)
10:10
10:10
10:20
10:30
Special Session
Acute coronary syndrome and non ST-elevation: questions and answers to the panellists.
– C.W. Hamm (Bad Nauheim, DE), J.-P. Bassand (Besançon, FR)
Panelists.
– M. Ohman (Durham, US), R.F. Storey (Sheffield, GB), D. Zahger (Beer Sheva, IL)
Pregnancy: questions and answers to the panellists.
– V. Regitz-Zagrosek (Berlin, DE)
Panelists.
– C. Gohlke-Baerwolf (Ballrechten-Dottingen, DE), A.H.E.M. Maas (Zwolle, NL), P. Presbitero (Rozzano, IT)
3840
3841
3842
3843
10:45-12:05 | Hands-On Tutorial Room 1 - Zone B
RIGHT VENTRICULAR ASSESSMENT BY REAL-TIME 3-DIMENSIONAL
ECHOCARDIOGRAPHY
Chairperson(s): H.B. van der Zwaan (Rotterdam, NL); J. Vletter-McGhie (Schipluiden, NL)
Hands-On Tutorial organised by Siemens AG, Healthcare Sector (on-site registration)
Hands-On Tutorial
10:45-12:15 | Hands-On Tutorial Room 2 - Zone B
HOME HEALTH APPLICATIONS FOR HEART FAILURE MANAGEMENT
Chairperson(s): C. Medd (Troinex, CH)
Hands-On Tutorial organised by GE Healthcare (on-site registration)
Hands-On Tutorial
11:00-12:30 | London - Zone A
MULTIMODALITY IMAGING IN PATIENTS WITH CORONARY ARTERY DISEASE –
LIVE FROM SPAIN
Chairperson(s): V. Fuster (New York, US); J.L. Zamorano Gomez (Madrid, ES)
Focus Imaging Intervention
Patient 1 - Patient with chest pain, intermediate probability of coronary heart disease and
inconclusive exercise stress test. What to do next? - LIVE.
Patient 1 - 3D stress echo assessment of ischemia. The new “independent observer” of automatic
quantitative 3D stress echo - LIVE.
Patient 2 - CT scan. Patient preparation and acquisition - Role of CT scan in the clinical scenario.
Practical reading with step by step approach - LIVE.
Live interventionists in clinic San Carlos University Hospital, Madrid.
– C. Fernandez-Gofin Loban (Madrid, ES), A. Goncalves (Porto, PT), P. Marcos-Alberca Moreno (Madrid, ES)
Panel.
– V. Delgado (Leiden, NL), F.E. Rademakers (Leuven, BE)
3844
3845
11:00-12:30 | The Hague - Zone A
Focus Cardiology Practice
TUESDAY – MORNING
SPORT AND THE HEART
Chairperson(s): A. La Gerche (Brussels, BE); L. Mont (Barcelona, ES)
Cardiac evaluation of the million dollar heart: assessment of the elite athlete.
Too much of a good thing . . . atrial arrhythmias in ultra-endurance.
Cardiac rehabilitation: exercise is the magic bullet!
Panel.
– A.J. Camm (London, GB), V. Conraads (Edegem, BE), F. Carre (Rennes, FR)
3846
237
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Rabat - Zone A (QR 509*)
MODULATORS OF INJURY AND PROTECTION IN ISCHAEMIA AND REPERFUSION
Chairperson(s): D.J. Hausenloy (London, GB); M. Ovize (Lyon, FR)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Secretome of apoptotic peripheral blood cells reduces myocardial damage after acute ischaemia
and prevents ventricular remodelling: a preclinical study.
– M. Lichtenauer, M. Mildner, K. Hoetzenecker, M. Zimmermann, B.K. Podesser, W. Sipos, E. Berenyi,
E. Tschachler, M. Gyoengyoesi, H.J. Ankersmit (Vienna, AT; Debrecen, HU)
miR-223 is critically involved in cardiac remodelling after myocardial infarction in mice.
– C. Troidl, H. Moellmann, F. Rybinsky, J. Wilhelm, S. Szardien, S. Voss, J. Hoffmann, K. Troidl, C.W. Hamm,
H. Nef (Bad Nauheim and Giessen, DE)
Ischaemic postconditioning confers protection via TNF-alpha: identifying the cellular origin of
TNF-alpha.
– L. Lacerda, M. Jacobs, L.H. Opie, S. Lecour (Cape Town, ZA)
Cardioprotective potential of heme oxygenase-1 in models of acute myocardial infarction.
– R. Hinkel, E. Gottlieb, B. Petersen, M. Thormann, J.C. Horstkotte, S. Lee, D. Qin, P. Wenzel, H. Niemann,
C. Kupatt (Munich, neaustadt a. Rgbe. and Mainz, DE)
Deletion of macrophage migration inhibitory factor protects the heart from severe
ischemia-reperfusion injury: A predominant role of anti-inflammation.
– X.-M. Gao, Y. Liu, D. White, Y.D. Su, B.G. Drew, C.R. Bruce, R. Bucala, G. Fingerle-Rowson, A.M. Dart,
X.-J. Du (Melbourne, AU; New Haven, US; Cologne, DE)
Asialoerythropoietin, a nonerythropoietic derivative of erythropoietin, displays broad anti-heart
failure activity.
– T. Takeyama, G. Takemura, H. Kanamori, A. Ogino, T. Kawaguchi, T. Watanabe, T. Fujiwara, H. Fujiwara,
S. Minatoguchi (Gifu, Kyoto and Hyogo, JP)
3847
3848
3849
3850
3851
3852
11:00-12:30 | Stockholm - Zone A (QR 519*)
BASICS IN HEART FAILURE
Chairperson(s): E.K. Iliodromitis (Athens, GR); S. Janssens (Leuven, BE)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Gain-of-function defect in the RyR2 promotes myocardial remodeling and heart failure in murine
hearts under pressure-induced overload.
– S. Sedej, A. Schmidt, S. Walther, M. Denegri, E. Bisping, F.R. Heinzel, C. Napolitano, S. Priori,
J. Kockskamper, B. Pieske (Graz, AT; Pavia, IT)
Nuclear export of HDAC4 mediates histone demethylation at H3K9 in the promoter region of ANF
in response to elevated preload.
– M. Hohl, J.-C. Reil, M. Tauchnitz, A.M. Zimmer, S.-A. Mueller, L.H. Lehmann, M.M. Kreusser, J. Backs,
M. Böhm, C. Maack (Homburg/Saar and Heidelberg, DE)
Dysregulation of microRNAs in diabetic post-ischemic heart failure patients.
– S. Greco, P. Fasanaro, S. Castelvecchio, Y. D’Alessandra, L. Menicanti, D. Arcelli, M. Di Donato,
A. Malavazos, C.M. Capogrossi, F. Martelli (San Donato Milanese, Rome and Milan, IT)
The activation of natural killer T cells ameliorates post-infarct heart failure in mice.
– M.A. Sobirin, S. Kinugawa, M. Takahashi, T. Ono, A. Fukushima, T. Yokota, T. Homma, N. Ishimori,
K. Iwabuchi, H. Tsutsui (Semarang, ID; Sapporo, JP)
STAT3 preserves dynamic control of mitochondrial NAD(P)H redox state to prevent
ROS-production after beta-adrenergic stimulation.
– M. Kohlhaas, A. Nickel, J.A. Saar, B. Stapel, M. Hohl, I. Bogeski, R. Kappl, M. Böhm, D. Hilfiker-Kleiner,
C. Maack (Homburg and Hannover, DE)
Mitochondrial transhydrogenase is a key regulator of antioxidative capacity in cardiac myocytes.
– A. Nickel, A. Von Hardenberg, M. Kohlhaas, J.-C. Reil, M. Hohl, S.-L. Puhl, A. Kasakov, B. Pasieka,
I. Bogeski, C. Maack (Homburg, DE)
3853
3854
3855
3856
3857
3858
11:00-12:30 | Tel Aviv - Zone A
EXPERIMENTAL TREATMENT OF HEART FAILURE
Chairperson(s): M.S. Nieminen (Helsinki, FI); P. de Groote (Lille, FR)
11:00
11:22
11:45
12:07
Soluble guanylate cyclase activators.
– V. Mitrovic (Bad Nauheim, DE)
Novel natriuretic peptides.
– F. Ruschitzka (Zurich, CH)
Ranolazine in heart failure with preserved ejection fraction.
– L.S. Maier (Göttingen, DE)
Cardiac myosin activators.
– J.R. Teerlink (San Francisco, US)
*Abstracts can
be accessed at:
238
QR 509
QR 519
Symposium
3859
3860
3861
3862
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Tripoli - Zone A (QR 521*)
REVISITING PROGNOSIS IN HEART FAILURE?
Chairperson(s): W. Banasiak (Wroclaw, PL); V. Mareev (Moscow, RU)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Heart failure mortality has more than halved in young adults: a Swedish registry study from 1987
to 2006.
– A. Barasa, A. Rosengren, K. Swedberg, M. Schaufelberger (Gothenburg, SE)
Impaired fasting glucose: a predictor of increased morbidity and mortality in patients with heart
failure.
– I. Gotsman, D. Zwas, D. Admon, C. Lotan, A. Keren (Jerusalem, IL)
Frequency and timing of heart failure readmissions in the netherlands.
– J.A. Overbeek, F.J.A. Penning-Van Beest, R.M.C. Herings, I. Agodoa (Utrecht, NL; Thousand Oaks, US)
Depressive symptoms and antidepressants in heart failure: a prospective long-term mortality
follow-up study.
– C. Diez, J. Lupon, B. Gonzalez, L. Cano, R. Cabanes, M. De Antonio, A. Urrutia, S. Altimir, R. Coll,
A. Bayes-Genis (Badalona, ES)
Why and how do patients with heart failure die? Insights from the TIME-CHF trial.
– P. Rickenbacher, M. Pfisterer, T. Burkard, W. Kiowski, F. Follath, D. Burckhardt, R. Schindler,
H.-P. Brunner-La Rocca (Bruderholz, Basel and Zurich, CH; Maastricht, NL)
Lipopolysaccharide responsiveness is an independent predictor of death in chronic heart failure.
– N. Ebner, T. Kung, G. Foeldes, A. Sandek, J. Springer, E. Jankowska, S. Genth-Zotz, W. Doehner,
S.D. Anker, S. Von Haehling (Berlin, DE; London, GB)
3863 (W)
3864
3865
3866
3867
3868
11:00-12:30 | Vienna - Zone A
HIGH THROUGHPUT TECHNOLOGY IN CONGENITAL HEART DISEASE
Chairperson(s): D. Franco (Jaen, ES); B.D. Keavney (Newcastle-upon-Tyne, GB)
11:00
11:22
11:45
12:07
Next generation sequencing to map mutations.
– A. Postma (Amsterdam, NL)
Meta-analysis of microarray data.
– S. Sperling (Berlin, DE)
High throughput phenotyping in mouse models.
– S. Bhattacharya (Oxford, GB)
Screening for mutations in the zebrafish.
– W. Rottbauer (Ulm, DE)
Symposium
3869
3870
3871
3872
11:00-12:30 | Warsaw - Zone A
11:00
11:22
11:45
12:07
Invasive and non-invasive monitoring.
– J.T. Parissis (Athens, GR)
Pathophysiology: impact on management.
– J.S. Hochman (New York, US)
Medical therapy.
– G. Jondeau (Paris, FR)
Mechanical support.
– E. Roig (Barcelona, ES)
Symposium
3873
3874
3875
3876
TUESDAY – MORNING
CARDIOGENIC SHOCK
Chairperson(s): V.-P. Harjola (Helsinki, FI); A. Mebazaa (Paris, FR)
11:00-12:30 | Hands-On Tutorial Room 3 - Zone B
HYPOTHERMIA FOR CARDIAC PROTECTION IN ACUTE MYOCARDIAL INFARCTION
Chairperson(s): D. Erlinge (Lund, SE)
Hands-On Tutorial organised by Philips Healthcare (on-site registration)
*Abstracts can
be accessed at:
Hands-On Tutorial
QR 521
239
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Moscow - Zone B (QR 531*)
IMPROVING CARE FOR PATIENTS WITH CHANNELOPATHIES: WHAT’S NEW?
Chairperson(s): S.G. Priori (Pavia, IT); R. Brugada Terradellas (Girona, ES)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Phenotype variability in patients carrying KCNJ2 mutations.
– H. Kimura, J. Zhou, H. Itoh, Y. Mizusawa, A. Miyamoto, M. Kawamura, T. Makiyama, M. Ito, H. Matsuura,
M. Horie (Otsu and Kyoto, JP)
Clinical outcome and therapeutic strategies in non proband children with genetically confirmed
LQTS.
– V. Probst, A. Brondex, F. Kyndt, J.J. Schott, S. Chatel, S. Beziau, H. Le Marec (Nantes, FR)
Mechanism of the Brugada syndrome: a novel loss of cAMP-dependent protein kinase
A-mediated Na channel Phosphorylation.
– T. Aiba, F. Farinelli, G. Hesketh, D. Edwards, R. Sekar, S. Biswas, W. Shimizu, G.F. Tomaselli (Suita, JP;
Baltimore, US)
N-3 fatty acids is associated with preventing ventricular arrhythmia in patients with Brugada-type
electrocardiogram.
– M. Tanaka, K. Nakamura, K. Nakagawa, M. Murakami, D. Miura, N. Nishii, S. Nagase, H. Morita,
K. Kusano, H. Ito (Okayama, JP)
Comparison of efficacy and safety of intravenous ajmaline vs. intravenous flecainide for the
diagnosis of Brugada syndrome among first-degree family members.
– P. Berne, J.M. Porres, I. Fernandez-Lozano, J.A. Arnaiz, L. Mont, A. Berruezo, R. Brugada, J. Brugada
(Barcelona, San Sebastian, Madrid, Valencia and Girona, ES)
Value of C-reactive protein in patients with asymptomatic and symptomatic Brugada syndrome.
– A. Bonny, F. Hidden-Lucet, I. Ditah, F. Larrazet, R. Frank, G. Fontaine (Paris and Bry sur marne, FR; Detroit,
US)
3877
3878
3879
3880
3881
3882
11:00-12:30 | Oslo - Zone B
JOINT GUIDELINES FOR THE DETECTION AND TREATMENT OF DYSLIPIDEMIAS
Chairperson(s): A. Catapano (Milan, IT); Z. Reiner (Zagreb, HR)
The Committee for Practice Guidelines
11:00
11:18
11:36
11:54
12:12
Symposium
Plasma lipids and global cardiovascular risk.
– I.M. Graham (Dublin, IE)
Controlled clinical trials and cardiovascular risk.
– G. De Backer (St. Martens Latem, BE)
The new joint Guidelines: an overview.
– M.-R. Taskinen (Helsinki, FI)
New biomarkers for atherosclerosis.
– O. Wiklund (Gothenburg, SE)
Panel discussion.
3883
3884
3885
3886
11:00-12:30 | Prague - Zone B
CONTROVERSIAL ISSUES IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
Chairperson(s): B. Merkely (Budapest, HU); J.G.F. Cleland (Kingston-upon-Hull, GB)
11:00
11:22
11:45
12:07
Should implantable cardioverter-defibrillator replacement be performed in octogenarians and/or
severe comorbidities?
– J.C. Daubert (Rennes, FR)
Implantable cardioverter-defibrillator replacement in patients with improved left-ventricular
ejection fraction.
– E. Erdmann (Cologne, DE)
Are implantable cardioverter-defibrillators overused in non-ischaemic cardiomyopathies?
– M.J. Schalij (Voorschoten, NL)
How appropriate are MADIT II criteria for patient selection?
– W. Zareba (Rochester, US)
*Abstracts can
be accessed at:
240
Clinical Seminar
QR 531
3887
3888
3889
3890
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Riga - Zone B (QR 648*)
YOU NEED PLUMBERS AND ELECTRICIANS TO BUILD A HOUSE
Chairperson(s): D. Himbert (Paris, FR); F.R. Eberli (Zurich, CH)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Transcatheter left atrial appendage occlusion in atrial fibrillation: comparison of non-dedicated
versus dedicated amplatzer devices.
– S. Gloekler, M. Schmid, A.A. Saguner, A.A. Khattab, A. Wahl, P. Wenaweser, S. Windecker, B. Meier
(Berne, CH)
Using the HAS-BLED bleeding risk score in patients with atrial fibrillation undergoing coronary
stenting: useful or not?
– J.M. Ruiz Nodar, F. Marin, V. Roldan, J. Valencia, S. Manzano-Fernandez, L. Caballero, J.A. Hurtado,
F. Sogorb, M. Valdes, G.Y.H. Lip (Alicante and Murcia, ES; Birmingham, GB)
Complete atrioventricular block after percutaneous closure of perimembranous ventricular septal
defect with modified double-disk occluder.
– Y. Bai, Y.W. Qin, X.X. Zhao, X. Zheng, H. Wu, S.P. Chen, J.Q. Hu, X.M. Huang, X.H. You, W.P. Li
(Shanghai, CN)
Changes in QRS duration during trans-catheter aortic valve implantation strongly predicts the risk
of permanent pacing.
– G. Mouillet, N. Lellouche, P. Lim, J.L. Monin, E. Fougeres, P.F. Lesault, B. Gellen, S. Champagne,
J.L. Dubois-Rande, E. Teiger (Créteil, FR)
Incidence and clinical significance of new bundle branch block in patients undergoing
transcatheter aortic valve implantation with the Medtronic corevalve and Edwards’ Sapien
prosthesis.
– A. Radinovic, S. Sala, A. Latib, M. Mussardo, N. Sora, G. Paglino, M. Montorfano, M. Gullace, P. Della
Bella, A. Colombo (Milan, IT)
Permanent pacemaker implantation and cardiac conduction disorders following transcatheter
aortic valve implantation with the Medtronic-CoreValve bioprosthesis.
– K. Boerlage-Van Dijk, Z.Y. Yong, K.T. Koch, M.M. Vis, B.J. Bouma, J.P.S. Henriques, R. Cocchieri,
J.J. Piek, J. Baan (Amsterdam, NL)
3891
3892
3893
3894
3895
3896
11:00-12:30 | Rome - Zone B (QR 644*)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
The extent of right ventricular electroanatomic scar predicts malignant arrhythmic events in
patients with arrhythmogenic right ventricular cardiomyopathy.
– F. Migliore, A. Zorzi, L. Leoni, B. Bauce, M. Perazzolo, C. Basso, G. Buja, G. Thiene, S. Iliceto, D. Corrado
(Padua, IT)
Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular
cardiomyopathy/dysplasia.
– S. Peters, M. Truemmel, B. Koehler (Gronau and Quedlinburg, DE)
Multidisciplinary approach to exercise-related sudden death families: a multicentric registry.
– E. Zorio Grima, J.R. Gimeno Blanes, T. Ripoll Vera, L. Monserrat Iglesias, P. Garcia Pavia, B. Aguilera Tapia,
A. Boraita Perez, J. Giner Blasco, J.P. Hernandez Rincon, X. Fosch Mur (Valencia, Murcia, Palma de
Mallorca, A Coruña and Madrid, ES)
Reduced risk of sudden cardiac death after alcohol septal ablation in patients with hypertrophic
obstructive cardiomyopathy.
– M. Jensen, C. Prinz, D. Horstskotte, F. Buuren, T. Bitter, L. Faber, H. Bundgaard (Copenhagen, DK; Bad
Oeynhausen, DE)
High risk of sudden death in hypertrophic cardiomyopathy caused by mutations in troponin T
gene: a cohort study of 161 families.
– D. Muniz Tolivia, T. Ripoll Vera, B. Garcia De La Villa, N. Govea, J.M. Gamez, R. Moreno, X. Fosch, A. Grau,
D. Cremer, J. Torres (Palma de Mallorca and Manacor, ES)
Complications in the clinical course of tako-tsubo cardiomyopathy: results of the German
Tako-Tsubo registry.
– B. Schneider, A. Athanasiadis, W. Pistner, J. Schwab, U. Gottwald, R. Schoeller, W. Toepel, K.-D. Winter,
T. Mueller-Honold, U. Sechtem (Lübeck, Stuttgart, Aschaffenburg, Nuremberg, Celle, Berlin, Idar-Oberstein,
Erkelenz and Augsburg, DE)
*Abstracts can
be accessed at:
QR 648
3897
3898
3899
3900
TUESDAY – MORNING
DETERMINANTS OF SUDDEN DEATH AND ARRHYTHMIAS IN CARDIOMYOPATHIES
Chairperson(s): E. Aliot (Vandoeuvre-lès-Nancy, FR); A. Keren (Jerusalem, IL)
3901
3902
QR 644
241
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Sofia - Zone B (QR 533*)
BLEEDING – THE DARK SIDE OF ANTI-THROMBOTIC THERAPY
Chairperson(s): F. Arribas Ynsaurriaga (Madrid, ES); L.C. Wallentin (Uppsala, SE)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Predicting bleeding risk in “real world” patients with atrial fibrillation with or without
anticoagulation: a comparison of two established bleeding prediction schemes in a nationwide
cohort study.
– J.B. Olesen, G.Y.H. Lip, P.R. Hansen, J. Lindhardsen, O. Ahlehoff, C. Andersson, P. Weeke, M.L. Hansen,
G.H. Gislason, C. Torp-Pedersen (Copenhagen, DK; Birmingham, GB)
Apixaban in patients with atrial fibrillation and their risk for cardiovascular hospitalization: insights
from the AVERROES trial.
– S. Hohnloser, S. Yusuf, J. Eikelboom, G. Steg, D. Atar, A. Budaj, D. Halon, C.P. Lau, L.S. Piegas,
S.J. Connolly (Frankfurt, DE; Hamilton, CA; Paris, FR; Oslo, NO; Warsaw, PL; Haifa, IL; Hong Kong, HK;
São Paulo, BR)
VKA treatment and bleeding rate of patients aged older than 80 years: results from a prospective
collaborative study.
– D. Poli, E. Antonucci, L. Di Gennaro, A. Falanga, F. Marongiu, S. Pedrini, S. Testa, W. Ageno, G. Palareti
(Florence, Rome, Bergamo, Cagliari, Brescia, Varese and Bologna, IT)
Warfarin and the risk of major bleeding events in patients with atrial fibrillation: a
population-based study.
– L. Azoulay, S. Dell’Aniello, T. Simon, C. Renoux, S. Suissa (Montreal, CA; Lawrenceville, US)
Combination therapy with warfarin and amiodarone increases risk of bleeding in patients with
atrial fibrillation - a nationwide study.
– S.S. Andersen, J. Raunso, M. Schmiegelow, J. Olesen, C.L.W. Selmer, M. Lambert, G.H. Gislason,
C. Torp-Pedersen, M.L. Hansen (Copenhagen, DK)
Clopidogrel or apixaban in atrial fibrillation patients unsuitable for vitamin-K antagonists for
stroke prevention in atrial fibrillation? Lessons from the recent aspirin-controlled trials.
– F.W.A. Verheugt, J. Jaspersfocks, M.A. Brouwer (Amsterdam and Nijmegen, NL)
3903
3904
3905
3906
3907
3908
11:00-12:30 | Brussels - Zone D
EUROBSERVATIONAL RESEARCH PROGRAMME OF THE ESC. ONGOING REGISTRIES
Chairperson(s): M.A. Alonso Garcia (Madrid, ES); D.V. Cokkinos (Athens, GR)
11:00
11:22
11:45
12:07
EORP: what and why.
– L. Tavazzi (Cotignola, IT)
General Registry: Heart Failure.
– A.P. Maggioni (Florence, IT)
Sentinel Registry: Ablation in Atrial Fibrillation.
– J. Brugada Terradellas (Barcelona, ES)
Special Registry: Pregnancy in Cardiac Disease.
– J.W. Roos-Hesselink (Rotterdam, NL)
Symposium
3909
3910
3911
3912
11:00-12:30 | Copenhagen - Zone D
MEET THE CHALLENGE ALONG THE CARDIOVASCULAR CONTINUUM
Chairperson(s): M. Tendera (Katowice, PL); D. Hu (Beijing, CN)
The European Society of Cardiology and the Chinese Society of Cardiology
11:00
11:22
11:45
12:07
High risk - how to identify atherosclerosis.
– H. Li (Beijing, CN)
What to treat in diabetics: blood pressure, glucose or lipids.
– T.F. Luescher (Zurich, CH)
Treatment strategies for coronary artery disease in China.
– Y. Yang (Beijing, CN)
Heart failure treatment: focus on comorbidities.
– R.A. De Boer (Groningen, NL)
*Abstracts can
be accessed at:
242
QR 533
Symposium
3913
3914
3915
3916
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Damascus - Zone D (QR 555*)
IMPROVING RISK ASSESSMENT
Chairperson(s): L. Tokgozoglu (Ankara, TR); D. Vanuzzo (Udine, IT)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Effect of hypercholesterolemia on cardiovascular function in children.
– G. Di Salvo, A.F. D’Aiello, L. Baldini, B. Castaldi, F. Del Gaizo, A. Mormile, G. Pacileo, L. Perrone,
M.G. Russo, R. Calabro (Milan and Naples, IT)
Improving cardiovascular risk prediction by adding parental history of myocardial infarction to the
SCORE risk function.
– I. Van Dis, D. Kromhout, J.M. Geleijnse, J.M.A. Boer, W.M.M. Verschuren (The Hague, Wageningen and
Bilthoven, NL)
Socio-economic risk factors in the community-based PEP Family Heart Study.
– G.-M. Haas, E. Liepold, P. Schwandt (Munich, DE)
Contribution of known genetic variants to increased risk of type-2 diabetes in Indian Asians.
– J. Sehmi, I.Y. Yeo, S. Salaheen, W. Zhang, D. Das, J. Danesh, E.S. Tai, M.I. McCarthy, J.C. Chambers,
J.S. Kooner (London, Cambridge and Oxford, GB; Singapore, SG)
Socioeconomic factors and concomitant diseases are related to the risk for venous
thromboembolism during 13 years of prospective follow-up.
– A. Gottsater, N. Isma, P.J. Svensson, B. Lindblad, J. Merlo, H. Ohlsson (Malmo, SE)
Serum beta2-microglobulin levels predict cardiovascular and all-cause mortality in patients on
chronic hemodialysis.
– Y. Kumada, H. Ishii, H. Takahashi, T. Aoyama, M. Tanaka, D. Kamoi, Y. Kawamura, K. Kawashima,
T. Murohara (Nagoya, JP)
3917
3918
3919
3920
3921
3922
11:00-12:30 | Helsinki - Zone D
LET’S TALK ABOUT SEX
Chairperson(s): D. Fitzsimons (Belfast, GB); L. Braun (Chicago, US)
11:00
11:22
11:45
12:07
Symposium
The physician’s role: what is effective management?
– G. Jackson (Croydon, GB)
Sexual dysfunction in men and women with heart disease - what do we know?
– E. Steinke (Wichita, US)
What is the current practice of cardiovascular nurses in Europe?
– T.M. Norekval (Bjoroyhamn, NO)
Do we have enough evidence to guide practice?
– T. Jaarsma (Norrkoping, SE)
3923
3924
3925
3926
11:00-12:30 | Lisbon - Zone D (QR 556*)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Trends of increasing medical radiation exposure in a population hospitalized for cardiovascular
disease (1970-2010).
– C. Carpeggiani, P. Landi, C. Michelassi, P. Marraccini, E. Picano (Pisa, IT)
Constructing a composite quality score for the care of acute myocardial infarction patients at
discharge.
– F. Schiele, M. Couralet, S. Guerin, C. Gardel, P. Loirat, E. Minvielle (Besançon, Villejuif and Saint Denis, FR)
Selection of aortic valve replacement versus transcatheter aortic valve implantation in high-risk
patients: a Markov model.
– H.G. Gada, T.M. Marwick (Cleveland, US)
Cost analysis of early cardiac device infections.
– B. Saberwal, S.Y. Ahsan, P. Lambiase, O. Segal, M. Lowe, C. Koo, L. Nunn, A.B. Gopalamurugan,
E. Rowland, A.W.C. Chow (London, GB)
Recent time trends in the incidence and case-fatality of coronary heart disease: the contribution
of interrupted-MIs in men and women 35-74 years old.
– M. Ferrario, G. Veronesi, L.E. Chambless, A. Borsani, S. Conti, C. Fornari, G. Cesana (Varese and Milan, IT;
Chapel Hill, US)
Cost evaluation of cardiac magnetic resonance imaging versus coronary angiography for the
work-up of coronary artery disease.
– K. Moschetti, C. Pinget, S. Muzzarelli, D. Locca, O. Bruder, H. Mahrholdt, J. Schwitter (Lausanne, CH;
Essen and Stuttgart, DE)
*Abstracts can
be accessed at:
QR 555
3927
3928
3929
TUESDAY – MORNING
NEW APPROACHES FOR BETTER QUALITY OF CARE
Chairperson(s): P. Giannuzzi (Veruno, IT); J. Perk (Kalmar, SE)
3930
3931
3932
QR 556
243
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Madrid - Zone D
SUBCLINICAL ATHEROSCLEROSIS – HOW TO DETECT AND WHEN TO TREAT
Chairperson(s): M. Naghavi (Houston, US); H. Saner (Berne, CH)
11:00
11:22
11:45
12:07
Symposium
Detection of subclinical carotid atherosclerosis.
– J.D. Spence (London, CA)
Detection of subclinical coronary atherosclerosis.
– G. Nickenig (Bonn, DE)
Can serum biomarkers add to decision making?
– W. Koenig (Ulm, DE)
How do current guidelines apply to subclinical atherosclerosis.
– D.A. Wood (London, GB)
3933
3934
3935
3936
11:00-12:30 | Beirut - Zone E (QR 559*)
CURRENT CLINICAL ASPECTS AND IMAGING OF PULMONARY ARTERIAL HYPERTENSION
Chairperson(s): J.S.R. Gibbs (London, GB); N. Galie (Bologna, IT)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
The changing picture of patients with pulmonary arterial hypertension in France.
– O. Sitbon, A. Yaici, V. Cottin, E. Bergot, G. Prevot, L. Rottat, V. Gressin, M. Humbert, G. Simonneau
(Clamart, Lyon, Caen, Toulouse and Paris, FR)
Survival in patients with pulmonary arterial hypertension associated with connective tissue
disease over the past decade.
– C.J. Valerio, B.E. Schreiber, C. Handler, C.P. Denton, J.G. Coghlan (London, GB)
Long-term survival in pulmonary arterial hypertension: the REVEAL registry.
– R.L. Benza, D.P. Miller, R.J. Barst, D.B. Badesch, A.E. Frost, M.D. McGoon (Pittsburgh, San Francisco,
New York, Denver, Houston and Rochester, US)
ESC-ERS 2009 pulmonary hypertension guidelines: an evaluation study in 9 European countries
(the guide to PH study).
– E. Leci, M. Palazzini, F. Sgro’, A. Manes, E. Conficoni, E. Beciani, C. Bachetti, E. Gotti, A. Branzi, N. Galie’
(Bologna, IT)
Right ventricular longitudinal peak systolic strain and long-term outcome of patients with
pulmonary hypertension.
– M.L.A. Haeck, R.W.C. Scherptong, N. Ajmone Marsan, E. Holman, H.W. Vliegen, M.J. Schalij, J.J. Bax,
V. Delgado (Leiden, NL)
Novel application of phase-contract cardiac magnetic resonance imaging in assessment of right
ventricle contractile status with maximal ventricular power divided by the square of end-diastolic
volume.
– H. Ide, T. Ueno, K. Ishimaru, M. Taira, S. Hamada, T. Kuratani, T. Sakaguchi, Y. Sawa (Osaka, JP)
3937
3938
3939
3940
3941
3942
11:00-12:30 | Berne - Zone E
ADVANCES IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Chairperson(s): D.T. Kremastinos (Athens, GR); P. Charron (Paris, FR)
11:00
11:22
11:45
12:07
Clinical Seminar
Recent advances in genetics.
– P. Van Tintelen (Groningen, NL)
Pathophysioloy and contribution of histology.
– M. Delmar (New York, US)
New insights into the electrophysiology of arrhythmogenic right ventricular cardiomyopathy.
– P. Lambiase (London, GB)
Long-term outcomes and indications for defibrillator.
– D. Corrado (Padua, IT)
3943
3944
3945
3946
11:00-12:30 | Bratislava - Zone E
NEUROCARDIAC IMAGING: AT THE HEART OF ELECTRICAL DISTURBANCES
Chairperson(s): P. Chevalier (Lyon, FR); N. Bruining (Rotterdam, NL)
11:00
11:22
11:45
12:07
Innervation of the heart.
– S.Y. Ho (London, GB)
Positron emission tomography.
– M.P. Law (Münster, DE)
Nuclear cardiology MIBG scintigraphy.
– D. Le Guludec (Paris, FR)
Cardiac magnetic resonance.
– A.P. Wijnmaalen (Leiden, NL)
*Abstracts can
be accessed at:
244
QR 559
Symposium
3947
3948
3949
3950
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Bucharest - Zone E
FUNCTIONAL VERSUS ANATOMIC DIAGNOSTIC ASSESSMENT OF CORONARY ARTERY
DISEASE
Chairperson(s): L. Badano (Padua, IT); A.N. Kitsiou (Athens, GR)
11:00
11:22
11:45
12:07
Clinical Seminar
Morphology.
– G. Korosoglou (Heidelberg, DE)
Function.
– F. Carreras Costa (Barcelona, ES)
Perfusion.
– D. Neglia (Pisa, IT)
A combined approach.
– O. Gaemperli (Zurich, CH)
3951
3952
3953
3954
11:00-12:30 | Budapest - Zone E
IMAGING IN PERCUTANEOUS VALVE THERAPY
Chairperson(s): O.W. Franzen (Copenhagen, DK); J.J. Bax (Leiden, NL)
11:00
11:22
11:45
12:07
Symposium
Update on percutaneous mitral valve therapy.
– A. Vahanian (Paris, FR)
Update on percutaneous aortic valve therapy.
– R. Erbel (Essen, DE)
Imaging in percutaneous mitral valve therapy.
– E.M. Tuzcu (Cleveland, US)
Imaging in percutaneous aortic valve therapy.
– S.R. Kapadia (Cleveland, US)
3955
3956
3957
3958
11:00-12:30 | Cairo - Zone E
CONGENITAL AORTIC VALVE DISEASE AND AORTOPATHY: RECENT ADVANCES
Chairperson(s): P. Trigo Trindade (Basel, CH); M.J. Antunes (Coimbra, PT)
11:00
11:22
11:45
12:07
Symposium
Bicuspid aortic valve: from congenital heart disease to active valve remodelling.
– J.J. Kaden (Mannheim, DE)
Management of ascending aortic aneurysms.
– A. Evangelista Masip (Barcelona, ES)
Management of aortic coarctation and recoarctation in adults.
– M. Carminati (San Donato, IT)
Sub- and supravalvular aortic stenoses.
– H. Baumgartner (Münster, DE)
3959
3960
3961
3962
11:00-12:30 | Ankara - Zone F (QR 588*)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
The late consequences of acute coronary syndromes: 2-year follow-up outcomes, procedures,
and treatment of patients from the Global Registry of Acute Coronary Events (GRACE).
– S. Goodman, W. Huang, J.M. Gore, P.G. Steg, K.A. Eagle, F.A. Anderson, K.A.A. Fox (Toronto, CA;
Worcester and Ann Arbor, US; Paris, FR; Edinburgh, GB)
Long-term survival after AMI according to anti-anginal therapy at discharge: the FAST-MI registry.
– E. Puymirat, N. Aissaoui, L. Lorgis, L. Bonello, V. Bataille, G. Mulak, E. Drouet, J. Ferrieres, T. Simon,
N. Danchin (Paris, Dijon, Marseille and Toulouse, FR)
Lack of effect of beta-blocker therapy in patients with ST-elevation acute myocardial infarction in
PCI era.
– B. Bao, N. Ozasa, T. Morimoto, Y. Furukawa, M. Shirotani, H. Ogawa, C. Tei, H. Fujiwara, K. Mitsudo,
T. Kimura (Kyoto, Kobe, Nara, Kumamoto, Kagoshima, Amagasaki and Kurashiki, JP)
Prediction of long-term survival in patients receiving optimal secondary prevention therapy after
acute myocardial infarction: the FAST-MI registry.
– E. Puymirat, N. Aissaoui, G. Lemesle, L. Lorgis, J.J. Dujardin, E. Drouet, G. Mulak, J. Ferrieres, T. Simon,
N. Danchin (Paris, Lille, Dijon, Douai and Toulouse, FR)
Effect of postconditioning on infarct size and ejection fraction in patients with ST elevation
myocardial infarction - one year follow-up.
– P. Sorensson, H. Arheden, L. Ryden, N. Saleh, P. Tornvall, J. Pernow (Stockholm and Lund, SE)
QRS score at discharge from hospital is still an independent predictor of survival during ten-year
follow-up of patients with acute myocardial infarction treated with thrombolytic therapy.
– B. Stefanovic, P. Mitrovic, Z. Vasiljevic, G. Matic, N. Radovanovic, A. Karadzic, A. Milosevic,
M. Radovanovic, J. Jankovic, A. Novakovic (Belgrade, RS)
*Abstracts can
be accessed at:
3963
TUESDAY – MORNING
POST MYOCARDIAL INFARCTION – CAN WE DO MORE?
Chairperson(s): U. Zeymer (Ludwigshafen, DE); B. Lindahl (Uppsala, SE)
3964
3965
3966
3967
3968
QR 588
245
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Athens - Zone F
CONTROVERSIAL ISSUES ON LATE-COMERS WITH STEMI
Chairperson(s): D. Dudek (Krakow, PL); D. Milicic (Zagreb, HR)
11:00
11:22
11:45
12:07
Clinical Seminar
The dimension of the problem.
– P. Widimsky (Prague, CZ)
When is late too late?
– F. Van de Werf (Leuven, BE)
The open-artery hypothesis revisited.
– V. Dzavik (Toronto, CA)
Options beyond revascularisation.
– A.M. Zeiher (Frankfurt, DE)
3969
3970
3971
3972
11:00-12:30 | Belgrade - Zone F
HOW TO PERFORM HYBRID MYOCARDIAL REVASCULARISATION
Chairperson(s): A. Repossini (Brescia, IT); R.M.C. Cruz Ferreira (Barreiro, PT)
11:00
11:45
How-to Session
Surgical perspective.
– J.O. Bonatti (Baltimore, US)
Interventional perspective.
– G.C. Schuler (Leipzig, DE)
3973
3974
11:00-12:30 | Berlin - Zone F
ANTIPLATELET THERAPY: HOW, WHY, WHEN
Chairperson(s): C. Patrono (Rome, IT); R.F. Storey (Sheffield, GB)
11:00
11:22
11:45
12:07
Clinical Seminar
In primary prevention.
– C. Bode (Freiburg, DE)
In acute coronary syndromes.
– G. Montalescot (Paris, FR)
For coronary stenting.
– D.J. Angiolillo (Jacksonville, US)
In patients with transient ischemic attack/stroke.
– P. Amarenco (Paris, FR)
3975
3976
3977
3978
11:00-12:30 | Paris - Zone F
HOT LINE III – ACUTE CORONARY SYNDROMES
Chairperson(s): R. Ferrari (Ferrara, IT); C. Stefanadis (Athens, GR)
11:00
11:13
11:18
11:31
11:36
11:49
11:54
12:07
12:12
12:25
246
Hot Line
PRODIGY: Randomized comparison of six versus twenty-four months clopidogrel therapy after
balancing anti-intimal hyperplasia stent potency in all comer patients undergoing percutaneous
coronary intervention. Results of the PRODIGY trial.
– M. Valgimigli (Ferrara, IT)
Discussant.
– A. Kastrati (Munich, DE)
The RUBY-1 trial: Safety, tolerability and efficacy of YM150, an oral factor Xa inhibitor, in
secondary prevention of ischaemic vascular events in patients following a acute coronary
syndrome.
– P.G. Steg (Paris, FR)
Discussant.
– S.D. Kristensen (Aarhus, DK)
EXAMINATION: A randomized comparison between everolimus-eluting stent and bare metal stent
in patients with ST-segment elevation myocardial infarction: the EXAMINATION trial.
– M. Sabate Tenas (Barcelona, ES)
Discussant.
– W. Wijns (Aalst, BE)
Newer generation everolimus-eluting stents eliminate the risk of very late stent thrombosis
compared with early generation sirolimus-eluting and paclitaxel-eluting stents.
– L. Raber (Berne, CH)
Discussant.
– J. Fajadet (Toulouse, FR)
CRISP AMI: A multi-center, randomized, controlled study of mechanical left ventricular unloading
with counterpulsation to reduce infarct size pre-PCI for acute myocardial infarction: rationale and
design of the CRISP AMI trial.
– M. Patel (Durham, US)
Discussant.
– K. Huber (Vienna, AT)
3979
3980
3981
3982
3983
3984
3985
3986
3987
3988
TUESDAY, 30 AUGUST 2011 – MORNING
11:00-12:30 | Tunis - Zone F (QR 598*)
TAGGING THE RISK IN VASCULAR DISEASE
Chairperson(s): P. Poredos (Ljubljana, SI); P.A. Sirnes (Moss, NO)
11:00
11:15
11:30
11:45
12:00
12:15
Abstract Session
Increased thermal heterogeneity in carotid arteries as a surrogate marker for coronary artery
disease: first clinical application of microwave radiometry.
– M. Drakopoulou, K. Toutouzas, A. Synetos, H. Nikolaou, K. Masoura, E. Tsiamis, K. Stathogiannis,
C. Grassos, E. Siores, C. Stefanadis (Athens, GR; Bolton, GB)
Progression of asymptomatic carotid stenosis: a risk factor for ipsilateral neurological events.
– L. Hirt (London, GB)
Do vascular markers predict cardiovascular death in primary prevention?
– E. Berard, V. Bongard, J.B. Ruidavets, J. Ferrieres (Toulouse, FR)
Risk factors for intima-media thickening and atherosclerotic plaque development in carotid
arteries.
– B. Sobien, G. Kopec, M. Podolec, H. Dziedzic, J. Zarzecka, B. Loster, P.J. Touboule, M. Desvarieux,
A. Pajak, P. Podolec (Krakow, PL; Paris, FR; New York, US)
Carotid intima-media thickness: differences between aneurysmatic and occlusive disease.
– K.M. Van De Luijtgaarden, M.T. Voute, S.E. Hoeks, E.J. Bakker, T.M. Valentijn, N.J. Ravensbergen,
F. Bastos Goncalves, D. Goei, H.J. Verhagen, D. Poldermans (Rotterdam, NL)
Long term prognosis value of ankle brachial index in coronary artery disease.
– F. Bouisset, V. Bongard, J.B. Ruidavets, D. Taraszkiewicz, M. Galinier, D. Carrie, M. Elbaz, J. Ferrieres
(Toulouse, FR)
3989
3990
3991
3992
3993
3994
11:00-12:30 | Zagreb - Zone F (QR 596*)
PREDICTING THE RISK AND ASSESSING THE PROGNOSIS: UPDATE FROM LARGE STROKE
STUDIES
Chairperson(s): M.V. Huisman (Leiden, NL); G. Agnelli (Perugia, IT)
11:00
11:15
11:30
11:45
12:00
Rates and risk predictors of stroke and its subtypes among people with diabetes mellitus.
– R. Ting, G.J. Hankey, N.E. Anderson, A.-S. Veillard, M. Romo, M. Wosik, D. Sullivan, R. O’Connell, D. Hunt,
A.C. Keech (Sydney, Perth and Melbourne, AU; Auckland, NZ; Helsinki, FI)
The risk of stroke in patients with acute myocardial infarction treated invasively and concomitant
impaired renal function.
– T. Podolecki, J. Kowalczyk, R. Lenarczyk, M. Mazurek, A. Sedkowska, G. Mencel, T. Was, G. Honisz,
L. Polonski, Z. Kalarus (Zabrze, PL)
Fasting serum glucose and risk of stroke in men and women: a 11-year longitudinal study.
– S.V. Ahn, H.C. Kim, I. Suh (Seoul, KR)
The impact of first stroke on the vital prognosis; Akita stroke registry.
– M. Izumi, K. Suzuki, K. Kario (Shimotsuke-city and Akita, JP)
Prognostic value of ambulatory ECG in prediction of stroke.
– Z. Binici, M.R. Mouridsen, L. Kober, A. Sajadieh (Copenhagen, DK)
The association between MMP-9 serum levels and progression of carotid artery atherosclerosis is
modified by statin treatment.
– W.S. Speidl, M. Hoke, J. Amighi, W. Mlekusch, A. Niessner, G. Maurer, R. Koppensteiner, E. Minar,
J. Wojta, M. Schillinger (Vienna, AT)
3995
3996
3997 (W)
3998
3999
4000
TUESDAY – MORNING
12:15
Abstract Session
*Abstracts can
be accessed at:
QR 598
QR 596
247
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
08:30-12:30 | Posters - Poster Zone C
POSTER SESSION 5
Poster Session
Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from
08:30 to 12:30.The presenter should be present throughout the coffee break (10:00 to 11:00) in order to discuss
the Poster.
METABOLIC DYSREGULATION AND CONTROL MECHANISMS (QR 30501*)
Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart
failure.
– N. Merabet, J.B. Bellien, E.G. Glevarec, L.N. Nicol, C.T. Thuillez, P.M. Mulder (Rouen, FR)
PPAR-gamma in coronary atherosclerosis: in vivo expression pattern and correlations with
hyperlipidemic status and statin treatment.
– A. Pucci, L. Formato, E. Brscic, S. Pizzimenti, F. Ferroni, G. Barrera, M. Rinaldi, I. Sheiban, L. Bergamasco,
M.T. Spinnler (Pisa, Moncalieri and Turin, IT)
EPA (eicosapentaenoic acid) levels were lower in the Advanced Stage of Chronic Kidney Disease with
Diabetic Patients.
– Y. Nakano, U. Ueeda, S. Hirohata, S. Kawada, K. Takagaki, A. Takaishi, S. Kusachi, H. Ito, T. Mima
(Imabari, Kanonji and Okayama, JP)
High serum uric acid level is associated with penile vascular disease severity and increased aortic
stiffness in erectile dysfunction patients with metabolic syndrome.
– N. Ioakeimidis, C. Vlachopoulos, P. Xaplanteris, D. Terentes-Printzios, A. Samentzas, K. Rokkas, A. Aggelis,
K. Siama, G. Lazaros, C. Stefanadis (Athens, GR)
Prevalence and prognostic significance of metabolic syndrome in patients with ST-segment elevation
myocardial infarction treated with primary percutaneous coronary intervention.
– I. Stankovic, M. Tesic, V. Kovacevic, V. Giga, S. Aleksandric, Z. Mehmedbegovic, M. Zivkovic, V. Dedovic,
M.M. Ostojic, M.C. Ostojic (Belgrade, RS)
Effect of DAXXK on cardiomyopathy in type 2 diabetic rats.
– Y. Kang, X. Liu (Tianjin, CN)
Acute effects of salt on rat adipose tissue and heart gene expression in vivo.
– M. Caprio, A. Armani, M.J. Young, A. Antelmi, E.Y. Lam, J. Morgan, P. Fuller, G. M.C. Rosano (Rome, IT;
Clayton, AU)
Beneficial effects of ezetimibe on visceral fat in patients with metabolic syndrome.
– H. Takase, Y. Dohi, T. Toriyama, T. Okado, H. Sonoda, A. Hagikura, Y. Goto, T. Hashimoto, G. Kimura
(Hamamatsu and Nagoya, JP)
Insulin resistance increases the incidence of new cardiovascular events in patients with manifest arterial
disease without known diabetes. The SMART study.
– S.N. Verhagen, P.M. Gorter, Y. Van Der Graaf, F.L.J. Visseren (Utrecht, NL)
Impact of metabolic syndrome on arterial stiffness and carotid intima-media thickness in adolescents.
– A. Gonzalez, J. Ferrer, L. Chacin, E. Silva, G. Bermudez, J.J. Villasmil, C. Esis, M. Bracho, S. Briceno
(Maracaibo, VE)
Cardiac effects of DPP-4-inhibition in db/db mice.
– M. Lenski, A. Kazakov, M. Böhm, U. Laufs (Homburg, DE)
Acute and chronic hyperglycaemia: looking for its true meaning.
– L.V. Paiva, R. Providencia, S. Barra, P. Gomes, A.C. Faustino, A.M. Leitao-Marques (Coimbra, PT)
Regular physical exercise training partially corrects metabolic alterations and improves peripheral
endothelial function in pre-diabetic, adipose patients with coronary artery disease.
– R. Hoellriegel, E. Beck, F. Woitek, V. Adams, S. Erbs, M. Blueher, M. Stumvoll, G. Schuler, A.H.P. Linke
(Leipzig, DE)
Adiponectin improves TG-rich lipoprotein metabolism by inhibiting VLDL synthesis via
COUP-TF2-dependent pathway.
– K. Tsubakio-Yamamoto, M. Nishida, D. Masuda, T. Ohama, Y. Nakagawa-Toyama, M. Ishigami, I. Komuro,
S. Yamashita (Osaka, JP)
Anti-inflammatory effects of oleic acid and hydroxytyrosol in murine 3T3-L1 adipocytes: a key for
protective mechanisms of mediterranean diets in obesity-related inflammation.
– E. Scoditti, M. Massaro, M.A. Carluccio, A. Gastaldelli, C. Storelli, R. De Caterina (Lecce, Pisa and Chieti, IT)
Role of posttranslational modification of CD36 in cardiac fatty acid utilization: lessons from the
spontaneously hypertensive rat.
– B. Lauzier, C. Merlen, F. Vaillant, B. Bouchard, P.C. Beguin, V.W. Dolinsky, J.R.B. Dyck, B.G. Allen,
G. Charron, C. Des Rosiers (Montreal and Edmonton, CA)
Chronic heart rate reduction in vivo with ivabradine preserves function and glucose metabolism of ex vivo
working hearts from dyslipidemic mice.
– F. Vaillant, B. Lauzier, D. Lachance, V. Bolduc, E. Thorin, J.C. Tardif, C.H. Des Rosiers (Montreal, CA)
Comparison of epicardial adipose tissue and abdominal visceral adipose tissue for the predictor of
atherosclerosis in thoracic and abdominal aorta using 320-MDCT.
– T. Matsushita, H. Hayashi, C. Kato, H. Miyabe, K. Kaigawa, T. Sato, T. Miyake, T. Hibino (Ichinomiya, Aichi,
JP)
*Abstracts can
be accessed at:
248
QR 30501
P4001
P4002
P4003
P4004
P4005
P4006
P4007
P4008
P4009
P4010
P4011
P4012
P4013
P4014
P4015
P4016
P4017
P4018
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Continuous positive airway pressure therapy positively affects AFABP level in patients with obstructive
sleep apnea.
– E. Sovova, M. Hobzova, M. Sova, V. Kolek, D. Stejskal, J. Zapletalova (Olomouc, CZ)
PPAR-gamma regulates trans-endothelial fatty acid transport via induction of fatty acid binding protein 4
in capillary endothelial cells in heart, red skeletal muscles and adipose tissue.
– K. Goto, T. Iso, H. Hanaoka, T. Suga, H. Matsui, M. Arai, K. Endo, F.J. Gonzalez, M. Kurabayashi (Gunma,
JP; Bethesda, US)
Lipocalin-type prostaglandin D synthase-mediated biosynthesis of PGD2 and its metabolites
15-deoxy-delta 12,14-PGJ2 synergistically stimulate nrf2 and protect hearts from ischemia/reperfusion
injury.
– Y. Katsumata, M. Sano, T. Matsuhashi, H. Ito, J. Endo, K. Shinmura, T. Tsugu, S. Yan, S. Toyama,
K. Fukuda (Tokyo, JP)
The presence of sphingosine-1 phosphate in reconstituted HDL is required for better protection against
lethal reperfusion injuries.
– M. Frias, S. Somers, X. Moren, L. Lacerda, L. Opie, R.W. James, S. Lecour (Geneva, CH; Cape Town, ZA)
P4019
P4020
P4021
P4022
INJURY AND PROTECTION IN ISCHEMIA/REPERFUSION AND OTHER CARDIAC PATHOLOGIES (QR
30502*)
*Abstracts can
be accessed at:
P4023
P4024
P4025
P4026
P4027
P4028
P4029
P4030
P4031
P4032
TUESDAY – MORNING
Functional consequences of myofilament protein alterations in a mouse model of post-infarction
remodeling.
– A. Balogh, D. Czuriga, E.T. Pasztor, D. Santer, B. Podesser, Z. Papp (Debrecen, HU; Vienna, AT)
Diastolic adaptive response to acute myocardial stretch: unraveling the role played by PKG and
actin-myosin interaction in the normal and ischemic heart.
– R. Ladeiras-Lopes, R. Castro-Ferreira, J. Neves, R. Fontes Carvalho, P. Castro-Chaves, A. Leite-Moreira
(Porto, PT)
Anthracycline-induced cytotoxicity: protective role of metformin.
– M.C. Asensio-Lopez, J. Sanchez-Mas, D.A. Pascual-Figal, S. Abenza, M.T. Perez-Martinez,
I.P. Garrido-Bravo, F. Pastor-Perez, M. Valdes, A. Lax (Murcia, ES)
The GRK2 inhibitor beta-ARKct potentiates the pro-contractile function of beta2-adrenergic receptor in
vivo under normal conditions and post-myocardial infarction.
– A. Lymperopoulos, G. Rengo, E. Gao, W.J. Koch (Ft. Lauderdale and Philadelphia, US; Naples, IT)
Assessment of circulating microRNAs as potential biomarkers for the diagnosis of acute coronary
syndrome.
– T. Zeller, T. Keller, F. Ojeda Echevarria, B. Stradmann-Bellinghausen, S. Tzikas, K. Perius, K.J. Lackner,
T.J. Munzel, S. Blankenberg (Mainz, DE)
Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute
myocardial infarction.
– C. Meune, B. Drexler, P. Haaf, T. Reichlin, M. Reiter, J. Meissner, C. Stelzig, M. Freese, K. Winkler,
C. Mueller (Basel, CH; Barcelona, ES)
First identification of preproANP signal peptide in plasma: initial assessment as a biomarker of cardiac
ischemia.
– C.J. Pemberton, T. Kleffmann, M. Siriwardena, P. Ruygrok, A.M. Richards (Christchurch, Dunedin and
Auckland, NZ)
Regulation of CCN genes in the heart after myocardial infarction - transcriptional and posttranscriptional
mechanisms.
– K. Kaminski, T. Bonda, M. Kozuch, S. Litvinovich, I. Bialuk, A. Taranta, E. Waszkiewicz, L. Chyczewski,
W.J. Musial, M.M. Winnicka (Bialystok, PL; Grodno, BY)
CyP, a toll-like receptor 4 antagonist, protects the heart from ischemia/reperfusion injury.
– A. Soldo, M. Molteni, C. Rossetti, S. Maggioni, A. Biondi, S. Gemma, R. Latini (Milan and Varese, IT)
Metastin/kisspeptin-10, tumor metastasis suppressor peptide, impairs postnatal angiogenesis in rat
hindlimb ischemia possibly due to induction of endothelial senescence.
– S. Yamaya (Yokohama, JP)
Safety of outpatient management of patients with acute chest pain and mildly elevated cardiac troponin
levels.
– C. Meune, T. Reichlin, A. Irfan, R. Twerenbold, J. Meissner, M. Reiter, P. Haaf, B. Drexler, K. Winkler,
C. Mueller (Basel, CH; Barcelona, ES)
Novel experimental protocol to study area at risk, infarct size, immunohistochemisty, and tissue protein
content on the same rodent heart.
– M.C. Ciuffreda, L. Calvillo, F. Pisano, M. Gnecchi (Pavia and Milan, IT)
Comparison of two different myocardial infarction models in porcine utilizing electromechanical mapping
system validated by cardiovascular magnetic resonance imaging.
– E. Lukacs, B. Magyari, Ö. Petnehazy, Z.S. Petrasi, L. Toth, I. Repa, I. Horvath (Pécs and Kaposvár, HU)
Dissipation of beta-dystroglycan with resultant hypercontracture of sarcomeres is culprit for formation of
contraction bands in rat injured hearts.
– H. Tanaka, H. Mani, T. Adachi, Y. Jiang, T. Takamatsu (Kyoto, JP)
Remote ischemic preconditioning releases a circulating cardioprotective factor but target tissue
response is attenuated due to an intrinsic cardioprotective activation in diabetic patients.
– R.V. Jensen, S.B. Kristiansen, P.H. Nielsen, T.T. Nielsen, H.E. Botker (Aarhus, DK)
P4033
P4034
P4035
P4036
P4037
QR 30502
249
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Genetic deletion of the E3 ubiquitin ligase SIAH2 lowers hypoxia-induced apoptosis and reduces infarct
size after coronary artery ligation.
– G. Pironti, C. Perrino, G.G. Schiattarella, G. Gargiulo, A. Cannavo, A. Franzone, A. Sannino, L. Scudiero,
A. Scognamiglio, G. Esposito (Naples, IT)
Normoxic cardiopulmonary bypass is associated with reduced transcriptomic changes in comparison to
hyperoxic procedure in cyanotic paediatric patients undergoing corrective congenital heart surgery.
– M.T. Ghorbel, G.D. Angelini, M. Caputo (Bristol, GB)
MicroRNA 375: new prognostic marker in acute myocardial infarction.
– N. Cortez-Dias, C. Jorge, P. Carrilho Ferreira, D. Silva, J. Silva Marques, R. Placido, S. Robalo Martins,
P. Canas Da Silva, F.J. Pinto, A. Nunes Diogo (Lisbon, PT)
Myocardial protection with retrograde coronary venous administration of adenosine in the setting of a
porcine coronary artery occlusion-reperfusion model.
– M.R. Torres, J.A. Ramires (São Paulo, BR)
Alleviation of peripheral and myocardial ischemia in mice by novel GRP78 activating peptides.
– B. Hardy, A. Raiter, A. Battler (Petach-Tikva, IL)
Inhibition of RIP1-mediated necrosis ameliorates myocardial ischemia-reperfusion injury and attenuates
adverse remodeling.
– M.I.F. Oerlemans, J. Liu, K. Den Ouden, B. Van Middelaar, H. Clevers, P.A.F.M. Doevendans, J.P.G. Sluijter
(Utrecht, NL; Jinan, CN)
The cardioprotective nucleoside adenosine inhibits autophagy in murine cardiomyocytes.
– M. Saric, E. Hamad, Y. Devaux, T. Chan, A.M. Feldman, D.R. Wagner (Luxembourg, LU; Philadelphia, US)
(Pro)renin receptor blockade improves cardiac function and reduces ventricular remodeling following
myocardial infarction in mice.
– L.J. Ellmers, A.M. Richards, C.J. Charles, M.T. Rademaker (Christchurch, NZ)
SAFE survival pathway is involved in the cardioprotective effect of remote ischemic preconditioning and
local ischemic postconditioning.
– V. Mateus, S. Tamareille, N. Ghaboura, J. Jeanneteau, A. Croue, D. Henrion, A. Furber, F. Prunier (Angers,
FR)
Ischaemic cardioprotection: pathogenic mechanism in type 2 diabetes mellitus?
– J.A. Povlsen, B. Loefgren, C. Dalgas, N.B. Stoettrup, H.E. Boetker, T.T. Nielsen (Aarhus, DK)
GLP-1(9-36)a and exendin-4 attenuate reoxygenation injury in isolated rat cardiomyocytes acting by
distinct signaling pathways.
– M. Treiman, L.B. Qian, N.L. Find, T. Engstrom (Copenhagen, DK)
P4038
P4039
P4040
P4041
P4042
P4043
P4044
P4045
P4046
P4047
P4048
CORONARY FLOW, MYOCARDIAL PERFUSION AND ISCHAEMIA (QR 30503*)
Mechanisms of coronary flow velocity reserve impairment in hypertrophic cardiomyopathy.
– H.-K. Kim, S.-P. Lee, G.-Y. Cho, Y.-J. Kim, D.-W. Sohn (Seoul, KR)
In vivo measurements of myocardial viscoelasticity by a new ultrasound method: validation and changes
with infarction.
– C. Pislaru, M.W. Urban, J.F. Greenleaf (Rochester, US)
Acute effects of biventricular pacing on myocardial perfusion detected by Doppler-derived coronary flow
reserve.
– E.M. Pasanisi, R. Sicari, U. Startari, L. Panchetti, A. Rossi, M.A. Piacenti, M.A. Morales (Pisa, IT)
The additive prognostic value of two-dimensional echo, lung ultrasound and C-reactive protein over
global registry of acute coronary events (GRACE) risk score in patients with acute coronary syndromes.
– G. Bedetti, L. Gargani, M. Scalese, C. Pizzi, R. Sicari, E. Picano (Imola, Pisa and Bologna, IT)
Long-term prognostic value of myocardial perfusion stress echocardiography in diabetic patients.
– P. Wejner-Mik, P. Lipiec, J.D. Kasprzak (Lodz, PL)
Elevation of hs-troponin T after CMR stress testing, another indicator of myocardial ischemia?
– M. Farazandeh, H.C. Eberle, D. John, A. Wolf, C. Jensen, T. Schlosser, K. Nassenstein, C.K. Naber,
G.V. Sabin, O. Bruder (Essen, DE)
Echocardiographic differentiation of hypo-perfused from normally perfused segments: comparison of 3D
strain imaging with 2D speckle tracking.
– R. Jasaityte, B. Heyde, D. Barbosa, D. Loeckx, P. Claus, J. D’hooge (Leuven, BE)
Impact on embolic particles during coronary interventional procedures on regional myocardial wall
motion in patients with stable angina pectoris.
– Y. Higuchi, K. Iwakura, A. Okamura, M. Date, H. Nagai, M. Ozawa, K. Fujii (Osaka, JP)
Diagnostic performance of pocket ultrasound system for fast-track evaluation of cardiology outpatients.
– H.M. El-Naggar, E. Abate, N.A. Marsan, E.R. Holman, E.E. Van Der Wall, J.J. Bax, V. Delgado (Leiden, NL)
Acute functional ischemic mitral regurgitation and systolic function of left ventricle in patients with first
ST-segment elevation myocardial infarction treated by percutaneous interventions.
– J. Kochanowski, P. Scislo, R. Piatkowski, M. Marchel, D. Kosior, G. Opolski (Warsaw, PL)
Mild afterload augmentation allows reappearance of post-systolic thickening in previously ischemic
myocardium.
– K. Masuda, T. Asanuma, A. Hioki, D. Sakurai, S. Nakatani (Suita, JP)
Negative stress echocardiography in severely obese patients has good prognostic value.
– M. Murphy (Augusta, US)
*Abstracts can
be accessed at:
250
QR 30503
P4049
P4050
P4051
P4052
P4053
P4054
P4055
P4056
P4057
P4058
P4059
P4060 (W)
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Prediction of overall mortality and major cardiac events by means of exercise echocardiography and
coronary angiography in patients with severe ischaemia.
– J. Peteiro, A. Bouzas-Mosquera, F. Broullon, A. Perez-Perez, O. Prada, E. Barge-Caballero,
A. Castro-Beiras (A Coruña, ES)
Comparison of peak supine bicycle, post-treadmill, and peak treadmill exercise echocardiography for the
detection of coronary artery disease.
– J. Peteiro, A. Bouzas-Mosquera, R. Estevez-Loureiro, G. Barge-Caballero, F. Garcia-Lopez,
M. Lopez-Perez, A. Castro-Beiras (A Coruña, ES)
Upright T wave in precordial lead V1 indicates the presence of significant coronary artery disease in
patients undergoing coronary angiography with otherwise unremarkable ECG.
– I. Stankovic, K. Milekic, B. Putnikovic, M. Panic, R. Vidakovic, P. Milicevic, A. Vlahovic Stipac, A. Aleksic,
A.N. Neskovic (Belgrade, RS)
Utility of the ST-segment deviation score in the risk prediction of patients with suspected acute
myocardial infarction.
– R. Twerenbold, M. Reiter, R. Reichlin, C. Balmelli Cattelan, B. Drexler, A. Irfan, K. Winkler, C. Heinisch,
S. Osswald, C. Mueller (Basel, CH; Barcelona, ES)
ST-segment deviation score in the early diagnosis of acute myocardial infarction.
– R. Twerenbold, T. Reichlin, R. Abaecherli, A. Irfan, M. Reiter, C. Balmelli Cattelan, P. Haaf, B. Drexler,
S. Osswald, C. Mueller (Basel, CH)
Diagnostic accuracy and feasibility of bedside pocket-sized ultrasound examination in patients admitted
to an internal medicine department.
– G.N. Andersen, B.O. Haugen, T. Graven, O.C. Mjoelstad, H. Dalen (Levanger and Trondheim, NO)
Common carotid artery kinking is predictor of cardiovascular events: long term follow-up study using by
carotid sonography.
– T. Watanabe, M. Iwai-Takano, Y. Takeishi (Fukushima, JP)
Novel four-dimensional speckle-tracking strain imaging for the assessment of myocardial viability after
acute myocardial infarction: validation study with myocardial contrast echocardiography.
– E. Abate, M.L. Antoni, G.E. Hoogslag, G. Nucifora, V. Delgado, D. Auger, T.G. Witkowski, M.J. Schalij,
J.J. Bax, N. Ajmone Marsan (Leiden, NL)
No-reflow phenomenon at patients with acute myocardial infarction - value of 3D echo perfusion
assessment.
– P. Scislo, J. Kochanowski, R. Piatkowski, M. Roik, M. Postula, G. Opolski (Warsaw, PL)
Accuracy of real time 3 dimensional speckle tracking in ischemic patients: comparison to magnetic
resonance imaging.
– D. Hayat, M. Kloeckner, J. Nahum, A. Bensaid, L. Macron, R. Gallet, J.L. Dubois-Rande, P. Gueret, P. Lim
(Créteil, FR)
Fragmented QRS complex on a 12-lead ECG in patients with acute myocardial infarction: a MRI study.
– M.A. Angue, L.L. Lorgis, C.A. Cochet, C.R. Richard, A.L. Lalande, M.Z. Zeller, A.G. Gudjoncik, P.B. Buffet,
F.B. Brunotte, Y.C. Cottin (Dijon, FR)
Comparison of coronary plaque characterization by spectral radiofrequency of intravascular ultrasound
signals (VH-IVUS and i-MAP).
– A. Hirohata, K. Yamamoto, E. Hirose, F. Sano, Y. Kobayashi, H. Takafuji, Y. Toyama, M. Ohara, K. Ohkawa,
T. Ohe (Okayama, JP)
P4061
P4062
P4063
P4064
P4065
P4066
P4067
P4068
P4069
P4070
P4071
P4072
MISCELLANEOUS (QR 30504*)
*Abstracts can
be accessed at:
P4073
P4074
TUESDAY – MORNING
The peer review process of the ESC - impact on cardiovascular science in Europe.
– S. Winnik, D.A. Raptis, M. Komajda, J.J. Bax, M. Tendera, K. Fox, F. Van De Werf, T.F. Luescher,
F. Ruschitzka, C.M. Matter (Zurich, CH; Paris, FR; Leiden, NL; Katowice, PL; London, GB; Leuven, BE)
Earthquake 2010 in Chile: impact on the incidence of subepicardial lesions, experience with
telelectrocardiography.
– F. Bello, E. Escobar, D. Lama, G. Mezzano, S. Pavlov (Santiago, CL)
Acute changes in circulating high sensitive troponin T during exercise induced myocardial ischemia.
– T. Reichlin, M. Zellweger, C. Maushart, M. Potocki, R. Twerenbold, M. Pansini, F. Forrer, S. Osswald,
C. Mueller (Basel, CH)
Myocardial perfusion imaging in asymptomatic patients with rheumatoid arthritis.
– M. Bernardes, H. Fernandes, E. Martins, P. Oliveira, M.J. Martins, T. Georgina, A. Oliveira, T. Faria,
J. Pereira, F. Ventura (Porto, PT)
Predicting the response to cardiac resynchronization therapy by regional wall motion analysis of
ECG-gated myocardial perfusion SPECT with cardioGRAF.
– I. Morishima, T. Sone, H. Tsuboi, H. Mukawa, M. Uesugi, Y. Kanzaki, H. Nagai, S. Ogasawara, Y. Shibata,
Y. Yura (Ogaki, JP)
Erythropoietin reduces LV perfusion defects measured by [99mTc]-sestamibi pinhole SPECT and
enhances migration of bone marrow-derived cells after myocardial infarction in mice.
– S. Brunner, B.C. Huber, T. Weinberger, M. Vallaster, T. Wollenweber, A. Gerbitz, M. Hacker, W.-M. Franz
(Munich and Erlangen, DE)
P4075
P4076
P4077
P4078
QR 30504
251
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Real-time dobutamine gated-SPECT myocardial perfusion imaging with an ultrafast gamma camera:
validation against MRI.
– R. Nkoulou, M. Wolfrum, S.M. Kueest, A.P. Pazhenkottil, J.R. Ghadri, L. Husmann, R.R. Buechel,
B.A. Herzog, O. Gaemperli, P.A. Kaufmann (Zurich, CH)
The usefulness of telemonitoring in an early detection and assessment of low pacing burden in patients
undergoing cardiac resynchronization therapy.
– M. Mazurek, E. Jedrzejczyk, A. Liberska, A. Wozniak, S. Pluta, A. Sokal, P. Pruszkowska, R. Lenarczyk,
O. Kowalski, Z. Kalarus (Zabrze, PL)
Do we need ECG telemonitoring during home-based cardiac rehabilitation?
– E. Piotrowicz, I. Korzeniowska-Kubacka, J. Wolszakiewicz, A. Chrapowicka, M. Batogowski,
B. Dobraszkiewicz-Wasilewska, A. Jasionowska, J. Gwilkowska, M. Banaszak-Bednarczyk, R. Piotrowicz
(Warsaw, PL)
Automated visceral and subcutaneous abdominal fat volume measurement: a validation study.
– F. Bastos Goncalves, M. Koek, N. Ravensbergen, M. Voute, H. Verhagen, W. Niessen, D. Poldermans
(Rotterdam, NL)
Impact of imaging parameters on the assessment of intra-cardiac blood flow by echocardiographic
tracking: simulations using computer-generated datasets.
– H. Gao, P. Claus, J. D’hooge, J.U. Voigt (Leuven, BE)
Echocardiographic prognostic implications in tako-tsubo cardiomyopathy. Insights from the tako tsubo
italian network (TIN).
– R. Citro, F. Rigo, Q. Ciampi, G. Provenza, M. Patella, E. Tagliamonte, C. Zito, O. Vriz, F. Silvestri,
E. Bossone (Salerno, Mestre-Venice, Benevento, Terni, Nocera Inferiore, Messina and Udine, IT)
Important change in the diagnosis of 1 in 5 patients admitted to a medical department after screening
with pocket-sized ultrasound.
– O.C. Mjolstad, T. Graven, G.N. Andersen, B. Haugen, H. Dalen (Trondheim and Levanger, NO)
Left ventricle apical rotation under exposure to hypobaric hypoxia at very high altitude: a sign of
subendocardial ischemia? Data from the HIGHCARE project.
– M. Revera, G. Osculati, G. Branzi, F. Ciambellotti, A. Faini, G. Bilo, G. Mancia, G. Parati (Milan, IT)
Dual microbubble targeting improves capture efficiency of an ultrasound contrast agent towards
activated platelets: an ex-vivo study.
– F. Guenther, A.L. Klibanov, M. Kramer, T. Heidt, M. Schwarz, E.A. Ferrante, K.H. Peter, C. Bode, C. Von
Zur Muhlen (Freiburg, DE; Charlottesville, US; Melbourne, AU)
Impaired systolic left ventricular strain rate reserve in patients with HFpEF.
– P. Lindqvist, K. Lindmark, S. Morner, C. Backman, M. Henein (Umeå, SE)
Influence of microbubble shell design on attachment efficiency in targeted ultrasound molecular imaging.
– E. Khanicheh, M. Mitterhuber, K. Kinslechner, J.R. Lindner, B. Kaufmann (Basel, CH; Portland, US)
3D fusion echocardiography improves transoeosphageal left ventricular assessment.
– D.X. Augustine, K. Rajpoot, C. Biasagianis, H. Pavolopoulous, X. Jin, S. Myerson, J. Newton, A. Noble,
H. Becher, P. Leeson (Oxford, GB)
The role of myocardial imaging in acute myocarditis: correlation of 2D speckle tracking strain rate and
strain imaging with myocardial biopsy findings.
– D. Sinning, M. Kasner, J.K. Gueffroy, U. Kuehl, H.P. Schultheiss, C. Tschoepe (Berlin, DE)
Echo-based differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy: a
3D-speckle-tracking-study.
– H. Baccouche, M. Maunz, T. Beck, E. Gaa, M. Banzhaf, U. Knayer, P. Fogarassy, M. Beyer (Kirchheim
unter Teck, DE)
Ultrasound comets in healthy athletes performing prolonged strenuous sea-level exercise: an early and
subclinical sign of increased interstitial edema.
– A. Pingitore, E. Garbella, P. Piaggi, D. Menicucci, F. Frassi, W. Lubrano, M. Passera, R. Bedini,
A. Gemignani, A. L’Abbate (Pisa, IT)
Experimental validations of a new echocardiographic method for depicting blood flow patterns in the left
ventricle.
– T. Uejima, A. Walkers, C. Prinz, J.U. Voigt, A. Fraser (Cardiff, GB; Västerås, SE; Leuven, BE)
Chronic kidney disease and its early progression are associated with the status of coronary
microcirculation.
– K. Nakanishi, S. Fukuda, K. Shimada, C. Miyazaki, S. Ehara, H. Taguchi, T. Muro, T. Kawarabayashi,
J. Yoshikawa, M. Yoshiyama (Osaka and Nishinomiya, JP)
Effects of caffeine on ischemia detection in myocardial perfusion scintigraphy associated with adenosine
stress.
– W. Azem Chalela, L. Vissotto Garchet Santos Reis, A. Falcao, L. Azouri, M. Izaki, J. Soares Junior,
C. Meneghetti, A. Farah, N. Nunes (São Paulo, BR)
P4079
P4080
P4081
P4082
P4083
P4084
P4085
P4086
P4087
P4088
P4089
P4090
P4091
P4092
P4093
P4094
P4095
P4096
UBIQUITOUS EFFECTS OF OBESITY AND THE METABOLIC SYNDROME (QR 30505*)
Has an abnormal lipid profile the same impact in obese patients compared to non-obese patients?
– A.T. Timoteo, A. Toste, B. Valente, M. Mota Carmo, R.C. Ferreira (Lisbon, PT)
What is the real impact of obesity in coronary heart disease?
– B.C. Picarra, A.R. Santos, R. Fernandes, A. Bento, M. Celeiro, A.F. Damasio, P. Dionisio, P. Semedo,
A. Caeiro, M. Trinca (Évora, PT)
*Abstracts can
be accessed at:
252
QR 30505
P4097
P4098
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
P4099
P4100
P4101
P4102
P4103
P4104
P4105
P4106
P4107
P4108
P4109
P4110
P4111
P4112
P4113
P4114
TUESDAY – MORNING
Screening for coronary artery disease in asymptomatic obese patients with erectile dysfunction.
– N. Ioakeimidis, C. Vlachopoulos, D. Terentes-Printzios, A. Samentzas, K. Baou, A. Aggelis, K. Rokkas,
C. Fassoulakis, C. Aggeli, C. Stefanadis (Athens, GR)
Non-invasive detection of vascular dysfunction in sleep apnea syndrome by cardio-ankle vascular index
and flow-mediated dilatation.
– A. Yoshihisa, M. Miyata, T. Sato, S. Suzuki, K. Sugimoto, H. Kunii, K. Nakazato, H. Suzuki, S. Saitoh,
Y. Takeishi (Fukushima, JP)
Do measures of arterial function and atherosclerotic burden add incremental benefit to Framingham risk
alone in predicting outcome in obese patients?
– B.A. Haluska, L. Jeffriess, T.H. Marwick (Brisbane, AU; Cleveland, US)
Weight loss effect on adiponectin and hs-CRP levels in patients with metabolic syndrome.
– E. Paschalidou, I. Efthimiadis, K. Makedou, S. Pavlidou, F. Dogramatzi, I. Klonizakis, A. Efthimiadis
(Thessaloniki, GR)
Low levels of IgM antibodies against phosphorylcholine (anti-pc) are related to abdominal obesity and
impaired fibrinolysis in the elderly.
– K. Pettersson, A. Siegbahn, H. Lettesjo, I. Dahlbom, J. Frostegard, L. Lind (Solna, Uppsala and Stockholm,
SE)
Obesity and cardiovascular disease (CVD): an association or a cause and effect relationship?
– M. El Shahawy, M. Entcheva, J. Cohn (Sarasota and Minneapolis, US)
Effect of an FTO polymorphism on overweight and obesity in the polish WOBASZ study - the preliminary
results.
– A. Piwonska, W. Piotrowski, R. Ploski (Warsaw, PL)
Significant cardiovascular risk factor burden seen in young, asymptomatic, and physically active subjects
with a normal and elevated adjusted Asian body mass index.
– G.K. Lee, H.W. Sim, Y. Tan, T. Ma, K.H. Lew, E.C. Tan, L.C. Lee, H.Y. Ong (Singapore, SG; Penang, MY)
Rapid increase in abdominal obesity and deteriorating cardiometabolic risk profile in Poland LIPIDOGRAM 2004 and 2006 nation-wide surveys of 32,683 individuals.
– B.M. Kaess, J. Jozwiak, C.P. Nelson, W. Lukas, M. Mastej, N.J. Samani, M. Tomaszewski (Leicester, GB;
Czestochowa and Katowice, PL)
Reducing cardiovascular risk factors in an obese population - preliminary findings from a community
based cardiovascular disease prevention programme in Ireland.
– I. Gibson, G. Flaherty, J. Jones, S. Connolly, J. Crowley (Galway, IE; London, GB)
Metabolic syndrome predicts incidence of coronary artery disease but not stroke in essential
hypertensive subjects: Data from a Greek 6-year-follow-up study.
– C. Tsioufis, K. Dimitriadis, A. Kasiakogias, C. Thomopoulos, D. Syrseloudis, D. Tsiachris, M. Almyroudi,
K. Kintis, I. Kallikazaros, C. Stefanadis (Athens, GR)
Identification of ARIA as novel factor in the pathophysiology of metabolic syndrome.
– Y. Akakabe, K. Ikeda, Y. Kitamura, M. Koide, M. Uraoka, Y. Nakagawa, H. Matsubara (Kyoto, JP)
Association of metabolic syndrome and arterial stiffness with angiographic coronary artery disease.
– A. Bechlioulis, K. Vakalis, K.K. Naka, N.D. Papamichael, C. Bourantas, A. Kotsia, C.S. Katsouras,
L.K. Michalis (Ioannina, GR)
Impact of metabolic syndrome on functional recovery after cardiac rehabilitation.
– N. Russo, L. Compostella, T. Setzu, G. Fadini, S. Iliceto, A. Avogaro, F. Bellotto (Padua and Cortina
D’Ampezzo, IT)
Predictive accuracy of metabolic syndrome definitions for the coronary artery disease.
– B. Parapid, N. Milic, M.C. Ostojic, N.M. Lalic, D. Micic, S. Damjanovic (Belgrade, RS)
Is height an independent marker of metabolic syndrome in a developing society? A cross-sectional study
of 22,180 Chilean adults.
– E. Koch, T. Romero, D. Sandoval, C.X. Romero, M.A. Bravo, O. Henriquez, L. Urrutia (Santiago, CL; San
Diego, US)
Respective contributions of traditional cardiovascular risk factors and metabolic syndrome in the
prediction of coronary heart disease.
– V. Bongard, D. Taraszkiewicz, K. Vazoumana, M. Galinier, D. Carrie, M. Elbaz, J.B. Ruidavets, J. Ferrieres
(Toulouse, FR)
Blood pressure variability and subclinical organ damage in metabolic syndrome.
– S.I. Dumitrescu, I. Tintoiu, V. Greere, G. Cristian, L. Chiriac, F. Pinte, G. Neagoe, M. Vicol, S. Stanciu,
V.A. Voicu (Bucharest, RO)
Aerobic capacity and endothelial function in patients with metabolic syndrome.
– J.A. Manfredi, C. Bermudez, M. Gutierrez, R. Pisabarro (Montevideo, UY)
P4115
P4116
P4117
HOW AND WHERE TO REDUCE BODY FAT – RUN OR CUT? (QR 30506*)
Visceral adipose amount as epicardial fat measure rather than body fat composition contributes to insulin P4118
resistance, metabolic derangement and systemic inflammation: study validated by CT.
– Y.H. Lai, C.H. Yun, C.C. Liu, J.Y. Hou, T.C. Hung, H.I. Yeh, S.C. Shih, C.L. Hung, C.H. Tsai (Taipei, TW)
The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in
P4119
patients with various manifestations of vascular disease.
– D.A. Kanhai (Utrecht, NL)
*Abstracts can
be accessed at:
QR 30506
253
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Which parameter is more related to angiographic coronary disease: waist circumference or body mass
index?
– A.T. Timoteo, H. Hamad, N. Santos, M. Mota Carmo, R.C. Ferreira (Lisbon, PT)
When essential hypertension is combined with visceral adiposity there is discordance between arterial
stiffness and peripheral wave reflections.
– V. Katsi, G. Souretis, D. Barlagiannis, I. Vlasseros, N. Alexopoulos, C. Stefanadis (Athens, GR)
Impact of body mass index and body composition on long term mortality of patients with heart failure.
– A.L. Gamez Lopez, J.L. Bonilla Palomas, M. Anguita Sanchez, J.C. Castillo Dominguez, D. Garcia Fuertes,
M. Crespin-Crespin, J. Suarez De Lezo (Córdoba, ES)
Body- mass index and late mortality in a general surgery population.
– T.M. Valentijn, S.E. Hoeks, E.J. Bakker, M.T. Voute, N.J. Ravensbergen, K.M. Van De Luijtgaarden,
F. Bastos Goncalves, D. Goei, H.J.M. Verhagen, D. Poldermans (Rotterdam, NL)
Waist circumference versus other obesity indices as determinants of coronary artery disease in essential
hypertensive patients: a 6-year-follow-up study.
– K. Dimitriadis, C. Tsioufis, A. Kasiakogias, I. Bafakis, M. Almyroudi, K. Kintis, I. Andrikou, I. Anastasopoulos,
I. Kallikazaros, C. Stefanadis (Athens, GR)
Abdominal fat in association with cardio-metabolic disturbances in men of European, African-Caribbean
and South Asian origin.
– R. Hajhosseiny (London, GB)
Correlation between waist circumference and hip circumference in patients with non-ST-elevation acute
coronary syndrome.
– S. Ribeiro, A. Gaspar, C. Vieira, V. Ramos, C. Braga, P. Azevedo, M.A. Pereira, A. Correia (Braga, PT)
The relationship between body mass index, obesity and cardiovascular risk.
– S.K. Malyutina, G. Simonova, Y.U. Nikitin, V. Gafarov, E. Veryovkin (Novosibirsk, RU)
Long term lifestyle intervention and optimized high intensity interval training program improve body
composition, cardiovascular risk and exercise parameters in obese patients with or without metabolic
syndrome.
– V.G. Gremeaux, J.D. Drigny, A.N. Nigam, M.J. Juneau, V.G. Guilbeault, M.G. Gayda (Montreal, CA)
Long-term high-intensity interval training improves QT dispersion parameters in metabolic syndrome
patients.
– J.D. Drigny, T. Guiraud, V.G. Gremeaux, M. Gayda, M. Juneau, A.N. Nigam (Montreal, CA; Saint Orens de
Gameville, FR)
Exercise training effectiveness in young patients who associate obesity and sleep apnea.
– C. Avram, M. Oravitan, B. Almajan-Guta, M. Marc, L. Hoble, M. Iurciuc, D. Gaita (Timisoara, RO)
Right ventricle in obesity - a supine exercise echocardiographic and radionuclide study.
– C.M. Stanescu, K. Branidou, D.A. Stanescu, G.A. Dan, V. Manoliu, A. Dan, C. Stan, C. Chirion,
D. Gologanu (Bucharest, RO)
Cardiometabolic risk reduction in morbidly obese patients six months after bariatric surgery.
– J. Domienik, O. Dzikowska-Diduch, W. Lisik, Z. Wierzbicki, P. Pruszczyk (Warsaw, PL)
Adrenergic and metabolic effects of bariatric surgery in obese subjects: a longitudinal study.
– G. Seravalle, F. Quarti Trevano, M. Colombo, P. Perego, V. Giardini, M. Volpe, V. Vella, S. Muraro,
G. Mancia, G. Grassi (Milan and Monza, IT)
The positive effect of surgical obesity intervention on cardiac structure and function is related to
concomitant alleviation of sleep apnoea.
– D. Kardassis, J. Hedner, L. Sjostrom, L. Grote, K. Karason (Gothenburg, SE)
Diastolic dysfunction in obesity cardiomyopathy may be permanent after bariatric surgery. A DTI study.
– M. Luaces Mendez, A. Antequera-Perez, M. Medina, A. Garcia-Munoz-Najar, E. Cancer-Minchot,
G. Canovas-Molina, A. Rodriguez-Robles, N. Gonzalez-Perez De Villar (Fuenlabrada, ES)
P4120
P4121
P4122
P4123
P4124
P4125
P4126
P4127
P4128
P4129
P4130
P4131
P4132
P4133
P4134
P4135
WHAT SHOULD WE EAT TO STAY HEALTHY? (QR 30507*)
Fatal and non-fatal outcomes, incidence of hypertension, and blood pressure changes in relation to
urinary sodium excretion.
– K. Stolarz-Skrzypek, T. Kuznetsova, L. Thijs, V. Tikhonoff, A. Olszanecka, S. Malyutina, E. Casiglia,
J. Filipovsky, K. Kawecka-Jaszcz, J.A. Staessen (Krakow, PL; Leuven, BE; Padua, IT; Novosibirsk, RU;
Pilsen, CZ)
Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis.
– O.H. Franco Duran, A. Buitrago Lopez, J. Sanderson, L. Johnson, E. Di Angelantonio, S. Warnakula,
A. Wood, J. Danesh (Cambridge, GB)
Red wine consumption and low- or high-dose resveratrol treatment improve aging biomarkers but do not
extend life span in rats.
– L.Y. Tanaka, D. Favarato, P.C. Brum, J.E. Krieger, F.R.M. Laurindo, P.L. Da Luz (São Paulo, BR)
Red grape extracts protective effects on endothelial progenitor cells function and improvement of their
polyphenols bioavailability.
– F. Felice, R. Di Stefano, Y. Zambito, G. Di Colo, C. D’onofrio, A. Balbarini (Pisa, IT)
Beneficial effects of cranberry juice on osteogenic endothelial progenitor cells in patients with early
atherosclerosis.
– A. Flammer, M. Gossl, E.A. Martin, R.J. Widmer, S. Khosla, L.O. Lerman, A. Lerman (Rochester, US)
*Abstracts can
be accessed at:
254
QR 30507
P4136
P4137
P4138
P4139
P4140
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
P4141
P4142
P4143
P4144
P4145
P4146
P4147
P4148
P4149
P4150
P4151
P4152
P4153
P4154
P4155
P4156
TUESDAY – MORNING
Acute and mid-term effects of tomato paste diet supplementation on endothelial function: a randomized,
cross-over study.
– P. Xaplanteris, C. Vlachopoulos, D. Terentes-Printzios, D. Kardara, N. Ioakeimidis, P. Pietri, N. Alexopoulos,
K. Aznaouridis, C. Stefanadis (Athens, GR)
Effects of coffee consumption on metabolic parameters in healthy volunteers and in patients with
coronary artery disease.
– B.M. Mioto, M.A. Moretti, J.A.F. Ramires, R.V. Amato, D. Tarasoutchi, K.M. Dias, L.A. Machado Cesar (São
Paulo, BR)
Long term coffee consumption is associated with improved endothelial function in elderly individuals:
ikaria study.
– E. Oikonomou, G. Siasos, C. Chrysohoou, D. Tousoulis, M. Zaromitidou, E. Gialafos, K. Zisimos,
G. Marinos, C. Pitsavos, C. Stefanadis (Athens, GR)
Influence of different vitamin D doses on structure, function, energy metabolism and inflammatory
mediators in the heart of Wistar rats.
– P.P. Santos, H.B. Assalin, B.P.M. Rafacho, M.F. Minicucci, P.S. Azevedo, F. Chiuso-Minicucci,
M.G. Roscani, A.A.H. Fernandes, L.A.M. Zornoff, S.A.R. Paiva (Botucatu, BR)
Plasma vitamin D levels and myopathic complications among statin users.
– A. Eisen, E. Lev, Z. Iakobishvili, A. Porter, D. Brosh, D. Hasdai, A. Mager (Petah Tikva, IL)
Determinants and cardiovascular correlates of vitamin D deficiency in australian women.
– D.T.M. Ngo, W.P.A. Chan, A.L. Sverdlov, J.D. Horowitz (Adelaide, South Australia, AU)
Impact of MTHFR C677T gene polymorphism, folate, B6 and B12 vitamin intake on homocysteine
concentration in Polish adult population.
– A. Waskiewicz, W. Piotrowski, G. Broda, A. Sobczyk-Kopciol, R. Ploski (Warsaw, PL)
Plant sterols and cardiovascular disease: a meta-analysis of 17 studies.
– B. Genser, G. Silbernagel, G. De Backer, E. Bruckert, R. Carmena, J. Chapman, J.E. Deanfield,
O.S. Descamps, E.R. Rietzschel, W. Marz (Graz, AT; Tübingen and Heidelberg, DE; Ghent and Brussels,
BE; Paris, FR; Valencia, ES; London, GB)
Carotenoid levels in plasma: can dietary intake and inflammation explain variability?
– M. Ryden, P. Leanderson, P. Garvin, M. Kristenson, L. Jonasson (Linköping, SE)
Social differences in nutrient intake in three CEE countries: the HAPIEE study.
– H. Pikhart, A. Peasey, S. Malyutina, A. Pajak, R. Kubinova, S. Boylan, M. Bobak (London, GB; Novosibirsk,
RU; Krakow, PL; Prague, CZ; Sydney, AU)
Impact of abdominal obesity and insulin resistance on cardiovascular events in Japanese
obesity-endemic area: Okinawa Tomishiro Cohort Study.
– M. Shimabukuro, M. Higa, K. Yamakawa, H. Masuzaki, M. Sata (Tokushima and Okinawa, JP)
Nutrition and cardiovascular risk factors in children: the PEP Family Heart Study.
– P. Schwandt, T. Bertsch, E. Liepold, G.M. Haas (Munich and Nuremberg, DE)
Effect of an FTO polymorphism on dietary habits in the Polish Wobasz study - the preliminary results.
– A. Piwonska, E. Sygnowska, R. Ploski (Warsaw, PL)
Living longer, living better; which are the secrets? The Ikaria study.
– D.B. Panagiotakos, C. Chrysohoou, G. Siasos, K. Zisimos, J. Skoumas, C. Pitsavos, C. Stefanadis (Athens,
GR)
Long-term adherence to the mediterranean diet seems to confer to a lower risk of hyperuricaemia in
elderly individuals. The ikaria study.
– C. Chrysohoou, J. Skoumas, V. Metaxa, G. Siasos, C. Zisimos, C. Mylonakis, N. Galiatsatos, A. Valatsou,
C. Pitsavos, C. Stefanadis (Athens and Ikaria, GR)
Fish consumption is associated with lower prevalence of depressive symptomatology, in elderly men and
women from the IKARIA study.
– C. Chrysohoou, G. Tsitsinakis, M. Zaromytidou, C. Sykaras, S. Plytaria, M. Xynogala, S. Lagoudakou,
B. Psaroudaki, C. Pitsavos, C. Stefanadis (Athens, GR)
Saturated fatty acids intake, polyunsaturated fatty acid intake and coronary heart disease mortality in
Japan: NIPPON DATA90 1990-2005.
– Y. Nakamura, Y. Kiyohara, T. Okamura, A. Higashiyama, M. Watanabe, A. Kadota, S. Nagasawa, K. Miura,
H. Ueshima (Kyoto, Fukuoka, Nishinomiya, Suita, Osaka and Otsu, JP)
Time duration between dinner and sleep and likelihood of developing acute coronary syndrome or stroke:
results of a case/case-control study.
– C.M. Kastorini, H. Milionis, D. Kandas, G. Papagiannopoulou, A. Litsardopoulou, E. Ntziou, V. Nikolaou,
K. Vemmos, J. Goudevenos, D.B. Panagiotakos (Ioannina and Athens, GR)
Adherence to the mediterranean diet reduces the likelihood of developing acute coronary syndrome and
stroke: a case/case-control study.
– C.M. Kastorini, H. Milionis, K. Kalantzi, A. Ioannidi, E. Georgousopoulou, M. Kostapanos, K. Vemmos,
V. Nikolaou, J. Goudevenos, D.B. Panagiotakos (Ioannina and Athens, GR)
The mediating effect of the mediterranean diet on serum protein levels, among apparently healthy
individuals.
– V. Bountziouka, A. Evangelopoulos, N. Vallianou, C. Katsagoni, M. Bonou, P. Avgerinos, E. Vogiatzakis,
J. Barbetseas, D.B. Panagiotakos (Athens, GR)
P4157
P4158
P4159
P4160
255
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
ACUTE CARDIAC CARE (QR 30508*)
The ASia-Pacific Evaluation of Chest pain Trial (ASPECT): two-hour emergency department rule-out
evaluation for chest pain.
– L.A. Cullen, M.P. Than, C.M. Reid, S.H. Lim, S. Aldous, M. Ardagh, A.M. Richards (Brisbane and
Melbourne, AU; Christchurch, NZ; Singapore, SG)
Are intra-aortic balloon pumps harmful in cardiogenic shock?
– D.A. Stub, W. Chan, D.J. Clark, A.E. Ajani, N. Andrianopoulos, A. Brennan, A. Black, G. New, C.M. Reid,
S.J. Duffy (Melbourne, AU)
Improving perioperative cardiac risk assessment and beta-blocker use for non-cardiac surgery
(INCREASE): the INCREASE quality improvement project.
– A. Rajamanickam, A. Usmani, P. Anbazhagan, A. Ramasamy, M. Pecic, E. Hixson, A. Jaffer, B. Harte
(Newark, Louisville, Cleveland and Miami, US)
Mid regional pro-atrial natriuretic peptide levels for dynamic risk stratification of patients with acute
coronary syndromes.
– O.S. Dhillon, S.Q. Khan, P.A. Quinn, I.B. Squire, A. Bergmann, J.E. Davies, L.L. Ng (Leicester, GB;
Henningsdorf, DE)
Quantification of endothelial dysfunction using c-terminal pro-endothelin in the early diagnosis and
risk-stratification of patients with suspected acute myocardial infarction.
– P. Haaf, C. Balmelli, T. Reichlin, B. Drexler, A. Irfan, M. Reiter, R. Twerenbold, C. Meune, S. Osswald,
C. Mueller (Basel, CH; Paris, FR)
Mechanisms of acute diastolic heart failure in an experimental model of no-reflow infraction.
– M. Schwarzl, P. Steendijk, S. Huber, H. Maechler, M. Truschnig-Wilders, B.M. Pieske, H. Post (Graz, AT;
Leiden, NL)
Acute myocardial infarction type 2: incidence and prognosis.
– B. Drexler, T. Reichlin, C. Balmelli, P. Haaf, R. Twerenbold, W. Hochholzer, M. Reiter, S. Osswald,
C. Mueller (Basel, CH)
The significance of each traditional WHO criterion used to diagnose acute myocardial infarction.
– A. Irfan, T. Reichlin, R. Twerenbold, M. Reiter, C. Balmelli, J. Meissner, P. Haaf, B. Drexler, S. Osswald,
C. Mueller (Basel, CH)
Comparison of 2 and 6 hour time intervals in the diagnosis of acute myocardial infarction.
– L.A. Cullen, J.H. Greenslade, A.F.T. Brown, C.J.K. Hammett, M.P. Than, K.H. Chu, J.P.J. Ungerer,
W.A. Parsonage (Brisbane, AU; Christchurch, NZ)
Appropriateness criteria for left ventricle wall stress measurement in patients with a myocardial
infarction.
– S. Barra, L. Paiva, R. Providencia, P. Gomes, C. Faustino, F. Caetano, A. Leitao Marques (Coimbra, PT)
Direct comparison of high-sensitive and sensitive cardiac troponin assays for risk stratification in
patients with acute chest pain.
– C. Balmelli, M. Reiter, T. Reichlin, R. Twerenbold, P. Haaf, A. Irfan, B. Drexler, C. Meune, S. Osswald,
C. Mueller (Basel, CH; Paris, FR)
Trauma induced secondary cardiac injury.
– H.D. De’ Ath, C. Rourke, J. Manson, R. Davenport, S. Khan, I. Raza, C. Spoors, C. Davies, M. Rothman,
K. Brohi (London, GB)
Impact of presentation time on the management and clinical outcomes of acute myocardial infarction in
Korea.
– K.-Y. Chen, S.W. Rha, Y.-J. Li, B.-G. Choi, C.-U. Choi, C.-G. Park, H.-S. Seo, D.-J. Oh, M.-H. Jeong,
G.-P. Li (Tianjin, CN; Seoul and Gwangju, KR)
Myocardial infarction fatality rates: an eastern European perspective from the international registry of
acute coronary syndromes in transitional countries.
– B. Xhyheri, S. Boystov, D. Becker, M. Dilic, Z. Vasiljevic, R. Bugiardini (Bologna, IT; Moscow, RU; Budapest,
HU; Sarajevo, BA; Belgrade, RS)
Myeloid-related protein 8/14 in the risk stratification of patients with suspected acute myocardial
infarction.
– B. Drexler, T. Reichlin, A. Irfan, C. Balmelli, R. Twerenbold, P. Haaf, M. Potocki, N. Schaub, S. Osswald,
C. Mueller (Basel, CH)
Intra-aortic balloon pump use, does the final balloon tip position matter?
– M. Siriwardena, A. Pilbrow, C. Frampton, G.W. Wilkins, A.M. Richards (Christchurch and Dunedin, NZ)
High-sensitive cardiac troponin T (hs-cTnT) assay is not superior to a previous cTnT assay generation for
the diagnosis of acute myocardial infarctions in a real-world emergency department.
– J. Mair, T. Ploner, A. Hammerer-Lercher, P. Schratzberger, A. Griesmacher, O. Pachinger (Innsbruck, AT)
Rule out acute myocardial infarction algorithm among patients with increased high sensitive troponin
levels.
– A. Irfan, T. Reichlin, R. Twerenbold, M. Reiter, C. Balmelli, J. Meissner, P. Haaf, B. Drexler, S. Osswald,
C. Mueller (Basel, CH)
The impact of metabolic status on therapeutic strategy decision and long term prognosis in patients with
acute myocardial infarction.
– R. Dragu, M. Kapeliovich, H. Hammerman, D. Aronson (Haifa, IL)
*Abstracts can
be accessed at:
256
QR 30508
P4161
P4162
P4163
P4164
P4165
P4166
P4167
P4168
P4169
P4170
P4171
P4172
P4173
P4174
P4175
P4176
P4177
P4178
P4179
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
P4180
P4181
P4182
P4183
P4184
P4185
P4186
P4187
P4188
P4189
P4190
P4191
P4192
P4193
P4194
P4195 (W)
TUESDAY – MORNING
Endothelial NO-synthase gene polymorphism as a genetic marker of unfavorable outcome in patients
with non-ST-segment elevation myocardial infarction against the background of metabolic syndrome.
– T. Glebovskaya, N. Burova, N. Solovjova (Saint Petersburg, RU)
Diabetes mellitus in acute coronary syndrome: an new independent marker of atrioventricular block and
need of pacemaker.
– C. Ferreira, P. Mateus, H. Ribeiro, A. Ferreira, S. Carvalho, I. Moreira, on behalf of Portuguese National
Registry Acute Coronary Syndrome Investigators (Vila Real, PT)
Multiple-biomarkers assessment offers additive risk prediction in patients with acute coronary syndrome.
– J.-K. Lee, W.-C. Yu, S.-J. Lin, F.-T. Chiang (Taipei, TW)
Characteristics and outcome of patients with or without history of coronary artery disease presenting
with an acute coronary syndrome in a chest pain unit: results of the german CPU registry.
– C.A. Correia De Freitas, S. Schneider, E. Giannitsis, T. Muenzel, C. Schmitt, L.S. Maier, H. Mudra, M. Oef,
J. Senges, M. Haude (Neuss, Ludwigshafen, Heidelberg, Mainz, Karlsruhe, Göttingen, Munich and
Brandenburg, DE)
Analysis of depolarization abnormalities in the evaluation of patients with chest pain.
– O. Galante, G. Amit, O. Luria, L.R. Davrath, S. Abboud, D. Zahger (Beer-Sheva, Tel-Aviv and Tel Aviv, IL)
Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred
for primary Percutaneous Coronary Intervention (pPCI).
– N. Joshi, B.R. Bawamia, S. Jamieson, A. Zaman, R. Edwards (Edinburgh and Newcastle-upon-Tyne, GB)
Changes in clinical profile, treatment and mortality in patients hospitalised for acute myocardial infarction
between 1985 and 2008.
– S.T. Nauta, J.W. Deckers, M. Akkerhuis, M. Lenzen, M.L. Simoons, R.T. Domburg (Rotterdam, NL)
Prognostic value of soluble ST2 in unselected cardiac patients admitted to the intensive care unit.
– B. Dieplinger, M. Egger, W. Koehler, F. Firlinger, W. Poelz, L. Hengst, K. Lenz, M. Haltmayer, T. Mueller
(Linz and Innsbruck, AT)
Risk scores prognostic effectiveness in patients presenting to the emergency department with chest pain
and nondiagnostic electrocardiogram.
– A. Conti, C. Poggioni, G. Viviani, M. Luzzi, E. Canuti, Y. Mariannini, G. Cerini, M. Zanobetti, F. Innocenti,
R. Pini (Florence, IT)
Association between circulating oxidized low-density lipoprotein and premature coronary artery disease
extent in men.
– K. Triantafyllou, F. Symeonides, S. Pastromas, H. Anninos, A. Papapanagiotou, C. Nounopoulos,
A. Kalofoutis, S. Koulouris (Athens, GR)
The German CPU registry: comparison of troponin positive to troponin negative patients.
– J.B. Schuettert, H. Darius, E. Giannitsis, M. Haude, G. Heusch, H. Mudra, T. Muenzel, J. Senges,
T. Voigtlaender, L.S. Maier (Göttingen, Berlin, Heidelberg, Neuss, Essen, Munich, Mainz, Ludwigshafen and
Frankfurt, DE)
Chest pain and its relation to acute coronary syndrome (ACS) in the Emergency Department (ED).
– M. Mockel, J. Searle, R. Muller, A.C. Slagman, H. Storchmann, P. Oestereich, W. Wyrwich, J.O. Vollert,
M. Koch, R. Somasundaram (Berlin, DE; Townsville, AU)
The efficacy of ivabradin in patients hospitalized with acute coronary syndrome.
– V. Moiseev, L. Dyatchuk, A. Potapenko, A. Abdulazizov, G. Kiyakbaev, Z.H. Kobalava (Moscow, RU)
The impact of hyperglycemia as a risk factor in patients with acute myocardial infarction is homogeneous
across different age groups?
– J.C. Nicolau, M. Franken, F.G. Lima, L.M. Baracioli, R.R. Giraldez, C.V. Serrano, T.F. Pinto, R. Holanda,
H. Graner, J.A.F. Ramires (São Paulo, BR)
Acute myocardial infarction in the ninth decade of life.
– M. Correia, C. Araujo, S. Mendes, L. Martins (Santa Maria Da Feira, PT)
Multicenter prospective continuous registry of 51217 CCU patients: feasibility and results with a digital
discharge record form.
– C. Tajer, H.C. Doval, J. Gagliardi, M. De Abreu, J. Mariani, M.A. Silberstein (Buenos Aires, AR)
Prognostic value of high sensitive troponin I (hsTnI) in unselected patients with acute dyspnea in the
Emergency Department.
– J. Searle, A.C. Slagman, F. Holert, B. Karow, A. Pinkowski, J.O. Vollert, R. Muller, S. Datwyler, C. Mueller,
M. Mockel (Berlin, DE; Townsville, AU; Abbott Park, US)
Cardiogenic shock complicating acute myocardial infarction is an indicator of increased mortality not
only during hospital stay but also one year after discharge. Results from the MITRA plus registry.
– K. Kouraki, A.K. Gitt, C. Juenger, R. Zahn, J. Senges, U. Zeymer (Ludwigshafen am Rhein, DE)
P4196
P4197
ACUTE CORONARY SYNDROME (QR 30509*)
Anti-connective tissue antibodies in pathogenesis and diagnosis of acute coronary syndrome.
– A.R. Babaeva, S.I. Davidov, A.A. Tarasov (Volgograd, RU)
The long term prognostic value of the troponin I level following acute coronary syndromes.
– I.R. Pearson, C.P. Gale, R. Das, E. Metcalf, N. Kilcullen, K. Viswanathan, C. Morrell, J.H. Barth, A.S. Hall
(Leeds, GB)
Patients with cerebral lacunar infarction should be regarded as vulnerable patients for coronary artery
disease.
– K. Otsui, N. Inoue, T. Mori, T. Ozawa, D. Isaka, K. Domoto, S. Inamoto, K. Onishi (Kobe, JP)
*Abstracts can
be accessed at:
P4198
P4199
P4200
QR 30509
257
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with acute chest pain.
– P. Haaf, B. Drexler, T. Reichlin, R. Twerenbold, M. Reiter, J. Meissner, C. Balmelli, C.H. Meune,
S. Osswald, C.H. Mueller (Basel, CH; Paris, FR)
123I-BMIPP/99m-Tc SPECT mismatch after primary percutaneous coronary intervention is strongly
associated with functional recovery only in anterior ST segment elevation myocardial infarction.
– H. Shibata, S. Yamada, Y. Taniguchi, S. Iwata, A. Shimane, T. Takaya, N. Miyoshi, K. Yokoi, T. Hayashi
(Himeji, JP)
Improved prognosis for patients with acute myocardial infarction and a decreasing “weekend-effect”
from 1997 to 2009.
– K.W. Hansen, A. Hvelplund, S.Z. Abildstrom, E. Prescott, M. Madsen, J.K. Madsen, J.S. Jensen,
C. Nordenberg, S. Galatius (Copenhagen, DK)
Cardiovascular mortality in post-myocardial infarction patients undergoing antidepressive
pharmacotherapy.
– J.K. Jensen, P. Weeke, G. Gislason, C. Torp-Pedersen (Gentofte, DK)
Utility and reliability of the REACH risk score in evaluating the risk of post-discharge bleeding in a
contemporary cohort of patients with ACS patients.
– E. Abu-Assi, S. Raposeiras Roubin, R.M. Agra-Bermejo, P. Cabanas-Grandio, S. Gestal Romari, E. Pereira
Lopez, J.M. Martinez Cereijo, J.M. Garcia Acuna, C. Pena Gil, J.R. Gonzalez-Juanatey (Santiago de
Compostela, ES)
Intracoronary infusion of mononuclear stem cells after acute revascularized myocardial infarction is not
associated with increased prevalence of late ventricular arrhythmias.
– L.F.H. Robbers, R. Delewi, Y. Van Beurden, R. Nijveldt, A.M. Beek, M.J.B. Kemme, A. Hirsch, F. Zijlstra,
J.J. Piek, A.C. Van Rossum (Amsterdam and Groningen, NL)
Wide fluctuations in capillary glucose levels during acute coronary syndrome predicts poor prognosis.
– G.K. Lee, W.T. Yeo, M.Y. Chan, K.K. Poh, C.S. Lau, R.C. Lee, T.C. Yeo (Singapore, SG)
The rs1333049, rs10757278 and rs4977574 polymorphisms of the locus 9p21- the association with 5-year
prognosis in patients with ST-elevation myocardial infarction.
– A. Kozieradzka, W. Pepinski, E. Waszkiewicz, M. Olszewska, D. Maciorkowska, M. Skawronska,
A. Niemcunowicz-Janica, S. Dobrzycki, W.J. Musial, K.A. Kaminski (Bialystok, PL)
Causes and pattern of death of non ST elevation acute coronary syndromes: ten year outcome of
prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK).
– G. Erdem, A. Bakhai, A.K. Taneja, J. Colllinson, W. Banya, M.D. Flather (London, GB)
The impact of microvascular damage in the reverse left ventricular remodeling with reperfused anterior
myocardial infarction.
– S. Hosokawa, Y. Hiasa, N. Mizobe, T. Nakagawa, S. Miyazaki, K. Mahara, R. Ogura, T. Takahashi, K. Kishi,
R. Otani (Komatsushima, JP)
Incidence and prognostic implications of central sleep apnea in the subacute phase of myocardial
infarction.
– H. Bonnemeier, A. Reshetnik, T. Demming, W. Maeuser, S. Puppe, A. Ziomka, N. Frey (Kiel, DE)
Body surface potential mapping predicts recovery of acute ischemic left ventricular dysfunction.
– M.M. Kylmala, T. Konttila, P. Vesterinen, M. Lindholm, M.S. Nieminen, M. Stenroos, H. Vaananen,
H. Hanninen, L. Toivonen (Helsinki, FI)
Prognostic value of soluble receptor for advanced glycation end products in acute coronary syndrome
with normal renal function.
– S. Raposerias-Roubin, B.K. Rodino-Janeiro, P. Aguiar-Souto, J.M. Garcia-Acuna, M.V. Reino-Maceiras,
L. Rey-Gonzalez, J.R. Gonzalez-Juanatey, E. Alvarez Castro (Santiago de Compostela, ES)
Prevalence, predictors, and 5-years mortality of patients with NSTEMI and insignificant coronary artery
disease.
– P. Cabanas Grandio, E. Abu Assi, S. Gestal Romani, S. Raposeiras Roubin, R. Agra Bermejo, E. Pereira
Lopez, J.M. Martinez Cereijo, J.M. Garcia Acuna, M. Rodriguez Cordero, J.R. Gonzalez Juanatey (Santiago
de Compostela, ES)
Gender difference in the prognostic value of estimated glomerular filtration rate at admission in
ST-segment elevation myocardial infarction.
– M.J.D. Grundeken, P. Damman, W.J. Kikkert, P. Woudstra, W.J. Kuijt, R.E. Harskamp, J.P. Van Straalen,
J. Fischer, J.G.P. Tijssen, R.J. De Winter (Amsterdam, NL)
Phase I clinical trial of TRO40303, a new mPTP inhibitor for reducing reperfusion injury.
– S. Schaller, S. Le Lamer, J. Afxantidis, C. Chaimbault, M. Michaud, P. Berna, R. Pruss, M. Latreille,
Y. Donazzolo, J.L. Abitbol (Marseille and Lyon, FR)
Effects of angiotensin II blockade on cardiomyocyte regeneration after myocardial infarction in rats.
– H. Segersvard, P. Lakkisto, H. Forsten, K. Immonen, R. Kosonen, J. Lakkisto, E. Palojoki, E. Kankuri,
M. Laine, I. Tikkanen (Helsinki, FI)
Incremental predictive value of red cell distribution width for 12-month clinical outcome after acute
myocardial infarction.
– J.H. Lee, K.H. Kim, W.S. Choi, S.H. Park, M.H. Bae, D.H. Yang, H.S. Park, Y. Cho, S.C. Chae, J.E. Jun
(Daegu, KR)
Predictors of reinfarction following PCI or medical management using the universal definition in patients
with total occlusion after myocardial infarction: results from OAT long term follow up.
– H.D. White, H.R. Reynolds, A.C. Carvalho, L. Liu, C.A. Pearte, V. Dzavik, M. Kruk, P.G. Steg, G.A. Lamas,
J.S. Hochman (Auckland, NZ; New York, Owings Mills and Miami Beach, US; São Paulo, BR; Toronto, CA;
Warsaw, PL; Paris, FR)
Predictors of working status in the long-term after acute myocardial infarction.
– J.C. Nicolau, R.R. Giraldez, F.G. Lima, M. Franken, L.M. Baracioli, T.F. Pinto, C.V. Serrano, R. Holanda,
H. Graner, F. Ganem (São Paulo, BR)
258
P4201
P4202
P4203
P4204
P4205
P4206
P4207
P4208
P4209
P4210
P4211
P4212
P4213
P4214
P4215
P4216
P4217
P4218
P4219
P4220
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
The coronary angiographic analysis of 16573 patients for coronary artery origination and course
anomalies.
– S. Yuksel, M. Meric, K. Soylu, O. Gulel, H. Zengin, S. Demircan, O. Yilmaz, M. Sahin (Kurupelit-Samsun, TR)
Sleep disordered breathing in patients with acute coronary syndromes.
– E. Kallergis, E. Simantirakis, S. Schiza, S. Chrysostomakis, I. Bouloukaki, D. Arfanakis, N. Tzanakis,
P. Vardas (Heraklion, GR)
Are novel markers of cardiovascular risk worth of measure in already high risk patients?
– A. Kablak-Ziembicka, T. Przewlocki, D. Sliwiak, E. Stepien, P. Pieniazek, P. Musialek, D. Rzeznik, W. Tracz,
P. Podolec (Krakow, PL)
Clopidogrel can be safely continued until coronary artery bypass grafting in patients with acute coronary
syndrome: a meta-analysis.
– S.S. Nijjer, G. Watson, T. Athanasiou, I. Malik (London, GB)
P4221
P4222
P4223
P4224
NEW INSIGHTS IN CORONARY INTERVENTIONS (PART I) (QR 30510*)
*Abstracts can
be accessed at:
P4225
P4226
P4227
P4228
P4229
P4230
P4231
P4232
P4233
P4234
TUESDAY – MORNING
Trends in pre-hospital delay and door-to-balloon time in patients with ST-elevation myocardial infarction
undergoing percutaneous coronary intervention in Switzerland 2000-2010.
– D. Radovanovic, P. Urban, G. Pedrazzini, H. Rickli, P. Erne (Zurich, Geneva, Lugano, St. Gallen and
Lucerne, CH)
In vitro comparison of EP217609, unfractionated heparin, enoxaparin and fondaparinux in the prevention
of cardiac catheter thrombosis.
– A. Kaeberich, U. Raaz, A. Vogt, L. Maegdefessel, C. Bal Dit Sollier, L. Drouet, E. Neuhart, C. Krezel,
K. Werdan, A. Schlitt (Halle, DE; Stanford, US; Paris and Romainville, FR)
Manual thrombus aspiration and abciximab administration in patients with ST-segment elevation
myocardial infarction undergoing primary percutaneous coronary intervention - preliminary results.
– S. Pyxaras, A. Perkan, S. Santangelo, M. Cinquetti, G. Barbati, G. Vitrella, S. Rakar, E. Della Grazia,
A. Salvi, G. Sinagra (Trieste and Padua, IT)
The efficacy of percutaneous coronary intervention in STEMI - differences by age.
– P. Buchta, A. Lekston, M. Gasior, D. Pres, M. Gierlotka, M. Tajstra, M. Hawranek, L. Polonski (Zabrze, PL)
Protective effect of telmisartan for impairment of endothelial function after coronary drug-eluting stent
implantation in hypertensive patients.
– M. Terashima, K. Nasu, H. Kaneda, M. Habara, T. Ito, N. Tanaka, Y. Kinoshita, M. Kimura, Y. Suzuki,
T. Suzuki (Toyohashi and Tokyo, JP)
Head-to-head comparison of sirolimus eluting stent vs. bare metal stent evaluating the endothelial
dysfunction in the same patient with multiple coronary artery lesions.
– A.N. Mischie, M.S. Nazzaro, F. De Felice, C. Musto, R. Fiorilli, C. Sinescu, R. Violini (Rome, IT; Bucharest,
RO)
Endothelial cell behaviour in response to DES drugs shows significant species differences: a comparison
of human, swine and rabbit endothelium.
– A.S.A. Autar, N. Faber, G. Ertas, W.J. Van Der Giessen, H.M.M. Van Beusekom (Rotterdam and Utrecht,
NL; Kocaeli, TR)
Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and
side branch struts: indirect evidence about the role of shear stress in healing after stenting.
– J.L. Gutierrez-Chico, F. Gijsen, E. Regar, J. Wentzel, B. De Bruyne, L. Thuesen, J. Ormiston, D. Mcclean,
S. Windecker, P.W. Serruys (Rotterdam, NL; Aalst, BE; Aarhus, DK; Auckland and Christchurch, NZ; Berne,
CH)
Different risk models predict markedly different probability of death for the same patient: implications of
using risk models for individual patients.
– H.S. Gurm, S.R. Kaufman, D.E. Smith, M. Moscucci, D. Share, R. Stern (Ann Arbor and Miami, US)
Prognostic value of inflammation markers on postoperative outcome in patients with non-significant
coronary artery disease.
– T.M. Valentijn, M.T. Voute, D. Goei, D. Poldermans (Rotterdam, NL)
Improvement of the global left ventricular function in patients with chronic coronary artery occlusion after
intracoronary adenosine administration.
– I. Petrenko, M.A. Popova, K.V. Gorbatikov, S.I. Mamedova, M.V. Krivov (Surgut and Tumen, RU)
Transcoronary pacing in a porcine model - impact of guidewire insulation.
– K.M. Heinroth, S. Unverzagt, M. Buerke, J. Carter, D. Mahnkopf, K. Werdan, R. Prondzinsky (Halle,
Rottmersleben and Merseburg, DE)
Different implantation sequences of hybrid overlapping drug-eluting stents have distinctive influence on
the endothelialization and arterial responses in rabbit iliac arteries.
– K.-Y. Chen, S.W. Rha, Y.-J. Li, Z. Jin, K.-L. Poddar, B.-G. Choi, D.-J. Oh, J.-H. Kim, Y.-J. Hong,
M.-H. Jeong (Tianjin, CN; Seoul and Gwangju, KR)
A novel drug-eluting balloon/drug-eluting stent system eluting sirolimus nanoparticles is safe in a porcine
coronary model.
– O. Sorop, I. Krabbendam-Peters, R. Van Duin, H.M.M. Van Beusekom, W.J. Van Der Giessen (Rotterdam
and Utrecht, NL)
P4235
P4236
P4237
P4238
QR 30510
259
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Initial clinical results of the TITANIC-XV prospective randomized trial: the titan vs everolimus stent in
diabetic patients.
– J.M. Nogales, J.R. Lopez-Minguez, L.J. Doncel Vecino, F. Pomar Domingo, P. Martinez Romero,
J.A. Fernandez Diaz, J.F. Diaz Fernandez, J. Moreu Burgos, M.R. Gonzalez Fernandez, A. Merchan Herrera
(Badajoz, Valencia, Cadiz, Madrid, Huelva and Toledo, ES)
Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in
elderly patients: five-year outcomes from a 1,791 patient multi-national registry.
– B.E.P.M. Claessen, J.W. Suh, G.D. Dangas, K. Obunai, C. Godino, J.H. Kim, C. Dimario, A. Colombo,
S.J. Park, R. Mehran (New York, US)
Does the presence of diabetes mellitus have differential impact in patients treated with
everolimus-eluting (Xience) stents versus paclitaxel-eluting (Taxus) stents?
– R. Byrne, J. Mehilli, S. Massberg, K.L. Laugwitz, S. Kufner, J. Pache, A. Schoemig, A. Kastrati (Munich, DE)
Nicorandil attenuates sirolimus increased thrombogenicity in FeCl3-induced in vivo thrombus model.
– H. Ishida, Y. Takahari, N. Higashijima, K. Aizawa, K. Serizawa, Y. Ishizuka (Isehara and Gotenba, JP)
Non-invasive parameter of flow mediated dilatation in brachial artery is associated with pan-coronary
plaque vulnerability in patients with coronary artery disease.
– T. Sawada, T. Emoto, Y. Motoji, T. Mizoguchi, T. Mizuguchi, K. Taira, H. Okamoto, S. Kim, A. Takarada,
M. Yokoyama (Sumoto, JP)
Tenascin-C level is related to coronary plaque rupture in patients with acute coronary syndrome.
– N. Sakamoto, K. Nakazato, H. Mizukami, S. Suzuki, K. Sugimoto, T. Yamaki, H. Kunii, H. Suzuki, S. Saitoh,
Y. Takeishi (Fukushima, JP)
P4239
P4240
P4241
P4242
P4243
P4244
NEW INSIGHTS IN CORONARY INTERVENTIONS (PART II) (QR 30511*)
Differences in clinical presentation of in-stent restenosis between bare metal versus drug-eluting stents.
– I. Villanueva Benito, I. Solla Ruiz, E. Paredes Galan, G. Bastos Fernandez, I. Gomez Blazquez, A. De Miguel,
V. Jimenez Diaz, A. Ortiz Saez, J.A. Baz Alonso, A. Iniguez Romo (Vigo, ES)
Quantitative optical coherence tomography signal analysis for in-stent restenotic tissue.
– N. Suzuki, K. Kozuma, T. Saito, N. Hosogoe, K. Naito, S. Otsuki, S. Ishikawa, H. Kyono, A. Miyazawa,
T. Isshiki (Tokyo, JP)
Specific criteria of exercise test in evaluation of patients after percutaneous coronary intervention.
– I. Mintale, M. Zabunova, D. Lurina, I. Narbute, S. Jegere, I. Zakke, A. Erglis (Riga, LV)
Difference of in-stent restenosis pattern of drug-eluting stent in early and late phase restenosis.
– T. Domei, S. Kuramitsu, M. Hyodo, Y. Soga, S. Shirai, K. Ando, H. Yokoi, M. Iwabuchi, M. Nobuyoshi
(Kitakyusyu, JP)
In-stent restenosis is not simply a benign clinical entity as it presents as ACS in 40% of cases.
– O.P. Guttmann, D.A. Jones, K. Rathod, T. Pain, A. Jain, A. Knight, A. Mathur, A. Wragg (London, GB)
Late restenosis after percutaneous coronary interventions with drug-eluting stent implantation in real
clinical practice.
– A. Omarov, I. Lazarev, T. Batyraliev, I. Pershukov, E. Merkulov, D. Fettser, J. Ramazanov, B. Kadyrov,
Z. Karben, B. Sidorenko (Almaty, KZ; Moscow, RU; Gaziantep, TR; Baku, AZ)
Clinical impact of restenotic patterns after femoropopliteal stenting.
– A. Tosaka, Y. Soga, O. Iida, T. Ishihara, K. Hirano, T. Suzuki, K. Sakai, H. Yokoi, M. Iwabuchi,
M. Nobuyoshi (Fukuoka, Amagasaki, Yokohama and Sendai, JP)
The morphological findings of early and late in-stent restenosis after drug-eluting stent implantation:
optical coherence tomography analysis.
– H. Yamaguchi, J. Takaoka, A. Miyamura, N. Atsuchi, H. Shirasawa, R. Arikawa, Y. Atsuchi (Kagoshima City,
JP)
Serial angiographic follow-up after successful implantation of sirolimus, paclitaxel, everolimus and
zotarolimus-eluting stent for chronic total occlusions: multicenter registry in asia.
– S. Nakamura, H. Ogawa, J.H. Bae, Y.H. Cahyadi, W. Udayachalerm, D. Tresukosol, S. Tansuphaswadikul
(Chiba and Kumamoto, JP; Daejeon, KR; Jakarta, ID; Bangkok, TH)
Efficacy and safety of everolimus eluting stent implantation for the treatment of in-stent restenosis within
bare-metal stent and drug-eluting stent.
– M. Almalla, J. Schroeder, V. Pross, N. Marx, R. Hoffmann (Aachen, DE)
Coronary artery disease severity and localization are not associated with family history of myocardial
infarction or stroke.
– A. Banerjee, C.C.S. Lim, L.E. Silver, S.J.V. Welch, A.P. Banning, P.M. Rothwell (Birmingham and Oxford,
GB)
Instruction to interventional cardiologists decrease radiation administered to patients during coronary
stenting.
– J.R. Azpiri, J.L. Assad, A. Davila, R. Garcia, R. Trevino (Monterrey, MX)
Evaluation of the endothelial function and intima-media thickness in Mexican children with metabolic
syndrome.
– N. Espinola Zavaleta, E. Molina Bello, M.E. Soto (Mexico City and Mexico, MX)
An average daily physical activity is an independent determinant of local carotid stiffness and myocardial
performance.
– M. Kozakova, C. Palombo, C. Morizzo, E. Muscelli, N. Guraschi, S. Pedri, E. Ferrannini, B. Balkau (Pisa and
Genoa, IT; Villejuif, FR)
*Abstracts can
be accessed at:
260
QR 30511
P4245
P4246
P4247
P4248
P4249
P4250
P4251
P4252
P4253
P4254
P4255
P4256
P4257
P4258
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Histopathological validation of optical coherence tomography analysis for lipid-rich plaque and thin-cap
fibroatheroma.
– K. Fujii, H. Hao, M. Fukunaga, T. Nakata, H. Sawada, M. Ohyanagi, T. Masuyama (Nishinomiya, JP)
Neointimal coverage of zotarolimus-eluting stent at 4, 6, 8 and 10 weeks follow-up: evaluation by optical
coherence tomography.
– M. Nishinari, T. Shimohama, T. Tojo, T. Shiono, R. Kameda, T. Izumi (Sagamihara, JP)
Effects of Waon therapy on peripheral hemodynamics, sympathetic nervous activity and oxidative stress
in patients with severe arteriosclerosis obliterans.
– C. Noda, T. Masuda, M. Kawano, Y. Takahashi, M. Kurashima, K. Miida, K. Kamiya, N. Aoyama, T. Izumi
(Sagamihara, JP)
The impact of the serum eicosapentaenoic acid to arachidonic acid ratio on periprocedural
microcirculatory damage in patients undergoing percutaneous coronary intervention.
– T. Nakata, K. Fujii, H. Sawada, M. Fukunaga, T. Iwasaku, D. Kawasaki, M. Masutani, M. Kawabata,
M. Ohyanagi, T. Masuyama (Nishinomiya, JP)
Genetic deletion of protein tyrosine phosphatase 1B protects against endotoxinic shock and improves
endothelial dysfunction.
– D. Coquerel, E.G. Gomez, R.S. Renet, V.R. Richard, F.T. Tamion (Rouen, FR)
Carotid echo-tracking shows improvement of vascular function after percutaneous aortic valve
replacement.
– G. Feltes, C. Almeria, C. Brito, A. Goncalves, R. Hernandez-Antolin, E. Garcia Fernandez, J. Heredia,
J.L. Rodrigo, C. Macaya, J.L. Zamorano (Madrid, ES)
Unrecognized myocardial infarction in the London Life Sciences Population (LOLIPOP) study.
– J. Sehmi, D. Das, N. Ahmed, A. Kooner, K. Miller, M. Kooner, H.S. Sidhu, A. Kirresh, J. Kooner,
J. Chambers (London, GB)
P4259
P4260
P4261
P4262
P4263
P4264
P4265
LONG-TERM OUTCOME AFTER DRUG ELUTING STENTING (QR 30512*)
*Abstracts can
be accessed at:
P4266
P4267
P4268
P4269
P4270
P4271
P4272
TUESDAY – MORNING
Real-world outcomes of percutaneous coronary intervention in the drug eluting stent (DES) era: analyses
from catholic university of korea-percutaneous coronary intervention (COACT) registry.
– S.M. Seo, K.Y. Chang, M.K. Kang, B.H. Whang, T.H. Kim, C.J. Kim, H.Y. Kim, P.J. Kim, W.S. Chung,
K.B. Seung (Seoul and Bucheon, KR)
Body mass index is inversely correlated to risk of definite stent thrombosis after percutaneous coronary
intervention with drug-eluting stent implantation - a register-based study.
– M. Schmiegelow, C. Torp-Pedersen, G. Gislason, C. Andersson, S. Pedersen, P. Riis Hansen
(Copenhagen, Denmark, DK)
Do obese patients need a higher daily dose of clopidogrel after percutaneous intervention?
– A. Rajamanickam, S. Butler, S. Ellis, J.B. Young, S. Kapadia (Newark and Cleveland, US)
Five-year clinical outcomes of sirolimus-eluting stent implantation for chronic total occlusion including
multivessel disease.
– H. Tanaka, K. Kadota, S. Habara, S. Hosogi, Y. Fuku, T. Goto, K. Mitsudo (Kurashiki, JP)
The influence of stent implantation on 5-year mortality in patients with ST-segment elevation myocardial
infarction.
– D. Pres, M. Gasior, M. Gierlotka, M. Hawranek, M. Tajstra, K. Wilczek, P. Buchta, A. Lekston, L. Polonski
(Zabrze, PL)
Clinical, procedural, cardiometabolic and laboratory correlates of platelet reactivity to clopidogrel and
aspirin on multiplate analyser in patients with coronary stenting.
– C. Kaymaz, I.H. Tanboga, H.C. Tokgoz, N. Poci, M.M. Can, N. Kirca, T. Aktemur, M. Saglam, N. Ozdemir
(Istanbul and erzurum, TR)
Periprocedural hsCRP reduction is a significant predictor for clinical outcome after drug-eluting stent
implantation.
– C.J. Kim, H.J. Park, S.M. Suh, T.H. Kim, S.Y. Jung, S.H. Ahn, P.J. Kim, K.Y. Chang, K.B. Seung (Seoul, KR)
Long term outcome of the second generation drug eluting stents in the real world setting - paclitaxel
versus zotarolimus eluting stent.
– S. Kasim, D. Moran, P. Kearney, E. McFadden (Cork, IE)
Differential response of local persistent hypercoagulability after zotarolimus-eluting, paclitaxel-eluting,
sirolimus-eluting and bare-metal stent implantation in patients with stable angina.
– K. Yamaguchi, T. Wakatsuki, T. Niki, Y. Taketani, S. Bando, K. Kusunose, T. Iwase, H. Yamada, T. Soeki,
M. Sata (Tokushima, JP)
Impact of acute kidney injury following percutaneous coronary intervention on clinical outcomes in
patients with ST-segment elevated myocardial infarction.
– K. Kume, Y. Yasuoka, R. Araki, T. Imanaka, R. Matsutera, H. Adachi, Y. Noda, S. Hattori, T. Sasaki
(Kawachinagano, JP)
Long-term serial angiographic outcomes after sirolimus-eluting stent implantation: contemporary
practice in real world population.
– E. Ko, K. Nasu, T. Itou, M. Habara, T. Kurita, Y. Kinoshita, E. Tsuchikane, Y. Asakura, O. Katoh, T. Suzuki
(Toyohashi, JP)
P4273
P4274
P4275
P4276
QR 30512
261
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Extracranial and lower extremity artery lesions as predictors of adverse one year outcome after ST
elevation myocardial infarction.
– M.V.Z. Zykov, D.S.M. Meshcheriakova, K.S.S. Shafranskaya, V.V.K. Kashtalap, O.L.B. Barbarash
(Kemerovo, RU)
Drug-eluting stents have no dramatic effects on dialysis patients.
– S. Oshima, K. Noda, H. Ogawa, S. Hokimoto, H. Shimomura, K. Nakao, R. Tsunoda, T. Matsumura,
K. Fijimoto, N. Yamamoto (Kumamoto, Kasuga, Yatsushiro and Nobeoka, JP)
Risk of bleeding in patients treated with vitamin k antagonists that undergo percutaneous coronary
interventions with stent implantation.
– G. Denas, S. Padayattil Jose, P. Gresele, V. De Micheli, S. Testa, R. Quintavalla, D. Poli, F. Marongiu,
V. Pengo (Padua, Perugia, Merate, Cremona, Parma, Florence and Cagliari, IT)
Very-late (8 years) clinical outcomes after unrestricted sirolimus-eluting stent implantation for severe
coronary artery disease.
– A. Ielasi, A. Latib, M.A. Gullace, J. Cosgrave, M. Mussardo, C. Godino, A. Chieffo, M. Carlino,
M. Montorfano, A. Colombo (Milan, IT)
Impact of stress testing before percutaneous coronary interventions on outcomes in patients with
chronic ischemic left ventricular dysfunction.
– E. Ammirati, V. Guida, F. Arioli, G. Calori, A. Latib, A. Colombo, P.G. Camici (Milan, IT)
Long term clinical outcomes after drug-eluting stent implantation for diffuse disease of the left anterior
descending coronary artery.
– C. Graidis, D. Dimitriadis, A. Ntatsios, V. Psifos, V. Karasavvides, J. Neroladakis, G. Karakostas,
E. Anagnostou, K. Gourgiotis, J. Voloudakis (Thessaloniki, GR)
Can we translate the high and low on-treatment platelet reactivity to early, mid and long term risks for
ischemic and bleeding events following the stent placement.
– C. Kaymaz, H.C. Tokgoz, I.H. Tanboga, N. Poci, T. Aktemur, N. Kirca, M.M. Can, M. Saglam, N. Ozdemir
(Istanbul and erzurum, TR)
The time-dependent loss in platelet response to aspirin and clopidogrel: Implications for patient
compliance to antiplatelets.
– C. Kaymaz, I.H. Tanboga, H.C. Tokgoz, N. Poci, N. Kirca, T. Aktemur, M.M. Can, M. Saglam, N. Ozdemir
(Istanbul and erzurum, TR)
Comparison of three-year clinical outcomes after transradial versus transfemoral percutaneous coronary
intervention.
– M. Natsuaki, T. Morimoto, Y. Furukawa, Y. Nakagawa, K. Kadota, M. Iwabuchi, S. Shizuta, T. Kita,
T. Kimura (Kyoto, Kobe, Tenri, Kurashiki and Kitakyushu, JP)
Effect of single long DES implantation on clinical outcomes in AMI patients undergoing PCI.
– K. Ahmed, M.H. Jeong, Y.K. Ahn, Y.J. Hong, D.S. Sim (Gwangju, KR)
Impact of insulin resistance on 1-year clinical outcomes in non-diabetic patients with drug-eluting stent
implantation.
– Y.K. Kim, S.W. Rha, A. Elnagar, K.Y. Chen, B.G. Choi, C.U. Choi, J.W. Kim, C.G. Park, H.S. Seo, D.J. Oh
(Seoul, KR)
Effect of percutaneous coronary intervention on 1-year outcomes of STEMI and NSTEMI patients: data
from the AMI-florence 2 registry.
– N. Carrabba, G.M. Santoro, A. Barchielli, D. Balzi, A. Zuppiroli, A. Santini, C. Landini, S. Valente,
G. Marchionni, G.F. Gensini (Florence, IT)
P4277
P4278
P4279
P4280
P4281
P4282
P4283
P4284
P4285
P4286
P4287
P4288
HYPERTENSION – MISCELLANEOUS (QR 30513*)
Impact of hypertension on progression of left ventricular hypertrophy and cardiovascular events in
patients with aortic valve stenosis.
– A.E. Rieck, D.C. Cramariuc, M.T.L. Lonnebakken, B.P.L. Lund, A.B.R. Rossebo, E.G. Gerdts (Bergen and
Oslo, NO)
Eicosapentaenoic acid suppresses adverse effects of C-Reactive protein overexpression on pressure
overload-induced cardiac remodeling.
– T. Nagai, T. Anzai, Y. Mano, H. Kaneko, A. Anzai, Y. Sugano, Y. Maekawa, T. Takahashi, T. Yoshikawa,
K. Fukuda (Tokyo, JP)
Incident chronic kidney disease in a hypertensive cohort: prospective results.
– E. Andrikou, C. Tsioufis, C. Thomopoulos, A. Kasiakogias, M. Almyroudi, I. Bafakis, K. Kintis,
D. Syrseloudis, D. Tsiachris, C. Stefanadis (Athens, GR)
Exercise testing as a tool for guiding therapy among prehypertensives/normal or high normal blood
pressure groups.
– V. Kothiwale, M. Mahajan (Belgaum, IN)
Administration time-dependent antihypertensive effects of low dose aspirin in well-controlled
hypertensive patients.
– J.H. Lee, S.C. Chae, S.H. Baek, C.W. Nam, D.J. Choi, J.B. Park, N.S. Chung, Y.J. Kim, D.S. Kim (Daegu,
Seoul and Busan, KR)
Assessment of target organ damage in patients with resistant hypertension.
– M. Salvetti, M.L. Muiesan, A. Paini, C. Agabiti Rosei, C. Aggiusti, F. Bertacchini, D. Stassaldi, C. Monteduro,
M. Castellano, E. Agabiti Rosei (Brescia, IT)
*Abstracts can
be accessed at:
262
QR 30513
P4289 (W)
P4290
P4291
P4292
P4293
P4294
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
P4295
P4296
P4297
P4298
P4299
P4300
P4301
P4302
P4303
P4304
P4305
P4306
P4307
P4308
P4309
TUESDAY – MORNING
Resistant hypertension prevalence and associated cardiovascular risk factors and renal disease: the
I-DEMAND study.
– M. Salvetti, E. Ambrosioni, A. Pessina, B. Trimarco, M. Volpe, G. Deferrari, R. Pontremoli, G. Leonetti,
F. Costa, E. Agabiti Rosei (Brescia, Bologna, Padua, Naples, Rome, Genoa and Milan, IT)
An unforgotten predictor of perioperative outcome in patients undergoing noncardiac surgery: pulmonary
hypertension.
– M. Biteker, M. Can, F. Biteker, E. Ilhan, A. Dayan, D. Duman (Istanbul, TR)
What threshold of body mass index is indicative of the presence of hypertension?
– F. Tanaka, S. Makita, T. Onoda, K. Tanno, M. Ohsawa, K. Itai, K. Sakata, A. Ogawa, A. Okayama,
M. Nakamura (Morioka and Tokyo, JP)
Incidence of sleep disorders and depression in relation to metabolic abnormalities in patients with true
resistant hypertension.
– E. Florczak, A. Prejbisz, A. Januszewicz, E. Szwench, P. Oleksiuk, E. Warchol, P. Sliwinski, P. Bielen,
I. Michalowska, K. Narkiewicz (Warsaw and Gdansk, PL)
Is vascular ventricular coupling in malignant phase hypertension abnormal? An echocardiographic
assessment of arterial and systolic elastance in patients with malignant hypertension.
– A. Shantsila, G. Dwivedi, M. Butt, A. Blann, D.G. Beevers, R.P. Steeds, G.Y.H. Lip (Birmingham, GB)
Impaired coronary microcirculation is accompanied by increased urine albumin excretion rate in
untreated hypertensives.
– D. Tsiachris, C. Tsioufis, K. Dimitriadis, I. Tatsis, D. Rousos, D. Syrseloudis, G. Latsios, C. Stefanadis
(Athens, GR)
Hypertensive emergencies and urgencies in an emergency department in Northern Italy.
– A. Paini, M. Salvetti, C. Agabiti Rosei, C. Aggiusti, D. Zotti, S. Cobelli, D. Stassaldi, C. Concoreggi,
E. Agabiti Rosei, M.L. Muiesan (Brescia, IT)
What does urinary albumin tell us in the management of hypertension?
– S. Murai, S. Tanaka, H. Sonoda, S. Yamashita, T. Sugiura, Y. Dohi, G. Kimura (Nagoya, JP)
Lack of regression of left ventricular hypertrophy is accompanied by adverse prognosis in essential
hypertensives. The role of clinical characteristics.
– D. Tsiachris, C. Tsioufis, A. Kasiakogias, K. Dimitriadis, I. Andrikou, A. Kordalis, I. Bafakis, C. Stefanadis
(Athens, GR)
Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients
with electrocardiographic left ventricular hypertrophy.
– C.W. Lee, P.H. Huang, S.S. Huang, H.B. Leu, C.C. Huang, T.C. Wu, J.W. Chen, S.J. Lin (Taipei, TW)
Effect of strong lipophilic statin on left ventricular diastolic function and left atrial function: results of
prospective study of one year follow-up in hypertension with preserved systolic function.
– T. Watanabe, R. Tanaka, K. Ono, R. Tanaka, A. Tanaka, S. Warita, T. Noda, S. Watanabe, M. Kawasaki,
S. Minatoguchi (Gifu, JP)
In hypertensive patients without LVH, adverse functional micro-circulation changes precede
morphological changes. A CFR/OCT study.
– G. Latsios, C. Tsioufis, D. Tsiachris, K. Dimitriadis, D. Rousos, D. Syrseloudis, I. Tatsis, C. Stefanadis
(Athens, GR)
Effect of intensive versus moderate blood pressure lowering on toll-like receptors 4 gene expression in
patients with essential hypertension.
– M. Marketou, J. Kontaraki, E. Zacharis, A. Giaouzaki, K. Stokos, G. Kochiadakis, P. Vardas (Heraklion, GR)
Fibrin clot properties in arterial hypertension and their modification by antihypertensive treatment.
– M. Rajzer, A. Undas, W. Wojciechowska, K. Kawecka-Jaszcz (Krakow, PL)
Salt intake adjusted for body weight is a strong predictor of cardiovascular damage in the general
population.
– H. Takase, Y. Dohi, T. Toriyama, T. Okado, H. Sonoda, A. Hagikura, T. Hashimoto, G. Kimura (Hamamatsu
and Nagoya, JP)
Exaggerated exercise blood pressure response is accompanied by increased levels of C-reactive protein,
osteoprotegerin and urinary albumin excretion in essential hypertensive subjects.
– K. Dimitriadis, C. Tsioufis, A. Aggelis, I. Bafakis, M. Almyroudi, A. Miliou, A. Michaelides, C. Stefanadis
(Athens, GR)
There is a parallel escalation between retinal vascular alterations and arterial stiffness in essential
hypertension.
– V. Katsi, G. Souretis, I. Vlasseros, N. Alexopoulos, A. Koumoulidis, C. Stefanadis, I. Kallikazaros (Athens,
GR)
Risk of cardiovascular events after a first admission to the emergency department for an hypertensive
emergency or urgency: a two years follow up.
– M. Salvetti, A. Paini, L. Tarozzi, C. Agabiti Rosei, C. Aggiusti, A. Bazza, F. Bertacchini, C. Concoreggi,
E. Agabiti Rosei, M.L. Muiesan (Brescia, IT)
P4310
P4311
P4312
PRESENTATION, DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE DISEASE (QR 30514*)
The modern epidemiology of valvular aortic stenosis.
– G.W. Eveborn, H. Schirmer, P.I. Lunde, G. Heggelund, K. Rasmussen (Tromsø, NO)
*Abstracts can
be accessed at:
P4313
QR 30514
263
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Another approach to main clinical characteristics of patients with aortic stenosis: A population based
study.
– E. Garbaz, B. Iung, G. Caranhac, G. Jondeau, A. Vahanian (Paris, FR)
Cardiac CT and 3D echocardiography reveals oval LVOT, leading to underestimation of LVOT and aortic
valve area by 2D echocardiography.
– A. Shiran, S. Adawi, R. Sachner, I. Asmer, M. Ganaeem, R. Rubinshtein, M. Shnapp, T. Gaspar (Haifa, IL)
Prognostic value of valvulo-arterial impedance (Zva) in patients with symptomatic severe aortic valve
stenosis undergoing to transcatheter aortic-valve implantation (CoreValve).
– C. Giannini, C. Cucco, A.I. Corciu, M.G. Delle Donne, C. Nardi, M. De Carlo, F.L. Dini, M. Marzilli,
A.S. Petronio, V. Di Bello (Pisa, IT)
Early changes of left ventricular deformation after interventional trans-femoral aortic valve replacement in
aortic stenosis: a speckle tracking strain analysis.
– S. Schattke, G. Baldenhofer, I. Prauka, W. Sanad, M. Laule, V. Stangl, G. Baumann, K. Stangl, F. Knebel
(Berlin, DE)
Determinants of non invasive coronary flow reserve in severe aortic stenosis.
– P. Meimoun, A.L. Germain, F. Elmkies, T. Benali, J. Boulanger, J. Clerc, H. Zemir, A. Luycx-Bore,
C. Tribouilloy (Compiegne and Amiens, FR)
Evaluation of subendocardial contractile function in aortic stenosis.
– B.M. Van Dalen, A. Tzikas, O.I.I. Soliman, H.B. Van Der Zwaan, W.B. Vletter, F.J. Ten Cate, M.L. Geleijnse
(Rotterdam, NL)
Assessment of anatomical regurgitant orifice in aortic regurgitation by real-time three-dimensional
transesophageal echocardiography.
– H. Mihara, H. Watanabe, M. Aikawa, M. Nagayama, R. Asano, M. Takayama, J. Umemura, M. Kanashiro,
S. Ichimiya, T. Sumiyoshi (Yokkaichi and Tokyo, JP)
Limitations of aortic Doppler diastolic backflow for the diagnosis and grading of aortic regurgitation:
comparison with magnetic resonance validated echocardiographic regurgitant fraction.
– P. Barbier, A. Staron, C. Cefalu’, G. Berna, P. Gripari, D. Andreini, G. Pontone (Milan, IT; Katowice, PL)
Transaortic flow velocity can be calculated from from dual source MDCT for diagnosis of aortic stenosis.
Proof of concept.
– C.J. Schultz, S.L. Papadopoulou, A. Moelker, A. Tzikas, R.J. Nuis, G.J.R. Ten Kate, M.L. Geleijnse, P.J. De
Feyter, P.P.T. De Jaegere, P.W. Serruys (Rotterdam, NL)
Predictors for cardiac death in patients with aortic valve stenosis.
– S. Herrmann, S. Stoerk, M. Niemann, K. Hu, J. Strotmann, W. Voelker, G. Ertl, F. Weidemann (Wurzburg
and Kiel, DE)
Prognostic value of brain natriuretic peptide in elderly patients with aortic stenosis.
– C. Cimadevilla, C. Cueff, N. Berjeb, B. Iung, A. Vahanian, D. Messika-Zeitoun (Paris, FR)
Clinical outcome in asymptomatic severe aortic stenosis: insights from the new aortic stenosis grading
classification.
– J. Magne, E. Donal, L. Davin, K. O’Connor, C. Pirlet, M. Rosca, C. Szymanski, B. Cosyns, L.A. Pierard,
P. Lancellotti (Liège, BE; Rennes, FR; Quebec, CA)
Clinical and echocardiographic characteristics and prognosis of patients with low flow severe aortic
stenosis despite preserved ejection fraction.
– C. Izumi, S. Takahashi, M. Miyake, S. Nakajima, M. Nishiga, J. Sakamoto, T. Tamura, H. Kondo, K. Kaitani,
Y. Nakagawa (Tenri, JP)
Echocardiographic score for risk stratification in asymptomatic moderate-severe aortic stenosis.
– C. Mazzone, N.B. Berlinghieri, M.T. Triggiani, P.F. Faggiano, C.P. Pandullo, A.D.L. Di Lenarda,
L.T. Tarantini, C.S. Stefenelli, F.F. Furlanello, G.C. Cioffi (Trieste, Brescia, Belluno and Trento, IT)
Left ventricular contractility in patients with low-flow, low-gradient severe aortic stenosis with normal
ejection fraction.
– R. Migliore, M.E. Adaniya, M. Barranco, G. Miramont, H. Tamagusuku (San Martin, AR)
Low-gradient severe aortic stenosis: a 5 years retrospective analysis.
– M. Moretti, M. Merlo, G. Barbati, E. Fabris, M. Morosin, L. Massa, B. Pinamonti, A. Pappalardo, G. Sinagra
(Trieste, IT)
Influence of aortic valve dysfunction and aortic diameters on the need for surgery after the diagnosis of
bicuspid aortic valve.
– J.M. Alegret, C. Ligero, O. Palazon, I. Duran, J.M. Vernis, A. Hernandez Aparicio, L. Krsticevic (Reus, ES)
Long-term prognosis of patients with severe aortic stenosis and atrial fibrillation.
– G.E. Hoogslag, M.L. Antoni, A.C.T. Ng, F. Van Der Kley, S.H. Ewe, N. Ajmone Marsan, M.J. Schalij,
E.E. Van Der Wall, J.J. Bax, V. Delgado (Leiden, NL)
Excess 1 year mortality ratios of elderly patients admitted for congestive heart failure according to the
presence of aortic stenosis: a comparison with normal age and gender matched individuals.
– J.H.A.J. De Sutter, N.I.C.O. Van De Veire, C. Weytjens, D. Debacquer, B. Van De Kerckhove, N. De Laet,
G. Van Camp (Ghent and Brussels, BE)
Metabolic syndrome is associated with more pronounced concentric LV hypertrophy in patients with
severe calcific aortic stenosis undergoing aortic valve replacement.
– M.-A. Clavel, R. Capoulade, J.G. Dumesnil, P. Mathieu, J.P. Despres, P. Pibarot (Quebec, CA)
Predictors of mortality in mixed aortic stenosis and regurgitation.
– N. Rashedi, B.P. Griffin, W.J. Stewart, T.H. Marwick (Cleveland, US)
Asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction: role of the
interaction between longitudinal function and valvulo-arterial impedance in the risk stratification.
– C. Zito, M. Cusma Piccione, J. Salvia, F. Antonini-Canterin, D. Donato, E. Alati, A. Pardeo, G. Di Bella,
G. Oreto, S. Carerj (Messina and Pordenone, IT)
264
P4314
P4315
P4316
P4317
P4318
P4319
P4320
P4321
P4322
P4323
P4324
P4325
P4326
P4327
P4328
P4329
P4330
P4331
P4332
P4333
P4334
P4335
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Outcome of patients with severe aortic stenosis and poor left ventricular function, high trans valvular
gradient versus low trans valvular and response to treatment.
– I. Ben-Dor, R. Torguson, G. Maluenda, P. Okubagzi, Z. Xue, K. Kent, J. Lindsay, L. Satler, A. Pichard,
R. Waksman (Washington, US)
Low-gradient severe aortic stenosis despite preserved left ventricular ejection fraction: a 5 years
retrospective analysis.
– M. Moretti, M. Merlo, G. Barbati, E. Fabris, M. Morosin, L. Massa, B. Pinamonti, A. Pappalardo, G. Sinagra
(Trieste, IT)
The predictive value of troponin, C-reactive protein and brain natriuretic peptide in patients with
symptomatic aortic stenosis.
– O.G. Solberg, T. Ueland, R. Wergeland, C.P. Dahl, S. Aakhus, P. Aukrust, L. Gullestad (Oslo, NO)
Impact of myocardial fibrosis on left ventricular hypertrophy in symptomatic severe aortic stenosis
patients.
– C. Bergamini, G. Golia, A. Milano, M. Dodonov, G. Faggian, A. Tomezzoli, C. Vassanelli (Verona, IT)
Validation of a new score for asymptomatic aortic stenosis.
– N. Farre, M. Gomez, M. Cladellas, L. Molina, A. Ramirez, J. Vila, M. Cainzos-Achirica, M. Ble, S. Ascoeta,
J. Bruguera (Barcelona, ES)
Impact of concomitant aortic regurgitation on the prognosis of severe aortic stenosis.
– S. Honda, T. Kitai, T. Tani, Y. Okada, T. Kita, Y. Furukawa (Kobe, JP)
Clinical outcomes of high-risk patients with severe aortic stenosis according to treatment modality.
– P. Wenaweser, T.M. Pilgrim, A. Kadner, C. Huber, S. Stortecky, H. Brinks, B. Meier, P. Jueni, T. Carrel,
S. Windecker (Berne, CH)
Lower left ventricular stroke volume predicts cardiovascular events in asymptomatic aortic stenosis (the
SEAS study).
– M.T. Lonnebakken, D. Cramariuc, K. Boman, A.B. Rossebo, K. Egstrup, S. Ray, C. Gohlke-Baerwolf,
E. Gerdts (Bergen and Oslo, NO; Skelleftea, SE; Svendborg, DK; Manchester, GB; Bad Krozingen, DE)
Angiotensin-receptors blockers but not angiotensin-converting enzyme inhibitors delay the progression
of aortic stenosis.
– R. Capoulade, M.A. Clavel, P. Mathieu, N. Cote, J.G. Dumesnil, M. Arsenault, E. Bedard, P. Pibarot
(Quebec, CA)
P4336
P4337
P4338
P4339
P4340
P4341
P4342
P4343
P4344
NEW INSIGHTS INTO THE PATHOPHYSIOLOGY OF AORTIC VALVE DISEASE (QR 30515*)
*Abstracts can
be accessed at:
P4345
P4346
P4347
P4348
P4349
P4350
TUESDAY – MORNING
Statin use reduces neoangiogenesis and intraleaflet haemorrhage in the aortic valve of degenerative
aortic stenosis.
– H. Akahori, T. Tsujino, Y. Naito, C. Yoshida, N. Sasaki, M.L. Kawabata, M. Ohyanagi, M. Mitsuno,
Y. Miyamoto, T. Masuyama (Nishinomiya and Kobe, JP)
Increased thrombin generation and platelet activation as a compensatory mechanism in patients with
aortic stenosis and acquired deficiency in high-molecular-weight vWF multimers.
– A. Undas, J. Natorska, K. Bykowska, M. Hlawaty, G. Marek, J. Sadowski (Krakow and Warsaw, PL)
Growth differentiation factor-15 AND ST2 levels in patients undergoing elective aortic valve surgery.
– K. Ang, L.L. Ng, D. Chin, J. Khoo, D. Chan, A. Sosnowski, M. Galinanes (Leicester, GB)
The severity of myocardial fibrosis in aortic stenosis is related to upregulation of procollagen type I
C-terminal proteinase.
– F. Valencia Serrano, B. Lopez Salazar, J.J. Gomez-Doblas, J. Diez Martinez, E. De Teresa Galvan (Malaga
and Pamplona, ES)
Serum osteoprotegerin and RANKL levels in patients with bicuspid and tricuspid aortic stenosis.
– O. Irtyuga, E. Zhiduleva, E. Vasilyeva, E. Kazakova, M. Budanova, O. Moiseeva (Saint- Repersburg, RU)
Active aortic valve calcification and inflammation in patients with aortic stenosis: a PET-CT study.
– M. Dweck, C. Jones, N. Joshi, A. Fletcher, H. Richardson, G. McKillop, E. Van Beek, N. Boon, J.H. Rudd,
D.E. Newby (Edinburgh and Cambridge, GB)
Wall shear stress in the ascending aorta in patients with bicuspid aortic valves differs significantly from
tricuspid aortic valves.
– C. Meierhofer, E.P. Schneider, C. Lyko, S. Martinoff, M. Markl, J. Hess, H. Stern, S. Fratz (Munich and
Freiburg, DE)
The association between bicuspid aortic valve function on circulating endothelial progenitor cells.
– M. Vaturi, L. Perl, D. Leshem-Lev, T. Bental, Y. Shapira, I. Yedidya, G. Greenberg, A. Sagie, A. Battler,
E.I. Lev (Petah Tikva, IL)
Echocardiography and collagen markers in “low flow and high gradient” aortic stenosis.
– K. Piestrzeniewicz, K. Luczak, M. Maciejewski, J. Drozdz (Lodz, PL)
Angiogenesis in degenerative aortic valve disease.
– A. Panzenboeck, J. Jakowitsch, R. Seitelberger, D. Bonderman, R. Rosenheck, H. Baumgartner, I. Lang
(Vienna, AT)
Association of sclerostin serum levels with the severity of aortic valve calcification.
– R. Koos, A.H. Mahnken, N. Marx, V. Brandenburg (Aachen, DE)
Neoangiogenesis, intraleaflet haemorrhage and macrophage infiltration are more remarkable in bicuspid
aortic valve stenosis than in tricuspid aortic valve stenosis.
– H. Akahori, T. Tsujino, Y. Naito, C. Yoshida, N. Sasaki, M.L. Kawabata, M. Ohyanagi, M. Mitsuno,
Y. Miyamoto, T. Masuyama (Nishinomiya and Kobe, JP)
P4351
P4352
P4353
P4354
P4355
P4356
QR 30515
265
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
The imbalance between proliferation and apoptosis contributes to degeneration of aortic valves and
bioprostheses - implications for FKBP12 therapeutic modulations.
– I. Tuleta, K. Alghaddioui, S. Pabst, N. Wernert, C.J. Preusse, A. Welz, G. Nickenig, D. Skowasch (Bonn, DE)
Insights into the initiation of aortic stenosis: roles of ACE-inhibitors and vitamin D.
– A.L. Sverdlov, D.T.M. Ngo, Y.Y. Chirkov, J.D. Horowitz (Adelaide, AU)
Tissue factor expressed by aortic valve interstitial cells is able to generate thrombin in vitro.
– J. Breyne, E. Jeanpierre, D. Corseaux, F. Juthier, C. Banfi, C. Zawadzki, A. Vincentelli, T. Le Tourneau,
B. Jude, S. Susen (Lille and Nantes, FR)
Relationship between insulin resistance and progression of left ventricular hypertrophy in patients with
aortic stenosis: a substudy of the ASTRONOMER trial.
– R. Capoulade, M.A. Clavel, J.G. Dumesnil, K.L. Chan, J.W. Tam, K.K. Teo, N. Cote, P. Mathieu,
J.P. Despres, P. Pibarot (Quebec, Ottawa, winnipeg and Hamilton, CA)
Phenotypes of bicuspid aortic valve disease and correlations with ascending aortic dilatation by
cardiovascular magnetic resonance.
– D. Domingo Valero, B. Igual Munoz, J. Estornell Erill, A. Maceira Gonzalez, M. Rodriguez Serrano,
F. Buendia Fuentes, D. Tejada Ponce, A. Andres Lahuerta, M.A. Arnau Vives, A. Salvador Sanz (Valencia,
ES)
MicroRNA expression profile of human aortic valve stenosis.
– P.J. Ohukainen, P. Taskinen, T. Peltonen, T. Juvonen, J. Satta, H. Ruskoaho, J. Rysa (Oulu, FI)
Differences in the secretome of ascending aortic aneurysms from patients with bicuspid or tricuspid
valves.
– S. Rocchiccioli, I. Foffa, S. Franceschi, S. Bevilacqua, M. Mariani, M.G. Andreassi, L. Citti, A. Cecchettini
(Pisa and Massa, IT)
CTGF regulates VSMC phenotypic differentiation and ECM organization, and contributes to the
development of thoracic aortic aneurysm in bicuspid and trileaflets aortic valve patients.
– G. Ferrari, E. Branchetti, K.R. Milewski, W.F. Seefried, R. Sainger, J.B. Grau, A. Parolari, J.E. Bavaria
(Philadelphia, US; Milan, IT)
Systematic familial screening identified a high frequency of heritability in calcific aortic valve disease.
– V. Probst, F.V. Valleix, T.L.T. Le Tourneau, F.K. Kyndt, H.L.M. Le Marec, J.J.S. Schott (Nantes, FR)
Expression of TFPI-2 in diseased aortic valves.
– J. Breyne, C. Zawadzki, F. Juthier, C. Banfi, D. Corseaux, A. Ung, A. Vincentelli, T. Le Tourneau, B. Jude,
S. Susen (Lille and Nantes, FR)
Aortic stenosis is as much a disease of the myocardium as of the valve - the role of diffuse myocardial
fibrosis as measured by EQ-CMR.
– A.S. Flett, D.M. Sado, G. Quarta, O. Huttin, D.J. Hausenloy, S.M. Banypersad, D. Pellerin, C. McGregor,
A.M. Taylor, J.C. Moon (London, GB)
Platelet derived chemokines, PF-4 and RANTES, are significantly increased in hemodynamically
significant degenerative aortic stenosis.
– Z. Motovska, D. Odvodyova, M. Karpisek, R. Petr, H. Hrabakova, V. Kocka, I. Simkova, S. Katina,
P. Widimsky (Prague and Brno, CZ; Bratislava, SK)
P4357
P4358
P4359
P4360
P4361
P4362
P4363
P4364
P4365
P4366
P4367
P4368
HEART FAILURE – LEFT VENTRICULAR DYSFUNCTION (QR 30516*)
Impact of levosimendan treatment, in acute heart failure patients, on mortality and re-hospitalization rate:
a long term follow-up.
– N. Bruno, M. Mancone, C. Caira, B. Brasolin, A. D’Ambrosi, F. Fedele (Rome, IT)
VE/VCO2 slope: What is the most powerful independent predictor of survival: overall, initial or final
VE/VCO2 slopes? A study in 786 consecutive patients with left ventricular systolic dysfunction.
– A. Musschoot, P. de Groote, M. Fertin, C. Goeminne, S. Peyrot, F. Mouquet, C. Bauters, N. Lamblin (Lille,
FR)
Selective HDL raising gene transfer increases survival, attenuates remodeling, and enhances cardiac
function following myocardial infarction in mice.
– S.C. Gordts, I. Muthuramu, F. Jacobs, E. Van Craeyveld, E. Nefyodova, B. De Geest (Leuven, BE)
How valid are the European Society of Cardiology echocardiographic diastolic criteria in diagnosing heart
failure with normal ejection fraction?
– G. Mahadevan, G. Dwivedi, D. Jiminez, L. Williams, M.P. Frenneaux (Birmingham, GB)
Acute beneficial impact of adaptive servo ventilation on hemodynamic data in heart failure patients with
Cheyne-Stokes respiration.
– A. Yoshihisa, M. Miyata, T. Sato, S. Suzuki, K. Sugimoto, H. Kunii, K. Nakazato, H. Suzuki, S. Saitoh,
Y. Takeishi (Fukushima, JP)
Physical exercise attenuates diabetes-induced left ventricular and myocardial dysfunction in rats.
– C. Gimenes, R. Gimenes, G.N. Guirado, M.D.M. Cezar, D.H.S. Campos, A.H.R. Takamoto, B.T. Nakatani,
R.T. Bueno, M.P. Okoshi, K. Okoshi (Botucatu, BR)
Remodelling of left ventricular mechanic in dilated cardiomyopathy: a two-dimensional speckle tracking
echocardiography study.
– B. Goebel, K. Haugaa, K. Meyer, A. Lauten, C. Jung, S. Otto, H.R. Figulla, T. Edvardsen, T.C. Poerner
(Jena, DE; Oslo, NO)
Evidence for impaired left ventricular contractility during normal pregnancy.
– M.E. Estensen, J.O. Beitnes, G. Grindheim, O.A. Smiseth, T. Henriksen, S. Aakhus (Oslo, NO)
*Abstracts can
be accessed at:
266
QR 30516
P4369
P4370
P4371
P4372
P4373
P4374
P4375
P4376
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
P4377
P4378
P4379
P4380
P4381
P4382
P4383
P4384
P4385
P4386
P4387
P4388
P4389
P4390
P4391
TUESDAY – MORNING
Cavopulmonary shunt after LVAD implantation improves haemodynamics in patients having relatively
impaired right heart: an in-silico analysis.
– S. Shimizu, T. Shishido, T. Kawada, Y. Sata, A. Kamiya, M. Sugimachi (Osaka, JP)
Effects of intraaortic balloon pump counterpulsation on left ventricular systolic and diastolic function in a
porcine model of acute ischemic heart failure;differences between ischemia and reperfusion.
– K. Malliaras, J. Terrovitis, A. Ntalianis, E. Charitos, N. Diakos, I. Pozios, E. Tseliou, L. Katsaros, S. Vakrou,
J. Nanas (Athens, GR)
Hyperdehydroepiandrosterone in hemodynamically instable neonates with refractory hypotension.
– A. Khashana, M. Hallman, A. Abdelwahab, S. Elsharkawy, H. Atwa, A. Ahmed (Ismailia, EG; Oulu, FI)
Alterations in ventriculo-arterial coupling and systemic arterial properties during normal pregnancy.
– M.E. Estensen, G. Grindheim, E.W. Remme, A. Swillens, O.A. Smiseth, P. Segers, T. Henriksen, S. Aakhus
(Oslo, NO; Ghent, BE)
Diagnostic value of Doppler transthoracic echocardiography in the estimation of left ventricular filling
pressure in patients with severe symptomatic systolic heart failure.
– B. Gellen, P.F. Lesault, F. Canoui Poitrine, P. Lim, P. Gueret, E. Teiger, J.L. Dubois Rande, L. Hittinger,
T. Damy (Créteil, FR)
Assessment of right ventricular regional and global function in asymptomatic patients with repaired
tetralogy of Fallot by ultrasound speckle tracking imaging.
– M. Xie, Y. Li (Wuhan, CN)
Non invasive hemodynamic evaluation of patients with acute heart failure in emergency department:
impedance cardiography compared with clinical evaluation and B type natriuretic peptide (BNP).
– M.W. Montera, S.B. Pereira, A. Volschan, M.S. Diniz, Y. Pereira, E.T. Mesquita (Rio de Janeiro, BR)
Aortic stiffness and left atrial volume index in adult dialyzed patients: dependence - compliance and
pressure.
– T. Zapolski, A. Jaroszynski, A. Drelich-Zbroja, A. Wysokinski, A. Ksiazek, M. Szczerbo-Trojanowska (Lublin,
PL)
Pressure volume relationship is related to coronary flow reserve in non-ischemic dilated cardiomyopathy.
– Q. Ciampi, F. Rigo, L. Pratali, S. Gherardi, B. Villari, E. Picano, R. Sicari (Benevento, Mestre-Venice, Pisa
and Cesena, IT)
Obese heart failure patients have less cardiac impairment than thinner counterparts.
– S. Chinnappa, N. Lewis, D. Barker, D. Goldspink, L.B. Tan (Leeds, GB)
Determinants of right ventricular mass in heart failure patients with reduced ejection fraction: a MRI
based study.
– J. Vormbrock, J. Liebeton, M. Hosseini, C. Schilling, A. Meissner, H. Yeni, H.-J. Trappe, G. Plehn (Herne,
DE)
Invasive evaluation of whether decline in pressure after initial immediate increment on improving AV
delay of CRT is due to vasodilatation or decline in cardiac function.
– P.A. Pabari, A. Kyriacou, Z.I. Whinnett, I. Wright, K. Willson, J. Mayet, A.D. Hughes, D.P. Francis (London,
GB)
Impact the transcatheter aortica valve implantation in patients with severe aortic stenosis with reduced
left ventricular ejection fraction.
– A.J. Munoz Garcia, P. Losada Mora, M.J. Molina Mora, M.F. Jimenez Navarro, I. Rodriguez Bailon,
J.H. Alonso Briales, M. Such Martinez, A.J. Dominguez Franco, J.M. Hernandez Garcia, E. De Teresa
Galvan (Malaga, ES)
Evaluation of systolic-diastolic left ventricular function in competitive athletes: study by
two-bidimensional speckle tracking.
– K. Savino, A. Lilli, C. Riccini, E. Bordoni, G. Ambrosio (Perugia and Lido Di Camaiore, IT)
Chronic GLP-1 treatment preserves diastolic function and improves survival in rats with pressure
overload.
– T.D. Nguyen, Y. Shingu, P.A. Amorim, M. Schwarzer, T. Doenst (Jena and Leipzig, DE)
Inhibition of ASK1 attenuates angiotensin II- or TGF-beta-stimulated cardiomyocyte hypertrophy and
fibroblast collagen synthesis: therapeutic potential of ASK1 inhibitors in myocardial remodelling.
– B. Wang, G.Y. Xu, P.Y. Ho, A. Kompa, B.M. Jucker, R.N. Willette, H. Krum (Melbourne, AU; King of
Prussia, US)
Asymptomatic left ventricular systolic dysfunction is prevalent and undertreated prior to diagnosis: a
report from the STOP-HF study.
– G. Murtagh, I.R. Dawkins, M.T. Ledwidge, E. Tallon, R. O’Hanlon, K. McDonald (Dublin, IE)
Levosimendan as a weaning strategy from inotropes.
– D. Bresson, F. Sibellas, C. Petitpe, O. Bastien, J.-J. Lehot, V. Cart-Regal, L. Sebbag, E. Bonnefoy (Bron,
FR)
Lung impedance guided preemptive treatment of evolving acute heart failure in course of acute
myocardial infarction reduces use of furosemide.
– M. Shochat, A. Shotan, M. Kazatsker, V. Gurovich, E. Noiman, A. Asif, Y. Levy, L. Vasilenko, D. Blondhaim,
S. Meisel (Hadera, IL)
Natriuretic peptide inhibition in the presence of angiotensin receptor blockade following short-term
treatment with LCZ696 in heart failure patients: effect on ANP, BNP, NT-proBNP and cGMP.
– Z. Kobalava, O. Averkov, I. Meray, L. Alexandriya, V. Moiseev, D. Albrecht, A. Feng, P. Chandra,
P.J. Jordaan (Moscow, RU; Basel, CH)
Insulin treatment retards post-ischemic heart failure by inhibition of myocardial CaMKII via PI3K-Akt
activation in rats.
– F. Gao, W.J. Xing, W.J. Yan, F. Fu, H.F. Zhang, J. Zhang, W.Y. Guo, H.C. Wang (Xi’an, CN)
P4392
P4393
P4394
P4395
P4396
P4397
267
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Excessive extracellular matrix metabolism identify a sub-group of post-myocardial infarction patients
with preserved left ventricular dysfunction who may benefit from eplerenone.
– N. Kambouridis, D.N. Tziakas, G. Chalikias, D. Stakos, S. Apostolakis, D. Papazoglou, A. Thomaidi,
A. Lantzouraki, D. Simeonidis, S.V. Konstantinides (Kavala and Alexandroupolis, GR)
Efficacy and safety of recombinant human Atrial Natriuretic Peptide (rhANP) for acute decompensated
heart failure: a multicenter randomized controlled dose-finding study.
– G. Wang (Beijing, CN)
Low-dose of beta-blocker in combination with milrinone improves cardiac function in patients with acute
decompensated heart failure.
– S. Kobayashi, T. Susa, T. Tanaka, W. Murakami, S. Okuda, M. Doi, T. Nao, Y. Wada, M. Yano,
M. Matsuzaki (Ube, JP)
The differences of hemodynamic response between nicorandil and carperitide in patients with acute
decompensated heart failure.
– H. Hattori, Y. Minami, H. Arashi, M. Higashitani, D. Yumino, J. Yamaguchi, F. Mori, T. Shiga, N. Hagiwara
(Tokyo, JP)
Administration of the cyclic peptide COR-1 in humans neutralizes anti-beta1 receptor-antibodies, but
does not induce other immune effects.
– M. Ungerer, V. Boivin, H.P. Holthoff, K. Adler, H. Degen, M.J. Lohse, R. Jahns, G. Munch (Martinsried and
Wurzburg, DE)
Ivabradin compare with bisoprolol reduces segmental diastolic dysfunction and improves diastolic
functional reserve in patients with diastolic heart failure.
– K.G. Adamyan, A.L. Chilingaryan (Yerevan, AM)
3’,4’-dihydroxyflavonol (DIOHF) attenuates diastolic dysfunction and cardiac remodelling in
streptozotocin-induced diabetic m(Ren2)27 rats.
– F.L. Khong, Y. Zhang, W. Qi, O.L. Woodman, D.J. Kelly (Melbourne, AU)
Effects of aliskiren on Left ventricular remodeling in patients with dilated cardiomyopathy.
– H. Sakai, T. Tsutamoto, C. Kawahara, M. Fujii, M. Yamaji, M. Ohnishi, T. Matsumoto, A. Wada, M. Horie
(Otsu, Inugami and Kusatsu, JP)
When conventional heart failure therapy is not enough: angiotensin receptor blocker or aldosterone
antagonist?
– S. Bangalore, S. Kumar, F.H. Messerli (New York and Omaha, US)
Comparative trial of efficacy and safety of cardosten, valsartan and their combination in patients with
chronic heart failure.
– Y.U. Zabolotneva, M. Kachanova, V.I. Petrov, G.P. Arutyunov, A.V. Yevzirikhina, S.V. Nedogoda,
Y.U.M. Lopatin, V.V. Tsoma, S.A. Sergeeva, O.I. Epstein (Moscow and Volgograd, RU)
Evaluating the trial strategy for dosage application of beta-blockers and their impact on the quality of life
using the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
– D.S.B. Melo, A.C.P. Barretto, A.I. Oliveira, A.H. Uchida, M.E. Ochiai, J.N. Cardoso, P.C. Morgado,
J.A.F. Ramires (São Paulo, BR)
Clinic blood pressure in stable heart failure patients treated with the dual-acting neprilysin and
angiotensin receptor inhibitor LCZ696.
– Z. Kobalava, Y. Kotovskaya, I. Meray, A. Globenko, V. Moiseev, D. Albrecht, A. Feng, P. Chandra,
P. Jordaan (Moscow, RU; Zurich, CH)
Optimum or maximum, that is the question: a retrospective analysis of pharmacological therapy achieved
in a hospital based, nurse led heart failure clinic.
– A. Birchall, D. Barnett, N. Buckley, K. Drewry, L. O’Toole, A. Al-Mohammad (Sheffield, GB)
Influence of eplerenone treatment on the number of endothelial progenitor cells in patients with chronic
heart failure.
– C. Jung, A. Floorvag, V. Oberle, M. Fritzenwanger, A. Lauten, M. Franz, B. Goebel, D. Barz, M. Ferrari,
H.R. Figulla (Jena, DE)
Renal effects of a novel dual acting V1a/V2 vasopressin receptor antagonist: comparison with
furosemide.
– P. Kolkhof, J.P. Stasch, E. Pook, C. Schmeck, C. Fuerstner, B. Albrecht-Kuepper (Wuppertal, DE)
Alternate anticoagulation with the parenteral anti-Xa agent otamaxiban in heparin compromised
conditions.
– I. Thethi, J. Fareed, W. Jeske, O. Iqbal, D. Hoppensteadt, B. Lewis, J.M. Walenga (Maywood, US)
Dose titration of the oral potassium binder RLY5016 to maintain normal serum potassium in heart failure
and chronic kidney disease patients on aldosterone antagonists.
– B. Pitt, D. Bushinsky, S. Halfon, D. Kitzman, M. Lainscak, V. Mathur, Y. Stasiv, I. Huang (Ann Arbor,
Rochester, Santa Clara, Winston-Salem and Woodside, US; Golnik, SI)
Evidence of altered isovolumic contraction during diastolic dysfunction with preserved ejection fraction in
chronic hypertensive pigs.
– M. Rienzo, D. Pongas, A. Bize, H.L. Chan, L. Sambin, L. Hittinger, J.B. Su, A. Berdeaux, B. Ghaleh (Créteil,
FR)
Assessment of both time-left atrial volume curve and left atrial emptying function by speckle tracking
echocardiography is useful to evaluate left ventricular diastolic function in elderly patients.
– T. Watanabe, R. Tanaka, K. Ono, M. Nagaya, N. Onishi, M. Iwama, T. Noda, S. Watanabe, M. Kawasaki,
S. Minatoguchi (Gifu, JP)
Albumin levels predict survival in patients with heart failure with normal ejection fraction.
– M. Liu, G.W.K. Yip, B.P.Y. Yan, C.P. Chan, Q. Zhang, Y.Y. Lam, R.J. Li, J.E. Sanderson, J.P. Sun, C.M. Yu
(Hong Kong, HK; Chengdu, CN)
Chronic inhibition of protein tyrosine phosphatase 1B improves diastolic function and limits endothelial
dysfunction in insulin resistant/obese mice.
– E. Gomez, N. Harouki, P. Mulder, F. Bauer, R. Hooft, C. Thuillez, V. Richard (Rouen, FR; Geneva, CH)
268
P4398
P4399
P4400
P4401
P4402
P4403
P4404
P4405
P4406
P4407
P4408
P4409
P4410
P4411
P4412
P4413
P4414
P4415
P4416
P4417
P4418
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Impact of left ventricular diastolic dysfunction on screening for left ventricular systolic dysfunction using
b-type natriuretic peptide: a report from the STOP - HF study.
– G. Murtagh, I.R. Dawkins, M.T. Ledwidge, R. O’Hanlon, E. Tallon, K. Md Donald (Dublin, IE)
Assessment of single ventricle diastolic function during stress echocardiography in adult patients after
fontan operation.
– L. Tomkiewicz-Pajak, L. Drabik, M. Olszowska, P. Rubis, M. Komar, W. Plazak, P. Podolec (Krakow, PL)
Prevalence of diastolic left ventricular dysfunction in European populations based on cross-validated
diagnostic thresholds.
– M. Kloch-Badelek, T. Kuznetsova, W. Sakiewicz, A. Ryabikov, S. Malyutina, K. Stolarz-Skrzypek,
E. Casiglia, K. Narkiewicz, K. Kawecka-Jaszcz, J.A. Staessen (Krakow and Gdansk, PL; Leuven, BE;
Novosibirsk, RU; Padua, IT)
Myeloperoxidase is critically linked to the development of diastolic heart failure following pressure
overload.
– F. Deuschl, A. Klinke, K. Friedrichs, F. Weinberger, B. Geertz, V. Rudolph, D. Lau, K. Klingel,
T. Eschenhagen, S. Baldus (Hamburg and Tübingen, DE)
SERCA2a gene transfer improves diastolic function in ischemic heart failure.
– K. Ishikawa, L. Tilemann, D. Ladage, K. Fish, Y. Kawase, R.J. Hajjar (New York, US)
Angiotensin II-induced diastolic dysfunction is associated with cardiac inflammation and peripheral
monocytosis.
– J. Hoffmann, H. Moellmann, D. Kraft, S. Voss, C. Troidl, S. Szardien, C. Liebetrau, A. Rolf, C.W. Hamm,
H.M. Nef (Bad Nauheim, DE)
P4419
P4420
P4421
P4422
P4423
P4424
FROM ELECTROCARDIOGRAPHY TO INVASIVE ELECTROPHYSIOLOGY (QR 30517*)
*Abstracts can
be accessed at:
P4425
P4426
P4427
P4428
P4429
P4430
P4431
P4432
P4433
TUESDAY – MORNING
Fragmented QRS signifies all cause mortality in left ventricular noncompaction cardiomyopathy.
– X.H. Ning, M. Tang, J. Sha, Z.M. Liu, R.H. Chen, K.P. Chen, S. Zhang (Beijing, CN)
The presence of J waves in 12-leads electrocardiogram is associated with the enlargement and
functional abnormality of right ventricular - evaluation by using cardiac magnetic resonance imaging.
– T. Takeuchi, T. Tomita, K. Shimada, A. Okada, K. Aizawa, A. Izawa, Y. Miyashita, S. Kumazaki, J. Koyama,
U. Ikeda (Matsumoto, JP)
Prevalence and prognosis impact of early repolarisation pattern in a general population.
– A. Rollin, J.B. Ruidavets, P. Maury, V. Bongard, M. Delay, A. Duparc, P. Mondoly, J. Ferrieres, D. Carrie
(Toulouse, FR)
Stepwise increasing levels of hsCRP are associated with atrial fibrillation and long QT in a general
population study.
– C. Ellervik (Copenhagen, DK)
Insights into location of type I ECG in patients with Brugada syndrome - correlation of ECG and
cardiovascular magnetic resonance imaging.
– C. Veltmann, T. Papavassiliu, T. Konrad, C. Doesch, F. Streitner, J. Kuschyk, C. Wolpert, M. Borggrefe,
R. Schimpf (Mannheim and Ludwigsburg, DE)
Increased Tpeak-Tend interval in Brugada syndrome is highly related to symptoms and mortality.
Validation of this marker in a large series of Brugada syndrome patients.
– A. Rollin-Garderes, P. Maury, F. Sacher, A. Duparc, P. Mondoly, M. Delay, J.L. Pasquie, F. Raczka,
V. Bongard, D. Carrie (Toulouse, Bordeaux and Montpellier, FR)
Prevalence and predictors of early repolarization and J wave in the general population.
– R. Mollo, A. Cosenza, G. Pinnacchio, G. Careri, M. Laurito, I. Coviello, A. Stazi, G.A. Lanza, F. Crea (Rome,
IT)
Electrocardiographic features of non-compaction cardiomyopathy.
– H. Xu, P. Fang, J. Deng, S. Zhao (Beijing, CN)
Circadian variations of ST segment elevation in Brugada syndrome: comparison between symptomatic
and asymptomatic patients.
– N. Behar, G. Kervio, B. Petit, S. Bodi, P. Maison-Blanche, P. Mabo (Rennes, FR)
Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular
hypertrophy and its regression in essential hypertension.
– D. Tsiachris, C. Tsioufis, A. Kasiakogias, K. Dimitriadis, C. Thomopoulos, D. Syrseloudis, L. Lioni, I. Bafakis,
G. Chlapoutakis, C. Stefanadis (Athens, GR)
Localised and spatially constrained sources in human atrial fibrillation.
– D.E. Krummen, R. Sehra, C. Briggs, S. Narayan (San Diego, US)
Endocardial voltage mapping is superior to contrast-enhanced magnetic resonance for imaging of
myocardial substrate of right ventricular tachycardia.
– M. Perazzolo Marra, A. Zorzi, F. Migliore, B. Bauce, L. Leoni, C. Basso, G. Buja, G. Thiene, S. Iliceto,
D. Corrado (Padua, IT)
Respiratory, cardiac cycle and patient movement compensation in a new 3D sensor guided
navigation-system.
– T. Gaspar, P. Sommer, S. Rolf, C. Piorkowski, G. Hindricks (Leipzig, DE)
Non-fluoroscopic sensor guided navigation of intracardiac EP catheters within pre-recorded cine loops.
– C. Piorkowski, G. Hindricks (Leipzig, DE)
P4434
P4435
P4436
P4437
P4438
QR 30517
269
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
Feasibility and acute efficacy of radiofrequency ablation of cavotricuspid isthmus dependent atrial flutter
guided by real-time 3-dimensional echocardiography.
– F. Regoli, F. Faletra, G. Nucifora, E. Pasotti, T. Moccetti, C. Klersy, A. Auricchio (Lugano, CH; Pavia, IT)
The complications of lead extraction with infected vegetations: a single-center experience and
consequences of transvenous extraction.
– M. Nagashima, M. Goya, Y. Soga, K. Hiroshima, K. Andou, M. Iwabuchi, H. Yokoi, M. Nobuyoshi
(Kitakyushu, JP)
Hurdles in ablation of atrial tachycardia in Fontan patients.
– I. Suman Horduna, M. Gujic, S. Ernst (London, GB)
Genetic deletion of the p66Shc adaptor protein protects against age-related cardiac arrhythmias.
– P. Francia, A. Ricotta, A. Uccellini, C. Balla, C. Adduci, S. Carosio, L. Barberi, A. Musaro’, F. Cosentino,
M. Volpe (Rome, IT)
Assessment of atrioventricular conduction intervals during percutaneous aortic valve implantation.
– J. Segura, J. Suarez De Lezo Jr, F. Mazuelos, M. Pan, M. Romero, E. Caballero, D.J. Pavlovic,
H. Mendoza, A. Medina, J. Suarez De Lezo (Córdoba and Las Palmas de Gran Canaria, ES)
P4439
P4440
P4441
P4442
P4443
VENTRICULAR ARRHYTHMIAS AND CATHETER ABLATION (QR 30518*)
Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable
cardioverter-defibrillator therapy.
– C. Schukro, L. Leitner, J. Siebermair, T. Pezawas, G. Stix, J. Kastner, M. Wolzt, H. Schmidinger (Vienna, AT)
Performance of a new ICD algorithm to detect lead failure noise and prevent inappropriate therapy.
– S. Beau, S. Greer, C. Ellis, C.O. West, J. Keeney, S. Asopa (Little Rock, Nashville and Sylmar, US)
Short-term enhancement of gap junctional coupling during early myocardial infarction modifies late
susceptibility to ventricular arrhythmias.
– F.S. Ng, S.A. Cooper, R.A. Chowdhury, P.M. Patel, E. Dupont, A.R. Lyon, N.S. Peters (London, GB)
Prevalence of syncope with a neuromediated profile in patients with the Brugada syndrome and relation
with ICD shocks.
– J.M. Rubio Campal, P. Sanchez-Borque, H.P. Gaebelt, S. Del Castillo, J. Benezet-Mazuecos, E. Macia,
M.A. Quinones, P.P. Perez, J.J. De La Vieja, J. Farre (Madrid, ES)
Predictors of long- term outcome after effective ablation of electrical storm in ischaemic cardiomyopathy:
implications for the ablation strategy.
– A. Dello Russo, M. Casella, G. Pelargonio, C. Carbucicchio, M. Zucchetti, P. Santangeli, S. Bartoletti, L. Di
Biase, A. Natale, C. Tondo (Milan and Rome, IT; Austin, US)
Ventricular arrhythmias are the major cause of death in patients with classical phenotype of fabry
disease.
– M. Niemann, T. Hartmann, S. Herrmann, K. Hu, D. Liu, M. Beer, G. Ertl, C. Wanner, F. Weidemann
(Wurzburg, DE)
Myocardial scar visualized by contrast-enhanced cardiac magnetic resonance predicts mayor arrhythmic
events in patients with non-ischemic dilated cardiomyopathy over a long-term follow-up.
– M. Perazzolo Marra, M. De Lazzari, F. Corbetti, F. Tona, F. Migliore, A. Zorzi, G. Thiene, C. Basso,
D. Corrado, S. Iliceto (Padua, IT)
Combined endocardial and epicardial catheter ablation in patients with arrhythmogenic right ventricular
dysplasia: The scar dechanneling technique.
– A. Berruezo, J. Fernandez-Armenta, L.L. Mont, D. Andreu, E. Arbelo, E. Diaz, C. Herzcku, J. Brugada
(Barcelona, ES)
Two different ablation strategies in patients with paroxysmal atrial fibrillation: a randomized comparison.
– E. Pokushalov, A. Romanov, S. Artemenko, A. Turov, V. Shabanov, I. Stenin (Novosibirsk, RU)
Left atrial appendage isolation to improve the outcome in patients with long standing persistent atrial
fibrillation and severe scarring.
– L. Di Biase, P. Mohanty, R. Bai, J. Sanchez, P. Santangeli, J.D. Burkhardt, S. Beheiry, D.J. Lakkireddy,
W. Lewis, A. Natale (Austin, San Francisco, Kansas City and Cleveland, US)
Ablation of peri-mitral flutter after ablation of long standing persistent AF: results from the PROPOSE
multicenter study.
– L. Di Biase, R. Bai, P. Mohanty, A. Dello Russo, S. Themistoclakis, A. Raviele, J.E. Sanchez, J.D. Burkhardt,
C. Tondo, A. Natale (Austin, US; Milan and Mestre, Venice, IT)
Periprocedural continuous anticoagulant therapy does not increase complication rate in ablation of atrial
fibrillation when compared to bridging therapy.
– J.M. Tapanainen, H. Bastani, F. Braunschweig, N. Drca, K. Gudmundsson, P. Insulander,
M. Jensen-Urstad, G. Kenneback, B. Sadighi, J. Schwieler (Stockholm, SE)
No permanent AV block after cryoablation of 1.303 substrates adjacent to the AV node, transient AV
block is a benign finding.
– P. Insulander, H. Bastani, F. Braunschweig, N. Drca, K. Gudmundsson, G. Kenneback, B. Sadigh,
J. Schwieler, J. Tapanainen, M. Jensen-Urstad (Stockholm, SE)
Ablation of paroxysmal and persistent atrial fibrillation: 12 months follow-up through continuous
subcutaneous monitoring.
– A. Romanov, E. Pokushalov, G. Corbucci, S. Artemenko, A. Turov, V. Shabanov (Novosibirsk, RU;
Maastricht, NL)
*Abstracts can
be accessed at:
270
QR 30518
P4444
P4445 (W)
P4446
P4447
P4448
P4449
P4450
P4451
P4452
P4453
P4454
P4455
P4456
P4457
TUESDAY, 30 AUGUST 2011 – MORNING POSTERS
P4458
P4459
P4460
P4461
P4462
P4463
P4464
P4465
P4466
P4467
P4468
P4469
P4470
P4471
P4472
P4473
P4474
TUESDAY – MORNING
Human atrial fibrillation may be caused by right atrial drivers.
– S. Narayan, D.E. Krummen, C. Briggs, R. Sehra (San Diego, US)
Conversion to sinus rhythm does not predict the efficacy of the ablation of persistent and long-standing
atrial fibrillation.
– E. Arbelo, N. Calvo, D. Andreu, R. Borras, A. Berruezo, E. Guiu, J. Brugada, L. Mont (Barcelona, ES)
The magnetic navigation system improves safety and allows high efficacy for ablation of arrhythmias.
– F. Akca, T. Bauernfeind, B. Schwagten, N.M.S. De Groot, L. Jordaens, T. Szili-Torok (Rotterdam, NL)
The risk of cerebrovascular events after ablation for paroxysmal atrial fibrillation.
– S. Fichtner, U. Czudnochowsky, T. Reents, J. Wu, C. Jilek, S. Ammar, H.L. Estner, G. Hessling,
I. Deisenhofer (Munich, DE)
Gastroparesia as an unusual complication of cryoballoon pulmonary vein isolation.
– A. Guiot, A. Savoure, B. Godin, H. Eltchaninoff, F. Anselme (Rouen, FR)
Haemoptysis after pulmonary vein isolation with a cryoballoon: an increased risk is associated with
extreme low freezing temperatures.
– R. Bhagwandien, P. Knops, Y. Van Belle, T. Szili-Torok, N. De Groot, L. Jordaens (Rotterdam, NL)
Atrial fibrillation triggers from the coronary sinus: comparison between isolation versus focal ablation.
– L. Di Biase, R. Bai, P. Mohanty, J.E. Sanchez, R. Horton, P. Santangeli, A. Dello Russo, J.D. Burkhardt,
C. Tondo, A. Natale (Austin, US; Milan, IT)
Rapid termination and elimination of human atrial fibrillation: ablation at rotors and focal drivers.
– S. Narayan, D.E. Krummen, C. Briggs, R. Sehra (San Diego, US)
One-year clinical outcome after pulmonary vein isolation using the novel endoscopic ablation system in
patients with paroxysmal atrial fibrillation.
– A. Metzner, B. Schmidt, A. Fuernkranz, E. Wissner, R. Tilz, M. Konstantinidou, A. Rillig, S. Mathew,
F. Ouyang, K.-H. Kuck (Hamburg, DE)
Analysis of factors influencing left atrial lesion formation following catheter ablation of atrial fibrillation
using delayed-enhancement MRI.
– T. Badger, N. Akoum, N.S. Burgon, P.A. Anderson, T.S. Haslam, C. Tek, G.P. Gardner, C.J. McGann,
E. Kholmovski, N.F. Marrouche (Salt Lake City, US)
Esophageal lesions following pulmonary vein isolation with a new duty-cycled phased radiofrequency
ablation catheter.
– D. Grosse-Meininghaus, O. Al-Taie, H. Zuenckel, W. Fischbach, J.C. Geller (Aschaffenburg and Bad Berka, DE)
Ablation of atrial fibrillation using a novel duty-cycled phased radiofrequency ablation system.
– T. Deneke, K. Buenz, O. Balta, H. Anders, M. Horlitz, M. Paesler, R. Haberkorn, E. Berenjkoub, B. Orth,
D.I. Shin (Cologne, DE)
Remote magnetic navigation is a high effective method for ablation of arrhythmias in patients with
complex congenital heart disease.
– F. Akca, T. Bauernfeind, N.M.S. De Groot, B. Schwagten, M. Witsenburg, L. Jordaens, T. Szili-Torok
(Rotterdam, NL)
Prospective randomized evaluation of efficacy and safety of cluster ECG-based versus linear ablation for
long-standing persistent atrial fibrillation.
– M. Fiala, J. Chovancik, V. Bulkova, O. Toman, R. Nevralova, L. Sknouril, J. Pindor, R. Labrova, J. Januska,
J. Spinar (Trinec, Prague and Brno, CZ)
Catheter ablation of atrial fibrillation under therapeutic coumadin: prevalence of pericardial effusion
comparing paroxysmal and non paroxysmal atrial fibrillation.
– L. Di Biase, J.D. Burkhardt, D.J. Lakkireddy, W. Lewis, P. Mohanty, S. Beheiry, P. Santangeli, B. Bai,
J.E. Sanchez, A. Natale (Austin, Kansas City, Cleveland and San Francisco, US)
Changing patient characteristics and pharmacotherapy in atrial fibrillation patients undergoing
radiofrequency ablation - a nationwide study.
– D. Karasoy, G.H. Gislason, J. Hansen, P. Soegaard, C. Torp-Pedersen, M.L. Hansen (Copenhagen, DK)
Asymptomatic stroke related to pulmonary vein isolation with irrigated tip ablation catheter.
– A. Mizukami, M. Suzuki, W. Nagahori, M. Ohno, A. Matsumura, Y. Hashimoto (Kamogawa, JP)
The close anatomical relationship between the coronary arteries and the myocardial infundibulum of the
right ventricle: a potential cause of coronary injury after catheter ablation of RVOT tachycardia.
– M. Murillo, G. Pizarro, E. Gonzalez Caballero, B. Fuertes, S. Bayona, J.A. Cabrera, D. Sanchez Quintana
(Badajoz and Madrid, ES)
Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter
ablation of atrial fibrillation.
– D. Scherr, D. Dalal, D. Spragg, K. Chilukuri, A. Cheng, S. Nazarian, C. Henrikson, R. Berger, H. Calkins,
J. Marine (Graz, AT; Baltimore, US)
Benefit of redo procedures using radiofrequency after failure of a first catheter ablation of atrial
fibrillation using cryotherapy.
– A. Guiot, A. Savoure, B. Godin, H. Eltchaninoff, F. Anselme (Rouen, FR)
Safety of catheter ablation for atrial fibrillation with therapeutic INRs: comparison with transition using
low molecular weight heparin.
– B. Saad, C. Slater, L.A. Oliveira Jr, R. Elias, D. Moura Neto, P. Maldonado, A. Camiletti, L.E. Camanho (Rio
de Janeiro, BR)
Ganglionated plexi ablation in patients with paroxysmal atrial fibrillation: data from continuous
subcutaneous monitoring.
– A. Romanov, E. Pokushalov, S. Artemenko, V. Shabanov, I. Stenin, D. Elesin, D. Losik, A. Turov
(Novosibirsk, RU)
Impact of irrigation flow rate on tissue temperature profile and lesion geometry in an ovine thigh muscle
radio-frequency ablation model.
– S. Nayyar, L. Mackenzie, D.H. Lau, D. Kelly, A.G. Brooks, K. Roberts-Thomson, P. Sanders (Adelaide, AU)
P4475
P4476
P4477
P4478
P4479
P4480
271
TUESDAY, 30 AUGUST 2011 – LUNCH TIME SESSIONS
12:30-13:50 | Hands-On Tutorial Room 1 - Zone B
TECHNICAL PRINCIPLES, CLINICAL INDICATIONS AND ANALYSIS OF CARDIAC
COMPUTED TOMOGRAPHY DATASETS
Chairperson(s): T. Pflederer (Erlangen, DE)
Hands-On Tutorial organised by Siemens AG, Healthcare Sector (on-site registration)
Hands-On Tutorial
12:45-13:30 | Vienna - Zone A
HIGHLY PURIFIED OMEGA-3 FATTY ACID ETHYL-ESTERS: WHAT DO THE DATA
TELL US?
Chairperson(s): J.P.J. Halcox (Cardiff, GB); H. Rupp (Marburg, DE)
Mini-Satellite Symposium organised by Abbott EPD
12:45
12:50
13:10
Mini-Satellite Symposium
Introduction.
– J.P.J. Halcox (Cardiff, GB), H. Rupp (Marburg, DE)
Implications of trial results for clinical practice.
– J.P.J. Halcox (Cardiff, GB)
Not all omega-3 formulations are the same.
– H. Rupp (Marburg, DE)
4481
4482
4483
12:45-13:45 | Oslo - Zone B
MEET THE GUIDELINES TASK FORCE II
Chairperson(s): J.J. Bax (Leiden, NL); U. Sechtem (Stuttgart, DE)
12:45
12:45
13:15
13:15
Special Session
Peripheral artery diseases: questions and answers to the panellists.
– M. Tendera (Katowice, PL), V. Aboyans (Limoges, FR)
Panelists.
– S. Kownator (Thionville, FR), M. Roffi (Geneva, CH), D.L. Clement (Ghent, BE), V. Riambau (Barcelona, ES),
M. De Carlo (Pisa, IT)
Dyslipidemias: questions and answers to the panellists.
– Z. Reiner (Zagreb, HR), A. Catapano (Milan, IT)
Panelists.
– I.M. Graham (Dublin, IE), G. De Backer (St. Martens Latem, BE), M.-R. Taskinen (Helsinki, FI), O. Wiklund
(Gothenburg, SE)
4484
4485
4486
4487
12:45-13:30 | Berne - Zone E
MEET THE TRIALIST V - CRISP AMI
Chairperson(s): K. Huber (Vienna, AT)
12:45
Meet the Trialists
CRISP AMI: A multi-center, randomized, controlled study of mechanical left ventricular unloading
with counterpulsation to reduce infarct size pre-PCI for acute myocardial infarction: rationale and
design of the CRISP AMI trial.
– M. Patel (Durham, US)
4488
12:45-13:30 | Bucharest - Zone E
RANOLAZINE: FROM LATE INa+ TO ISCHEMIA INHIBITION
Chairperson(s): A.J. Camm (London, GB)
Mini-Satellite Symposium organised by MENARINI
12:45
12:50
Mini-Satellite Symposium
Welcome & Introduction.
– A.J. Camm (London, GB)
Ranolazine: from late INa+ to ischemia inhibition.
– E. Braunwald (Boston, US)
4489
4490
12:45-13:30 | Cairo - Zone E
ULTRASOUND IN PRIVATE PRACTICE – UPDATE 2011
Chairperson(s): F.J. Sonntag (Henstedt-Ulzburg, DE); P.A. Sirnes (Moss, NO)
Mini-Satellite Symposium organised by GE Healthcare
12:45
13:05
13:20
272
Mini-Satellite Symposium
Echocardiography update 2011 - Digital workflow - Image acquisition, review and quantification.
– W. Fehske (Niederkassel, DE)
Vascular ultrasound update 2011 - Assessing the grade of carotid stenosis.
– M. Dauzat (Nimes, FR)
Vascular ultrasound update 2011 - Ultrasound assessment of vertebral arteries.
– I. Schuster-Beck (Nimes, FR)
4491
4492
4493
TUESDAY, 30 AUGUST 2011 – LUNCH TIME SESSIONS
12:45-13:30 | Athens - Zone F
DEVICE THERAPY IN 2011: WHAT’S NEW?
Chairperson(s): M. Taborsky (Olomouc, CZ); H. Heidbuchel (Leuven, BE)
Mini-Satellite Symposium organised by Medtronic
12:45
12:50
13:05
13:20
Mini-Satellite Symposium
Introduction.
– M. Taborsky (Olomouc, CZ)
Cardiac resynchronization therapy: from guidelines to clinical practice.
– S.H. Hohnloser (Frankfurt, DE)
Modern implantable cardioverter-defibrillator therapy: saving lives.
– M. Sopher (Bournemouth, GB)
Discussion.
– H. Heidbuchel (Leuven, BE)
4494
4495
4496
4497
12:45-13:30 | Belgrade - Zone F
PHOSPHODIESTERASE TYPE-5 INHIBITION IN PULMONARY ARTERIAL
HYPERTENSION: WHEN SCIENCE MEETS REAL LIFE
Chairperson(s): O. Sitbon (Clamart, FR)
Mini-Satellite Symposium organised by Pfizer Ltd
12:45
12:50
13:05
13:25
Mini-Satellite Symposium
Welcome and introductory remarks.
– O. Sitbon (Clamart, FR)
Latest news in phosphodiesterase type-5 inhibition.
– J.L. Vachiery (Brussels, BE)
Pulmonary arterial hypertension in an adolescent with congenital heart disease: a case-based
discussion.
– M.A. Gatzoulis (London, GB)
Concluding remarks.
– O. Sitbon (Clamart, FR)
4498
4499
4500
4501
12:45-13:30 | Tunis - Zone F
CONTRACTILITY MODULATION (CCM): CURRENT AND FUTURE CLINICAL
APPLICATIONS
Chairperson(s): M. Borggrefe (Mannheim, DE); A. Auricchio (Lugano, CH)
Mini-Satellite Symposium organised by Impulse Dynamics Germany GmbH
12:45
12:55
13:10
13:25
Mini-Satellite Symposium
CCM: addressing unmet clinical needs in heart failure.
– G. Hasenfuss (Göttingen, DE)
Direct and indirect molecular effects of CCM: how is myocardial function improved?
– C. Butter (Bernau bei Berlin, DE)
Assessing the clinical impact of CCM: past and ongoing clinical studies.
– K.-H. Kuck (Hamburg, DE)
Concluding remarks.
– A. Auricchio (Lugano, CH)
4502
4503
4504
4505
TUESDAY – LUNCH TIME
12:45-13:30 | Zagreb - Zone F
RIGHT HEART FAILURE AND PULMONARY ARTERIAL HYPERTENSION
Mini-Satellite Symposium
Chairperson(s): M.A. Gomez Sanchez (Pozuelo de Alarcon, ES); G. Simonneau (Clamart, FR)
Mini-Satellite Symposium organised by GSK
12:45
12:48
13:01
13:14
13:27
Introduction.
– M.A. Gomez Sanchez (Pozuelo de Alarcon, ES)
Uses and limitations of echocardiography in pulmonary arterial hypertension.
– S. Rosenkranz (Cologne, DE)
Magnetic resonance imaging in pulmonary arterial hypertension: is it the future?
– A. Vonk Noordegraaf (Amsterdam, NL)
Is there specific treatment for right heart failure in pulmonary hypertension?
– N. Galie (Bologna, IT)
Concluding comments.
– G. Simonneau (Clamart, FR)
4506
4507
4508
4509
4510
273
TUESDAY, 30 AUGUST 2011 – AFTERNOON
14:00-15:30 | London & The Hague - Zone A
A STEP FURTHER IN HEART FAILURE MANAGEMENT
EBAC Accredited Educational Programme
EBAC Accredited Educational Programme organised by the Universitätsklinikum Des Saarlandes
Course Director: Prof. Michael Böhm (Homburg/Saar, DE)
Chairperson(s): J.S. Borer (New York, US); K. Swedberg (Gothenburg, SE)
14:00
14:05
14:25
14:45
15:05
15:25
Introduction.
– K. Swedberg (Gothenburg, SE)
The systolic heart failure treatment with the If inhibitor ivabradine (SHIFT) study: most recent
analysis.
– J.S. Borer (New York, US)
Heart rate slowing: the key to effective heart failure management.
– M. Böhm (Homburg/Saar, DE)
A new hope for heart failure patients.
– M.R. Cowie (London, GB)
Panel discussion: targeting heart rate in the management of heart failure.
– K. Swedberg (Gothenburg, SE), J.S. Borer (New York, US), M. Böhm (Homburg/Saar, DE), M.R. Cowie
(London, GB), J.-C. Tardif (Montreal, CA)
Conclusion.
– J.S. Borer (New York, US)
4511
4512
4513
4514
4515
4516
“This educational programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for
one hour of External CME credits. Each participant should claim only those hours of credit that have actually
been spent in the educational activity. EBAC works in cooperation with the European Accreditation Council for
Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists
(UEMS).”
Programme supported by an unrestricted educational grant from SERVIER
14:00-15:30 | Stockholm - Zone A
TRANSCATHETER MITRAL VALVE REPAIR THERAPY: WHAT HAVE WE LEARNED SO
FAR?
Chairperson(s): A. Vahanian (Paris, FR); N.M. Moat (London, GB)
Satellite Symposium organised by Crossroads, the Abbott Vascular education network
14:00
14:05
14:20
14:40
15:00
15:15
Satellite Symposium
Introduction.
– A. Vahanian (Paris, FR)
Surgical approaches to mitral regurgitation.
– N.M. Moat (London, GB)
Non-surgical techniques for imitral valve regurgitation.
– O.W. Franzen (Copenhagen, DK)
Latest clinical data with transcatheter mitral valve repair therapy.
– A. Vahanian (Paris, FR)
Proposed criteria for patient selection for transcatheter mitral valve repair.
– F. Maisano (Segrate, IT)
Discussion and take-home message.
– A. Vahanian (Paris, FR), N.M. Moat (London, GB)
4517
4518
4519
4520
4521
4522
14:00-15:30 | Warsaw - Zone A
TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) FOR HIGH RISK PATIENTS
WITH SEVERE AORTIC STENOSIS
Chairperson(s): E.M. Tuzcu (Cleveland, US); C.W. Hamm (Bad Nauheim, DE)
Satellite Symposium organised by Edwards Lifesciences
14:00
14:05
14:20
14:35
14:50
15:05
274
Satellite Symposium
Introduction.
– E.M. Tuzcu (Cleveland, US), C.W. Hamm (Bad Nauheim, DE)
The forgotten epidemic: severe aortic stenosis and undertreatment.
– B. Iung (Paris, FR)
What is TAVI? Expanding treatment options.
– O. Wendler (London, GB)
What is the current evidence for TAVI? The PARTNER trial results.
– A. Pichard (Washington, US)
TAVI case overviews and patient selection/screening criteria.
– H. Eltchaninoff (Rouen, FR)
Panel: Q and A.
– H. Eltchaninoff (Rouen, FR), C.W. Hamm (Bad Nauheim, DE), B. Iung (Paris, FR), A. Pichard (Washington,
US), E.M. Tuzcu (Cleveland, US), O. Wendler (London, GB)
4523
4524
4525
4526
4527
4528
TUESDAY, 30 AUGUST 2011 – AFTERNOON
14:00-15:30 | Hands-On Tutorial Room 3 - Zone B
SPECKLE TRACKING BASED DEFORMATION IMAGING IN VENTRICULAR FUNCTION
ASSESSMENT
Chairperson(s): I. Salgo (Andover, US)
Hands-On Tutorial organised by Philips Healthcare (on-site registration)
Hands-On Tutorial
14:00-15:30 | Moscow - Zone B
THE UNENDING STORY – NEW MECHANISTIC AND CLINICAL INSIGHTS INTO ASPIRIN
Chairperson(s): C. Patrono (Rome, IT); M.A. Hull (Leeds, GB)
Satellite Symposium organised by Bayer HealthCare Pharmaceuticals
14:00
14:02
14:30
15:00
Satellite Symposium
Welcome and introduction.
– M.A. Hull (Leeds, GB)
COX- and beyond COX-inhibition - A new mechanistic approach to disease prevention?
– P. Patrignani (Chieti, IT)
Determinants of the interindividual variability in response to low-dose aspirin in different clinical
settings.
– C. Patrono (Rome, IT)
Does aspirin have gastrointestinal benefits?
– M.A. Hull (Leeds, GB)
4529
4530
4531
4532
14:00-17:30 | Riga - Zone B
CASE-BASED APPROACH TO ISCHEMIC HEART DISEASE MANAGEMENT
Satellite Symposium
Chairperson(s): V. Mathew (Rochester, US); D. Holmes (Rochester, US); C. Di Mario (London, GB)
Satellite Symposium organised by Mayo Clinic
14:00
Introduction.
– V. Mathew (Rochester, US)
4533
14:06
Appropriateness of coronary revascularization in stable disease.
– V. Mathew (Rochester, US)
Is stable coronary disease really stable?
– B.J. Gersh (Rochester, US)
Panel discussion.
– D. Holmes (Rochester, US), C. Di Mario (London, GB), V. Mathew (Rochester, US), B.J. Gersh (Rochester,
US), M. Farkouh (New York, US)
Illustrative case: ST Elevation Myocardial Infarction (STEMI).
– H. Ting (Rochester, US)
Systems based approaches to reperfusion therapy in the 21st century.
– H. Ting (Rochester, US)
21st century acute reperfusion therapy and STEMI networks: a European perspective.
– K. Huber (Vienna, AT)
Panel discussion.
– D. Holmes (Rochester, US), C. Di Mario (London, GB), H. Ting (Rochester, US), K. Huber (Vienna, AT),
B.J. Gersh (Rochester, US)
“Ischemic heart disease: chronic to acute”
14:30
14:45
14:48
15:00
15:12
15:30
Coffee break.
16:00
Introduction.
– C. Di Mario (London, GB)
Illustrative case: ischemic heart failure.
– N. Pereira (Rochester, US)
Delivering optimal heart failure management and identifying patients at risk for advanced heart
failure.
– N. Pereira (Rochester, US)
Advanced heart failure: selecting patients for transplantation, ventricular assist devices and total
artificial heart.
– R. Daly (Rochester, US)
Opportunities and challenges of delivering advanced heart failure therapy: a European
perspective.
– M.G. Crespo-Leiro (La Coruña, ES)
Panel discussion.
– C. Di Mario (London, GB), N. Pereira (Rochester, US), R. Daly (Rochester, US), T. Munger (Rochester, US),
R. Frantz (Rochester, US), M.G. Crespo-Leiro (La Coruña, ES)
Balancing clinical need and resource utilization in ischemic heart disease: appropriateness
criteria for selecting diagnostic tools and treatment options.
– D. Holmes (Rochester, US)
Summary remarks.
– V. Mathew (Rochester, US)
4535
4536
4537
4538
4539
4540
TUESDAY – AFTERNOON
14:18
4534
“Sequelae of ischemic heart disease: ischemic heart failure”
16:05
16:07
16:22
16:37
16:52
17:07
17:27
4541
4542
4543
4544
4545
4546
4547
4548
275
TUESDAY, 30 AUGUST 2011 – AFTERNOON
14:00-15:30 | Rome - Zone B
ADDRESSING GAPS IN PATIENT CARE: THE IMPORTANCE OF ANTICOAGULATION IN
SECONDARY PREVENTION
Chairperson(s): D.L. Bhatt (Newton, US); P.G. Steg (Paris, FR)
Satellite Symposium organised by theheart.org / Medscape Education
14:00
14:05
14:30
14:55
15:20
Satellite Symposium
Introduction.
– D.L. Bhatt (Newton, US)
Addressing the residual risk post ACS: can we reduce the gap.
– P.G. Steg (Paris, FR)
Combination therapy or triple antiplatelet therapy: the Importance of anticoagulation in secondary
prevention.
– C. Bode (Freiburg, DE)
The overlap of the cardiovascular syndromes of AF-related stroke and atherothrombosis:
managing the complex patient.
– K.A.A. Fox (Edinburgh, GB)
Conclusion remarks.
– D.L. Bhatt (Newton, US)
4549
4550
4551
4552
4553
14:00-15:30 | Sofia - Zone B
BAROREFLEX ACTIVATION THERAPY FOR THE TREATMENT OF RESISTANT
HYPERTENSION AND HEART FAILURE
Chairperson(s): E. Braunwald (Boston, US); A. Zanchetti (Milan, IT)
Satellite Symposium organised by CVRx Inc.
14:00
14:10
14:25
14:50
15:05
15:15
15:27
Satellite Symposium
Brief Introduction and history of the baroreflex as a therapeutic target for cardiovascular disease.
– E. Braunwald (Boston, US)
Carotid baroreflex physiology and baroreflex activation therapy mechanism of action.
– A. Zanchetti (Milan, IT)
Results of baroreflex activation therapy for hypertension.
– P.W. De Leeuw (Maastricht, NL)
Result of baroreflex activation therapy for heart failure.
– H.N. Sabbah (Detroit, US)
2nd generation baroreflex activation therapy and ongoing clinical trials.
– G. Hasenfuss (Göttingen, DE)
Questions & answers.
– E. Braunwald (Boston, US)
Final remarks.
– A. Zanchetti (Milan, IT)
4554
4555
4556
4557
4558
4559
4560
14:00-15:30 | Berne - Zone E
PITAVASTATIN: NEW EFFECTIVE OPTION FOR CARDIOVASCULAR RISK REDUCTION
Chairperson(s): J. Chapman (Paris, FR); J.J.P. Kastelein (Amsterdam, NL)
Satellite Symposium organised by Recordati
14:00
14:05
14:25
14:45
15:05
15:25
276
Welcome.
– J.J.P. Kastelein (Amsterdam, NL)
Pitavastatin: a different pharmacology.
– A. Catapano (Milan, IT)
Which is the ideal statin for polymedicated patients.
– C. Borghi (Bologna, IT)
Pitavastatin and high-density lipoprotein: an added value.
– J. Chapman (Paris, FR)
Pitavastatin LIVES study.
– J.J.P. Kastelein (Amsterdam, NL)
Closing remarks.
– J. Chapman (Paris, FR)
Satellite Symposium
4561
4562
4563
4564
4565
4566
TUESDAY, 30 AUGUST 2011 – AFTERNOON
14:00-15:30 | Budapest - Zone E
GUIDELINES IN CLINICAL PRACTICE – THE REALITY OF
CARDIOVASCULAR RISK MANAGEMENT TODAY
EBAC Accredited Educational Programme
EBAC Accredited Educational Programme organised by the Sahlgrenska Academy - Gothenburg University
Course Director: Prof. K. Swedberg (Gothenburg, SE)
Chairperson(s): P.J. Barter (Sydney, AU); C.J. Packard (Glasgow, GB)
14:00
14:05
14:30
14:55
15:20
Introduction.
– P.J. Barter (Sydney, AU)
Counting the cost of poor adherence to cardiovascular disease prevention guidelines.
– E. Bruckert (Paris, FR)
Optimising cardiovascular disease risk management - Tailoring treatment to the patient.
– L. Tokgozoglu (Ankara, TR)
Future opportunities for cardiovascular disease prevention.
– S.J. Nicholls (Cleveland, US)
Summary.
– C.J. Packard (Glasgow, GB)
4567
4568
4569
4570
4571
“This educational programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for
one hour of External CME credits. Each participant should claim only those hours of credit that have actually
been spent in the educational activity. EBAC works in cooperation with the European Accreditation Council for
Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists
(UEMS).”
Programme supported by an unrestricted educational grant from AstraZeneca
14:00-15:30 | Athens - Zone F
14:00
14:10
14:25
14:40
14:55
15:10
15:25
Satellite Symposium
Welcome and introduction.
– J.L. Zamorano Gomez (Madrid, ES)
Oral anticoagulation in atrial fibrillation - Recent changes and open questions.
– A.J. Camm (London, GB)
Target or dose: are all the novel oral anticoagulants the same?
– J. Weitz (Ontario, CA)
From dose finding to ENGAGE AF - TIMI 48 - Why study two dosages of edoxaban in atrial
fibrillation.
– R.P. Giugliano (Boston, US)
Future perspectives in oral anticoagulation for patients and physicians.
– R. De Caterina (Chieti, IT)
Panel discussion.
– A.J. Camm (London, GB), R. De Caterina (Chieti, IT), R.P. Giugliano (Boston, US), J. Weitz (Ontario, CA),
J.L. Zamorano Gomez (Madrid, ES)
Closing.
– A.J. Camm (London, GB)
4572
4573
4574
4575
4576
4577
4578
TUESDAY – AFTERNOON
ORAL ANTICOAGULATION – NEW STRATEGIES TOWARD OPTIMIZED THERAPY
Chairperson(s): A.J. Camm (London, GB); J.L. Zamorano Gomez (Madrid, ES)
Satellite Symposium organised by Daiichi Sankyo Europe GmbH
14:00-15:30 | Belgrade - Zone F
THERAPEUTIC OPTIONS FOR PULMONARY ARTERIAL HYPERTENSION IN 2011,
THE START OF A NEW DECADE
Chairperson(s): G. Simonneau (Clamart, FR); N. Galie (Bologna, IT)
Satellite Symposium organised by Eli Lilly and Company
14:00
14:05
14:20
14:35
14:50
15:05
15:20
Satellite Symposium
Introduction.
– G. Simonneau (Clamart, FR)
Appropriate diagnostic approach for pulmonary arterial hypertension.
– A. Torbicki (Warsaw, PL)
Learning from registries.
– J.S.R. Gibbs (London, GB)
Combination therapy for pulmonary arterial hypertension.
– N. Galie (Bologna, IT)
Long term efficacy of drugs approved for pulmonary arterial hypertension.
– M.A. Gomez Sanchez (Pozuelo de Alarcon, ES)
Future perspectives in pulmonary arterial hypertension therapy.
– J.L. Vachiery (Brussels, BE)
Q&A and closing remarks.
– N. Galie (Bologna, IT), G. Simonneau (Clamart, FR), A. Torbicki (Warsaw, PL), J.S.R. Gibbs (London, GB),
J.L. Vachiery (Brussels, BE), M.A. Gomez Sanchez (Pozuelo de Alarcon, ES)
4579
4580
4581
4582
4583
4584
4585
277
TUESDAY, 30 AUGUST 2011 – AFTERNOON
14:00-15:30 | Berlin - Zone F
NEW ADVANCES FOR THE CARDIOVERSION OF RECENT ONSET ATRIAL FIBRILLATION
Chairperson(s): J.-Y. Le Heuzey (Paris, FR); A. Capucci (Bologna, IT)
Satellite Symposium organised by MSD
14:00
14:05
14:30
14:50
15:15
15:25
Satellite Symposium
Welcome and opening remarks.
– J.-Y. Le Heuzey (Paris, FR)
RHYTHM-AF: a “real world” look at treatment patterns for recent onset atrial fibrillation.
– H.J.G.M. Crijns (Maastricht, NL)
Unmet needs for the management of recent onset atrial fibrillation and new perspectives on the
guidelines for cardioversion of atrial fibrillation.
– D. Atar (Oslo, NO)
A new treatment option for the cardioversion of patients.
– P. Kirchhof (Münster, DE)
Panel discussion and questions and answers.
– J.-Y. Le Heuzey (Paris, FR)
Closing remarks.
– A. Capucci (Bologna, IT)
4586
4587
4588
4589
4590
4591
14:00-15:30 | Paris - Zone F
INNOVATIONS IN STROKE PREVENTION FOR ATRIAL FIBRILLATION: CLINICAL
EVIDENCE AND INTERACTIVE CASE SCENARIOS
Chairperson(s): F. Andreotti (Rome, IT); C.B. Granger (Durham, US)
Satellite Symposium organised by BMS/Pfizer
14:00
14:05
14:25
14:40
15:00
15:25
Satellite Symposium
Welcome and introduction.
– F. Andreotti (Rome, IT)
Risk assessment and therapeutic gaps in the practice of stroke prevention in atrial fibrillation
(SPAF).
– G.Y.H. Lip (Birmingham, GB)
What have we learned from SPAF trials using antiplatelet agents?
– J. Eikelboom (Hamilton, CA)
What have we learned from SPAF trials using oral anticoagulants?
– C.B. Granger (Durham, US)
Audience interaction: challenges in clinical practice.
– L.C. Wallentin (Uppsala, SE)
Closing remarks.
– C.B. Granger (Durham, US)
4592
4593
4594
4595
4596
4597
14:00-15:30 | Tunis - Zone F
TARGETING THE EVIDENCE FOR TRIPLE ANTIPLATELET THERAPY IN HIGH-RISK ACUTE
CORONARY SYNDROMES (ACS) PERCUTANEOUS CORONARY INTERVENTION (PCI):
DEPLOYING BASIC SCIENCE IN CLINICAL PRACTICE
Chairperson(s): J.-P. Collet (Paris, FR); H. Schuehlen (Berlin, DE)
Satellite Symposium organised by Eli Lilly and Company
14:00
14:05
14:25
14:45
15:05
15:25
Satellite Symposium
Introduction and welcome.
– J.-P. Collet (Paris, FR)
Know your enemy: understanding the science of thrombus formation.
– J. Silvain (Paris, FR)
Analysing the clinical intelligence: choosing the right antiplatelet combination for the right patient.
– G. De Luca (Novara, IT)
Strategies for treating high-risk ACS patients: decisions from the front line.
– D. Fraser (Manchester, GB)
Discussion.
Closing remarks.
– H. Schuehlen (Berlin, DE)
4598
4599
4600
4601
4602
14:15-15:35 | Hands-On Tutorial Room 1 - Zone B
3D GUIDED INTERVENTIONS FOR STRUCTURAL AND CORONARY HEART DISEASE
Chairperson(s): G. Brockmann (Munich, DE); H. Rittger (Coburg, DE)
Hands-On Tutorial organised by Siemens AG, Healthcare Sector (on-site registration)
278
Hands-On Tutorial
TUESDAY, 30 AUGUST 2011 – AFTERNOON
15:30-16:30 | Moderated Posters - Poster Zone C (QR 361*)
GLOBAL CARDIO-VASCULAR RISK AND BURDEN
Chairperson(s): M.K. Mathew (Chennai, IN); K. Kotseva (London, GB)
Moderated Posters
Posters must be set up between 13:30 and 14:00, removed between 18:00 and 18:30 and be on display from 14:00 to
18:00.The following abstracts were chosen for their outstanding quality and will be discussed in a special area in the Poster
hall during the Moderated Poster Session chaired by the two above-mentioned chairpersons between 15:30 and 16:30.
15:30
15:37
15:45
15:52
16:00
16:07
16:15
P4603
P4604
P4605
P4606
P4607
P4608
P4609
P4610
TUESDAY – AFTERNOON
16:22
Longitudinal trends in cardiovascular mortality and major cardiovascular risk factors in the Czech
population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA.
– J. Bruthans, R. Cifkova, Z. Skodova, V. Adamkova, M. Jozifova, M. Galovcova, P. Wohlfart, J. Holub,
V. Lanska (Prague, CZ)
Twenty year trends in cardiovascular risk factors in India.
– R. Gupta, S. Guptha, A. Agrawal, V.P. Gupta (Jaipur, IN)
Clinical utility of standard lipids and apolipoproteins in relation to coronary heart disease events
in the elderly. The three city study.
– C. Straczek, H. Marti-Soler, C. Helmer, K. Ritchie, C. Tzourio, J.P. Empana (Paris, Villejuif, Bordeaux and
Montpellier, FR)
Ambulatory heart rate predicts cardiovascular and noncardiovascular outcome: Dublin outcome
study.
– L. Van Der Poel, E. Dolan, E.T. O’Brien (Dublin, IE)
Economic burden of cardiovascular diseases in Russian Federation.
– A. Kontsevaya, A. Kalinina (Moscow, RU)
Galectin-3, cardiovascular risk factors, and outcome in the general population.
– R.A. De Boer, D.J. Van Veldhuisen, R.T. Gansevoort, A. Muller Kobold, H.H.W. Sillje, W.H. Van Gilst,
H.L. Hillege, S.J.L. Bakker, P. Van Der Harst (Groningen, NL)
Adiponectin and long term mortality in coronary heart disease patients according to the severity
of the disease.
– S. Hascoet, M. Elbaz, V. Bongard, F. Bouisset, B. Perret, M. Galinier, D. Carrie, J. Ferrieres, J.B. Ruidavets
(Toulouse, FR)
The effects of air pollution on cardiovascular system: a systematic review of evidence.
– B. Parapid, N. Milic, S. Jankovic, L.J. Markovic-Denic, V. Spiric-Tomic, Z. Gledovic, J. Marinkovic
(Belgrade, RS)
*Abstracts can
be accessed at:
QR 361
279
TUESDAY, 30 AUGUST 2011 – AFTERNOON
15:30-16:30 | Moderated Posters - Poster Zone C (QR 362*)
LEFT ATRIAL MECHANICS BY ECHOCARDIOGRAPHY
Chairperson(s): P. Colonna (Bari, IT); R.E. Ronderos (La Plata, AR)
Moderated Posters
Posters must be set up between 13:30 and 14:00, removed between 18:00 and 18:30 and be on display from 14:00 to
18:00.The following abstracts were chosen for their outstanding quality and will be discussed in a special area in the Poster
hall during the Moderated Poster Session chaired by the two above-mentioned chairpersons between 15:30 and 16:30.
15:30
15:37
15:45
15:52
16:00
16:07
16:15
16:22
A comprehensive characterization of the normal murine left atrium: high frame rate
echocardiographic study of morphology and function.
– P. Barbier, U. Guerrini, M. Franzosi, L. Castiglioni, E. Nobili, F. Colazzo, T.M. Li Causi, L. Sironi, E. Tremoli
(Milan, IT)
Evaluation of the left atrial appendage with real-time three-dimensional transesophageal
echocardiography: implications for catheter-based left atrial appendage closure.
– G. Nucifora, F. Faletra, F. Regoli, E. Pasotti, G. Pedrazzini, T. Moccetti, A. Auricchio (Lugano, CH)
Strain and strain rate evaluation of atrial phasic function in normal aging.
– A. Boyd, D.A.B. Richards, T. Marwick, L. Thomas (Sydney, AU; Cleveland, US)
Left ventricular longitudinal systolic function and arterial stiffness are the main determinants of
left atrial function in patients with risk factors.
– R. Dulgheru, A. Ciobanu, S. Magda, R.C. Rimbas, A.D. Margulescu, S. Mihaila, M. Cinteza, D. Vinereanu
(Bucharest, RO)
Prediction of left atrial booster pump function by tissue Doppler late diastolic myocardial velocity
from septal mitral annulus.
– M. Masuda, K. Iwakura, A. Okamura, Y. Koyama, K. Inoue, M. Date, Y. Higucgu, K. Fujii (Osaka, JP)
Atrial mechanical function as a predictor of recurrent attack in patient with paroxysmal atrial
fibrillation.
– J. Yoon, J. Moon, J.Y. Kim, P.K. Min, B.K. Lee, B.K. Hong, S.J. Rim, H.M. Kwon (Seoul, KR)
The left atrial filling 2D speckle strain rate is biphasic: implications for a correct interpretation of
atrial physiology.
– P. Barbier, C. Cefalu’, G. Berna (Milan, IT)
Atrial mechanical function than LA size, as a predictor of recurrence in patient with paroxysmal
atrial fibrillation.
– J. Yoon, J. Moon, J.Y. Kim, P.K. Min, Y.W. Yoon, B.K. Lee, B.K. Hong, S.J. Rim, H.M. Kwon (Seoul, KR)
P4611
P4612
P4613
P4614
P4615
P4616 (W)
P4617
P4618
16:00-17:20 | Hands-On Tutorial Room 1 - Zone B
CARDIAC MAGNETIC RESONANCE IMAGING IN CARDIOMYOPATHIES
Chairperson(s): G. von der Recke (Bonn, DE)
Hands-On Tutorial organised by Siemens AG, Healthcare Sector (on-site registration)
Hands-On Tutorial
16:00-17:30 | Hands-On Tutorial Room 3 - Zone B
IMPROVING CARDIAC CARE BY PATIENT-SPECIFIC MODELING – FOCUS ON CARDIAC
Hands-On Tutorial
RESYNCHRONIZATION THERAPY
Chairperson(s): R. Razavi (London, GB); J. Weese (Hamburg, DE); M. Sermesant (Sophia Antipolis, FR)
Hands-On Tutorial organised by Philips Healthcare (on-site registration)
16:00-17:30 | Berlin - Zone F
NEW ADVANCES IN CARDIOVASCULAR RISK REDUCTION IN HIGH-RISK PATIENTS
Chairperson(s): J.J.P. Kastelein (Amsterdam, NL); C. Baigent (Oxford, GB)
Satellite Symposium organised by MSD
16:00
16:05
16:20
16:40
17:00
17:15
17:25
Welcome and opening remarks.
– J.J.P. Kastelein (Amsterdam, NL)
Unmet medical need in the treatment of high-risk patient populations.
– J.J.P. Kastelein (Amsterdam, NL)
Insights from the SHARP study results.
– C. Baigent (Oxford, GB)
Effective treatment options with add-on or combination therapy.
– M. Davidson (Chicago, US)
Patient case studies discussion: therapeutic choices in high-risk patients.
– D. Mueller-Wieland (Dusseldorf, DE)
Panel discussion an Q&A.
– J.J.P. Kastelein (Amsterdam, NL)
Closing remarks.
– J.J.P. Kastelein (Amsterdam, NL)
*Abstracts can
be accessed at:
280
QR 362
Satellite Symposium
4619
4620
4621
4622
4623
4624
4625
TUESDAY, 30 AUGUST 2011 – AFTERNOON
16:30-18:00 | Belgrade - Zone F
16:30
16:35
17:00
17:25
17:50
Satellite Symposium
Welcome & introduction.
– A.J. Camm (London, GB)
Chronic stable angina: a well-treated condition or one requiring new therapeutic strategies?
– J.L. Lopez-Sendon (Madrid, ES)
The role of the late sodium current as a new target in ischaemic heart disease.
– A. Zaza (Milan, IT)
European management of ischaemic heart disease - Evolving targets for personalised treatment.
– A.J. Camm (London, GB)
Conclusions & summary.
– J.L. Lopez-Sendon (Madrid, ES)
4626
4627
4628
4629
4630
TUESDAY – AFTERNOON
A NEW PARADIGM IN THE TREATMENT OF ISCHAEMIC HEART DISEASE
Chairperson(s): A.J. Camm (London, GB); J.L. Lopez-Sendon (Madrid, ES)
Satellite Symposium organised by MENARINI
281
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
14:00-18:00 | Posters - Poster Zone C
POSTER SESSION 6
Poster Session
Posters must be set up between 13:30 and 14:00, removed between 18:00 and 18:30 and be on display from
14:00 to 18:00.The presenter should be present throughout the coffee break (15:30 to 16:30) in order to discuss
the Poster.
THE CHANGING STRUCTURE OF THE GROWING HEART (QR 30601*)
Creating mouse embryonic stem cell-derived cardiomyocyte sheet using three-dimensional bioreactor
cultivation system.
– K. Matsuura, T. Shimizu, J.K. Yakashita, N. Hagiwara, T. Okano (Tokyo and Kyoto, JP)
Interaction of TGF-beta-receptor 1 kinase and mechanical stress determine cardiac fibroblast
differentiation and myofibroblast dedifferentiation.
– R.B. Driesen, J. Abi-Char, R. Fagard, K.R. Sipido, V.V. Petrov (Leuven, BE)
The cardiac beta-catenin interaction partner four-and-a-half LIM protein 2 (FHL2) promotes cardiac
differentiation in vitro.
– A. Renger, C. Noack, M.P. Zafiriou, R. Dietz, M.W. Bergmann, L. Zelarayan (Göttingen, Berlin and
Hamburg, DE)
Electrical stimulation for cardiac bioengineering with subcutaneous and cardiac adipose-tissue derived
progenitor cells (ATDPCs).
– A. Llucia-Valldeperas, B. Sanchez, C. Soler-Botija, S. Roura, C. Prat-Vidal, C. Galvez-Monton, R. Bragos,
A. Bayes-Genis (Badalona and Barcelona, ES)
Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell
differentiation.
– A. Bondue, S. Tannler, G. Chiapparo, S. Chabab, M. Ramialison, C. Paulissen, B. Beck, R. Harvey,
C. Blanpain (Brussels, BE; Darlinghurst, AU)
Specifically designed, bioactive nanofiber-matrix supports cell-based therapy in ischemic tissue repair.
– J. Tongers, M.J. Webber, M.-A. Renault, J.G. Roncalli, E. Klyachko, T. Thorne, J. Bauersachs, S.I. Stupp,
D.W. Losordo (Hannover, DE; Evanston and Chicago, US)
Ion channel and cardiac ontogeny of human cardiomyocytes derived from vector-free induced pluripotent
stem cells.
– W. Shim, A. Mehta, Y.Y. Chung, A. Ng, H.M. Wei, G. Dusting, W. Sun, P. Wong (Singapore, SG;
Melbourne, AU)
Molecular patterning of the arterial pole of the mouse heart.
– P. Parisot, M. Theveniau-Ruissy, R. Kelly (Marseille, FR)
Cardiac-specific RNAi knockdown of Abra disrupts heart function and decreased lifespan in Drosophila
melanogaster.
– K.L. Beaumont, E. Rosato, N.W. Chong (Leicester, GB)
Murine alternatively spliced tissue factor is not sufficient for embryonic development and does not trigger
coagulation.
– S.H.M. Sluka, A. Akhmedov, J. Vogel, T.F. Luscher, F.C. Tanner (Zurich, CH)
Notch 1 mutations in patients with aortic aneurysm and bicuspidal valve.
– O. Freylikhman, A. Malashicheva, T. Tatarinova, N. Tsoy, O. Irtyuga, O. Moiseeva, A. Kostareva,
E. Shlyakhto (Saint-Patersburg, RU)
Heterogeneity of global gene expression profiles between endocardial and epicardial normal myocardium
diminishes in canine failing hearts.
– K.D. Min, M. Asakura, H. Asanuma, S. Ito, A. Takahashi, H. Sasaki, H. Takahama, S. Yamazaki,
N. Mochizuki, M. Kitakaze (Osaka and Kyoto, JP; Baltimore, US)
Vasculogenic recruitment switch is activated in idiopathic dilated cardiomyopathy.
– S. Roura Ferrer, C. Galvez-Monton, J.M. Pujal Reyes, C. Prat-Vidal, C. Soler-Botija, A. Llucia-Valldeperas,
A. Bayes-Genis (Badalona, ES)
A comprehensive characterization of the normal murine left atrium: anatomy and histology.
– L. Castiglioni, E. Nobili, F. Colazzo, M. Franzosi, T.M. Li Causi, U. Guerrini, L. Sironi, E. Tremoli, P. Barbier
(Milan, IT)
Novel cardiovascular quantitative trait loci in a rat intercross.
– R. Ahmed, P. Muckett, S. Cook (London, GB)
P4631
P4632
P4633 (W)
P4634
P4635
P4636
P4637
P4638
P4639
P4640
P4641
P4642
P4643
P4644
P4645
THE MANY FACETS OF REGENERATION (QR 30602*)
Increasing the efficacy of myocardial gene therapy with an intra-aortic balloon pump in a large animal
model of heart failure.
– D. Ladage, L. Tilemann, K. Ishikawa, C. Kho, A. Lee, R.J. Hajjar, Y. Kawase (New York, US)
Influence of non-cardiomyocytes on persistence and survival of rat neonatal cardiomyocytes after
injection into infarcted syngeneic hearts.
– B. Krausgrill, S. Oeckenpoehler, M. Maass, M. Raths, M. Halbach, K. Schenk, J. Hescheler,
J. Mueller-Ehmsen (Cologne, DE)
*Abstracts can
be accessed at:
282
QR 30601
QR 30602
P4646
P4647
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Atorvastatin improves effects of transplanted mesenchymal stem cells through AMP-activated protein
kinase in post-infarcted porcine hearts.
– Q.-T. Dong, Y.-J. Yang, L. Song, H.-Y. Qian (Beijing, CN)
Connexin 43 expression is essential for functional cardiomyogenic differentiation of human fetal
mesenchymal stem cells.
– A.A. Ramkisoensing, D.A. Pijnappels, J. Swildens, M.J. Schalij, A.A.F. De Vries, D.E. Atsma (Leiden, NL)
Mesenchymal stem cells modulate the immune response and ameliorate cardiac dysfunction in a mouse
model of acute coxsackie virus B3-induced myocarditis.
– K. Savvatis, S. Van Linthout, D. Westermann, J. Schefold, A. Weithaeuser, P.M. Becher, H.P. Schultheiss,
C. Tschoepe (Berlin, DE)
Intracoronary delivery of allogeneic mesenchymal precursor cells directly after acute myocardial
infarction decreases infarct size and improves cardiac function in sheep.
– H.J. Houtgraaf, R. De Jong, D. De Groot, I. Hoeffer, G. Pasterkamp, H.J. Duckers (Rotterdam and Utrecht, NL)
Cardiopoietic mesenchymal stem cells for treatment of ischemic cardiomyopathy: first-in-man phase II
multicentre clinical trial.
– J. Bartunek, D. Dolatabadi, M. Vanderheyden, J. Dens, M. Ostojic, A. Behfar, S. Henry, M. Tendera,
S. Waldman, A. Terzic (Aalst, Charleroi, Genk and Mont-Saint-Guibert, BE; Belgrade, RS; Rochester and
Philadelphia, US; Katowice, PL)
Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells.
– Y. Shimizu, S. Shintani, R. Shibata, Y. Izumi, Y. Ogura, M. Ishii, T. Murohara (Nagoya, JP)
Selected CD133+ endothelial progenitor cells to create angiogenesis in no-option patients. The design of
the PROGENITOR randomized trial.
– P. Jimenez-Quevedo, J. Gonzalez Ferrer, L. Llorente, M. Sabate, X. Garcia Moll, R. Hernandez-Antolin,
N. Gonzalo, C. Banuelos, M. Del Trigo, C. Macaya (Madrid and Barcelona, ES)
MicroRNA126 is secreted in microvesicles from CD34 stem or progenitor cells and is critical for their
proangiogenic capacity - down-regulation in patients with type-2 diabetes.
– P. Mocharla, S. Briand, G. Giannotti, C. Doerries, T.F. Luescher, U. Landmesser (Zurich, CH; Pisa, IT)
Mobilization of Oct4+ very small embryonic-like cells induced by physical exercise in patients with
coronary artery disease.
– W. Wojakowski, B. Machalinski, M. Kotowski, E.K. Zuba-Surma, M. Kazmierski, M. Kucia, E. Nabialek,
S. Dworowy, M.Z. Ratajczak, M. Tendera (Katowice, Szczecin and Krakow, PL; Louisville, US)
Targeted positioning of endothelial progenitor cells to the injured mouse carotid artery using magnetic
nanoparticles.
– M.U. Becher, K. Zimmermann, D. Wenzel, B.K. Fleischmann, G. Nickenig, N. Werner, A. Pfeifer (Bonn, DE)
Ex vivo priming of late outgrowth endothelial progenitor cells with erythropoietin before transplantation
enhances their angiogenic potential and requires the CD131 receptor subunit.
– G. Sarlon, Y. Bennis, F. Sabatier, M. Clot-Chabot, F. Dignat-George, B. Guillet, P. Pisano (Marseille, FR)
Dynamics of active and passive contribution of stem cell scaffolding in cardiomyoplasty for post
myocardial infarction.
– W. Shim, L. Qian, Y.C. Gu, M.S. Atan, K.P. Lim, L.P. Tan, C.H. Lim, Y.K. Sin, P. Wong (Singapore, SG)
P4648
P4649
P4650
P4651
P4652
P4653
P4654
P4655
P4656
P4657
P4658
P4659
STEM CELLS – DO ALL ROADS LOAD TO REGENERATION? (QR 30603*)
*Abstracts can
be accessed at:
P4660
P4661
P4662
TUESDAY – AFTERNOON
LQTS2 modelling with patient-specific induced pluripotent stem cell -derived cardiomyocytes.
– V.J. Kujala, A.L. Lahti, K. Aalto-Setala (Tampere, FI)
The role of microRNA-145 in the differentiation of human embryonic stem cells into smooth muscle cells.
– K. Yamahara, S. Yamaguchi, K. Homma, H. Itoh (Osaka and Tokyo, JP)
Central role of cardiomyocytes in cell therapy: transplantation of cardiac tissue sheets with defined cell
populations from pluripotent stem cells.
– H. Masumoto, T. Shimizu, T. Ikeda, T. Okano, R. Sakata, J.K. Yamashita (Kyoto and Tokyo, JP)
Excitation propagation in cardiac cell monolayer derived from human pluripotent stem cells.
– S. Kadota, I. Minami, K. Agladze, N. Nakatsuji (Kyoto, JP)
Induced pluripotent stem cell derived cardiomyocytes integrate electrically after transplantation in murine
hearts.
– G. Peinkofer, M. Halbach, S. Baumgartner, B. Krausgrill, A. Fatima, T. Saric, J. Hescheler,
J. Mueller-Ehmsen (Cologne, DE)
Transendocardial cell injection is not superior compared with intracoronary infusion in a porcine model of
chronic ischemic heart disease: a randomized study imaging labelled cells.
– T. Van Der Spoel, K.V. Vrijsen, F. Nijsen, J.P.G. Sluijter, J. Bemelmans, M.J.M. Cramer, I. Hoefer,
P.A.F.M. Doevendans, E. Van Belle, S.A.J. Chamuleau (Utrecht, NL)
Effect of intracoronary injection of mononuclear bone marrow cells on electrocardiographic parameters
in patients after acute myocardial infarction: two year follow-up study.
– E. Trzos, J.D.K. Kasprzak, T.R. Rechcinski, M.K.-P. Krzeminska-Pakula, K.W.-D. Wierzbowska-Drabik,
B.U. Uznanska, U.C.-G. Cieslik-Guerra, M.K. Kurpesa (Lodz, PL)
Exercise capacity, arrhythmic risk profile and pulmonary function is not influenced by bone marrow stem
cells i.c. infusion in patients with acute myocardial infarction.
– M. Popiel, E. Straburzynska-Migaj, P. Breborowicz, S. Grajek, A. Katarzynska-Szymanska, M. Lesiak, L. Gil,
A. Czyz, K. Sawinski, M. Kozlowska-Skrzypczak (Poznan, PL)
P4663
P4664
P4665
P4666
P4667
QR 30603
283
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Effect of autologous 5-azacytidine-cultured bone-marrow stem cells on perfusion and left ventricular
function in patients with heart failure.
– T.M. Belyavskaya, E.A. Scridlevskaya, A.G. Konoplyannikov, L.E. Samoilenko, V.B. Sergienko,
R.S. Akchurin (Moscow and Obninsk, RU)
Subpopulations of c-kit+ HSC display differences in proliferation potential and gene expression pattern
after CFU assay.
– P. Mark, A. Toelk, C.A. Lux, A. Skorska, E. Pittermann, D. Scharfenberg, W. Li, N. Ma, G. Steinhoff
(Rostock, DE)
Perivascular administration of mesenchymal stem cells from bone marrow inhibits neointimal formation
in a paracine fashion in rat carotid arteries.
– Y. Iso, S. Yamaya, J. Spees, Y. Takeyama, H. Suzuki (Yokohama, JP; Vermont, US)
Intramyocardial bone marrow cell injection in patients with chronic myocardial ischemia: results long
term follow-up.
– S.F. Rodrigo, J. Van Ramshorst, S.L. Beeres, P. Dibbets-Schneider, M.P.M. Stokkel, J.J. Zwaginga,
E.E. Van Der Wall, M.J. Schalij, J.J. Bax, D.E. Atsma (Leiden, NL)
Essential, but not differential role of CXCR7 and CXCR4 on platelet-derived SDF-1-mediated adhesion of
human CD34+ cells in vitro and after vascular injury in vivo.
– V. Panagiota, K. Sopova, A. Perk, A. Paul, M. Gawaz, K. Stellos (Tübingen, DE)
Functional restoration of hyperglycemia-exposed bone marrow stem cells by oxytocin.
– Y.S. Kim, Y. Ahn, S.M. Kwon, S.H. Lee, J.H. Kim, M.H. Jeong, J.G. Cho, J.C. Park, J.C. Kang (Gwangju
and Pusan, KR)
Intracoronary bone marrow derived CD34+ cells improve left ventricular function in patients with severe
dilated cardiopathy.
– J. Bartolucci, F. Figueroa, F. Carrion, R. Lamich, P. Pedreros, C. Carvallo, P. Sanhueza, E. Abarzua,
C. Goset, C. Nazzal (Santiago, CL)
Cardiomyocyte damage-released extracellular S100A1 protein promotes regeneration of infarcted
myocardium by enhanced egress of bone marrow-derived progenitor cells.
– D. Rohde, G. Qiu, N. Herzog, H.A. Katus, K. Peppel, P. Most (Heidelberg, DE; Philadelphia, US)
Bone marrow stem-cell therapy for idiopathic dilated cardiomyopathy.
– J. Suarez De Lezo, M. Romero, M. Pan, M.D. Carmona, J. Segura, S. Nogueras, J. Suarez De Lezo Jr,
F. Mazuelos, D. Mesa, I. Herrera (Córdoba, ES)
Identification of BMSP-1 by bioinformatic secretome analysis as a novel cardioprotective protein
produced by human CXCR4+ bone marrow cells.
– M. Korf-Klingebiel, T. Brod, C. Willenbockel, K.C. Wollert (Hannover, DE)
Human relevance of pre-clinical studies in stem cell therapy; overview and meta-analysis of large animal
models of ischemic heart disease.
– T. Van Der Spoel, S.J. Jansen Of Lorkeers, P. Agostoni, E. Van Belle, M. Gyongyosi, J.P.G. Sluijter,
M.J.M. Cramer, P.A.F.M. Doevendans, S.A.J. Chamuleau (Utrecht, NL; Vienna, AT)
Matrix metalloproteinases and transforming growth factor beta gene expression - an interaction of proand antiatherosclerotic factors in acute coronary syndromes.
– A. Kulach, J. Dabek, Z. Gasior (Katowice, PL)
P4668
P4669
P4670
P4671
P4672
P4673
P4674
P4675
P4676
P4677
P4678
P4679
NOVEL IMAGING APPROACHES TO MYOCARDIAL FUNCTION (QR 30604*)
Endothelin and N-terminal pro-B type natriuretic peptide reflect impaired right ventricular function and
decreased exercise capacity in patients with systemic sclerosis.
– M. Ciurzynski, P. Bienias, K. Irzyk, Z. Rymarczyk, M. Kostrubiec, A. Szewczyk, M. Siwicka, Z. Bartoszewicz,
U. Demkow, P. Pruszczyk (Warsaw, PL)
Effect of multiple pacing sites on left ventricular function. experimental study.
– S. Toumanidis, A. Kaladaridis, D. Bramos, E. Skaltsiotes, G. Kottis, A. Antoniou, I. Agrios, D. Takos,
I. Mathew, N. Vasiladiotis (Athens, GR)
Effects of continuous positive airway pressure on cardiac remodeling in obstructive sleep apnea as
assessed by cardiac biomarkers, echocardiography and cardiac MRI.
– D. Jassal, J. Colish, J.R. Walker, N. Elmayergi, M. Lytwyn, A. Francis, S. Bohonis, M. Zeglinski,
I.D. Kirkpatrick, S. Sharma (Winnipeg, CA)
Correlations between left atrial volume index and echocardiographic parameters of increased filling
pressure after acute myocardial infarction in hypertensive patients.
– R. Musetescu, D. Toader, E.A. Belu, A.E. Musetescu, M. Popescu, D.D. Ionescu (Craiova, RO)
Reduced segmental left ventricular systolic strain after anthracycline chemotherapy.
– P.W. Stoodley, D. Richards, A. Boyd, R. Hui, P. Harnett, S. Meikle, J. Clarke, L. Thomas (Sydney, AU)
Quantitative assessment of left ventricular function by 2D-speckle tracking during exercise: a feasibility
study.
– C. Szymanski, M. Campana, J. Magne, M. Rosca, L. Pierard, P. Lancellotti (Liège, BE; Brescia, IT)
Longitudinal global strain: a new surrogate of systolic function in myocardial infarction.
– S. Pires, N. Cortez-Dias, L. Santos, S. Ribeiro, D. Silva, C. Jorge, P. Carrilho, J. Silva Marques, M.G. Lopes,
F.J. Pinto (Lisbon, PT)
Assessment of left ventricular function by real-time three-dimensional speckle tracking echocardiography
compared to magnetic resonance imaging.
– C. Bremont, L. Macron, D. Hayat, J. Nahum, A. Bensaid, J.L. Dubois-Rande, P. Gueret, P. Lim (Créteil, FR)
*Abstracts can
be accessed at:
284
QR 30604
P4680
P4681
P4682
P4683
P4684
P4685
P4686
P4687
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Analysis of right ventricular dimensions and function after tricuspid valvuloplasty concomitant with
complex left-sided heart surgery.
– G. Koppers, R. Reyskens, W. Mullens, P.M. Vandervoort, J. Dens, H. Gutermann, C. Van Kerrebroeck,
R. Dion, D. Verhaert (Hasselt and Genk, BE)
Deterioration of right ventricular myocardial systolic function in monocrotaline-induced pulmonary
arterial hypertension canine model: echocardiographic evaluation by 2D speckle tracking.
– S. Nishio, H. Yamada, R. Tamai, K. Endo, S. Hayashi, K. Kusunose, T. Soeki, T. Wakatsuki, Y. Sakai,
M. Sata (Tokushima and Osaka, JP)
Advanced echocardiographic imaging for the evaluation of right ventricular function in pulmonary
hypertension.
– S. Pica, S. Ghio, G. Tonti, L. Scelsi, C. Raineri, R. Camporotondo, A. Pazzano, L. Oltrona Visconti (Pavia
and L’Aquila, IT)
Assessment of right ventricular longitudinal peak systolic strain measurement in the subcostal view:
feasibility and validation in patients with suspected pulmonary hypertension.
– M.L.A. Haeck, R.W.C. Scherptong, M.L. Antoni, N. Ajmone Marsan, H.W. Vliegen, E.R. Holman,
M.J. Schalij, J.J. Bax, V. Delgado (Leiden, NL)
Right ventricular dysfunction in patients with end-stage renal disease.
– D. Benzarouel, M. El Hattaoui (Marrakech, MA)
Acute effect of passive smoking on pulmonary stiffness and right ventricular function in young healthy
volunteers.
– M.G. Kaya, M. Yarlioglues, N. Kalay, I. Gul, I. Ozdogru (Kayseri, TR)
Early and medium-term evolution of right ventricular function in patients with severe aortic valve stenosis
after transcatheter aortic valve implantation.
– M. Delgado Ortega, M.D. Mesa Rubio, M. Ruiz Ortiz, M.L. Pena Pena, M. Santisteban Sanchez De Puerta,
J. Suarez De Lezo Cruz-Conde, M. Pan Alvarez-Osorio, S. Ojeda Pineda, J. Suarez De Lezo Herrero De
Tejada, F. Mazuelos Bellido (Córdoba, ES)
Left ventricular function in hypertension: new insight by speckle tracking echocardiography.
– C. Zito, E. Imbalzano, A. Saitta, G. Oreto, M. Cusma-Piccione, G. Di Bella, R. Nava, M. Ferro, E. Alati,
S. Carerj (Messina, IT)
Difference in right ventricular adaptation to afterload between patients with pulmonary hypertension in
mild stage and patients with left-sided heart failure.
– S. Fuke, K.F. Kusano, M. Tanaka, A. Ogawa, S. Nagase, K. Nakamura, T. Sato, T. Ujihira, H. Ito (Okayama,
JP)
Effect of age, gender and ethnicity on LV rotation and torsion in healthy individuals.
– J.P. Sun, R. Guo, X.S. Yang, F. Fang, Y.Y. Lam, P.W. Lee, C.M. Yu (Hong Kong, HK)
Noninvasive assessment of myocardial fiber orientation using echocardiography-based shear wave
imaging.
– W.-N. Lee, M. Pernot, M. Couade, A. Bel, P. Bruneval, A.A. Hagege, M. Fink, M. Tanter, E. Messas (Paris,
FR)
Quantitative assessment of myocardial stiffness using shear wave imaging in normal and hypertrophic
isolated rat hearts.
– M. Pernot, M. Couade, P. Mateo, B. Crozatier, R. Fischmeister, M. Tanter (Paris and Chatenay-Malabry, FR)
P4688
P4689
P4690
P4691
P4692
P4693
P4694
P4695
P4696
P4697
P4698
P4699
APPROPRIATENESS OF IMAGING (QR 30605*)
*Abstracts can
be accessed at:
P4700
P4701
TUESDAY – AFTERNOON
Cardiovascular screening by pocket-sized ultrasound among patients admitted to cardiac department at
a Norwegian non-university hospital.
– K. Skjetne, T. Graven, J.O. Kleinau, B.O. Haugen, H. Dalen (Levanger and Trondheim, NO)
Pocket sized echo: effectiveness for ward based transthoracic studies.
– S. Gianstefani, N. Catibog, A. Whittaker, A. Douiri, J.A. Reiken, M.J. Monaghan (London, GB)
Value of computed tomography coronary angiography in the triage of acute chest pain in the emergency
department.
– G. Pires De Morais, N. Bettencourt, G. Silva, N. Ferreira, M. Carvalho, D. Leite, J. Rocha, C. Fonseca,
V. Gama Ribeiro (Vila Nova de Gaia, PT)
CT coronary angiography in asymptomatic high risk patients.
– L.A. Neefjes, G.J.R. Ten Kate, A. Rossi, K. Nieman, J.M.H. Galema-Boers, E.J.G. Sijbrands, G.P. Krestin,
N.R. Mollet, P.J. De Feyter (Rotterdam, NL)
The use of CT coronary angiography in a community rapid access chest pain clinic.
– G. Koulaouzidis, A. Powell, K. Wong, T. McArthur, C. Metcalf, J. Hill, K. Manis, P.J. Jenkins,
D. Brennand-Roper (London, GB)
How accurate are stress tests in predicting specific areas of ischemia?
– A. Rajamanickam, S. Kapadia, T. Catacutan, A. Chadi, A. Satra, M. Nasif, S. Butler, S. Ellis, J.B. Young,
M. Cerqueira (Newark and Cleveland, US)
Incremental value of non-invasive stress testing on the diagnostic yield of invasive coronary angiography.
– R. Buechel, M.J. Zellweger (Basel, CH)
Appropriateness of echocardiography requests in the hospital setting: results from a multicenter
evaluation in the Florence area, Italy.
– P. Ballo, F. Bandini, L. Chiodi, A. Fortini, R. Laureano, M. Milli, G. Nenci, G.M. Santoro, P. Vannelli,
A. Zuppiroli (Florence, Borgo San Lorenzo and Figline Valdarno, IT)
P4702
P4703
P4704
P4705
P4706
P4707 (W)
QR 30605
285
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
CORONARY AND CAROTID ATHEROSCLEROSIS (QR 30606*)
Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a
quantitative [15O]H2O PET/CT study.
– I. Danad, P.G. Raijmakers, Y.E. Appelman, H.J. Harms, S. De Haan, C. Van Kuijk, O.S. Hoekstra,
A.A. Lammertsma, A.C. Van Rossum, P. Knaapen (Amsterdam, NL)
Quantitative evaluation of coronary in-stent restenoses with emstone high-definition CT in comparison
with quantitative coronary angiography and Intra-vascular ultrasound: preliminary results.
– D. Andreini, G. Pontone, S. Mushtaq, A. Bartorelli, D. Trabattoni, E. Bertella, E. Conte, G. Ballerini, M. Pepi
(Milan, IT)
Anatomical versus functional severity of coronary artery stenoses using coronary computed tomography
angiography and myocardial perfusion imaging.
– H. Fukuda, M. Moroi, H. Masai, T. Kunimasa, R. Nakazato, T. Furuhashi, K. Sugi (Tokyo, JP)
Impact of microalbuminuria on the characteristics of coronary plaques using computed tomography
angiography in diabetic patients.
– A. Sato, Y. Kakefuda, T. Adachi, E. Ojima, H. Watabe, A. Atsumi, T. Kimura, T. Hoshi, K. Aonuma (Tsukuba,
JP)
Efficacy on cardiac function in percutaneous coronary intervention for chronic total occlusions analyzed
by echocardiography.
– H. Takimura, T. Muramatsu, R. Tsukahara, Y. Ito, T. Sakai, H. Ishimori, K. Hirano, M. Nakano,
M. Yamawaki, M. Araki (Yokohama, JP)
Transthoracic coronary flow reserve stratifies outcomes in patients with intermediate or equivocal left
main coronary artery disease.
– A. Djordjevic-Dikic, M. Tesic, J. Stepanovic, V. Giga, M. Dobric, B. Beleslin, I. Paunovic, I. Jovanovic,
D. Zamaklar-Trifunovic, M. Ostojic (Belgrade, RS)
Neointimal hyperplasia is enhanced at fracture site in sirolimus-eluting stents as assessed by optical
coherence tomography.
– M. Kashiwagi, A. Tanaka, H. Kitabata, K. Komukai, T. Tanimoto, Y. Ino, K. Hirata, M. Mizukoshi, T. Imanishi,
T. Akasaka (Wakayama, JP)
High pressure post-dilatation procedure may induce neointimal coverage on sirolimus-eluting stent
struts.
– M. Taniike, M. Nishino, T. Yoshimura, D. Nakamura, N. Makino, H. Kato, Y. Egami, R. Shutta, J. Tanouchi,
Y. Yamada (Sakai, JP)
Optical coherence tomography in combination with intracoronary thermography for the detection of
functional and morphological characteristics of culprit lesions in patients with ACS.
– M. Riga, K. Toutouzas, A. Karanasos, E. Tsiamis, A. Synetos, A. Michelongona, M. Drakopoulou,
C. Stefanadis (Athens, GR)
Calculation the translesional pressure gradients on coronary stenosis by combining three-dimensional
coronary angiography parameters with frame count data.
– B. Tar, P. Lugosi, S. Ember, M. Svab, J. Santa, Z. Beres, S. Bakk, R. Kolozsvari, P. Polgar, Z. Koszegi
(Nyíregyháza and Debrecen, HU)
Value of intravascular ultrasound in borderline left main stenosis. Analysis of 159 consecutive lesions.
– D.H. Koschyk, F. Markworth, Y. Von Kodolitsch, R. Koester, B. Goldmann, S. Willems, J. Kaehler,
H. Reichenspurner, T. Meinertz, S. Baldus (Hamburg, DE)
Tissue characterization of in-stent neointima using integrated backscatter intravascular
ultrasound;Comparison with optical coherence tomography.
– K. Sato, H. Takebayashi, K. Goto, S. Kodama, M. Taniguchi, Y. Kikuta, Y. Fujiwara, S. Hiramatsu, S. Haruta
(Fukuyama, JP)
Clinical presentations of acute coronary syndrome related to the lesion pathophysiology assessed by
intravascular ultrasound and optical coherence tomography.
– M. Kato, K. Dote, S. Sasaki, E. Kagawa, Y. Nakano, M. Kajikawa, A. Higashi, K. Itakura (Hiroshima, JP)
Diagnosis of subtle type A aortic dissection using transesophageal echocardiography.
– J. Albers, L.O. Conzelmann, C.-F. Vahl (Mainz, DE)
Integrated ultrasound study as a gatekeeper for coronary and carotid atherosclerosis.
– F. Rigo, N. Gaibazzi, P.C. Ballo, A. Moreo, C. Giannattasio, E. Grolla, C. Palombo (Mestre-Venice, Parma,
Florence, Milan and Pisa, IT)
Subclinical arteriosclerotic change in patients with diabetes or hypertension who have normal
intima-media thickness on carotid ultrasound.
– S.A. Kim, S.H. Jo, H.S. Kim, S.J. Han, W.J. Park, C.Y. Rhim, J.-W. Ha (Anyang-Si, Gyeonggi-Do and
Seoul, KR)
Potential role of low kV ex vivo micro-CT for 3D morphometry of paraffin embedded coronary vessels
before histology.
– D. Panetta, C. Kusmic, G. Pelosi, F. Viglione, A. Del Guerra, A. L’Abbate, P.A. Salvadori (Pisa, IT)
Uptake of aluminium phtalocyanine in endarterectomy carotid plaques in human: study in vitro.
– Y.U.E. Efremova, G.N. Soboleva, E.R. Andreeva, N.V. Radukhina, E.M. Tararak, Y.U.A. Karpov (Moscow,
RU)
*Abstracts can
be accessed at:
286
QR 30606
P4708
P4709
P4710
P4711
P4712
P4713
P4714
P4715
P4716
P4717
P4718
P4719
P4720
P4721
P4722
P4723
P4724
P4725
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Trends in baseline carotid intima-media thickness (cIMT) and LDL-C levels in statin LDL-C lowering
studies during 1988-2008.
– M.H. Davidson, Q. Dong, J.E. Tomassini, D. Neff, A.B. Polis, A.M. Tershakovec (Chicago and Whitehouse
Station, US)
Noninvasive assessment of carotid plaque inflammation: first clinical application of microwave
radiometry.
– A. Synetos, M. Drakopoulou, K. Toutouzas, H. Nikolaou, K. Stathogiannis, A. Michelongona, E. Tsiamis,
C. Grassos, E. Siores, C. Stefanadis (Athens, GR; Bolton, GB)
P4726
P4727
DETECTION AND QUANTIFICATION OF ATHEROSCLEROTIC BURDEN (QR 30607*)
*Abstracts can
be accessed at:
P4728
P4729
P4730
P4731
P4732
P4733
P4734
P4735
P4736
P4737
P4738
P4739
TUESDAY – AFTERNOON
Carotid plaque score versus coronary artery calcium score in the prediction of cardiovascular event in
patients with diabetes mellitus.
– N. Yokoyama, R. Iino, K. Konno, T. Isshiki (Tokyo, JP)
Family history of early cardiovascular disease is associated with carotid atherosclerosis in patients with
familial hypercholesterolemia.
– C. Masoura, C. Pitsavos, K. Aznaouridis, I. Skoumas, C. Vlachopoulos, K. Psarros, V. Metaxa, K. Liontou,
C. Stefanadis (Athens, GR)
Prevalence and predictors of asymptomatic carotid atherosclerosis in climacteric women.
– I. Lucena, L. Costa, A.P. Tavares-Souza, D. Fantato, B. Bezerra, N. Morais, P. Veras, M. Novaes,
J.C. Nicolau (São Paulo and Recife, BR)
Functional arterial stiffness predicts a thickening of carotid intima-media one year later in patients with
lifestyle-related disease.
– M. Ogura N, D. Kamekawa, K. Kamiya, A. Mastunaga, M. Kimura, R. Shimizu, T. Ogura, C. Noda,
M. Yamaoka-Tojo, T. Masuda (Sagamihara and Yamanashi, Japan, JP)
Radiofrequency-based estimates of local common carotid stiffness and intima-media thickness:
implications for detecting early vascular involvement in hypertension and diabetes.
– C. Palombo, M. Kozakova, G. Bini, C. Morizzo, R. Miccoli, G. Dell’Omo, R. Pedrinelli, V. Di Bello,
N. Guraschi, A. Balbarini (Pisa and Genoa, IT)
The grading of a carotid bruit and its relationship to carotid artery peak systolic velocities.
– M. Matangi, A. Dillon, A. Johri, D. Armstrong, U. Jurt, R. Pal, D. Brouillard (Kingston, CA)
Arterial stiffness in families with premature coronary artery disease.
– T.A. Mulders, B. Van Den Boogaard, A. Bakker, M.D. Trip, E.S.G. Stroes, B.J.H. Van Den Born,
S.J. Pinto-Sietsma (Amsterdam, NL)
Familial AAA: high prevalence and decreased cardiac risk factors.
– K.M. Van De Luijtgaarden, S.E. Hoeks, M.T. Voute, E.J. Bakker, T.M. Valentijn, N.J. Ravensbergen,
F. Bastos Goncalves, H.J. Verhagen, D. Majoor Krakauer, D. Poldermans (Rotterdam, NL)
Brachial-ankle pulse wave velocity as a predictor of cardiovascular events: a meta-analysis of
longitudinal studies.
– K. Aznaouridis, C. Vlachopoulos, C. Stefanadis (Athens, GR)
Addition of claudication to the Framingham risk score improves mortality prediction.
– A.G. Kieback, M. Dorr, T. Ittermann, R. Lorbeer, H. Wallaschofski, H. Voelzke, S.B. Felix (Greifswald, DE)
The ankle brachial index is an independent predictor of mortality in anticoagulated patients with atrial
fibrillation.
– V. Roldan, F. Marin, P. Gallego, J.M. Torregrosa, B. Muina, E. Jover, S. Montoro-Garcia, M. Valdes,
V. Vicente, G.Y.H. Lip (Murcia, ES; Birmingham, GB)
Arterial structure and function in patients with familial combined hyperlipidemia.
– C. Masoura, C. Pitsavos, I. Skoumas, K. Aznaouridis, C. Vlachopoulos, K. Psarros, V. Metaxa, K. Liontou,
C. Stefanadis (Athens, GR)
Lipoprotein (a) levels independently predict elevated coronary calcium score in those at intermediate or
high risk of a cardiovascular event- implications for screening algorithms.
– M.E. Legget, C.J. Ellis, C. Edwards, N. Van Pelt, J.A. Ormiston, J. Christiansen, H. Winch, G. Gamble,
R. Young (Auckland, NZ)
Living in a city centre increases the risk of CT verified coronary artery calcification.
– A. Diederichsen, O. Gerke, J. Lambrecthsen (Odense and Svendborg, DK)
Impact of left ventricular hypertrophy on the presence of coronary artery disease using multislice
computed tomography in asymptomatic patients without coronary artery calcification.
– K. Harada, N. Terada, A. Okada, M. Shigekiyo, H. Yoshikawa, A. Hirono, T. Yamamoto, H. Yamamoto,
K. Tamura, H. Fujinaga (Tokushima, JP)
Prediction of cardiovascular risk from nocturnal pulse wave signal using the autonomic state indicator
(ASI) technology.
– B. Sanner, D. Sommermeyer, D. Zou, D.N. Eder, J. Hedner, J. Ficker, W. Randerath, T. Penzel, L. Grote
(Wuppertal, Karlsruhe, Nuremberg, Solingen and Berlin, DE; Gothenburg, SE)
Clinical application of carotid intima and media thickness for coronary artery disease using inverse
probability-weighted estimators.
– G. Kim, H.J. Youn, Y.S. Choi, H.O. Jung, S.Y. Jung, S.H. Ann, T.S. Kim, J.E. Yi (Seoul, KR)
Relationship between the carotid atherosclerotic burden and severe coronary artery disease.
– D. Lowenstein Haber, M. Perea, M. Villanueva, M. Pipkin, R. Danielo, C. Rodriguez Correa, E. Guevara,
G. Guinta, M. Cors, E. Bozovich (Buenos Aires, AR)
P4740
P4741
P4742
P4743
P4744
P4745
QR 30607
287
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Early vascular ageing in coronary artery disease and diabetes mellitus.
– Z. Lenkey, B. Gaszner, M. Illyes, R. Bocskei, L. Priegl, Z.S. Sarszegi, F.T. Molnar, I.G. Horvath, A. Cziraki
(Pécs and Budapest, HU)
Association between UKPDS risk score and coronary artery disease severity, ankle-brachial index,
cardiovascular autonomic neuropathy and diastolic dysfunction in type 2 diabetes mellitus.
– C.J. Magri, A. Cassar, S. Fava, H. Felice, A. Fenech (Msida, MT)
P4746
P4747
CARDIOVASCULAR RISK; MARKERS AND TECHNIQUES (QR 30608*)
Incremental value of using NT pro-BNP and cystatin C as predictors of adverse events in low and
intermediate risk patients presenting to Emergency Department with chest pain.
– S. Mathewkutty, K. Shah, R. Iyengar, L. Hermann, L. Razzouk, R. Esquitin, R. Vedanthan, L. Ramanathan,
A. Aneja, M. Farkouh (New York and Cleveland, US)
Presentation and management of acute coronary syndromes in the elderly: the Myocardial Ischaemia
National Audit Project (MINAP) 2003-2010.
– C.P. Gale, B.A. Cattle, A. Woolston, T.H. West, A.D. Simms, K.A.A. Fox, R.M. West (Leeds and Edinburgh,
GB)
Age and in-patient mortality after presentation to hospital with acute coronary syndrome: the Myocardial
Ischaemia National Audit Project (MINAP) 2003-2010.
– C.P. Gale, B.A. Cattle, A. Woolston, T.H. West, A.D. Simms, K.A.A. Fox, R.M. West (Leeds and Edinburgh,
GB)
Cancer mortality in a population hospitalized for cardiovascular disease.
– C. Carpeggiani, C. Michelassi, P. Landi, P. Marraccini, E. Picano (Pisa, IT)
Need for cardiac valvular surgery in 2011: preliminary results from a community screening of an Italian
unselected population.
– L.E. Pastormerlo, A. Dushpanova, F. Pali, D. Della Latta, A. Nardelli, D. Chiappino, M. Emdin, S. Maffei (Pisa
and Massa, IT)
Biomarkers and clinical factors associated with atrial fibrillation in Russian population.
– P.G. Platonov, M.A. Shkolnikova, J.G. Smith, Y.V. Shubik, D. Jdanov, V.M. Shkolnikov (Lund, SE; Moscow
and Saint Petersburg, RU; Rostock, DE)
Regional comparison of selected cardiovascular risk factors of Croatian hospitalized coronary heart
disease patients in the period of 6 years (2003-2009).
– H. Vrazic, J. Sikic, T. Lucijanic, K. Matic, T. Bozin, I. Subjak, M. Udovicic, S. Sokol, I. Sakic, M. Bergovec
(Zagreb, HR)
Appropriate cutoff values for serum uric acid levels in relation to multiple cardiometabolic risk factors
among Japanese junior high school students.
– M. Hongo, H. Hidaka, S. Sakaguchi, K. Nakanishi, A. Izawa, U. Ikeda, Y. Yazaki (Matsumoto, JP)
Clinical applicability of the 30-year Framingham risk score. Usefulness in cardiovascular risk stratification
and diagnosis of subclinical carotid atherosclerosis.
– D.A. Siniawski, W.M. Masson, J. Krauss, A.M. Cagide (Buenos Aires, AR)
Long term effects of nutraceuticals (Berberine, Red Yeast Rice, Policosanol) in elderly
hypercholesterolemic patients.
– G. Marazzi, L. Cacciotti, F. Pelliccia, M. Volterrani, G. Caminiti, L. Iaia, B. Sposato, A. Carluccio, G. Rosano
(Rome, IT)
Do risk scores for silent atherosclerosis underestimate disease risk?
– F. Moscoso Costa, J. Ferreira, S. Carvalho, G. Cardoso, R. Cale, P.G. Santos, M. Santos, C. Aguiar,
M. Trabulo, M. Mendes (Lisbon, PT)
Metabolic profile and control by treatment and relationships with blood pressure values in patients from
central and eastern European countries: the BP-CARE metabolic study.
– G. Seravalle, G. Brambilla, R. Cifkova, S. Laurent, K. Narkiewicz, J. Redon, C. Farsang, F. Quarti Trevano,
G. Mancia, G. Grassi (Milan and Monza, IT; Prague, CZ; Paris, FR; Gdansk, PL; Valencia, ES; Budapest, HU)
First and fifth day BNP and long-term mortality in ST-elevation myocardial infarction patients.
– A. Tycinska, R. Sawicki, B. Sobkowicz, A. Lisowska, B. Mroczko, W.J. Musial, S. Dobrzycki,
A. Kozieradzka, M. Szmitkowski (Bialystok, PL)
Evaluation of risk factors for cardiovascular events among patients on the cadaveric renal transplant list.
– N.Y. Wong, C.T. Chin, S.M. Zaini, P.S. Tee, L.W. Khin, S.M. Koh, T. Kee, W.C. Tan (Singapore, SG)
Prevalence of left ventricular hypertrophy in patients with chronic obstructive pulmonary disease.
– S. Rekhraj, J. George, A. Nadir, B. Szwejkowski, A.D. Struthers (Dundee, GB)
Ambulatory blood pressure monitoring is associated with subclinical atherosclerosis in normotensive
spinal cord injury subjects.
– J.D. Garcez-Seabra, J.R. Matos-Souza, D. Goulart, E. Abib, K.R. Pithon, A. Cliquet Junior, W. Nadruz
Junior (Campinas, BR)
Difference in efficiency of lipid lowering pharmacotherapy in ambulatory patients between primary and
specialist care - 3ST-POL.
– D. Sliz, M. Naruszewicz, K.J. Filipiak, J. Siebert, A. Mamcarz (Warsaw and Gdansk, PL)
Correlations between various obesity parameters and coronary artery disease severity.
– A. Farrag, A. El Hag, A. Hassan, B. Zarief (Cairo, EG)
A cardiovascular risk profile derived from administrative data.
– H. De Vries (Amsterdam, NL)
*Abstracts can
be accessed at:
288
QR 30608
P4748
P4749
P4750
P4751
P4752
P4753
P4754
P4755
P4756
P4757
P4758
P4759
P4760
P4761
P4762
P4763
P4764
P4765
P4766
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
P4767
P4768
P4769
P4770
P4771 (W)
P4772
P4773
P4774
P4775
P4776
P4777
P4778
P4779
P4780
P4781
P4782 (W)
TUESDAY – AFTERNOON
High cardiovascular risk increases cost and length of sick leave from non-cardiovascular cause.
– L.M. Ruilope, E. Calvo-Bonacho, M.A. Sanchez-Chaparro, J.C. Sainz, M. Ruiz-Moraga,
L. Quevedo-Aguado, C. Fernandez-Labandera, A. Zanchetti (Madrid and Malaga, ES; Milan, IT)
Hypertension, the strongest risk factor for CVD events and mortality in an Iranian population: Isfahan
cohort study.
– M. Talaei Pashiri, M. Sadeghi, S. Oveisgharan, N. Sarrafzadegan (Isfahan, IR)
Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in asymptomatic
normoalbuminuric type 1 diabetes patients.
– U.M. Mogensen, T. Jensen, L. Kober, H. Kelbaek, U. Dixen, J. Hilsted, K.F. Kofoed (Copenhagen, DK)
Diabetes mellitus and its influence in cardiac rehabilitation program for coronary patients.
– M. Paiva, A. Rocha, A. Lebreiro, A. Correia, A. Sousa, C. Sousa, I. Rangel, V. Araujo, F. Parada, M. Maciel
(Porto, PT)
Significant differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients.
– K. Koh, M. Quon (Incheon, KR; Bethesda, US)
Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events.
– C. Saely, P. Rein, A. Vonbank, K. Huber, H. Drexel (Feldkirch and Vienna, AT; Triesen, LI)
Impact of previous metabolic control in the post acute coronary syndrome outcome in diabetics.
– S. Monteiro, R. Teixeira, R. Batista, E. Jorge, F. Saraiva, P. Mendes, H. Martins, P. Monteiro, M. Freitas,
L. Providencia (Coimbra, PT)
Alpha hydroxybutyric acid as a novel biomarker for coronary heart disease.
– K. Ikewaki, H. Nagase, K. Shimizu, H. Matsuzawa, S. Yagi, M. Nishizawa, T. Ohno, Y. Nakada, M. Shimizu,
S. Mochizuki (Tokorozawa, Osaka and Tokyo, JP)
Circulating leukocyte telomere length and oxidative stress: a new target for statin therapy.
– S. Saliques, J.R. Teyssier, C. Vergely, J. Lorin, M. Farnier, A. Donzel, S. Ragot, Y. Cottin, L. Rochette,
M. Zeller (Dijon, FR)
Serum cathepsin S predicts the risk for mortality in elderly men and woman.
– E. Jobs, E. Ingelsson, U. Riserus, E. Nerpin, M. Jobs, J. Sundstrom, S. Basu, A. Larsson, L. Lind, J. Arnlov
(Uppsala, Stockholm and Falun, SE)
sRAGE (soluble receptor of advanced glycation end-products): a new biomarker of arterial thrombosis
during systemic lupus erythematosus.
– H. Maillard-Lefebvre, N. Costedoat-Chalumeau, N. Grossin, J. Salleron, S. Dubucquoi, E. Hachulla,
P.-Y. Hatron, E. Boulanger, Z. Amoura, M. Lambert (Lille and Paris, FR)
Are the traditional cardiovascular disease risk factors enough for assessing the cardiovascular risk in
inflammatory joint diseases?
– T. Korotaeva, E. Loginova, D. Novikova, N. Klimova, L. Denisov (Moscow, RU)
Plasma concentration of matrix metalloproteinase-2 is related to thrombotic events in patients in patients
with stable coronary disease.
– A. Komarov, A. Dobrovolsky, E. Titaeva, O. Shakmatova, T. Ilyushchenko, G. Dzhalilova, A. Deev,
E. Panchenko (Moscow, RU)
Estrone, coronary artery disease, and death in postmenopausal women.
– A.P. Mansur, T.C.B.F. Silva, N.H. Lopes, J.Y. Takada, S.D. Avakian, J.A.F. Ramires (São Paulo, BR)
Is uric acid a novel risk factor? Its interplay with arterial stiffness, peripheral and central pressures in
healthy, normotensive individuals.
– P. Xaplanteris, C. Vlachopoulos, P. Pietri, I. Dima, D. Terentes-Printzios, E. Christoforatou, A. Samentzas,
C. Stefanadis (Athens, GR)
Erythrocyte anisocytosis is associated with cholesterol content of erythrocyte membrane. Preliminary
atomic-force microscopy data.
– D.N. Tziakas, D. Stamopoulos, G. Chalikias, D. Stakos, S. Apostolakis, A. Thomaidi, A. Lantzouraki,
H. Boudoulas, S.V. Konstantinides (Alexandroupolis and Athens, GR)
AB0 blood type is not associated with outcome after vascular surgery.
– E.J. Bakker, S.E. Hoeks, M.T. Voute, K.M. Van De Luijtgaarden, Y.R.B.M. Van Gestel, H.J.M. Verhagen,
D. Poldermans (Rotterdam, NL)
Vitamin D deficiency is associated with increased 30-day cardiovascular events after vascular surgery.
– K.M. Van De Luijtgaarden, M.T. Voute, S.E. Hoeks, N.J. Ravensbergen, T.M. Valentijn, E.J. Bakker,
F. Bastos Goncalves, D. Goei, H.J. Verhagen, D. Poldermans (Rotterdam, NL)
Predictors of perioperative renal failure after noncardiac, nonvascular surgery in patients with previously
normal renal function.
– M. Biteker, F. Biteker, D. Duman, A. Dayan (Istanbul, TR)
Risk factors and hospital mortality in STEMI: multicenter study.
– I. Santos Rodriguez, G. Perez Ojeda, N. Alonso Orcajo, S. Estrada Gomez, M.J. Ruiz Olgado, J.M. Duran,
P. Pabon Osuna, M.A. Cruz Banuelos, C. Hernandez, F. De Castro (Salamanca, Burgos, León, Zamora and
Castilla y León, ES)
HDL-cholesterol predicts survival after heart transplantation.
– C.M. Tavares Aguiar, M.J. Rebocho, M. Abecasis, M. Marques, J.P. Neves (Carnaxide, PT)
Long term prognosis value of heart rate in coronary artery disease.
– F. Bouisset, V. Bongard, J.B. Ruidavets, D. Taraszkiewicz, M. Galinier, D. Carrie, M. Elbaz, J. Ferrieres
(Toulouse, FR)
Women with established coronary heart disease have worse control of hypertension than men. Data
from Euroaspire III survey -Poland.
– S. Surowiec, P. Jankowski, R. Wolfshaut-Wolak, M. Loster, T. Grodzicki, A. Pajak, K. Kawecka-Jaszcz
(Krakow, PL)
P4783
P4784
P4785
P4786
P4787
P4788
P4789
289
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Cardiovascular risk factors in a Roma community.
– E. Apetrei, C. Matei, M. Creteanu, M. Creteanu Jr, D. Iliescu, C. Jianu (Bucharest, Suceava, Radauti and
Drobeta Turnu Severin, RO)
Does risk factors for cardiovascular disease have a similar prevalence in rural and urban Polish primary
care patients? Insights from IDEA study.
– M. Chrostowska, A. Szyndler, M. Hoffmann, K. Polonis, K. Narkiewicz (Gdansk, PL)
P4790
P4791
OPTICAL COHERENCE TOMOGRAPHY (QR 30609*)
Spatial distribution of culprit lesion thin-cap fibroatheromas in acute coronary syndromes. An optical
coherence tomography study.
– M. Riga, K. Toutouzas, A. Karanasos, E. Tsiamis, A. Synetos, A. Papanikolaou, K. Stathogiannis,
E. Stefanadi, G. Triantafyllou, C. Stefanadis (Athens, GR)
Association of intimal thickening of non-atheromatic coronary segments with culprit plaque morphology.
– A. Karanasos, K. Toutouzas, E. Tsiamis, M. Riga, A. Synetos, M. Drakopoulou, G. Triantafyllou, C. Tsioufis,
D. Tousoulis, C. Stefanadis (Athens, GR)
Comparative assessment of vascular healing following implantation of drug eluting stents in animal
models and man.
– K. Steigerwald, C. Malle, J. Jehle, A. Kastrati, A. Schoemig, M. Joner (Munich, DE)
Insights on the substrate of coronary stent thrombosis obtained with optical coherence tomography.
– N. Gonzalo Lopez, F. Alfonso Manterola, J. Escaned Barbosa, C. Banuelos De Lucas, P. Jimenez
Quevedo, C. Nolte, A. Fernandez Ortiz, E. Garcia, R. Hernandez Antolin, C. Macaya Miguel (Madrid, ES)
Incidence, predictors and long term prognosis of stent edge dissections detected by optical coherence
tomography.
– K. Bouki, E. Sakkali, D. Chatzopoulos, S. Psychari, J. Makrygiannis, D. Barmperis, E. Kapsali, T. Apostolou
(Piraeus, GR)
Neointimal coverage on second generation drug-eluting stent struts crossing side-branch vessels
compared with paclitaxel-eluting stent: an optical coherence tomography analysis.
– K. Nasu, M. Habara, T. Kurita, T. Ito, E. Ko, D. Yokota, Y. Kinoshita, M. Terashima, T. Suzuki (Toyohashi,
JP)
New insights into the coronary bifurcation with the use of off-line 3-dimensional terumo OFDI imaging.
– V. Farooq, J.H. Heo, B.D. Gogas, T. Okamura, J. Gomez-Lara, S. Brugaletta, M. Radu,
H.M. Garcia-Garcia, P.W. Serruys (Rotterdam, NL)
Optical coherence tomography tissue characterization predicts plaque progression of nonculprit lesion
after acute coronary syndrome.
– K. Komukai, A. Tanaka, T. Tanimoto, H. Kitabata, Y. Ino, K. Kimura, K. Hirata, M. Mizukoshi, T. Imanishi,
T. Akasaka (Wakayama, JP)
Clinical impact of small-sized stent mal-apposition after stent implantation as detected by optical
coherence tomography.
– K. Ishibashi, H. Kitabata, K. Komukai, T. Tanimoto, Y. Ino, K. Kimura, K. Hirata, M. Mizukoshi, T. Imanishi,
T. Akasaka (Wakayama, JP)
Favorable effects of lipid-soluble statin on neointimal growth after sirolimus-eluting stents implantation
as compared to water -soluble statin.
– R. Shutta, M. Nishino, M. Taniike, N. Makino, H. Kato, Y. Egami, J. Tanouchi, Y. Yamada (Sakai, JP)
Differences of optical coherence tomographic findings and clinical outcomes between excimer laser and
cutting balloon angioplasty for focal in-stent lesion.
– M. Nishino, M. Taniike, N. Makino, H. Kato, Y. Egami, R. Shutta, H. Morita, J. Tanouchi, Y. Yamada (Sakai,
JP)
Natural consequence of stent malapposition tissue prolapse, thrombus and stent edge dissection
assessed by optical coherence tomography.
– H. Kawamori, J. Shite, T. Shinke, H. Otake, D. Matumoto, M. Nakagawa, Y. Nagoshi, A. Kozuki, H. Hariki,
T. Inoue (Kobe, JP)
In vivo optical coherence tomography assessment of very late drug-eluting stent thrombosis compared
with late restenosis and no-event patients.
– S. Miyazaki, Y. Hiasa, T. Takahashi, P. Chen, R. Ogura, S. Hosokawa, K. Kishi, R. Ohtani (Komatsushima,
JP)
Uneven distribution of the factors of plaque vulnerability in atherosclerotic plaques in the left anterior
descending coronary arteries detected by optical coherence tomography color-coded mapping.
– Y. Ishihara, M. Kawasaki, A. Hattori, T. Aoyama, S. Ojio, M. Arai, K. Nishigaki, G. Takemura, S. Minatoguchi
(Gifu City, JP)
Comparison of contrast media and low molecular dextran for frequency-domain optical coherence
tomography imaging.
– Y. Ozaki, H. Kitabata, K. Ishibashi, K. Komukai, T. Tanimoto, Y. Ino, K. Kimura, M. Mizukoshi, T. Imanishi,
T. Akasaka (Wakayama, JP)
Interstudy reproducibility of the second generation, Fourier domain OCT in patients with coronary artery
disease.
– Z. Jamil, G. Tearney, N. Bruining, K. Sihan, G. Van Soest, J. Ligthart, B. Bouma, E. Regar (Rotterdam, NL;
Boston, US)
*Abstracts can
be accessed at:
290
QR 30609
P4792
P4793
P4794
P4795
P4796
P4797
P4798
P4799
P4800
P4801
P4802
P4803
P4804
P4805
P4806
P4807
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Safety and feasibility of the second generation, Fourier domain optical coherence tomography:
comparison to a historic cohort - a single center experience.
– T. Okamura, N. Gonzalo, J.L. Gutierrez-Chico, G. Van Soest, N. Bruining, G. Tearney, B. Bouma,
P.W. Serruys, F. Zijlstra, E. Regar (Rotterdam, NL; Boston, US)
Detection of macrophage accumulation within atherosclerotic coronary plaque with use of attenuation
curve in optical coherence tomography.
– H. Haruta, T. Takayama, T. Hiro, A. Hirayama (Tokyo, JP)
Angioscopic findings of arterial repair following everolimus-eluting stent implantation: 8-month follow-up
study in patients.
– M. Awata, F. Sera, T. Ishihara, T. Watanabe, M. Fujita, O. Iida, Y. Ishida, S. Nanto, M. Uematsu, S. Nagata
(Amagasaki and Suita, JP)
Clinical predictors of fibrous cap thickness and macrophage accumulation in coronary plaques.
– T. Sato, T. Kameyama, T. Noto, H. Inoue (Toyama, JP)
P4808
P4809
P4810
P4811
FRACTIONAL FLOW RESERVE (QR 30610*)
*Abstracts can
be accessed at:
P4812
P4813
P4814
P4815
P4816
P4817
P4818
P4819
P4820
P4821
TUESDAY – AFTERNOON
Percent stenosis is a weak predictor of Fractional Flow Reserve (FFR) in intermediate coronary lesions:
insights from a large french multicenter registry.
– E. Van Belle, T. Cuisset, G. Rioufol, C. Pouillot, E. Teiger, D. Barreau, M. Hanssen, L. Belle, C. Bretelle,
P. Dupouy (Lille, Marseille, Lyon, St. Denis de la Réunion, Créteil, Toulon, Hagenau, Annecy, Valence and
Antony, FR)
Nitroprusside: an excellent alternative for fractional flow reserve assessment.
– D. Lindefjeld, J. Diaz, R. Cardenal, A. Gomez, C. Sanchez, J. Roa, J. Landero, P. Gomez, M. Gracia,
E. Bobo (Huelva, ES)
Adenosine versus nitroprusside to induce maximal hyperaemia for fractional flow reserve assessment.
– A.M. Leone, A.R. De Caterina, A. Aurelio, E. Basile, D. Russo, A. Iaconelli, G. Niccoli, I. Porto, A.G. Rebuzzi,
F. Crea (Rome, IT)
Influence of percutaneous coronary intervention on true microvascular resistance in patients with non-ST
elevation acute coronary syndrome.
– C. Akdeniz, Y. Nisanci, S. Umman, B. Umman, E. Golcuk, M. Sezer (Istanbul, TR)
Impact of predilatation on periprocedural microvascular injury in patients with non-ST elevation acute
coronary syndrome undergoing stenting.
– C. Akdeniz, S. Umman, Y. Nisanci, B. Umman, A. Kaplan, E. Aslanger, O. Kiraslan, A. Yilmaz, A. Atakan,
M. Sezer (Istanbul, TR)
Effects of cardiovascular risk factors on macrovascular endothelial function and microvascular reactivity
assessed with near-infra red spectroscopy in adults with different cardiovascular status.
– M. Gayda, M. Juneau, J.C. Tardif, J. Lambert, A. Nigam (Montreal, CA)
Determinants of coronary flow velocity reserve in patients with moderate or severe aortic stenosis and
nonobstructive coronary arteries.
– M. Banovic, T. Vujisic-Tesic, M. Callahan, I. Nedeljkovic, D. Trifunovic, M. Petrovic, O. Petrovic, C. Offord,
M. Ostojic (Belgrade, RS; Rochester, US)
Safety of deferring revascularization in lesions with FFR ≥0.75 but a small IVUS-derived lumen area.
– S. Junagade, M.-Y. Chan, A.-F. Low, S.-G. Teo, A.-M. Richards, T.-C. Yeo, H.-C. Tan, C.-H. Lee
(Singapore, SG)
The value of fractional flow reserve in predicting myocardial protective effect in patients with previous
myocardial infarction undergoing percutaneous coronary intervention.
– Y. Ishibashi, M. Yamauchi, M. Uematsu, R. Kamijima, A. Hayashi, Y. Akashi, H. Musha, Y. Miyake
(Yokohama and Kawasaki, JP)
Which reaction in coronary arteries induced by acetylcholine at low or moderate doses, is clinically
useful?
– H. Teragawa, N. Mitsuba, K. Nishioka, S. Kurisu, Y. Kihara (Hiroshima, JP)
Usefulness of a trans-stent fractional flow reserve gradient for assessing the immediate results of
drug-eluting stent implantation.
– H.S. Lim, S.J. Tahk, H.M. Yang, D.Y. Joe, M.H. Yoon, B.J. Choi, S.Y. Choi, J.S. Park, G.S. Hwang,
J.H. Shin (Suwon, KR)
Superior diagnostic accuracy of combined intracoronary hemodynamic information in assessment of
functional lesion severity.
– T.P. Van De Hoef, M. Siebes, S.A.J. Chamuleau, J. Baan Jr, J.P.S. Henriques, M. Voskuil, M. Bax,
J.A.E. Spaan, J.J. Piek, M. Meuwissen (Amsterdam, Utrecht and Breda, NL)
Effect of venous pressure on fractional flow reserve and index of microcirculatory resistance in patients
with stable chest pain syndromes.
– A. Alfiadh, M. Mok, T. Lancefield, D. Clark, O. Farouque (Melbourne, AU)
Coronary endothelial function by the index of microcirculatory resistance can be estimated by evaluating
left ventricular contractile reserve at low dose dobutamine echocardiography.
– M. Leung, S. Lo, C. Juergens, D. Leung (Sydney, AU)
Feasibility of transradial approach without radial artery spasm prophylaxis for intracoronary spasm
provocation test.
– A. Karagianni, T. Schaeufele, A. Athanasiadis, A. Yilmaz, U. Sechtem (Stuttgart, DE)
P4822
P4823
P4824
P4825
P4826
QR 30610
291
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Prognostic value of TIMI flow grade II in the era of GP IIb/IIIa antagonists in patients undergoing direct
PCI for acute myocardial infarction.
– D. Rzepka, H. Bonnemeier, T. Demming, J. Heckmann, B. Weidtmann, N. Frey (Kiel, DE)
Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization.
– J. Ma, J. Qian, J. Ge (Shanghai, CN)
High asymmetric dimethylarginine and C-reactive protein levels in conjunction with low testosterone
concentration have an additive unfavourable effect on penile vasculature and carotid wall thickness.
– D. Terentes-Printzios, C. Vlachopoulos, N. Ioakeimidis, K. Rokkas, P. Xaplanteris, I. Dima, A. Aggelis,
K. Aznaouridis, C. Aggeli, C. Stefanadis (Athens, GR)
Effects of n-3 polyunsaturated fatty acids on left ventricular function and coronary flow in children with
type 1 diabetes mellitus.
– E. Aburawi, P. Liuba, M. Odermarsky, S. Sjoblad, E. Pesonen (Lund and Al-Ain, AE; Lund, SE)
Impact of a “fractional flow reserve (FFR)-guided” coronary revascularization strategy on individual
decision making: insights from a large french multicenter registry.
– E. Van Belle, T. Cuisset, G. Rioufol, C. Pouillot, E. Teiger, D. Barreau, M. Hanssen, L. Belle, C. Besnard,
P. Dupouy (Lille, Marseille, Lyon, La Réunion, Créteil, Toulon, Hagenau, Annecy and Antony, FR)
P4827
P4828
P4829
P4830
P4831
NON INVASIVE AND INVASIVE CORONARY IMAGING (QR 30611*)
Intravascular ultrasound findings at in-stent restenosis segment of overlapped drug-eluting stent.
– Y. Sakamoto, T. Muramatsu, R. Tsukahara, Y. Ito, H. Ishimori, K. Hirano, M. Nakano, M. Yamawaki,
M. Araki, H. Takimura (Yokohama, JP)
Reproducibility of intravascular ultrasound iMAP for radiofrequency data analysis: implications for design
of longitudinal studies.
– J.H. Heo, S. Brugaletta, H.M. Garcia-Garcia, J. Gomez-Lara, J.M.R. Lighthart, R. Diletti, P.W. Serruys
(Rotterdam, NL)
Association of elevated blood glucose levels on admission with tissue characterization in non-diabetic
patients with acute coronary syndrome with ST segment elevation.
– K. Trusinskis, D. Juhnevica, K. Strenge, D. Sondore, I. Narbute, G. Latkovskis, S. Jegere, I. Kumsars,
J. Dijkstra, A. Erglis (Riga, LV; Leiden, NL)
Longitudinal distribution of the necrotic rich plaques in non-culprit vessels of patients presenting with
acute coronary syndromes. Substudy of the PROSPECT trial.
– J.J. Wykrzykowska, H.M. Garcia-Garcia, A. Maehara, M. Fahy, A. Lansky, B. De Bruyne, G. Mintz,
G. Weisz, G. Stone, P.W. Serruys (Amsterdam and Rotterdam, NL; New York, US; Aalst, BE)
European multicenter study on the between-center reproducibility of volumetric radiofrequency-based
intravascular ultrasound analyses in coronary lesions prior to stenting.
– J. Huisman, R. Egede, A. Rdzanek, D. Boese, R. Erbel, J. Kochman, L.O. Jensen, M. Hartmann,
G.S. Mintz, C. Von Birgelen (Enschede, NL; Odense, DK; Warsaw, PL; Essen, DE; New York, US)
Detection of thin-cap fibroatheroma by plaque composition analysis using iMap-intravascular ultrasound
in patients with stable angina pectoris.
– S. Koga, S. Ikeda, T. Nakata, T. Yoshida, M. Takeno, Y. Koide, K. Maemura (Nagasaki, JP)
Combined use of intravascular ultrasound and optical coherence tomography in patients suffering from
stent thrombosis.
– F. Alfonso Manterola, J. Dutary, N. Gonzalo, P. Jimenez-Quevedo, M. Paulo, C. Banuelos, J. Escaned,
M.J. Perez-Vizcayno, R. Hernandez, C. Macaya (Madrid, ES)
Distribution of coronary atherosclerosis in relation to peripheral vascular changes in patients with erectile
dysfunction.
– N. Ioakeimidis, C. Vlachopoulos, A. Aggelis, D. Terentes-Printzios, K. Aznaouridis, A. Samentzas,
K. Rokkas, E. Christoforatou, E. Tsiamis, C. Stefanadis (Athens, GR)
Expansive coronary remodeling is associated with low endothelial shear stress, high plaque volume and
increased elasticity.
– A. Antoniadis, Y. Chatzizisis, S. Katranas, V. Giannoglou, K. Koskinas, G. Giannoglou (Thessaloniki, GR)
Dual-source CT angiography and intravascular ultrasound assessment of restenosis in patients after
coronary stenting for bifurcation left main stenosis.
– J. Veselka, D. Zemanek, P. Cadova, P. Hajek, P. Tomasov, M. Maly, T. Adla (Prague, CZ)
Benefits of pancreas transplantation on coronary atherosclerosis and microvascular dysfunction: a serial
IVUS study.
– M. De Carlo, F. Donati, L. Misuraca, P. Marchetti, B. Papini, M. Barsotti, F. Vistoli, S. Del Prato, U. Boggi,
A.S. Petronio (Pisa, IT)
The impact of plaque characterization assessed by intravascular ultrasound on myocardial perfusion after
primary angioplasty in patients with ST-segment elevation myocardial infarction.
– T. Nakata, K. Fujii, M. Fukunaga, D. Kawasaki, M. Kawabata, M. Masutani, M. Ohyanagi, T. Masuyama
(Nishinomiya, JP)
The relationship between lipid volume in coronary plaque and slow flow phenomenon in percutaneous
coronary intervention.
– T. Nihei, S. Namiuchi, T. Kawaguchi, T. Takii, C. Takahashi, T. Sugie, A. Kato (Sendai, JP)
Prevalence of angioscopic in-stent thrombosis after drug-eluting stent implantation (cypher vs TAXUS). a
serial observation with coronary angioscopy.
– D. Kitano, T. Takayama, T. Hiro, A. Hirayama (Tokyo, JP)
*Abstracts can
be accessed at:
292
QR 30611
P4832
P4833
P4834
P4835
P4836
P4837
P4838
P4839
P4840
P4841
P4842
P4843
P4844
P4845
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Angioscopic prevalence in the patients with diabetes mellitus after drug-eluting stent implantation
(everolimus- versus paclitaxel-eluting stent). A serial observation with coronary angioscopy.
– D. Kitano, T. Takayama, T. Kanai, M. Akabane, T. Kawano, M. Ichikawa, H. Haruta, Y. Hayashida, T. Hiro,
A. Hirayama (Tokyo, JP)
Appearance of thrombus formation and yellow plaque in proximal and distal stent segment after
paclitaxel-eluting stent implantation.
– Y. Kakefuda, A. Sato, T. Adachi, H. Watabe, E. Ojima, Y. Naruse, T. Hoshi, N. Murakoshi, K. Aonuma
(Tsukuba, JP)
3D quantitative coronary angiography (QCA) confers additional advantage over 2D QCA for the
assessment of intermediate left main stenosis: a comparison with intravascular ultrasound.
– I. Porto, I. Dato, D. Todaro, M. Calabrese, S. Rigattieri, A.M. Leone, G. Niccoli, F. Burzotta, C. Trani, F. Crea
(Rome, IT)
Coronary artery angiographic changes in veterans intoxicated by mustard gas.
– M. Shabestari, F. Jabari, B. Gohari, N. Moazen, H. Azizi, T. Moghiman, S. Ibrahimzadeh, A. Amirabadi
(Mashhad, IR)
Should dual axis rotational coronary angiography be the preferred mode of coronary angiography?
– C.P. Lim, L.L.H. Chua, S.T. Lim (Singapore, SG)
Culprit lesion characteristics in acute coronary syndrome and stable angina assessed by optical
coherence tomography, angioscopy, intravascular ultrasound and multidetector computed tomography.
– Y. Ozaki, M. Okumura, T.F. Ismail, S. Motoyama, H. Naruse, K. Hattori, H. Kawai, M. Sarai, J. Ishii,
J. Narula (Toyoake, JP; London, GB; Irvine, US)
Evaluation of the spatial relationship between the site of most severe narrowing and plaque vulnerability,
as assessed by virtual histology intravascular ultrasound.
– M.A. De Graaf, J.E. Van Velzen, F.R. De Graaf, C.E. Veltman, M.J. Schalij, E.E. Van Der Wall, J.D. Schuijf,
J.J. Bax, J.W. Jukema (Leiden, NL)
VH-IVUS-Identified vulnerable plaques are associated with increased MACE. The VIVA (VH-IVUS in
Vulnerable Atherosclerosis) study.
– P. Calvert, D.R. Obaid, M. O’Sullivan, L.M. Shapiro, D.C. McNab, C.G. Densem, P.M. Schofield, K.K. Ray,
N.E.J. West, M.R. Bennett (Cambridge and London, GB)
The association between necrotic core distribution at the coronary bifurcation and side branch
bifurcation angle: a virtual histology intravascular ultrasound study.
– H. Amano, K. Wagatsuma, M. Toda, H. Nii, Y. Uchida, Y. Fujii, J. Yamazaki (Tokyo, JP)
Insulin resistance is associated with VH-IVUS derived amount of necrotic core in plaque components in
patients with coronary artery disease.
– Y.M. Park, S.H. Han, K. Shin, M.G. Kim, W.C. Kang, K.K. Koh, K. Lee, T. Ahn, I.S. Choi, E.K. Shin (Incheon,
KR)
P4846
P4847
P4848
P4849
P4850
P4851
P4852
P4853
P4854
P4855
STEMI: MANAGEMENT AND OUTCOME (QR 30612*)
*Abstracts can
be accessed at:
P4856 (W)
P4857
P4858
TUESDAY – AFTERNOON
Impact of thrombus burden in ST-elevation myocardial infarction patients treated with or without
thrombus aspiration.
– M.A. Kampinga, Y.L. Gu, W.G. Wieringa, A.F.M. Van Den Heuvel, E.S. Tan, G. Pundziute, H.W. Van Der
Werf, I.C.C. Van Der Horst, F. Zijlstra, B.J.G.L. De Smet (Groningen and Rotterdam, NL)
Treatment of multivessel coronary artery disease in primary PCI for ST elevation myocardial infarction:
culprit only revascularisation is associated with higher MACE rates.
– T.E. Pain, D.A. Jones, K. Rathod, R. Weerackody, S. Gallagher, A. Jain, C. Knight, A. Mathur, A. Wragg
(London, GB)
Treatment of no-reflow during acute myocardial infarction: head to head dipyridamole versus verapamil.
– A. Arrivi, G. Tanzilli, N. Cocco, K. Mukred, F. Pelliccia, V. Pasceri, E. Mangieri (Rome, IT)
Outcome of primary PCI using prasugrel, bivalirudin and preferred radial access.
– A. Baumbach, T. Johnson, V. Oriolo, D. Smith, J. Usher, A. Davies, J. Strange (Bristol, GB)
Patients with acute ST segment elevation myocardial infarction treated with percutaneous coronary
intervention discharged before or at fourth days of hospitalization have worse long term outcome.
– M. Hawranek, M. Gierlotka, M. Gasior, D. Pres, A. Kurek, P. Buchta, T. Osadnik, M. Wrobel, A. Lekston,
L. Polonski (Zabrze, PL)
Ivabradine improves short-term outcomes after primary percutaneous coronary intervention in patients
presenting with acute ST-segment elevation myocardial infarction.
– S. Cay, G. Cagirci, N. Sen, R. Atak, A.D. Demir, A.R. Erbay (Istanbul, Antalya, Ankara, Eskisehir and Yozgat,
TR)
Compared long-term survival of reperfused STEMI, non-reperfused STEMI and NSTEMI with or without
PCI: 3-year results from the FAST-MI registry.
– E. Puymirat, N. Aissaoui, G. Lemesle, L. Lorgis, M. Hanssen, E. Drouet, G. Mulak, J. Ferrieres, T. Simon,
N. Danchin (Paris, Lille, Dijon, Haguenau and Toulouse, FR)
Ventricular fibrillation is a major determinant of in-hospital mortality but does not impact long-term
mortality after myocardial infarction: the FAST-MI registry.
– E. Marijon, E. Puymirat, N. Aissaoui, G. Lemesle, L. Lorgis, L. Belle, V. Bataille, E. Drouet, T. Simon,
N. Danchin (Paris, Lille, Dijon, Annecy and Toulouse, FR)
P4859
P4860
P4861
P4862
P4863
QR 30612
293
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
A well organized regional network is a major determinant of improvement of acute myocardial infarction
management.
– C. El Khoury, P. Serre, E. Flocard, O. Capel, X. Jacob, L. Banaei, A. Desplanques, E. Bonnefoy-Cudraz
(Vienne, Bourg en Bresse, Lyon and Saint Denis, FR)
A randomized comparison of systematic vs. angiography-guided thrombus aspiration prior to coronary
stenting in patients with less than 12h ST-elevation MI. A pilot study.
– A. Moynagh, D. O H-Ici, J. Uribe, T. Hovasse, T. Unterseeh, Y. Louvard, T. Lefevre, J. Garot, M.C. Morice,
P. Garot (Massy and Quincy, FR)
Long-term clinical outcomes of infarct-related artery versus multivessel revascularization in acute
ST-segment elevation myocardial infarction with multivessel disease: an analysis from KAMIR.
– H.W. Lee, T.J. Hong, S.K. Ahn, M.J. Yang, J.H. Choi, B.W. Kim, H.C. Lee, K.S. Cha (Busan, KR)
Early ambulance initiation versus cath-lab initiation of high dose clopidogrel in STEMI patients
undergoing primary PCI.
– S. Postma, J.H.E. Dambrink, M.J. De Boer, A.T.M. Gosselink, J.P. Ottervanger, J.C.A. Hoorntje,
A.J. Wienke, H. Suryapranata, A.W.J. Van ’T Hof (Zwolle and Nijmegen, NL)
Mortality of patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock
treated by PCI is correlated to the infarct related artery - results from the PL-ACS Registry.
– P. Trzeciak, M. Gierlotka, M. Gasior, M. Zembala, Z. Kalarus, K. Wilczek, L. Polonski (Zabrze, PL)
Door to balloon time in primary angioplasty via the radial versus femoral approach and direct culprit
vessel PCI versus initial diagnostic angiography.
– M. Egred, A. Bagnall, J. Ahmed, A. Zaman, I. Purcell, R. Edwards, B. Keavney, I. Spyridopoulos
(Newcastle-upon-Tyne, GB)
False activation for primary percutaneous coronary intervention is not a benign phenomenon.
– U. Chaudhry, C. Mavroudis, R.D. Rakhit (London, GB)
Long-term outcomes of patients with acute myocardial infarction undergoing primary PCI excluded from
the HORIZONS-AMI trial: results from a high volume recruiting center.
– L. Fiocca, R. Rossini, H. Parise, G. Musumeci, A. Vassileva, N. Lortkipanidze, O. Valsecchi, R. Mehran,
G.W. Stone, G. Guagliumi (Bergamo, IT; New York, US)
A multimedia campaign in a Dutch region reduces patient delay in ST-elevation acute myocardial
infarction treatment.
– M. Bax, T.C.M. Heemskerk, T. Eckhardt, G.A.M. Ariens, P.J.M. Uitewaal, S. Imami, J.W. Bech,
P. Oemrawsingh, L. Savalle, C.E. Schotborgh (The Hague and Delft, NL)
PCI in STEMI: wire reperfusion, determinants and prognostic implications.
– J. Szarfer, M.A. Riccitelli, A. Garcia Escudero, J. Gagliardi, G. Gigena, F. Blanco, R. Blanco, A. Alonso,
A. Rodriguez, R. Sarmiento (Buenos Aires, AR)
Primary PCI with DES implantation in patients with STEMI/LBBB. Euro Heart Survey ACS III registry
(2006-2008).
– W. Wojakowski, M. Tendera, M. Tubaro, M. Gierlotka, H. Bueno, M. Hochadel, Y. Hasin, J.-P. Bassand,
A.K. Gitt (Katowice and Zabrze, PL; Rome, IT; Madrid, ES; Ludwigshafen am Rhein, DE; Tiberias, IL;
Besançon, FR)
Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention
in the United States and Canada: insights from the APEX-AMI trial.
– R.H. Mehta, P. Kaul, R.D. Lopes, M.R. Patel, K.S. Pieper, P.W. Armstrong, C.B. Granger (Durham, US;
Edmonton, CA)
Clinical outcomes in unselected patients presenting with acute STEMI complicated by cardiogenic shock
in the primary PCI era - Early percutaneous haemodynamic support is indicated but underutilised.
– R.P. Weerackody, K. Qureshi, A. Kapur, A. Wragg, E. Smith, R.A. Archbold (London, GB)
Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction,
demonstrated by early and late CMR.
– S. Limalanathan, J. Eritsland, G.O. Andersen, N.E. Klow, M. Abdelnoor, P. Hoffmann (Oslo, NO)
Multivessel coronary disease determines 5-year mortality of patients with cardiogenic shock treated with
percutaneous coronary intervention for ST-segment elevation myocardial infarction.
– M. Hawranek, D. Pres, M. Gasior, M. Gierlotka, M. Tajstra, J. Piegza, T. Osadnik, A. Lekston, L. Polonski
(Zabrze, PL)
Reperfusion strategies in greater paris area and associated mortality in a 6-year registry.
– N. Karam, M. Tafflet, S. Bataille, J.M. Juliard, J.Y. Letarnec, G.A. Capitani, F. Templier, P. Garot,
Y. Lambert, X. Jouven (Paris, Melun, Corbeil-Essonnes, Garches, Massy and Le Chesnay, France, FR)
Factors predicting mortality after primary percutaneous coronary intervention: impact of transradial
access.
– I. Hizoh, G. Szabo, A. Kecskes, N. Kiss, L. Major, Z. Gulyas, K. Hering, Z. Majoros, I. Zatroch, R.G. Kiss
(Budapest, HU)
Temporal trends in treatment and outcomes of patients with ST-segment elevation myocardial infarction
(STEMI) in clinical practice - analysis from the PL-ACS registry.
– L. Polonski, M. Gasior, M. Gierlotka, P. Buszman, W. Ruzyllo, J. Dubiel, W. Banasiak, Z. Kalarus,
M. Zembala, G. Opolski (Zabrze, Katowice, Warsaw, Krakow and Wroclaw, PL)
Assessment of the management of acute myocardial infarction in emergency room, compared to
prehospital management.
– P. Serre, C. El Khoury, E. Flocard, O. Capel, K. Echahed, S. Cieslak, F. Pajot, E. Bonnefoy-Cudraz (Bourg
en Bresse, Vienne, Lyon, Valence, Bourgoin Jallieu and montelimar, FR)
Impact of guidelines on the evolution of reperfusion strategies in acute STEMI.
– N. Karam, M. Tafflet, S. Bataille, C. Lapandry, H. Auger, A. Greffet, S. Dubourdieu, F. Dupas, X. Jouven,
Y. Lambert (Paris, FR)
294
P4864
P4865
P4866
P4867
P4868
P4869
P4870
P4871
P4872
P4873
P4874
P4875
P4876
P4877
P4878
P4879
P4880
P4881
P4882
P4883
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
P4884
P4885
P4886
P4887
P4888
P4889
P4890
P4891
P4892
P4893
P4894
P4895
P4896
P4897
TUESDAY – AFTERNOON
The impact of symptom-to-door time and door-to-balloon time on 12-month mortality in patients
undergoing primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
– J.H. Lee, W.S. Choi, S.H. Park, D.H. Yang, H.S. Park, Y. Cho, S.C. Chae, J.E. Jun, M.H. Jeong, Y.J. Kim
(Daegu and Gwangju, KR)
Does field-triage of STEMI patients by paramedics improve door-to-balloon times and clinical outcomes
in infarct PCI? Insights from the Melbourne Interventional Group (MIG) registry.
– W.Y. Childs, N. Andrianopoulos, S. Sidharta, L. Roberts, S.J. Duffy, A. Ajani, J. Lefkovits, D. Clark,
O. Farouque, G. New (Melbourne, AU)
A higher baseline hemoglobin concentration is associated with a higher in-hospital mortality in patients
with ST-segment elevation myocardial infarction.
– O. Zouaghi, B.B. De Breyne, F.S. Sibellas, W.S. Sijilmassi, G.K. Kirkorian, E.B.C. Bonnefoy-Cudraz (Lyon,
FR)
ADAMTS1 is a novel acute biphasic marker for ischemia and reperfusion in myocardial infarction.
– S. Hirohata, M. Obika, H. Ogawa, T. Miyoshi, R. Shinohata, S. Usui, S. Kusachi, Y. Ninomiya, H. Ito
(Okayama, JP)
National efforts to improve door-to-balloon time in ST-elevation myocardial infarction: results from 15
primary percutaneous coronary intervention centers in taiwan.
– S.K. Chua, J.J. Cheng, S.H.H. Liao (Taipei, TW)
The influence of Killip-Kimball classification on 5-year mortality in patients with ST-segment elevation
myocardial infarction treated with percutaneous coronary intervention.
– D. Pres, M. Gasior, M. Gierlotka, M. Hawranek, M. Tajstra, K. Wilczek, P. Buchta, A. Lekston, L. Polonski
(Zabrze, PL)
Gender disparities in the management in ST and non ST segment elevation myocardial infarction. Insights
from the Euro Heart Survey ACS III Registry.
– F. Schiele, H. Bueno, M. Tubaro, M. Hochadel, N. Meneveau, W. Wojakowski, M. Gierlotka, K.A.A. Fox,
A.K. Gitt, J.-P. Bassand (Besançon, FR; Madrid, ES; Rome, IT; Ludwigshafen am Rhein, DE; Katowice and
Zabrze, PL; Edinburgh, GB)
Is it possible to simplify risk stratification scores for patients with ST-segment elevation acute myocardial
infarction submitted to primary angioplasty?
– A.T. Timoteo, J.P. Lopes, L. Cardona, J.A. Oliveira, M.L. Ferreira, R.C. Ferreira (Lisbon, PT)
Major bleeding is a predictor of mid-term mortality in STEMI patients treated with primary PCI. The ANIN
myocardial infarction registry.
– M. Polanska-Skrzypczyk, M. Karcz, P. Bekta, C. Kepka, W. Ruzyllo, A. Ciszewski, A. Witkowski (Warsaw,
PL)
Triple versus dual antiplatelet therapy in acute myocardial infarction in relation to renal function: data
from the korean acute myocardial infarction registry: data from the korean acute myocardial.
– S.J. Ha, S.H. Woo, W. Kim, S.R. Lee, S.K. Oh, S.W. Rha, Y.S. Jang, M.H. Jeong, C.J. Kim, H.S. Kim
(Seoul, Jeonju, Iksan and Gwangju, KR)
Contrast induced nephropathy after primary PCI for STEMI: usefulness of a new definition.
– J. Silvain, V. Spagnoli, O. Barthelemy, A. Bellemain-Appaix, F. Beygui, N. Vignolles, G. Cayla, S. O’Connor,
J.-P. Collet, G. Montalescot (Paris, FR)
Evaluation of right ventricular function by 2D speckle tracking strain and strain rate imaging in acute
myocardial infarction due to right coronary artery occlusion.
– R.B. Bakal, K. Teber, B. Dindar, O. Omaygenc, C. Dogan, O. Candan, A. Demirkiran, S. Akpinar, G. Sahin,
N. Ozdemir (Istanbul, TR)
Clinical and angiographic predictors and implications of successful thrombus aspiration in STEMI.
– A. Blasco, F.J. Goicolea, A. Muniz, B. Perez, M. Hernandez, L. Goicolea, A. Peinado, J.A. Fernandez,
A. Garcia-Touchard, J.F. Oteo (Madrid, ES)
The controlled reperfusion with bivalirudin and intra coronary abciximab in the porcine myocardial
infarction/reperfusion model.
– P.P. Buszman, W. Wojakowski, M. Debinski, K. Milewski, W. Jackiewicz, J. Pajak, B. Orlik, B. Trela,
M. Kawka, P.E. Buszman (Katowice, PL)
The off hours paradigm in primary percutaneous coronary intervention can be overcome by network
structures.
– R.G. Birkemeyer, T. Miljak, U. Meyerfeldt, M. Neuhaus, D. Hildebrand, H. Kohler, W. Jung
(Villingen-Schwenningen, DE)
Associations between symptom-to-door time and biomarkers on 12-month mortality in patients with
acute myocardial infarction.
– J.H. Lee, K.H. Kim, W.S. Choi, S.H. Park, M.H. Bae, D.H. Yang, H.S. Park, Y. Cho, S.C. Chae, J.E. Jun
(Daegu, KR)
Impact of target treatment delays according to current STEMI guidelines on myocardial salvage.
– L. Sanchis, X. Bosch, S. Goncalves, A. Regueiro, A. Betriu, M. Masotti, V. Martin, M. Sabate, J. Ortiz
(Barcelona, ES)
Multi-vessel disease identified at PPCI: prevalence, associations and outcome.
– D. Austin, Z. Adam, M. Awan, A.G.C. Sutton, J.A. Hall, R.A. Wright, D.F. Muir, N.M. Swanson, J. Carter,
M.A. De Belder (Middlesbrough, GB)
Intravenous aldosterone blockade at presentation improves myocardial perfusion after primary PCI for
STEMI.
– F. Beygui, J.P. Labbe, N. Vignolles, B. Bertin, A. Bellemain-Appaix, J. Silvain, G. Cayla, O. Barthelemy,
J.-P. Collet, G. Montalescot (Paris, FR)
May G-CSF after large anterior acute STEMI influence LV systolic and diastolic function? Results of Stem
Cells Mobilization in Acute Myocardial Infarction (STEM-AMI) trial.
– F. Gentile, V. Dadone, L. Lenatti, C. Malafronte, G. Pompilio, L. Squadroni, F. Di Gennaro, S. Maggiolini,
G. Colombo, F. Achilli (Cinisello Balsamo, Lecco, Milan, Monza and Merate, IT)
P4898
P4899
P4900
P4901
P4902
P4903
295
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Characteristics, mortality and prognosis factors of acute right ventricular myocardial infarction in the
modern era.
– C. Meune, N. Aissaoui, K. Wahbi, O. Merceron, S. Weber (Paris, FR)
Evaluating the potential effect of N-acetylcysteine on early remodeling biomarkers of ST-segment
elevation myocardial infarction: A double blind placebo controlled study.
– A.H. Talasaz, H. Khalili, F. Fahimi (Tehran, IR)
Acute myocardial infarction: pre-hospital epidemiology profile in the city of Moscow.
– N. Plavunov, V. Baratashvili, Y.U. Ovasapian (Moscow, RU)
Ventricular fibrillation during first 48 hours of ST-elevation myocardial infarction treated with primary
angioplasty does not affect one-year survival.
– M. Demidova, C.-J. Hoijer, D. Erlinge, P.G. Platonov (Lund, SE)
Efficacy of a new accelerated streptokinase regime in acute myocardial infarction (a double blind
randomized clinical trial).
– S. Ghaffari, B. Kazemiarbat, I. Ghorbani Golzari, L. Pourafkari (Tabriz, IR)
Age related mortality of primary PCI patients at a high volume UK cardiac centre.
– N. Malik, G.G. Babu, R.K. Aggarwal, P.A. Kelly, J.R. Davies, N.M. Robinson (Basildon, GB)
Impact of diverting off-hours calls to emergency medical dispatch centers on time delays and acute
revascularization procedures for patients with acute myocardial infarction. Data from RICO survey.
– F. Dumont, L. Lorgis, J.M. Yeguiayan, M. Zeller, A. Avondo, G. Dentan, J.N. Beis, Y. Cottin, M. Freysz,
G. Morel (Dijon and Fontaine les Dijon, FR)
Mid-term outcomes of iodixanol versus iomeprol contrast medium after primary angioplasty for st
elevation myocardial infarction.
– L. Bertelli, F.A. Sgura, M. Manicardi, A. Campioli, G. Spadafora, C. Leuzzi, R. Rossi, G. Biondi Zoccai,
G.M. Sangiorgi, M.G. Modena (Modena, IT)
Survival in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary angioplasty
is not dependent on socio-economic status in the UK.
– S.S. Kalra, A.M. Shah, J.A. Byrne, J.M. Hill, R. Dworakowski, A. Qasim, P.A. MacCarthy, N. Melikian
(London, GB)
Myocardial infarction complicated by cardiogenic shock in patients with multivessel coronary artery
disease treated with percutaneous coronary intervention - 3-year outcomes.
– A. Lekston, B. Hudzik, M. Gasior, J. Szkodzinski, G. Slonka, M. Gierlotka, M. Hawranek, L. Polonski
(Zabrze, PL)
Use of statins at hospital discharge influence 5-year mortality of patients with acute ST segment
elevation myocardial infarction treated with percutaneous coronary intervention.
– M. Hawranek, M. Gierlotka, M. Gasior, U. Nowak, A.M. Frycz-Kurek, M. Tajstra, T. Osadnik, B. Hudzik,
A. Lekston, L. Polonski (Zabrze, PL)
Stringent glycemic control on the first day post admission improves outcome in patients with acute
ST-segment elevation myocardial infarction.
– Y. Yazeed, Y. Sharaf, H. Kandil, S.H. El Tobgi (Cairo, EG)
Sex-specific coronary heart disease mortality trends in Brazil from 1980 to 2008.
– A.S. Cordeiro Da Rocha, B.R. Tura, A.R. De Lorenzo, F.J.M. Pittella, M.A. Mattos (Rio de Janeiro, BR)
How different is the management? Results from the brazilian acute coronary syndrome registry.
– L. Piegas, A. Avezum, H.P. Guimaraes, H.J.L. Reis, A.J. Muniz, E.S. Santos, P. Smith, J.R.Z. Mendes,
R. De Souza (São Paulo, Belém do Pará and Juiz de Fora, BR)
Clinical predictors of ten-year event-free survival after myocardial infarction.
– G. Berton, R. Cordiano, R. Palmieri, G.L. Guarnieri, C. Cavuto, A. Cati, F. Gidoni Guarnieri, G. Preti, R. De
Toni, P. Palatini (Conegliano, Adria, Bassano and Padua, IT)
Long-term outcomes and glucometabolic status in non-diabetic patients with acute myocardial infarction.
– L. David, A. Grosu (Chisinau, MD)
P4904
P4905
P4906
P4907
P4908
P4909
P4910
P4911
P4912
P4913
P4914
P4915
P4916
P4917
P4918
P4919
TREATMENT OF HYPERTENSION (QR 30613*)
Long-term effects of music therapy on patients with hypertension and acute myocardial infarction after
previous revascularization; 9-year experience.
– P.M. Mitrovic, Z. Vasiljevic, B. Stefanovic, A. Paladin, M. Radovanovic, N. Radovanovic, D. Rajic, G. Matic,
T. Jozic, A. Novakovic (Belgrade, RS)
The combination of drug and CPAP - therapy of the patients with II - III stage arterial hypertension and a
high degree of cardiovascular risk.
– Y.E.A. Pavlyuk, Y.U.N. Sirenko, Y.U.N. Pogoretskiy, O.L. Recovets (Kiev, UA)
Antihypertensive and metabolic effects of perindopril/amlodipine in hypertensives with coronary artery
disease: results of the perindopril/amlodipine reducing blood pressure level study (PEARL study).
– V.L. Nagy, E. Lantos, N. Habony (Budapest, HU)
Long term effect of continuous positive airway pressure on hypertension control in patients with
obstructive sleep apnea: A 3 year follow-up study.
– A. Kasiakogias, C. Tsioufis, C. Thomopoulos, L. Lioni, D. Aragiannis, K. Kintis, M. Almyroudi, M. Alchanatis,
I. Kallikazaros, C. Stefanadis (Athens, GR)
Prognosticators of left ventricular mass regression in hypertensive patients: a prospective study.
– E. Andrikou, C. Tsioufis, C. Thomopoulos, I. Andrikou, N. Alexopoulos, I. Bafakis, M. Poulakis,
D. Aragiannis, D. Syrseloudis, C. Stefanadis (Athens, GR)
*Abstracts can
be accessed at:
296
QR 30613
P4920
P4921
P4922
P4923
P4924
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
P4925
P4926
P4927
P4928
P4929
P4930
P4931
P4932
P4933
P4934
P4935
P4936
P4937
P4938
P4939
P4940
TUESDAY – AFTERNOON
Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of
drug-resistant hypertension.
– H. Ahmed, P. Neuzil, J. Skoda, J. Petru, L. Sediva, S. Kralovec, V.Y. Reddy (New York, US; Prague, CZ)
Gene Expressions of Angiotensin II Receptor Type 1A and Angiotensin Converting Enzyme in
Spontaneously Hypertensive Rats after Losartan Treatment.
– K.C. Kim, M.S. Cho, Y.M. Hong (Seoul, KR)
Treatment by ACE inhibitors of an arterial hypertension at patients with hepatic pathologies.
– I. Komissarenko, I.A. Komissarenko, O.M. Mikheyeva, L.B. Lazebnik (Moscow, RU)
Short-term effects of percutaneous renal denervation on central hemodynamics and aortic stiffness: a
prospective evaluation.
– M. Reppel, K.F. Franzen, F. Himmel, S. Gisch, T. Graf, F. Bode, H. Schunkert, J. Weil, K. Mortensen
(Lübeck, DE)
Pre-clinical experience with a next-generation system for prolonged baroreflex activation.
– T.E. Lohmeier, K. Ludwig, R.S. Kieval (Jackson and Minneapolis, US)
Treatment of hypertension in the elderly - data from an international cohort of hypertensives treated by
cardiologists.
– F. Mahfoud, M. Thoenes, M. Böhm, B.V. Khan, W. Kirch, L. Thevasthasan, P. Bramlage (Homburg,
Dresden and Mahlow, DE; Atlanta and New York, US)
The influence of antihypertensive treatment on arterial stiffness and arterial wall shear stress.
– M. Rajzer, W. Wojciechowska, M. Klocek, K. Kawecka-Jaszcz (Krakow, PL)
Cancer risk not increased by RAAS blockade - real world population study in Taiwan.
– P. Pai, C.H. Muo, P.C. Chen, Y.T. Lee (Taichung, TW)
Preventive effects of valsartan on stroke are emphasized in patients without treatment of calcium
channel blockers: sub-analysis of KYOTO HEART study.
– H. Yamada, T. Sawada, M. Koide, J. Shiraishi, H. Matsubara (Kyoto, JP)
Effect of spironolactone treatment on microalbuminuria and proteinuria in patients with resistant arterial
hypertension: insights from the ASPIRANT trial.
– E. Kocianova, J. Vaclavik, R. Sedlak, M. Plachy, K. Navratil, J. Plasek, J. Jarkovsky, T. Vaclavik, R. Husar,
M. Taborsky (Olomouc, Prostejov, Brno, Ostrava, Prague and Hranice na Morave, CZ)
Effects of azelnidipine on single cardiomyocyte mechanics.
– G. Iribe, K. Kaihara, H. Ito, K. Naruse (Okayama, JP)
Daily physical activity and blood pressure control in hypertensive patients followed in primary care
centers in Chile.
– M. Bravo, C.X. Romero, T. Romero, E. Koch, D. Sandoval, M. Cano, I. Ahlers, O. Henriquez, A.I.J. Gajardo
(Santiago, CL; San Diego, US)
Blood pressure reduction in diabetic patients with cardio-renal complications. Results from the 3A
registry.
– M.V. Lehmann, R. Dechend, E. Kaiser, E. Deeg, J. Senges, U. Zeymer, R.E. Schmieder (Erlangen, Berlin,
Nuremberg and Ludwigshafen, DE)
Favorable effect of angiotensin receptor blockers compared to calcium blockers on exercise-induced
inflammatory and coagulative response.
– C. Liakos, G. Vyssoulis, A. Michaelides, E. Chatzistamatiou, G. Theodosiades, M. Toutouza, C. Tsioufis,
A. Miliou, M. Markou, C. Stefanadis (Athens, GR)
Trends in hypertension prevalence, control and guidelines implementation in Spain through last decade.
– A. Cordero, V. Bertomeu-Martinez, P. Mazon, L. Facila, J. Cosin, V. Bertomeu-Gonzalez, M. Rodriguez,
E. Galve, I. Lekuona, J.R. Gonzalez-Juanatey (Alicante, Santiago de Compostela, Castellón, Valencia,
Pamplona, Barcelona and Bilbao, ES)
Pharmacological instrument for the genetically determined arterial hypertension treatment.
– O. Zabela, V. Shylau, E. Fedulova, O. Kardash, N. Nadina, T. Krasnenkova, E. Shafranovskaya (Minsk, BY)
Ace2 enzyme, that breaks down angiotensin I and angiotensin II, shows increased activity in patients with
treated hypertension.
– M. Fagyas, K. Uri, I. Manyine Siket, I. Edes, Z. Papp, A. Toth (Debrecen, HU)
P4941
TRANSCATHETER AORTIC VALVE IMPLANTATION – IMAGING (QR 30614*)
Implications of aortic valve calcification for paravalvular aortic regurgitation post-transcatheter aortic
valve implantation.
– S.H. Ewe, A.C.T. Ng, J.D. Schuijf, F. Van Der Kley, A. Colli, A. De Weger, N.A. Marsan, M.J. Schalij,
J.J. Bax, V. Delgado (Leiden, NL; Badalona, ES)
Transfemoral aortic valve implantation: new criteria to predict vascular complications.
– K. Hayashida, T. Lefevre, B. Chevalier, T. Hovasse, M. Romano, P. Garot, D. Mylotte, J. Uribe, B. Cormier,
M.C. Morice (Massy and Quincy, FR)
Clinical and echocardiographic predictors of paravalvular aortic regurgitation after implantation of
CoreValve aortic valve prosthesis.
– M. Crespin-Crespin, D. Mesa Rubio, M. Ruiz Ortiz, M. Delgado Ortega, M.C. Leon Del Pino, J. Suarez De
Lezo Cruz-Conde, M. Pan Alvarez-Ossorio, D. Garcia Fuertes, J. Suarez De Lezo Herreros De Tejada,
F. Mazuelos Bellido (Córdoba, ES)
*Abstracts can
be accessed at:
P4942
P4943
P4944
QR 30614
297
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
The Doppler-based renal resistive index predicts acute kidney injury in patients after transcatheter aortic
valve implantation.
– J.-M. Sinning, V. Adenauer, H. Steinhaeuser, A. Ghanem, C. Hammerstingl, E. Grube, G. Nickenig,
N. Werner (Bonn, DE)
Incidence of peri-procedural ischemic brain lesions in cerebral MRI: comparison of transcatheter aortic
valve implantation and conventional aortic valve replacement.
– M.B. Arnold, S. Ensminger, S. Ott, S. Achenbach, 0. Roerick, R. Feyrer, A. Doerfler, W.G. Daniel,
M. Weyand, J. Ludwig (Erlangen, DE)
Prediction of aortic annulus plane angulation and C-arm positioning by 3D analysis of pre-procedural
multislice computed tomography: benefit on safety outcome in patients referred for TAVI.
– M. Samim, P.R. Stella, J. Kluin, F. Ramjankhan, R.P.J. Budde, P. Agostoni, G. Sieswerda, L. Van
Herwerden, P.A.F.M. Doevendans, E. Van Belle (Utrecht, NL; Lille, FR)
TAVI operator radiation dose compared to PCI and ICD operators: do we need additional radiation
protection for trans-catheter structural heart interventions.
– M. Drury-Smith, A. Maher, C. Douglas-Hill, R. Singh, M. Bhabra, J. Cotton, S. Khogali (Wolverhampton, GB)
Intracardiac echocardiography: a new guiding tool for transcatheter aortic valve implantation.
– T. Bartel, N. Bonaros, G. Friedrich, L. Mueller, S. Mueller (Innsbruck, AT)
Validation and characterization of Doppler-echocardiographic measures of prosthetic valve effective area
following transcatheter aortic implantation.
– M.-A. Clavel, J. Rodes-Cabau, S. Bergeron, E. Dumont, R. Bagur, R. De Larochelliere, D. Doyle,
J. Lemieux, J.G. Dumesnil, P. Pibarot (Quebec, CA)
Predictive factors of aortic regurgitation after transcatheter aortic valve implantation: a 2D- and
3D-transoesophageal echocardiographic study in 135 patients.
– P. Gripari, M. Muratori, N. Ajmone Marsan, S. Hooi Ewe, C.T. Arnold, F. Van Der Kley, M. Fusari, J.J. Bax,
G. Tamborini, M. Pepi (Milan, IT; Leiden, NL)
Choice of CoreValve prosthesis size in case of disagreement between echocardiography and computed
tomography: impact on procedural and 1-year results.
– M. De Carlo, G. Benedetti, M. Schlueter, C. Giannini, C. Nardi, M. Coceani, F. Guarracino, P. Marraccini,
A.S. Petronio (Pisa, IT)
Multimodality imaging in transcatheter aortic valve implantation and post-procedural outcome:
comparison between cardiovascular magnetic resonance, cardiac computed tomography and
echocardiography.
– A. Jabbour, T. Ismail, A. Gulati, I. Roussin, F. Alpendurada, S. Davies, M. Mullen, M. Rubens, N. Moat,
R. Mohiaddin (London, GB)
3-mensio software for the measurement of the aortic annulus before TAVI: agreement with multi-slice
tomography and with echocardiography.
– M. De Carlo, G. Benedetti, M. Schlueter, C. Giannini, M. Coceani, M.G. Delle Donne, F. Guarracino,
P. Marraccini, A.S. Petronio (Pisa, IT)
Right ventricular function deteriorates after surgical aortic valve replacement but not after transcatheter
aortic valve implantation.
– A. Kempny, G.-P. Diller, S. Orwat, G. Kaleschke, G. Kerckhoff, R. Schmidt, J. Mascherbauer, H. Reinecke,
H. Baumgartner (Münster, DE)
Longitudinal left ventricular 2D strain is a strong predictor of myocardial recovery and symptomatic
improvement after transcatheter aortic valve implantation.
– A. Kempny, G.-P. Diller, S. Orwat, G. Kaleschke, G. Kerckhoff, S. Schmidt, J. Mascherbauer, H. Reinecke,
H. Baumgartner (Münster, DE)
Value of 3d-echocardiography in patient selection prior to implantation of a corevalve-prosthesis.
– R. Schueler, M. Weber, D. Momcilovic, A. Ghanem, J.M. Sinning, N. Werner, G. Nickenig, C. Hammerstingl
(Bonn, DE)
Impact of severe left ventricular systolic dysfunction on clinical and echocardiographic outcomes
following transcatheter aortic valve implantation for severe aortic stenosis.
– C. Fiorina, M. De Carlo, G.P. Ussia, A. Ramondo, F. Maisano, S. Klugmann, F. Bedogni, C. Tamburino,
A.S. Petronio, F. Ettori (Brescia, Pisa, Catania, Padua and Milan, IT)
Aortic leaflet calcification and annulus dimensions on contrast MSCT predict the need for balloon
post-dilatation during TAVI.
– C.J. Schultz, A. Rossi, N. Van Mieghem, L. Papodopoulou, R. Van Domburg, A. Moelker, R. Van Geuns,
K. Nieman, P.W. Serruys, P.P.T. De Jaegere (Rotterdam, NL)
Impact of three dimensional transesophageal echocardiography on prosthesis sizing for transcatheter
aortic valve implantation.
– O. Husser, S. Rauch, M. Resch, J. Nunez, V. Bodi, M. Hilker, C. Schmid, G.A.J. Riegger, A. Luchner,
C. Hengstenberg (Regensburg, DE; Valencia, ES)
Anatomical constraints in transcatheter aortic valve implantation: really a limitation in patient treatment?
– O. Sousa, D. Caeiro, M. Carvalho, J. Rocha, D. Leite, N. Bettencourt, J. Ribeiro, A. Albuquerque,
L. Simoes, V. Gama (Vila Nova de Gaia, PT)
Valvulo-arterial impedance (Zva): a new index of global hemodynamic load in the evaluation of severe
aortic stenosis treated by transcutaneous aortic valve prosthetic implantation (Corevalve).
– C. Giannini, C. Cucco, A.I. Corciu, M.G. Delle Donne, V. Barletta, M. De Carlo, F.L. Dini, M. Marzilli,
A.S. Petronio, V. Di Bello (Pisa, IT)
298
P4945
P4946
P4947
P4948
P4949
P4950
P4951
P4952
P4953
P4954
P4955
P4956
P4957
P4958
P4959
P4960
P4961
P4962
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
TRANSCATHETER AORTIC VALVE IMPLANTATION – CLINICAL (QR 30615*)
*Abstracts can
be accessed at:
P4963
P4964
P4965
P4966
P4967
P4968
P4969
P4970
P4971
P4972
P4973
P4974
P4975
P4976
TUESDAY – AFTERNOON
Transcatheter aortic valve implantation: impaired kidney function is an important predictor for survival
and quality of life. Results from the German aortic valve interventions registry.
– S. Sack, G.C. Schuler, H. Sievert, R. Hambrecht, K.E. Hauptmann, C. Naber, U. Gerckens, R. Zahn,
E. Grube, J. Senges (Munich, Leipzig, Frankfurt, Bremen, Schweinfurt, Essen, Siegburg, Ludwigshafen am
Rhein and Ludwigshafen, DE)
Role of inflammation and reactive oxygen species in Acute Kidney Injury (AKI) after Transcatheter Aortic
Valve Implantation (TAVI).
– R. Dworakowski, O. Wendler, A.M. Bhan, E. Alcock, J. Byrne, B. Brickham, T. Dew, A.M. Shah,
P. MacCarthy (London, GB)
Incidence and outcome of Paravalvular Aortic Regurgitation (PAR) after transfemoral aortic valve
implantation (TAVI).
– P.C. Patsalis, F. Al-Rashid, M. Riebisch, B. Plicht, D. Wendt, M. Thielmann, H. Jakob, H. Eggebrecht,
R. Erbel, P.H. Kahlert (Essen and Frankfurt, DE)
Transcatheter aortic valve implantation via direct aortic approach: initial clinical experience with this
novel approach.
– M. Chan, C. Di Mario, S.W. Davies, F. Azeem, R. Trimlett, N. Moat (London, GB)
Frequency and predictors of acute kidney injury, and its impact on outcome after transcatheter aortic
valve implantation.
– K. Gebauer, M. Meyborg, N. Malyar, G. Kerkhoff, G. Kaleschke, H. Baumgartner, H. Reinecke (Münster, DE)
The burden of not treating patients with severe aortic stenosis: comparison of secondary care resource
consumption in TAVI versus medical management cohort of 30 patients in a UK NHS setting.
– M. Cook, P. Brasseur, R. Busca (Watford, GB; Tolochenaz, CH)
Previous heart surgery does not influence the outcome of Transcatheter Aortic Valve Implantation (TAVI)
patients: results of the German registry on TAVI.
– M. Kasel, M. Horack, G.C. Schuler, K.-H. Kuck, U. Sechtem, H.G. Richardt, S. Sack, R. Zahn, J. Senges,
E. Hoffmann (Munich, Ludwigshafen, Leipzig, Hamburg, Stuttgart and Bad Segeberg, DE)
Quality of life dynamics after transcatheter aortic valve implantation.
– M. Krane, M.A. Deutsch, N. Piazza, T. Muhtarova, E. Yacine, D. Mazzitelli, B. Voss, H. Ruge, S. Bleiziffer,
R. Lange (Munich, DE)
Non-responding to transcatheter aortic valve implantation: impact of mitral valve regurgitation and left
atrial enlargement on symptomatic benefit.
– M. Gotzmann, W. Bojara, M. Lindstaedt, A. Ewers, A. Germing, A. Muegge (Bochum, DE)
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe
aortic stenosis.
– M. Barbanti, G.P. Ussia, D. Capodanno, P. Aruta, A.M. Pistritto, V. Cammalleri, M. Scarabelli, G. Del
Campo, C. Mignosa, C. Tamburino (Catania, IT)
Hemodynamic results after TAVI: up to 3 years follow-up of 338 patients after corevalve implantation.
– A. Opitz, I. Hettich, A. Hutter, S. Bleiziffer, H. Ruge, N. Piazza, D. Mazzitelli, R. Lange (Munich, DE)
Transcatheter aortic valve implantation: economic evaluation of the FRANCE (FRench Aortic National
Corevalve and Edwards) registry.
– K. Chevreul, M. Brunn, B. Cadier, I. Durand-Zaleski, A. Pavie, P. Gueret (Paris and Créteil, FR)
Acute results and late outcomes of transcatheter aortic valve implantation according to the valve
academic research consortium classification: results of the prospective single centre Rouen registry.
– B. Borz, E. Durand, M. Godin, C. Tron, C. Sanchez Giron, P.Y. Litzler, J.P. Bessou, A. Cribier,
H. Eltchaninoff (Rouen, FR)
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year
clinical outcome.
– F. Saia, C. Ciuca, C. Marrozzini, N. Taglieri, C. Moretti, C. Savini, E. Pilato, F. Petridis, R. Di Bartolomeo,
A. Marzocchi (Bologna, IT)
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual
treatment.
– F. Saia, C. Ciuca, C. Marrozzini, T. Palmerini, N. Taglieri, C. Moretti, B. Bordoni, G. Dall’ara, A. Branzi,
A. Marzocchi (Bologna, IT)
Transcatheter aortic valve implantation: 1 year follow-up and predictors of mortality. Data from a
multi-centre real world registry.
– R. Zahn, G.C. Schuler, H. Sievert, R. Erbel, R. Hambrecht, G. Nickenig, K.E. Hauptmann, S. Sack,
J. Senges, U. Gerckens (Ludwigshafen am Rhein, Leipzig, Frankfurt, Essen, Bremen, Bonn, Trier, Munich,
Ludwigshafen and Siegburg, DE)
Transcatheter aortic valve implantation: a new therapeutic option in patients with degenerated aortic
bioprostheses? Results from the German aortic valve interventions registry.
– R. Zahn, T. Bauer, G.C. Schuler, H. Sievert, P. Kahlert, R. Hambrecht, G. Nickenig, K.E. Hauptmann,
C.H. Naber, U. Gerckens (Ludwigshafen am Rhein, Leipzig, Frankfurt am Main, Essen, Bremen, Bonn, Trier
and Siegburg, DE)
Transcatheter aortic valve implantation versus balloon valvuloplasty - periprocedural outcome data from
the German-TAVI Registry.
– R. Hein, R. Zahn, M. Horack, U. Gerckens, H. Sievert, K.-H. Kuck, R. Hambrecht, H. Ince, J. Senges,
H. Mudra (Munich, Ludwigshafen, Bonn, Frankfurt am Main, Hamburg, Bremen and Rostock, DE)
P4977
P4978
P4979
P4980
QR 30615
299
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Transcatheter aortic valve implantation in low-gradient aortic stenosis: results from the german
transcatheter aortic interventions-registry.
– A. Lauten, M. Ferrari, C. Jung, R. Zahn, H. Sievert, A. Linke, E. Grube, S. Sack, J. Senges, H.R. Figulla
(Jena, Ludwigshafen am Rhein, Frankfurt, Leipzig, Siegburg and Munich, DE)
Transcatheter aortic valve implantation for severe symptomatic aortic stenosis: results in patients with
porcelain aorta.
– R. Zahn, G.C. Schuler, H. Sievert, R. Erbel, R. Hambrecht, G. Nickenig, K.E. Hauptmann, C.H. Naber,
S. Sack, U. Gerckens (Ludwigshafen am Rhein, Leipzig, Frankfurt am Main, Essen, Bremen, Bonn, Trier,
Munich and Siegburg, DE)
Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of
triple-therapy.
– U. Zeymer, R. Zahn, U. Gerckens, G. Richard, H.R. Figulla, J. Senges (Ludwigshafen am Rhein, Siegburg,
Bad Segeberg and Jena, DE)
Incidence of corevalve dislocation - a single-center experience.
– F. Al-Rashid, P. Patsalis, H. Eggebrecht, B. Plicht, T. Konorza, D. Wendt, M. Thielmann, H. Jakob, R. Erbel,
P.H. Kahlert (Essen, DE)
Patient prosthesis mismatch after transfemoral TAVI: survival in 12 month follow up.
– H. Westhoelter, P. Kahlert, F. Al-Rashid, T.F.M. Konorza, R. Erbel, B. Plicht (Essen, DE)
Learning curve of transcatheter aortic valve implantation: trends in mortality over the years.
– P. Salinas, R. Moreno, L. Calvo, D. Dobarro, G. Galeote, S. Jimenez-Valero, A. Sanchez-Recalde,
A. Alvarez, I. Plaza, J. Lopez-Sendon (Madrid, ES)
Prosthesis performance and outcome of transcatheter aortic valve implantation: a single center
experience.
– V. Gasparetto, M. Napodano, A. D’onofrio, C. Fraccaro, G. Tarantini, D. Pittarello, R. Bianco, G. Gerosa,
S. Iliceto, G. Isabella (Padua, IT)
Bleeding risk factors in transcatheter aortic valve implantation (TAVI) patients.
– J. Stepinska, K. Czerwinska, A. Witkowski, M. Dabrowski, M. Banaszewski, P. Michalek, Z. Chmielak,
K. Kusmierski, T. Hryniewiecki, M. Demkow (Warsaw, PL)
Periprocedural bleeding predicts outcome after transcatheter aortic valve implantation (TAVI).
– B.P. Halliday, R. Dworakowski, B. Brickham, O. Wendler, P. MacCarthy (London, GB)
Conduction abnormalities after balloon valvuloplasty predict permanent pacemaker requirement in
transcatheter aortic valve implantation.
– D. John, S. Hausen, G. Latsios, S. Yuecel, H.-C. Eberle, M. Farazandeh, U. Gerckens, E. Grube, O. Bruder,
C.K. Naber (Essen, Bonn and Siegburg, DE)
Invasive assessment of atrioventricular conduction changes following transcatheter aortic valve
implantation with self-expandable or balloon-expandable prosthesis.
– A. Rollin-Garderes, N. Dumonteil, P. Mondoly, B. Marcheix, A. Duparc, N. Boudou, D. Tchetche,
P.H. Maury, M. Delay, D. Carrie (Toulouse, FR)
Gender differences in clinical presentation and outcome of transcatheter aortic valve implantation for
severe aortic stenosis.
– K. Hayashida, M.C. Morice, B. Chevalier, T. Hovasse, M. Romano, P. Garot, B. Cormier, T. Lefevre (Massy
and Quincy, FR)
Success of transcatheter aortic valve implantation (TAVI) according to standardized outcome definitions
by the valve academic research consortium (VARC).
– B.E. Stahli, R. Bunzli, J. Grunenfelder, D. Bettex, D.L. Nguyen-Kim, V. Falk, T.F. Luscher, R. Corti,
W. Maier, L. Altwegg (Zurich, CH)
Transcatheter aortic valve implantation with the Edwards valve prosthesis in patients with low (<20%)
logistic euroscore: results of a prospective single center registry.
– M. Godin, B. Borz, C. Tron, E. Durand, F. Doguet, P.-Y. Litzler, J.-P. Bessou, A. Cribier, H. Eltchaninoff
(Rouen, FR)
Impact of mitral regurgitation on outcome of transcatheter aortic valve implantation.
– A. D’onofrio, V. Gasparetto, M. Napodano, C. Fraccaro, V. Renier, G. Tarantini, D. Pittarello, S. Iliceto,
G. Isabella, G. Gerosa (Padua, IT)
Impact of prosthesis-patient mismatch on hemodynamic and clinical outcomes after transcatheter aortic
valve implantation with balloon-expandable valves.
– S.H. Ewe, V. Delgado, G. Tamborini, M. Muratori, M. Pepi, F. Van Der Kley, M. Fusari, P. Biglioli, J.J. Bax,
N.A. Marsan (Leiden, NL; Milan, IT)
Numerous patients fail the aortic annulus criteria in transcatheter aortic valve implantation - comparison
of current devices.
– D. John, S. Hausen, G. Latsios, S. Yuecel, H.-C. Eberle, M. Farazandeh, U. Gerckens, E. Grube,
C.K. Naber, O. Bruder (Essen, Bonn and Siegburg, DE)
P4981
P4982
P4983
P4984
P4985
P4986
P4987
P4988
P4989
P4990
P4991
P4992
P4993
P4994
P4995
P4996
P4997
HEART FAILURE – LEFT VENTRICULAR FUNCTION (QR 30616*)
Matrix metalloproteinase-1 is differently regulated in patients with heart failure and normal EF compared
to reduced EF: a trigger for cardiac dilation.
– D. Westermann, D. Lindner, C. Tschoepe, H.-P. Schultheiss (Berlin, DE)
*Abstracts can
be accessed at:
300
QR 30616
P4998
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
P4999
P5000
P5001
P5002
P5003
P5004
P5005
P5006
P5007
P5008
P5009
P5010
P5011
P5012
P5013
P5014
P5015
TUESDAY – AFTERNOON
High diastolic stiffness modifies sarcomeric structure in failing human cardiomyocytes.
– D. Czuriga, R.J.P. Musters, A. Borbely, I. Falcao-Pires, S.J.P. Bogaards, A.F. Leite-Moreira, Z. Papp, J. Van
Der Velden, G.J.M. Stienen, W.J. Paulus (Amsterdam, NL; Porto, PT; Debrecen, HU)
Left atrial reservoir function is reduced in diastolic heart failure in a compensated state.
– M. Obokata, S. Tange, H. Arima, N. Kobayashi, Y. Ono, J. Kuribara, G. Ui, M. Kurabayashi (Maebashi, JP)
Genetic predisposition in hypertension with normal ejection fraction to oxidative stress is greater than
that of controls and increases with the degree of left ventricular diastolic dysfunction.
– A. Fazakas, Z.S. Szelenyi, P. M Szabo, A. Patocs, M. Doleschall, I. Karadi, A. Vereckei (Budapest, HU)
Left ventricular diastolic dysfunction and cardiovascular autonomic neuropathy in type 2 diabetes
mellitus.
– C.J. Magri, A. Cassar, S. Fava, A. Fenech (Msida, MT)
Left atrial diastolic dysfunction: an unrecognized cause of pulmonary venous hypertension.
– H. Kadakia, S. Channah, J.T. Heywood, A. Johnson, M. Smith, T. Khan (San Diego, US)
Efficacy and safety of ivabradine in hemodialysed patients with diastolic heart failure.
– G. Cice, S. D’isa, A. D’Andrea, G. Rosano, M.G. Russo, R. Calabro (Naples and Rome, IT)
Serum cystatin C is associated with diastolic dysfunction and altered collagen metabolism in
hypertensive patients with heart failure.
– A. Gonzalez Miqueo, A. Huerta, B. Lopez Salazar, O. Beloqui, J. Diez (Pamplona, ES)
Coordinated changes in titin phosphorylation increase myofilament stiffness in failing hearts.
– M. Krueger, L. Gout, M. Von Frieling-Salewsky, S. Koetter, W.A. Linke (Bochum, DE)
In patients with heart failure and normal ejection fraction, integrated backscatters are markers of
diastolic function.
– B. D’here, D. Stepowski, C. Vallet, B. Kurtz, J. Caudron, J.N. Dacher, V. Richard, M. Vasse, H. Eltchaninoff,
F. Bauer (Rouen, FR)
Association between neurohormonal activation and submaximal exercise capacity in patients with
diastolic dysfunction and diastolic heart failure.
– A. Duvinage, R. Stahrenberg, G. Gelbrich, G. Hasenfuss, R. Wachter, B. Pieske, F. Edelmann (Göttingen
and Leipzig, DE; Graz, AT)
Prolonged diastolic vortex duration in heart failure with preserved ejection fraction.
– T.T. Le, F. Huang, R.S. Tan (Singapore, SG)
Left atrial volume index has more accuracy than left atrial diameter index for the diagnosis of heart failure
with normal ejection fraction in outpatients.
– A.J. Lagoeiro Jorge, M.L. Ribeiro, M.L.G. Rosa, F.V. Licio, L.C.M. Fernandes, P.G. Lanzieri, B.A.L. Jorge,
E.T. Mesquita (Niterói and Rio de Janeiro, BR)
Elevated mid-region pro-adrenomedullin is associated with increased mortality in stable outpatients with
diastolic dysfunction.
– Y. Xue, P. Taub, A. Fard, N.M. Iqbal, H. Nguyen, P. Clopton, A.S. Maisel (San Diego, US)
The effect of Losartan plus Hydrochlorothiazide combination therapy on left ventricular diastolic function
in patient with hypertension: EDEN Multicenter Trial.
– K. Ishii, H. Ito, H. Kihara, H. Watanabe, K. Shimada, K. Iwakura, J. Yoshikawa (Osaka, Okayama,
Asahikawa, Tokyo and Nishinomiya, JP)
Anemia and mortality in patients with heart failure associated with preserved LV ejection fraction in
Korean acute heart failure registry.
– J.E. Kim, S.M. Kim, S.Y. Lee, J.W. Bae, K.K. Hwang, D.W. Kim, M.C. Cho (Cheongju, KR)
What distinguishes restrictive cardiomyopathy from heart failure with preserved ejection fraction?
– S. Schwartzenberg, A. From, R.A. Nishimura, P. Sorajja, M. Redfield, B. Borlaug (Rehovot, IL; Rochester,
US)
Regional strain imaging diastolic index changes differently in patients with CAD or hypertension.
– K.G. Adamyan, A.L. Chilingaryan (Yerevan, AM)
Relationship of left ventricular diastolic function and sympathetic innervation in patients with dilated
cardiomyopathy.
– A. Patrianakos, C. Goudis, E. Nyktari, G. Solidakis, S. Koukouraki, N. Karkavitsas, P.E. Vardas (Heraklion,
GR)
Arterial properties for the diagnosis of diastolic heart failure.
– T. Weber, A. Haiden, M. Ammer, M. Rammer, V. Riegelnik, R. Zweiker, B. Eber (Wels and Graz, AT)
Epicardial fat is a determinant of diastolic dysfunction.
– J.L. Cavalcante, B.K. Tamarappoo, D.H. Kwon, C. Alraies, S. Halliburton, D. Dey, D.S. Berman,
T.H. Marwick (Cleveland and Los Angeles, US)
Left atrial mechanical function at rest and during dobutamine stress in healthy young and elderly subjects
as evaluated by cardiac magnetic resonance - a study of left ventricular compliance.
– K.A. Ahtarovski, N.G. Vejlstrup, K.K. Iversen, J.T. Loenborg, T. Engstroem (Copenhagen, DK)
Analysis of circulating glycosylated N-terminal-proBNP and nonglycosylated N-terminal proBNP in
patients with heart failure (HF) and chronic renal failure (CRF) on hemodialysis.
– T. Nishikimi, M. Ikeda, Y. Takeda, T. Ishimitsu, N. Minamino, K. Kuwahara, Y. Nakagawa, H. Kinoshita,
K. Nakao (Kyoto, Tochigi and Osaka, JP)
Relationship between amino-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume
index in older subjects at risk of heart failure.
– J.M. Coller, M. McGrady, C. Reid, B. Boffa, D. Liew, S. Stewart, R. Wolfe, H. Krum, D.J. Campbell,
D.L. Prior (Melbourne, AU)
Left atrial longitudinal strain by speckle tracking echocardiography correlates well with NT-proBNP levels
in patients admitted to the cardiac intensive care unit.
– M. Cameli, E. Palmerini, M. Lisi, E. Bennati, R. De Vito, R. Favilli, S. Mondillo (Siena, IT)
P5016
P5017
P5018
P5019
P5020
P5021
P5022
301
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases bioactive BNP level with the improvement of left
ventricular mass index in patients with chronic heart failure.
– T. Tsutamoto, H. Sakai, C. Kawahara, M. Fujii, M. Yamaji, M. Ohnishi, T. Matsumoto, A. Wada,
T. Yamamoto, M. Horie (Inugami, Otsu and Kusatsu, JP)
Reference intervals for C-type natriuretic peptide plasma levels in healthy newborns and infants.
– M. Cabiati, M. Cantinotti, C. Caselli, S. Storti, N. Assanta, T. Prescimone, B. Murzi, D. Giannessi, S. Del Ry
(Pisa, IT)
Adiponectin and brain natriuretic peptide relationship in newborns, infants and children.
– C. Caselli, M. Cantinotti, M. Cabiati, S. Storti, T. Prescimone, N. Assanta, B. Murzi, S. Del Ry, D. Giannessi
(Pisa and Siena, IT)
Chronic hypoxemia and acute exercise-induced changes in oxygenation do not have a clinically relevant
impact on circulating concentrations of B-type natriuretic peptides.
– M. Zurek, M.T. Maeder, M. Brutsche, C.H. Mueller (Zurich, St. Gallen and Basel, CH)
The impact of n terminal pro natriuretic peptide (NT pro BNP) on number needed to screen for heart
failure by echocardiography. Prospective observational comparative study.
– M. Al Barjas, R. Morris, D. Nair, J. Davar (London, GB)
Relationship between ACE-2 activity, infarct size and left ventricular systolic function following STEMI.
– J. Ortiz, M. Riera, X. Bosch, T. De Caralt, R.J. Perea, J. Pascual, M.J. Soler (Barcelona, ES)
The effect of renal function on brain natriuretic peptide and N-terminal pro brain natriuretic peptide
levels, and their correlation.
– H. Takase, Y. Dohi, T. Toriyama, T. Okado, H. Sonoda, A. Hagikura, G. Kimura (Hamamatsu and Nagoya,
JP)
Comparative study on the severity of heart failure based on NYHA heart failure classification and the
levels of NT-proBNP, BNP and (NT-proBNP/BNP in pmol/L).
– T. Shimada, T. Sumiyoshi, S. Sasaki, M. Nagayama, T. Tobaru, O. Doi, H. Kambara (Shizuoka and Tokyo,
JP)
Simultaneous determination of plasma levels and cardiac expression of CNP in end-stage heart failure
patients undergoing left ventricular assist devices.
– M. Cabiati, R. Caruso, C. Caselli, C. Baroni, T. Prescimone, M. Frigerio, D. Giannessi, S. Del Ry, O. Parodi
(Pisa and Milan, IT)
Short term effects of cardiac resynchronization therapy on inflammatory and neurohormonal markers.
– A. Kusiak, J. Wilinski, D. Czarnecka, W. Wojciechowska, B. Bacior, M. Jastrzebski, T. Sondej, A. Przybyla,
M. Kocowska, K. Kawecka-Jaszcz (Krakow, PL)
Six minute walk test reflects neurohormonal activation in systemic sclerosis patients.
– K. Irzyk, M. Ciurzynski, P. Bienias, Z. Rymarczyk, M. Kostrubiec, A. Szewczyk, M. Siwicka,
B. Bartoszewicz, U. Demkow, P. Pruszczyk (Warsaw, PL)
Increased levels of fibroblast growth actor 23 (FGF23) in chronic heart failure patients.
– D. Gruson, S. Goletti, S. Ahn, M.F. Rousseau (Brussels, BE)
Sympathetic overactivation in dilated phase of hypertrophic cardiomyopathy.
– R. Ushijima, S. Joho, Y. Oda, D. Harada, T. Hirai, H. Asanoi, H. Inoue (Toyama and Imizu, JP)
Brain natriuretic peptide and renal dysfunction: cardio-renal interactions in patients with acute heart
failure.
– A.-G. Fruntelata, O.F. Tautu, M. Merisor, G. Calcaianu, S. Andrei, G. Stefan, M.C. Greavu, M. Dorobantu
(Bucharest, RO)
Clinical, echocardiographic and neurohormonal response to cardiac resynchronization therapy: are they
interchangeable?
– G.E. Hoogslag, U. Hoke, H.F. Verwey, J. Thijssen, D. Auger, N. Ajmone Marsan, E.E. Van Der Wall,
M.J. Schalij, J.J. Bax, V. Delgado (Leiden, NL)
Statin treatment reduces early cardiac inflammatory infiltration and apoptosis and prevents progression
in the long term.
– T.J. Fang, C.C. Fang, K.S. Lin (Taipei, TW)
Prognostic value of exercise-induced left ventricular systolic dysfunction in hypertensive patients with no
angiographic evidence of coronary artery disease.
– O. Prada-Delgado, E. Barge-Caballero, J. Peteiro, A. Bouzas-Mosquera, E. Mendez-Eirin, A. Lopez-Sainz,
G. Barge-Caballero, R. Estevez-Loureiro, M. Crespo-Leiro, A. Castro-Beiras (A Coruña, ES)
Desmin expression and mitochondrial changes in heart muscle from patient with idiopathic dilated
cardiomyopathy.
– A. Pawlak, A. Nasierowska-Guttmajer, A. Karkucinska-Wieckowska, E. Czarnowska, R.J. Gil (Warsaw, PL)
Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure introduction and use of the volume-based wall stress index.
– P. Alter, H. Rupp, F. Stoll, P. Adams, M.B. Rominger, B. Maisch (Marburg, DE)
Diagnosis of heart failure in a primary health care center: usefulness of Framingham clinical criteria, ECG
and NT-proBNP.
– J.M. Verdu, J. Comin-Colet, M. Domingo, J. Lupon, S. Fuentes, A. Mena, J.M. Baena, M.A. Munoz,
J.M. Casacuberta, J. Bruguera (Barcelona, Badalona and Santa Coloma de Gramanet, ES)
Pathophysiology of asymptomatic left ventricular dysfunction in systemic sclerosis.
– C. Carmona-Henryon, F. Thuny, F. Schnell, L. Potton, C. Bergerot, L. Ernande, H. Rafi, M. Ovize,
P. Croisille, G.A. Derumeaux (Lyon, Rennes and Clichy, FR)
Diagnostic value of rigid body rotation in noncompaction cardiomyopathy: a new objective and
quantitative functional diagnostic criterion.
– B.M. Van Dalen, K. Caliskan, O.I. Soliman, F. Kauer, H.B. Van Der Zwaan, W.B. Vletter, F.J. Ten Cate,
M.L. Geleijnse (Rotterdam, NL)
302
P5023
P5024
P5025
P5026
P5027
P5028
P5029
P5030
P5031
P5032
P5033
P5034
P5035
P5036
P5037
P5038
P5039
P5040
P5041
P5042
P5043
P5044
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Clinical characteristics and prognosis of patients with post-capillary reactive pulmonary hypertension
caused by left heart disease.
– S. Tatebe, Y. Fukumoto, K. Sugimura, K. Satoh, Y. Miura, K. Nochioka, S. Yamamoto, H. Shimokawa
(Sendai, JP)
Novel insights into the pathogenesis of cardiac fibrosis in the failing heart.
– D.M. Kaye, X.M. Gao, O. Khammy, Y. Zhang, J. Mariani, X.J. Du, M.T. Maeder (Melbourne, AU)
Novel biomarkers enhance diagnostic differentiation between acute heart failure and pulmonary disease
exacerbation in patients presenting with dyspnea.
– G.S. Filippatos, D. Farmakis, O. Hartmann, C. Mueller, W.F. Peacock, J. Parissis, N. Morgenthaler,
P. Ponikowski, S.A. Anker, A. Maisel (Athens, GR; Hennigsdorf and Berlin, DE; Basel, CH; Cleveland and
San Diego, US; Wroclaw, PL)
An easily applicable in everyday clinical practice diagnostic algorithm for the detection of iron deficiency
in heart failure.
– J. Terrovitis, E. Kaldara, A. Ntalianis, C. Kapelios, S. Sventzouri, S. Vakrou, N. Michelinakis, G. Sainis,
C. Matsouka, J. Nanas (Athens, GR)
Decreased circulating T regulatory cells are associated with chronic heart failure and secondary
pulmonary hypertension.
– L. Koller, S. Blum, M. Korpak, A. Hermann, G. Zorn, G. Maurer, J. Wojta, R. Pacher, M. Huelsmann,
A. Niessner (Vienna, AT)
Two-dimensional speckle tracking imaging detects early subendocardial fibrosis reflecting elevated wall
stress in Dahl salt-sensitive rat.
– T. Ishizu, Y. Seo, R. Koshizuka, Y. Kameda, T. Kimura, D. Xu, N. Murakoshi, S. Sakai, K. Aonuma
(Tsukuba, JP)
CD34+ and endothelial progenitor cells in patients with chronic heart failure.
– K.A. Khmelnitskaya, E.V. Shlyakhto (Saint Petersburg, RU)
Management of patients with systolic heart failure by cardiologists versus general practitioners in Poland:
do we implement ESC guidelines efficiently?
– E.A. Jankowska, B. Kurian, C. Zajaczkowski, W. Banasiak, P. Ponikowski (Wroclaw and Warsaw, PL)
Circulating levels of n-3 polyunsaturated fatty acids in patients with chronic heart failure. Data from the
GISSI-HF trial.
– R. Latini, S. Masson, M. Tacconi, R. Bernasconi, L. Dragani, V. Milani, M.G. Franzosi, R. Marchioli,
L. Tavazzi, G. Tognoni (Milan, Santa Maria Imbaro and Cotignola, IT)
P5045
P5046
P5047
P5048
P5049
P5050
P5051
P5052
P5053
ELECTROCARDIOGRAM: OLD FEATURES AND NEW TOOLS (QR 30617*)
*Abstracts can
be accessed at:
P5054
P5055
P5056
P5057
P5058
TUESDAY – AFTERNOON
Pacemaker-related endocarditis: clinical features and prognosis. Results of a large single center series
over a 24-year period (1987-2010).
– J.C. Castillo Dominguez, M. Anguita, M. Ruiz, D. Mesa, M. Delgado, E. Romo, A. Lopez-Granados,
J. Arizon, J. Suarez De Lezo (Córdoba, ES)
The contribution of paced QRS morphology to assessment of right ventricular pacing site.
– L. Kamenik, T. Hnatek, P. Sedlon, J. Skvaril, M. Cernohous, E. Krcova, M. Zavoral (Prague, CZ)
Apical pacing versus septal pacing in patients with atrial fibrillation and ejection fraction above 39%. We
still believe that apical pacing is the right choice?
– G. Vanerio, D. Banina, P. Fernandez Banizzi, L. Vidal (Montevideo, UY)
Permanent pacemaker implantation via the femoral vein: a safe alternative when pectoral approach is
contraindicated.
– J. Elduayen-Gragera, F. Diaz-Cortegana, A. Martinez-Naharro, S. Sanchez-Giralt, J.J. Garcia-Guerrero,
J. Fernandez De La Concha, A. Redondo, R. Alonso Gonzalez (Badajoz, ES)
AAI mode pacing in patients with sick sinus syndrome. 20 years follow-up data from a single Norwegian
non-university hospital.
– J.O. Kleinau, T. Graven, H. Dalen (Levanger and Trondheim, NO)
Efficacy of antitachycardia pacing in hypertrophic cardiomyopathy with implantable
cardioverter-defibrillators.
– C.H. Lee, S. Kim, H.O. Choi, K.H. Kim, G. Nam, K. Choi, Y. Kim (Seoul, KR)
Long term evolution of atrio-ventricular conduction in sinus dysfunction patients. Is AV block the only
clinical outcome?
– P. Mabo, A. Solnon, A. Tassin, R.P. Martins, L. Graindorge, J.P. Cebron (Rennes, Nantes, Angers and
Clamart, FR)
Use of a wearable cardioverter defibrillator among pre-partum pregnant women: an analysis of safety,
characteristics and outcomes.
– M. Saltzberg, S. Szymkiewicz, N. Bianco (Newark and Pittsburgh, US)
Increased risk of sudden death in patients with Medtronic sprint fidelis ICD lead.
– P. Palmisano, L. Nuzzi, M. Zaccaria, P. Guida, F. Nacci, M. Anaclerio, G. Luzzi, S. Favale (Bari, IT)
Use of implantable cardioverter defibrillator and cardiac resynchronization therapy in high-risk patients:
an Italian survey study on 220 cardiology departments.
– G. Inama, C. Pedrinazzi, M. Landolina, F. Oliva, M. Senni, A. Proclemer, M. Zoni Berisso (Crema, Pavia,
Milan, Bergamo, Udine and Genoa, IT)
P5059
P5060
P5061 (W)
P5062
P5063
QR 30617
303
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Minimizing ICD therapies: the ADVANCE III trial.
– M. Gasparini, A. Proclemer, A. Arenal, B. Lemke, M. Wijffels, J. De Sousa, M. Lunati, A. Okreglicki,
J.O. Schwab, E. Santi (Rozzano, Udine, Milan and Rome, IT; Madrid, ES; Ludenscheid and Bonn, DE;
Nieuwegein, NL; Lisbon, PT; Cape Town, ZA)
The long-term clinical outcomes of radiofrequency catheter ablation for inducible ventricular tachycardia
prior to implantation of cardioverter-defibrillator.
– H. Suenaga, S. Saito (Kamakura City, JP)
Tachycardia zone setting to avoid inappropriate shock in Brugada syndrome patients with implantable
cardioverter defibrillator.
– N. Nishii, H. Morita, M. Kubo, K. Nakagawa, M. Tanaka, M. Murakami, S. Nagase, K. Kusano, H. Itoh
(Okayama, JP)
Follow up of patients with automatic implantable cardioverter defibrillator without testing the
defibrillation threshold.
– M.E. Trucco, M. Arce, J. Palazzolo, F. Femenia (Mendoza, AR)
Shock waveform optimization improves defibrillation success in patients with single coil defibrillation
system.
– J. Gabriels, A.S. Budzikowski, C. Mitre, O. Esan, T. Bustros, J. Kassotis (New York, US)
The noninvasive assessment of the effect of defibrillation on cardiac index in patients with heart failure
and implanted cardioverter-defibrillator.
– P. Krzesinski, D. Michalkiewicz, Z. Orski, K. Krzyzanowski, K. Makowski, G.G. Gielerak (Warsaw, PL)
Subcutaneous ICD - initial experience.
– P. Galvao Santos, D. Cavaco, P.P. Adragao, F. Morgado, K. Reis Santos, P. Carmo, F. Costa, M. Mendes
(Lisbon, PT)
DC cardioversion of atrial fibrillation for patients over 75 years: is it worth the energy?
– N. Child, G. Hunter, P. O’Kane, J. Paisey, R. Balasubramaniam, T. Levy (Southampton and Bournemouth,
GB)
Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular
hypertrophy according to age in the general population.
– D. Tsiachris, C. Chrysohoou, E. Oikonomou, G. Lazaros, K. Dimitriadis, D. Maragiannis, D. Roussos,
E. Christoforatou, C. Pitsavos, C. Stefanadis (Athens, GR)
Redefining the african 12-lead ECG: electrocardiographic findings in heart disease-free urban africans.
– K. Sliwa, G. Lee, M.J. Carrington, I.W.P. Obel, S. Pretorius, S. Stewart (Cape Town and Johannesburg, ZA;
Melbourne, AU)
Association of nocturnal dipping of heart rate, heart rate variability and cardiovascular mortality in
patients on chronic hemodialysis.
– T. Aoyama, H. Ishii, H. Takahashi, Y. Kumada, M. Tanaka, D. Kamoi, Y. Kawamura, K. Kawashima,
T. Murohara (Nagoya, JP)
Variations of J point elevation in the electrocardiogram of an apparently healthy caucasian population.
– S. Heng, E. Clark, P.W. Macfarlane (Glasgow, GB)
Configuration of P-wave morphology of lead V3-V6 in lower right atrial tachycardia.
– Y. Huo, S. Richter, B. Andrea, A. Arya, R. Schoenbauer, T. Gaspar, P. Sommer, U. Wetzel, G. Hindricks,
A. Bollmann (Leipzig, DE)
Electrocardiographic abnormalities and risk of development of severe cardiac involvement.
– S. Nagao, H. Watanabe, M. Kodama, J. Tanaka, E. Suzuki, I. Narita, Y. Aizawa (Niigata, JP)
The prevalence and significance of electrocardiographic abnormalities in a dilated cardiomyopathy
cohort characterised by cardiovascular magnetic resonance.
– A. Gulati, T. Ismail, N. Ismail, A. Jabbour, S. Raza, K. Morarji, A. Ali, F. Alpendurada, D. Pennell, S. Prasad
(London, GB)
T-wave alternans in apparently healthy subjects and in different subsets of patients with ischemic heart
disease.
– R. Mollo, I. Coviello, A. Spinelli, G. Pinnacchio, G. Careri, I. Battipaglia, A. Cosenza, F. Infusino, G.A. Lanza,
F. Crea (Rome, IT)
Validation of the clinical value of ECG algorithm in preablation location of arrhythmogenic foci in patients
with RVOT arrhythmias.
– M. Pytkowski, A. Maciag, A. Jankowska, I. Kowalik, A. Kraska, D. Luczak, M. Farkowski, H. Szwed
(Warsaw, PL)
Wide QRS tachycardias: comparison among two electrocardiographic algorithms. Is there a better
accuracy?
– F. Darrieux, E. Kaiser, S. Barbosa, J.C. Sousa, A.A. Carmo, R. Grinberg, S. Lara, D. Hachul,
M. Scanavacca, E. Sosa (São Paulo, BR)
Effect of primary percutaneous coronary intervention for acute myocardial infarction on deceleration
capacity of heart rate.
– A. Bauer, K. Rizas, C. Eick, C. Zuern, M. Gawaz (Tübingen, DE)
Spatial QRS-T angle is significantly increased in asymptomatic sarcoid patients with ventricular
arrhythmias.
– E. Gialafos, V. Kouranos, K. Aggeli, T. Papaioannou, A. Kalianos, S. Stampola, J. Arapis, A. Rapti,
J. Gialafos, C. Stefanadis (Athens, GR)
A study of QTc interval in healthy subjects with and without early repolarization.
– G.K. Panicker, D. Manohar, D.R. Karnad, V. Salvi, S.N. Kothari, Y.Y. Lokhandwala (Mumbai, IN)
Patients who increase troponin levels after transcatheter aortic valve implantation manifest distinct
electrocardiographic findings.
– M. Vavuranakis, C. Moldovan, T. Papaioannou, D. Brachatis, M. Kariori, C. Chrysochoou, G. Lazaros,
V. Voudris, S. Thomopoulou, C. Stefanadis (Athens, GR)
304
P5064
P5065
P5066
P5067
P5068
P5069
P5070
P5071
P5072
P5073
P5074
P5075
P5076
P5077
P5078
P5079
P5080
P5081
P5082
P5083
P5084
P5085
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
NEW INSIGHTS IN DRUGS AND MECHANISMS (QR 30618*)
*Abstracts can
be accessed at:
P5086
P5087
P5088
P5089
P5090
P5091
P5092
P5093
P5094
P5095
P5096
P5097
P5098
P5099
P5100
TUESDAY – AFTERNOON
Are dietary omega-3 fatty acids antiarrhythmic, proarrhythmic, both or neither?
– G.E. Billman, I.M. Bonilla, C.A. Carnes, W.S. Harris, E. Vanoli, P.B. Adamson, P.J. Schwartz (Columbus,
Sioux Falls and Oklahoma City, US; Pavia, IT)
Interest of hydroquinidine in asymptomatic Brugada patients with inducible VF.
– A. Bouzeman, S. Traulle, A. Messali, F. Extramiana, E. Marijon, J.S. Hermida, A. Leenhardt (Paris and
Amiens, FR)
Inhibition of sodium-calcium-exchanger by SEA0400 does not prevent irregular activity in an isolated
rabbit heart model of atrial fibrillation.
– G. Frommeyer, C. Pott, S. Ghezelbash, T. Uphaus, D. Kaiser, L. Eckardt, P. Milberg (Münster, DE)
Dronedarone exerts anti-thrombotic properties - a novel pleiotropic effect?
– A. Breitenstein, S. Sluka, A. Akhmedov, G.G. Camici, J. Steffel, F. Duru, T.F. Luscher, F.C. Tanner (Zurich,
CH)
Carvedilol targets human atrial-selective K2P3.1 (TASK1) potassium leak channels.
– D. Thomas, K. Staudacher, I. Staudacher, E. Ficker, C. Seyler, J. Gierten, J. Kisselbach, P.A. Schweizer,
H.A. Katus, R. Becker (Heidelberg, DE; Cleveland, US)
Evaluation of propafenone effectiveness and safety for the management of atrial fibrillation in patients
with chronic heart failure with preserved left ventricle ejection fraction.
– O. Miller, A. Tarasov, U. Pozdnyakov, S. Luchinsky, V. Doschitsyn, O. Reynbakh (Novosibirsk, Zhukovsky
and Moscow, RU)
Dronedarone in clinical routine use in patients with atrial arrhythmias.
– J. Salmas, S. John, J. Kornej, U. Wetzel, D. Husser, G. Hindricks, A. Bollmann (Leipzig, DE)
Effects of ranolazine on torsades de pointes in an isolated rabbit heart model.
– M. Zabel, J. Seegers, N. Wallisch (Göttingen, DE)
High levels of n-3 polyunsaturated fatty acids in cell membranes may increase risk of postoperative atrial
fibrillation - a potential proarrhythmic effect?
– L. Bjorgvinsdottir, D.O. Arnar, O.S. Indridason, R. Heidarsdottir, B. Torfason, R. Palsson, G.V. Skuladottir
(Reykjavik, IS)
Anti-arrhythmic effects of very low density lipoproteins.
– Y. Shao, A. Miljanovic, S. Gizurarson, T. Ramunddal, J. Boren, E. Omerovic (Gothenburg, SE)
Does the combination of therapeutic hypothermia and acute coronary angiography improve outcome.
– J. Bro-Jeppesen, J. Kjaergaard, F. Pedersen, M. Wanscher, S. Nielsen, J. Moller, C. Hassager
(Copenhagen, DK)
Differences in baseline electrophysiologic properties and electrical remodeling among pacemaker
patients who develop atrial tachyarrhythmias: results of the ASSERT mechanisms of atrial fibrillation St.
– J. Healey, C.W. Israel, S.J. Connolly, S.H. Hohnloser, G.M. Nair, A. Capucci, M.R. Gold, I.C. Van Gelder,
C.P. Lau, C.A. Morillo (Hamilton, CA; Frankfurt am Main, DE; Ancona, IT; Charleston, US; Groningen, NL;
Hong Kong, HK)
Targeting of heterocellular coupling in fibrotic neonatal rat myocardial cultures by lentiviral connexin43
knockdown is anti-arrhythmic.
– S.F. Askar, B.O. Bingen, J. Swildens, D.L. Ypey, A. Van Der Laarse, D.E. Atsma, A.A.F. De Vries,
M.J. Schalij, D.A. Pijnappels (Leiden, NL)
The hyperglycemia causes electrical and structural remodeling of ventricular myocardium in
heart/muscle-specific manganese superoxide dismutase -deficient mice model.
– S. Ishikawa, S. Niwano, H. Niwano, M. Murakami, Y. Masaki, T. Kosukegawa, S. Kurokawa, Y. Noda,
T. Shimizu, T. Izumi (Kanagawa and Tokyo, JP)
Effect of antiarrhythmic peptide on ventricular arrhythmia inducing by lysophosphatidic acid.
– T.J. Wang, Q. Zhou, C.T. Zhang, Y.J. Yang, R.D. Xu, L. Ruan (Beijing, Xiangfan and Wuhan, CN)
Predictors of regional atrial myocardial fibrosis: implications for obesity atrial fibrillation.
– H. Abed, A.J. Nelson, A. Carbone, M. Alasady, D.P. Leong, D. Kelly, S.G. Worthley, W.P. Abhayaratna,
G.A. Wittert, P. Sanders (Adelaide and Melbourne, AU)
A prospective study evaluating the efficacy of catheter ablation of atrial fibrillation in patients with
obstructive sleep apnoea syndrome.
– T. Neumann, D. Pajitnev, S. Zaltsberg, J. Schmitt, H. Greiss, A. Berkowitsch, C.W. Hamm, H.F. Pitschner,
M. Kuniss (Bad Nauheim, DE)
Dietary omega-3 fatty acids promote disturbances in intracellular calcium cycling in ventricular myocytes
isolated from post myocardial infarction hearts.
– G.E. Billman, A.E. Belevych, H.-T. Ho, D. Terentyev, I.M. Bonilla, W.S. Harris, C.A. Carnes, S. Gyorke
(Columbus and Sioux Falls, US)
Alterations in connexin and ion channel gene expression induced by autonomic stimulation: a potential
modulation factor of atrial remodeling?
– M.M. Oliveira, G. Postolache, V. Geraldes, J.P. Gomes, C. Tavares, S. Laranjo, R. Ferreira, I. Rocha
(Lisbon, PT)
Obesity-induced regional and global conduction disturbances predispose to atrial fibrillation, independent
of hemodynamic changes.
– H. Abed, P. Kuklik, A. Nelson, M. Alasady, D.H. Lau, D. Kelly, S.G. Worthley, W.P. Abhayaratna,
G.A. Wittert, P. Sanders (Adelaide and Melbourne, AU)
P5101
P5102
P5103
P5104
P5105
QR 30618
305
TUESDAY, 30 AUGUST 2011 – AFTERNOON POSTERS
Dynamic weight gain and atrial electrical remodelling: implications for atrial fibrillation.
– H. Abed, P. Kuklik, A. Brooks, D. Kelly, D. Lau, M. Alasady, W.P. Abhayaratna, G.A. Wittert, P. Sanders
(Adelaide, Melbourne and Canberra, AU)
The impact of hypertension on the electroanatomical characteristics of patients with atrial fibrillation.
– T. Wang, Y.L. Xia, Z.Z. Xie, S.L. Zhang, L.J. Gao, Y.Z. Yang (Dalian, CN)
LDL-cholesterol destabilizes calcium handling in cultured atrial myocytes by reducing connexin-40
expression and slowing the conduction velocity of the calcium signal.
– M. Barriga, R. Cal, A. Llach, L. Badimon, J. Cinca, V. Llorente-Cortes, L. Hove-Madsen (Barcelona, ES)
Blockade of the Na+/Ca2+ exchange system with KB-R7943 and of the beta-adrenergic receptor with
propranolol decreases myocardial electrophysiological heterogeneity produced by acute local stretching.
– L. Such-Miquel, F.J. Chorro-Gasco, I. Trapero, M. Zarzoso, G. Parra, L. Brines, J. Canoves, F. Pelechano,
A. Alberola, L. Such (Valencia, ES)
306
P5106
P5107
P5108
P5109